data_2l5n_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l5n _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 . . . . . 0 N--CA 1.471 0.621 0 CA-C-O 121.213 0.53 . . . . 1.0 111.822 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -55.73 137.32 71.32 Favored Pre-proline 0 CA--C 1.549 0.926 0 O-C-N 121.848 -0.532 . . . . 1.0 112.007 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -72.82 142.0 34.61 Favored 'Trans proline' 0 N--CA 1.503 2.039 0 C-N-CA 122.347 2.031 . . . . 1.0 112.953 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.5 m -113.92 94.78 4.98 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 121.514 0.673 . . . . 1.0 110.013 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 66.4 mt -109.73 143.43 39.52 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.791 0.805 . . . . 1.0 110.394 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.9 t -102.08 133.26 47.19 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.949 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.522 ' N ' ' CD2' ' A' ' 13' ' ' LEU . 0.9 OUTLIER -108.87 139.9 43.08 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.618 0.723 . . . . 1.0 110.457 -179.695 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.1 m -74.55 109.8 8.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.899 -0.591 . . . . 1.0 109.869 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.7 tp -69.41 106.56 2.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.406 0.622 . . . . 1.0 110.878 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.4 pt -111.04 142.29 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-O 121.811 0.815 . . . . 1.0 110.857 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.67 127.13 33.93 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.85 -0.531 . . . . 1.0 111.058 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -115.73 162.13 17.72 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 120.952 0.406 . . . . 1.0 110.201 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 22.4 m120 57.47 34.77 25.07 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.94 -0.393 . . . . 1.0 109.94 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 49.4 m -60.21 114.68 10.54 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-O 119.089 -0.482 . . . . 1.0 111.528 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.8 149.83 18.79 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 121.533 1.489 . . . . 1.0 112.01 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.91 145.1 42.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 122.041 0.924 . . . . 1.0 111.374 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.2 m-20 64.14 18.48 11.28 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.945 -0.571 . . . . 1.0 111.093 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.5 t -110.66 147.17 34.86 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.948 0.88 . . . . 1.0 110.658 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 61.4 ttp -139.12 116.15 10.96 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.624 -0.716 . . . . 1.0 109.982 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 59.0 mt -69.71 149.4 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.978 0.894 . . . . 1.0 110.532 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.515 ' O ' ' OG1' ' A' ' 28' ' ' THR . 1.1 tpt -118.74 63.78 0.77 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.766 0.793 . . . . 1.0 109.58 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.515 ' OG1' ' O ' ' A' ' 27' ' ' MET . 33.7 m -178.02 146.59 0.42 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.104 -0.702 . . . . 1.0 109.104 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -85.04 151.41 24.18 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.295 -0.878 . . . . 1.0 110.444 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 mp -103.79 105.41 47.82 Favored Pre-proline 0 N--CA 1.482 1.166 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.894 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -87.78 152.09 7.36 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.374 2.05 . . . . 1.0 112.688 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 63.0 p -59.19 -179.02 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.653 -0.655 . . . . 1.0 111.19 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.6 p -139.65 144.93 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-O 121.264 0.554 . . . . 1.0 111.077 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 82.3 mtt85 -99.99 125.18 45.98 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.385 -0.598 . . . . 1.0 109.385 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 t -124.23 153.47 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-O 122.557 1.17 . . . . 1.0 111.189 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -124.7 138.16 54.31 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 114.968 -1.015 . . . . 1.0 110.6 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 51.5 p -125.51 131.85 52.73 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.754 -0.657 . . . . 1.0 111.3 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -77.99 47.53 0.65 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.473 0.654 . . . . 1.0 109.886 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.401 ' O ' ' CD1' ' A' ' 40' ' ' TYR . . . -149.53 -169.24 15.72 Favored Glycine 0 N--CA 1.466 0.645 0 N-CA-C 110.572 -1.011 . . . . 1.0 110.572 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.401 ' CD1' ' O ' ' A' ' 39' ' ' GLY . 0.8 OUTLIER -142.36 108.73 5.29 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.264 0.554 . . . . 1.0 110.232 -179.499 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -119.69 84.35 30.64 Favored Pre-proline 0 N--CA 1.474 0.733 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.475 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -56.3 -19.3 27.49 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.305 2.003 . . . . 1.0 111.862 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.2 t -145.31 -101.71 0.1 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.997 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.1 mm 58.8 37.97 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.856 -0.424 . . . . 1.0 109.856 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 39.45 70.9 0.19 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.89 0.376 . . . . 1.0 111.266 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.1 m -56.23 -14.52 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.048 0.452 . . . . 1.0 110.784 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 48' ' ' GLU . 22.2 p30 -58.94 -33.81 71.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.312 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.494 ' N ' ' OD1' ' A' ' 47' ' ' ASN . 74.6 tt0 -91.0 63.64 5.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.996 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 69.1 mt -148.37 110.68 4.65 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.441 0.638 . . . . 1.0 109.995 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -143.31 156.55 44.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 122.054 0.93 . . . . 1.0 111.865 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -115.78 140.87 48.8 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.82 -1.082 . . . . 1.0 108.416 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 16.7 p90 -141.24 144.62 34.81 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 122.082 0.944 . . . . 1.0 112.24 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.4 m -105.53 156.09 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 114.857 -1.065 . . . . 1.0 108.947 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -97.19 142.8 28.67 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.454 0.645 . . . . 1.0 110.523 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.617 ' C ' ' H ' ' A' ' 57' ' ' GLY . 79.6 mt -131.35 40.46 3.43 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.648 -0.705 . . . . 1.0 110.377 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.7 m -60.01 14.24 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.901 -0.59 . . . . 1.0 111.982 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.617 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . -148.3 159.17 27.94 Favored Glycine 0 N--CA 1.466 0.689 0 N-CA-C 110.444 -1.062 . . . . 1.0 110.444 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.5 t -148.24 130.5 15.57 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.577 0.703 . . . . 1.0 110.976 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.638 ' O ' ' N ' ' A' ' 61' ' ' GLY . 2.1 mt-10 179.91 123.1 0.22 Allowed Pre-proline 0 CA--C 1.55 0.943 0 CA-C-N 115.677 -0.692 . . . . 1.0 110.657 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -45.57 71.42 0.01 OUTLIER 'Trans proline' 0 N--CA 1.511 2.531 0 C-N-CA 122.524 2.149 . . . . 1.0 113.939 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.638 ' N ' ' O ' ' A' ' 59' ' ' GLU . . . -145.27 155.68 26.6 Favored Glycine 0 N--CA 1.47 0.951 0 N-CA-C 110.349 -1.1 . . . . 1.0 110.349 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -86.09 87.1 7.36 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 122.302 -0.529 . . . . 1.0 109.768 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.505 ' ND1' ' CE1' ' A' ' 65' ' ' TYR . 61.1 t-80 -92.38 137.51 32.31 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.548 0.69 . . . . 1.0 112.342 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -90.42 115.93 27.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.623 -0.717 . . . . 1.0 109.212 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.505 ' CE1' ' ND1' ' A' ' 63' ' ' HIS . 71.1 m-85 -104.75 135.22 46.54 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.878 0.847 . . . . 1.0 111.455 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -81.06 142.09 33.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.899 -1.046 . . . . 1.0 111.252 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.9 t -74.94 117.5 19.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.373 0.606 . . . . 1.0 110.417 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -106.73 114.8 29.12 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 122.334 1.064 . . . . 1.0 109.886 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.3 t -85.52 169.27 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 115.57 -0.741 . . . . 1.0 110.871 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -94.4 111.8 55.11 Favored Pre-proline 0 CA--C 1.553 1.09 0 CA-C-N 115.668 -0.696 . . . . 1.0 109.833 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -48.09 131.3 21.53 Favored 'Trans proline' 0 N--CA 1.506 2.217 0 C-N-CA 121.782 1.654 . . . . 1.0 112.859 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.8 mt -99.54 109.51 55.42 Favored Pre-proline 0 CA--C 1.554 1.099 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.792 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.97 55.63 3.43 Favored 'Trans proline' 0 N--CA 1.506 2.246 0 C-N-CA 122.069 1.846 . . . . 1.0 113.095 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -175.09 -44.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.242 0.544 . . . . 1.0 110.882 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.545 ' CG2' ' H ' ' A' ' 76' ' ' LYS . 63.7 mt -112.63 174.22 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-O 121.559 0.695 . . . . 1.0 110.114 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.545 ' H ' ' CG2' ' A' ' 75' ' ' ILE . 60.5 tttp -117.83 156.44 28.37 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 122.583 1.182 . . . . 1.0 111.238 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.9 tt -99.39 153.17 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 115.367 -0.833 . . . . 1.0 109.966 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.9 t -108.14 -49.68 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 122.142 -0.349 . . . . 1.0 110.665 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -179.69 -175.99 0.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 122.316 1.055 . . . . 1.0 110.52 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.404 HG23 ' H ' ' A' ' 81' ' ' SER . 3.4 mt -129.86 167.42 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 122.15 0.976 . . . . 1.0 109.307 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.404 ' H ' HG23 ' A' ' 80' ' ' ILE . 33.7 t -167.04 106.09 0.63 Allowed Pre-proline 0 CA--C 1.554 1.131 0 CA-C-O 118.438 -0.791 . . . . 1.0 111.452 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -62.39 -173.78 2.74 Favored 'Cis proline' 0 N--CA 1.507 2.283 0 CA-C-N 120.191 1.104 . . . . 1.0 111.528 -0.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -118.54 -23.51 7.11 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.516 0.674 . . . . 1.0 109.191 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 t -144.36 149.85 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.1 m -136.39 157.11 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-O 121.75 0.786 . . . . 1.0 111.567 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 71.7 m -109.1 119.13 38.6 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.174 -0.921 . . . . 1.0 110.613 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.8 mt -122.7 126.22 47.14 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.701 -0.682 . . . . 1.0 110.222 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -83.64 130.52 34.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.587 0.708 . . . . 1.0 110.255 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -104.02 136.15 44.19 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.652 0.739 . . . . 1.0 110.297 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -138.1 140.45 39.97 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.331 1.063 . . . . 1.0 111.053 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -67.18 167.33 12.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.842 -1.072 . . . . 1.0 110.644 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 . . . . . 0 N--CA 1.473 0.686 0 CA-C-O 121.653 0.739 . . . . 1.0 110.972 -179.667 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 112.793 0.664 . . . . 1.0 112.793 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.32 118.14 50.36 Favored Pre-proline 0 CA--C 1.549 0.908 0 O-C-N 121.85 -0.531 . . . . 1.0 112.159 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.47 141.79 35.57 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 CA-C-N 120.404 1.18 . . . . 1.0 113.392 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.1 m -107.36 157.4 17.98 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.575 0.702 . . . . 1.0 110.024 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.09 139.41 28.89 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.445 0.64 . . . . 1.0 110.428 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.3 m -123.5 120.19 32.16 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.509 0.671 . . . . 1.0 110.571 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 35.7 mt -130.52 134.08 46.77 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.454 -0.794 . . . . 1.0 110.027 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.5 m -58.67 179.58 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.6 tp -120.33 112.99 19.71 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-O 121.602 0.715 . . . . 1.0 111.043 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.5 pt -116.78 154.26 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-O 121.809 0.814 . . . . 1.0 110.763 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.82 125.56 41.35 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.806 -0.559 . . . . 1.0 110.536 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.483 ' O ' ' O ' ' A' ' 19' ' ' ASN . 63.9 tttm -119.7 137.68 53.76 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.615 0.721 . . . . 1.0 109.707 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 18' ' ' LYS . 82.3 m-20 43.53 100.84 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.993 -0.549 . . . . 1.0 110.876 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.3 m -136.55 132.43 18.7 Favored Pre-proline 0 N--CA 1.479 0.979 0 CA-C-O 119.45 -0.31 . . . . 1.0 111.577 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -36.84 95.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 121.641 1.561 . . . . 1.0 112.541 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -39.33 161.79 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.53 0.681 . . . . 1.0 111.869 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 72.61 12.19 5.47 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 122.006 -0.433 . . . . 1.0 110.746 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.7 p -133.51 153.75 51.38 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.745 0.783 . . . . 1.0 110.661 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 47.8 ttp -143.74 138.6 28.93 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.46 0.647 . . . . 1.0 110.184 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 69.9 mt -75.02 154.12 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.611 0.72 . . . . 1.0 111.047 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.6 ttt -107.13 -28.01 10.24 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 121.391 0.615 . . . . 1.0 109.859 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.0 m -64.75 138.2 58.24 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.575 -0.528 . . . . 1.0 109.575 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -66.99 -6.74 18.14 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.287 -0.883 . . . . 1.0 111.261 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.2 mt 59.38 95.24 0.05 OUTLIER Pre-proline 0 CA--C 1.548 0.868 0 CA-C-O 118.736 -0.649 . . . . 1.0 111.864 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -85.99 154.91 9.87 Favored 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 122.649 2.233 . . . . 1.0 112.744 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.6 m -57.89 175.59 0.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.614 -0.679 . . . . 1.0 111.26 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.6 m -132.59 133.46 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-O 121.317 0.58 . . . . 1.0 111.091 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -104.98 126.84 52.48 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -130.07 155.63 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 122.163 0.982 . . . . 1.0 111.2 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -119.52 138.8 52.94 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.426 -0.807 . . . . 1.0 110.165 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.5 p -129.97 141.93 50.7 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 115.855 -0.611 . . . . 1.0 110.723 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -82.77 164.23 20.75 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.719 -0.474 . . . . 1.0 109.719 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.51 -157.88 18.13 Favored Glycine 0 N--CA 1.472 1.07 0 N-CA-C 110.827 -0.909 . . . . 1.0 110.827 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -152.77 98.79 2.38 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.471 0.653 . . . . 1.0 110.829 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.46 ' C ' ' H ' ' A' ' 43' ' ' SER . 0.1 OUTLIER -174.42 75.08 0.34 Allowed Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.497 179.743 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.4 38.88 0.35 Allowed 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 121.691 1.594 . . . . 1.0 111.86 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.46 ' H ' ' C ' ' A' ' 41' ' ' ASN . 38.7 m -170.11 97.14 0.28 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.413 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.1 mt -127.96 53.56 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 109.805 -0.442 . . . . 1.0 109.805 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.552 ' C ' ' H ' ' A' ' 47' ' ' ASN . 4.7 p-10 39.43 56.98 2.17 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.499 -0.319 . . . . 1.0 111.235 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.3 m -70.14 35.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.052 0.453 . . . . 1.0 111.098 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.552 ' H ' ' C ' ' A' ' 45' ' ' ASN . 70.9 m-20 -59.97 -24.18 64.2 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.295 -0.412 . . . . 1.0 110.577 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.513 ' O ' ' C ' ' A' ' 49' ' ' LEU . 96.4 mt-10 -124.38 -54.85 1.67 Allowed 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.934 -0.576 . . . . 1.0 110.009 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.513 ' C ' ' O ' ' A' ' 48' ' ' GLU . 9.1 mp -25.42 113.7 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.074 0.464 . . . . 1.0 110.845 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -141.76 -171.86 3.43 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.898 0.856 . . . . 1.0 111.551 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.455 ' O ' ' CG ' ' A' ' 52' ' ' TYR . . . -93.19 158.02 15.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.928 -1.033 . . . . 1.0 108.321 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.455 ' CG ' ' O ' ' A' ' 51' ' ' ALA . 91.8 m-85 -153.6 157.84 40.29 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 122.273 1.035 . . . . 1.0 111.889 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.3 147.22 22.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 114.64 -1.164 . . . . 1.0 109.357 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.402 ' N ' ' OD1' ' A' ' 54' ' ' ASP . 23.0 p-10 -115.88 106.23 13.58 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.452 0.644 . . . . 1.0 110.606 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.524 ' C ' ' H ' ' A' ' 57' ' ' GLY . 24.4 mt -104.77 32.77 3.93 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.802 -0.635 . . . . 1.0 110.179 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 88.9 p -62.4 8.71 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.849 -0.614 . . . . 1.0 111.859 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.524 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . -88.88 -168.73 44.18 Favored Glycine 0 N--CA 1.47 0.959 0 N-CA-C 110.84 -0.904 . . . . 1.0 110.84 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 82.0 p -162.41 76.71 0.47 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.413 0.625 . . . . 1.0 111.446 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -138.13 88.03 15.68 Favored Pre-proline 0 N--CA 1.472 0.666 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.589 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -48.09 108.76 0.19 Allowed 'Trans proline' 0 N--CA 1.504 2.11 0 C-N-CA 122.364 2.043 . . . . 1.0 112.775 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.74 -165.04 25.41 Favored Glycine 0 N--CA 1.47 0.909 0 N-CA-C 110.343 -1.103 . . . . 1.0 110.343 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.477 ' CD ' ' H ' ' A' ' 62' ' ' GLU . 0.9 OUTLIER -71.77 142.89 49.7 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.261 -0.552 . . . . 1.0 109.641 179.477 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.45 ' O ' ' CD1' ' A' ' 65' ' ' TYR . 62.7 t-80 -161.12 126.02 3.6 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.149 -0.62 . . . . 1.0 112.45 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -77.24 117.32 18.65 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.806 -0.813 . . . . 1.0 108.806 178.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.45 ' CD1' ' O ' ' A' ' 63' ' ' HIS . 91.4 m-85 -94.38 -122.77 0.1 Allowed 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.985 -0.447 . . . . 1.0 111.821 -178.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -160.3 130.68 5.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.127 0.489 . . . . 1.0 110.732 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.7 t -92.94 115.94 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.122 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -142.27 151.83 42.42 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.742 0.782 . . . . 1.0 110.487 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.6 t -134.63 157.39 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-O 121.405 0.622 . . . . 1.0 111.201 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -58.26 147.28 67.6 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 115.575 -0.738 . . . . 1.0 110.681 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -73.64 162.08 40.56 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 121.892 1.728 . . . . 1.0 112.417 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.84 101.41 12.82 Favored Pre-proline 0 N--CA 1.48 1.048 0 CA-C-N 115.3 -0.864 . . . . 1.0 110.526 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -50.04 140.33 32.33 Favored 'Trans proline' 0 N--CA 1.502 2.026 0 C-N-CA 121.31 1.34 . . . . 1.0 113.064 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.432 ' N ' ' ND2' ' A' ' 74' ' ' ASN . 1.1 m120 78.88 -11.9 1.15 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.555 0.742 . . . . 1.0 111.318 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 42.9 mm -125.96 153.17 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 122.276 1.036 . . . . 1.0 110.006 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -121.65 158.5 28.53 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 122.751 1.262 . . . . 1.0 110.735 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.6 tt -99.3 95.88 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 115.125 -0.943 . . . . 1.0 109.813 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.7 t -44.91 -53.48 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 O-C-N 121.975 -0.453 . . . . 1.0 110.893 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -167.8 -146.2 0.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.685 0.755 . . . . 1.0 110.559 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.9 mt -148.63 157.18 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 109.238 -0.653 . . . . 1.0 109.238 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 82' ' ' PRO . 43.3 t -163.17 101.05 1.0 Allowed Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 118.434 -0.793 . . . . 1.0 111.672 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.474 ' O ' ' N ' ' A' ' 81' ' ' SER . 24.0 Cg_exo -63.97 -166.31 1.35 Allowed 'Cis proline' 0 N--CA 1.511 2.541 0 CA-C-N 120.134 1.083 . . . . 1.0 111.393 -0.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -129.81 -18.7 3.4 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.446 0.641 . . . . 1.0 109.512 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.2 t -142.86 135.7 25.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.889 -0.782 . . . . 1.0 108.889 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.9 m -130.65 146.34 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-O 121.841 0.829 . . . . 1.0 111.376 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.0 t -106.29 131.99 52.86 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.071 -0.968 . . . . 1.0 110.49 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 35.1 mt -134.26 126.2 29.32 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.056 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -91.7 122.11 33.96 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.484 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.7 mt -93.43 140.69 29.3 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.415 0.626 . . . . 1.0 109.972 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -133.06 144.68 50.17 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.954 0.883 . . . . 1.0 111.2 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -69.67 144.56 52.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.195 -0.911 . . . . 1.0 110.809 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 121.634 0.73 . . . . 1.0 110.81 -179.706 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 . . . . . 0 CA--C 1.535 0.396 0 CA-C-O 120.819 0.342 . . . . 1.0 111.641 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 40.03 84.36 0.18 Allowed Pre-proline 0 CA--C 1.538 0.499 0 O-C-N 121.833 -0.542 . . . . 1.0 112.119 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.35 135.17 64.53 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.3 2.0 . . . . 1.0 112.954 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 68.2 m -127.96 122.56 32.65 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.679 0.752 . . . . 1.0 109.827 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.4 mt -137.02 164.66 27.84 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.647 0.737 . . . . 1.0 110.509 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.2 m -101.54 128.35 47.83 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.348 0.594 . . . . 1.0 110.282 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 tp -123.4 153.56 40.22 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.61 -0.723 . . . . 1.0 110.227 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.442 ' HG ' ' N ' ' A' ' 15' ' ' LEU . 47.1 t -106.18 152.24 23.72 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.03 0.443 . . . . 1.0 109.906 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.442 ' N ' ' HG ' ' A' ' 14' ' ' SER . 1.5 pp -119.71 117.48 28.36 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.353 0.596 . . . . 1.0 111.035 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.3 pt -110.99 163.08 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-O 121.724 0.773 . . . . 1.0 110.713 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.76 116.46 24.04 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.89 -0.506 . . . . 1.0 110.944 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.5 mmtt -61.15 -32.67 72.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.91 0.386 . . . . 1.0 110.68 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -144.54 76.06 1.48 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.133 0.492 . . . . 1.0 110.252 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.1 m -60.47 116.07 16.33 Favored Pre-proline 0 CA--C 1.554 1.119 0 CA-C-O 118.873 -0.584 . . . . 1.0 111.385 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.96 138.17 52.35 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 120.926 1.084 . . . . 1.0 111.846 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.47 152.5 43.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.922 0.868 . . . . 1.0 111.592 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.4 m-20 69.08 6.28 5.56 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.097 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.0 p -100.73 145.64 28.22 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.61 0.719 . . . . 1.0 110.785 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -136.61 116.4 13.09 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.506 0.67 . . . . 1.0 110.332 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 65.7 mt -69.32 148.43 11.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.828 0.823 . . . . 1.0 110.828 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 46.9 mtt -114.23 -35.67 4.93 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.677 -0.692 . . . . 1.0 109.935 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.6 m -79.78 147.92 31.64 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.498 -0.556 . . . . 1.0 109.498 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -78.68 150.9 32.47 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.289 -0.882 . . . . 1.0 110.069 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 tp -76.39 112.7 22.84 Favored Pre-proline 0 CA--C 1.557 1.214 0 CA-C-N 115.678 -0.692 . . . . 1.0 111.983 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -90.53 151.7 4.33 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 121.456 1.437 . . . . 1.0 112.567 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.3 p -84.03 170.16 14.2 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.618 -0.676 . . . . 1.0 110.834 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.2 p -135.88 136.54 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 121.558 0.694 . . . . 1.0 110.949 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 42.4 mtm105 -98.24 130.99 44.95 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.929 -0.578 . . . . 1.0 109.464 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 t -124.24 128.59 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 121.963 0.887 . . . . 1.0 111.428 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -97.43 153.33 18.18 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.534 -0.757 . . . . 1.0 110.341 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 16.1 p -131.9 133.08 44.19 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.166 0.507 . . . . 1.0 111.315 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -80.75 47.04 0.93 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.245 0.545 . . . . 1.0 109.648 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.54 -171.71 34.65 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 110.558 -1.017 . . . . 1.0 110.558 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.53 ' CD2' ' N ' ' A' ' 41' ' ' ASN . 62.4 t80 -107.6 164.36 12.29 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.473 0.654 . . . . 1.0 110.636 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.53 ' N ' ' CD2' ' A' ' 40' ' ' TYR . 4.8 p30 -114.3 90.76 21.47 Favored Pre-proline 0 N--CA 1.477 0.923 0 CA-C-N 116.147 -0.478 . . . . 1.0 111.056 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -50.78 -41.5 54.49 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 121.746 1.631 . . . . 1.0 112.025 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.9 t -171.27 42.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.576 0.227 . . . . 1.0 110.732 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.7 tt -58.64 126.77 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.978 0.418 . . . . 1.0 110.415 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.522 ' C ' ' H ' ' A' ' 47' ' ' ASN . 44.6 p-10 -99.96 86.13 3.2 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.947 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.9 m -72.25 33.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.99 0.424 . . . . 1.0 110.675 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.522 ' H ' ' C ' ' A' ' 45' ' ' ASN . 71.5 m-80 -100.99 -10.22 20.76 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.311 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -131.53 1.84 4.11 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.469 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.608 ' O ' ' CG ' ' A' ' 50' ' ' PHE . 51.1 mt -95.81 154.85 17.01 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.608 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 70.3 m-85 -165.72 174.21 9.96 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.795 0.807 . . . . 1.0 111.694 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.432 ' C ' ' CG ' ' A' ' 52' ' ' TYR . . . -111.64 169.94 8.47 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.052 -0.976 . . . . 1.0 108.431 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.432 ' CG ' ' C ' ' A' ' 51' ' ' ALA . 22.8 m-85 -151.23 169.58 21.58 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 122.181 0.991 . . . . 1.0 112.134 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.3 m -136.26 144.77 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 114.73 -1.123 . . . . 1.0 109.496 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -85.58 83.49 7.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.404 0.621 . . . . 1.0 110.374 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 57' ' ' GLY . 1.2 mp -94.15 -26.8 16.54 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.603 -0.726 . . . . 1.0 109.769 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 55' ' ' LEU . 47.5 t 29.61 -90.26 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.644 0.735 . . . . 1.0 112.336 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . -129.07 71.49 0.49 Allowed Glycine 0 N--CA 1.472 1.06 0 N-CA-C 111.039 -0.824 . . . . 1.0 111.039 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.479 ' HG ' ' N ' ' A' ' 59' ' ' GLU . 27.8 t -83.26 163.41 20.74 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.728 0.775 . . . . 1.0 111.343 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.479 ' N ' ' HG ' ' A' ' 58' ' ' SER . 36.5 mp0 -130.93 148.75 71.5 Favored Pre-proline 0 N--CA 1.48 1.062 0 CA-C-N 115.593 -0.73 . . . . 1.0 111.255 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -39.79 144.06 0.37 Allowed 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 122.064 1.843 . . . . 1.0 113.387 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 142.27 -137.68 8.02 Favored Glycine 0 N--CA 1.468 0.809 0 N-CA-C 110.517 -1.033 . . . . 1.0 110.517 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -140.09 69.93 1.36 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.322 0.582 . . . . 1.0 109.553 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -93.03 130.84 38.48 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.09 -0.505 . . . . 1.0 112.124 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -82.41 142.01 32.3 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.117 -0.697 . . . . 1.0 109.117 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -133.2 136.45 45.66 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.753 0.787 . . . . 1.0 111.675 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -73.19 135.78 44.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.07 -0.968 . . . . 1.0 111.485 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.83 129.02 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.173 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -121.01 149.58 42.45 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.816 0.817 . . . . 1.0 110.513 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.1 t -124.54 137.54 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 115.978 -0.555 . . . . 1.0 111.316 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -63.05 115.24 16.08 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-O 118.483 -0.77 . . . . 1.0 110.26 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.8 136.17 42.82 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 CA-C-N 120.281 1.136 . . . . 1.0 113.032 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.5 mp -91.73 115.99 65.61 Favored Pre-proline 0 CA--C 1.553 1.07 0 CA-C-N 115.481 -0.781 . . . . 1.0 110.442 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -50.41 134.66 39.07 Favored 'Trans proline' 0 N--CA 1.506 2.226 0 C-N-CA 120.968 1.112 . . . . 1.0 113.496 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 67.59 4.87 4.05 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.417 0.687 . . . . 1.0 111.436 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.4 mm -138.26 154.36 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 122.319 1.057 . . . . 1.0 109.721 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -127.34 165.47 19.67 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 122.425 1.107 . . . . 1.0 111.074 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.8 pt -118.49 121.5 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 115.471 -0.786 . . . . 1.0 109.887 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 80.2 t -56.1 -50.58 69.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 O-C-N 122.086 -0.384 . . . . 1.0 110.378 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 177.67 147.61 0.14 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 122.198 0.999 . . . . 1.0 110.418 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 16.3 pt -84.52 172.1 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.347 -0.842 . . . . 1.0 109.789 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 t -178.26 119.13 0.25 Allowed Pre-proline 0 CA--C 1.552 1.027 0 CA-C-O 117.941 -1.028 . . . . 1.0 111.438 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -65.38 141.22 48.09 Favored 'Cis proline' 0 N--CA 1.509 2.411 0 CA-C-N 120.657 1.27 . . . . 1.0 111.444 -1.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -76.58 -18.02 58.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.769 0.795 . . . . 1.0 109.546 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.2 t -137.01 143.96 33.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.937 -0.764 . . . . 1.0 108.937 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.9 m -135.24 160.15 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.832 0.825 . . . . 1.0 111.469 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 58.1 m -116.08 130.2 56.69 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.021 -0.99 . . . . 1.0 110.365 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 83.0 mt -134.62 123.15 23.33 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.681 -0.691 . . . . 1.0 110.034 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -93.69 123.9 37.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.497 0.665 . . . . 1.0 110.145 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 64.9 mt -105.76 157.61 17.32 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.657 -0.701 . . . . 1.0 110.129 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -145.89 138.13 25.4 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.606 0.717 . . . . 1.0 111.023 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -69.49 143.46 53.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.564 -0.744 . . . . 1.0 110.324 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 86.0 t60 . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 121.53 0.681 . . . . 1.0 111.019 -179.823 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 54.8 mmm-85 . . . . . 0 N--CA 1.477 0.886 0 CA-C-O 121.661 0.743 . . . . 1.0 111.702 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 41.57 97.23 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 123.36 0.664 . . . . 1.0 112.0 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.6 140.98 54.32 Favored 'Trans proline' 0 N--CA 1.498 1.783 0 C-N-CA 122.403 2.069 . . . . 1.0 113.111 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 71.4 m -129.52 107.85 9.79 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.528 0.68 . . . . 1.0 110.228 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 60.5 mt -110.61 159.67 17.36 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.795 0.807 . . . . 1.0 110.439 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.9 m -119.58 120.67 37.4 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.538 0.685 . . . . 1.0 110.72 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.8 132.56 53.33 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.419 -0.81 . . . . 1.0 110.093 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.0 m -65.33 160.04 22.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.075 -0.511 . . . . 1.0 109.863 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.2 tp -113.44 126.91 55.86 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.5 0.667 . . . . 1.0 110.856 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.5 pt -117.53 179.75 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.707 0.765 . . . . 1.0 111.017 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.69 115.27 29.27 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.284 0.564 . . . . 1.0 111.197 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -113.44 166.23 11.7 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.321 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 48.8 26.83 1.38 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.875 0.369 . . . . 1.0 110.015 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.9 m -63.94 129.7 94.04 Favored Pre-proline 0 CA--C 1.547 0.843 0 CA-C-O 119.057 -0.497 . . . . 1.0 112.175 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.28 141.28 56.18 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 121.753 1.635 . . . . 1.0 111.427 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.41 149.08 49.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 122.125 0.964 . . . . 1.0 111.232 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 74.41 6.22 4.59 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.881 -0.6 . . . . 1.0 111.195 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.6 p -113.21 146.4 39.37 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.794 0.807 . . . . 1.0 110.745 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 24.6 ptm -142.6 139.9 31.49 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.518 0.675 . . . . 1.0 110.14 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 75.6 mt -88.33 145.81 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.697 0.761 . . . . 1.0 111.027 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 20.8 ttt -111.83 -23.5 10.54 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.781 -0.645 . . . . 1.0 109.511 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.534 ' HG1' ' H ' ' A' ' 88' ' ' GLN . 24.1 p -87.7 121.95 30.76 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.501 0.667 . . . . 1.0 109.242 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -63.84 141.47 58.76 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.271 -0.893 . . . . 1.0 110.869 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.401 ' N ' ' CD1' ' A' ' 30' ' ' LEU . 10.7 mp -81.56 118.09 70.8 Favored Pre-proline 0 CA--C 1.554 1.123 0 N-CA-C 112.238 0.459 . . . . 1.0 112.238 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -86.2 162.79 9.98 Favored 'Trans proline' 0 N--CA 1.501 1.957 0 C-N-CA 122.383 2.056 . . . . 1.0 112.793 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 56.5 m -70.44 168.52 15.97 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.563 -0.711 . . . . 1.0 111.259 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.9 p -136.82 139.11 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-O 121.427 0.632 . . . . 1.0 111.116 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 80' ' ' ILE . 1.6 mpt_? -102.38 124.41 47.89 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.134 -0.691 . . . . 1.0 109.134 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.5 t -120.33 125.69 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 122.0 0.905 . . . . 1.0 111.132 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -98.59 147.04 25.21 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.288 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 70.4 p -129.39 131.28 46.78 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.492 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -53.78 -72.52 0.06 Allowed 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.723 0.773 . . . . 1.0 110.139 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.21 -171.93 0.09 OUTLIER Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.009 -0.837 . . . . 1.0 111.009 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -106.24 175.89 5.35 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.658 0.742 . . . . 1.0 110.944 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -136.42 74.28 54.4 Favored Pre-proline 0 N--CA 1.472 0.644 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.644 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -52.09 -37.72 69.17 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 C-N-CA 122.29 1.993 . . . . 1.0 111.892 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 44' ' ' ILE . 70.8 m -146.55 -97.69 0.09 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.383 -0.372 . . . . 1.0 110.832 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 43' ' ' SER . 68.7 mt 59.12 128.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.897 0.38 . . . . 1.0 110.086 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.524 ' ND2' ' N ' ' A' ' 45' ' ' ASN . 0.1 OUTLIER -56.34 90.64 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.194 0.521 . . . . 1.0 110.772 -179.847 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.1 t -57.11 -17.05 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.017 0.437 . . . . 1.0 110.867 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -83.17 12.22 5.46 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.395 0.617 . . . . 1.0 110.182 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -132.93 54.86 1.93 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.205 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 85.4 mt -144.03 110.33 5.47 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.974 -0.557 . . . . 1.0 109.721 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -147.79 157.4 43.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 122.022 0.915 . . . . 1.0 111.791 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -119.25 139.39 51.96 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.871 -1.059 . . . . 1.0 108.433 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -117.56 168.39 10.45 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 122.536 1.16 . . . . 1.0 112.1 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.3 m -123.93 139.32 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 114.458 -1.246 . . . . 1.0 109.367 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.486 ' C ' ' H ' ' A' ' 56' ' ' SER . 40.0 p-10 -99.79 78.49 2.14 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.565 0.697 . . . . 1.0 110.484 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 56' ' ' SER . 23.9 mt -71.86 45.94 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.539 -0.755 . . . . 1.0 109.844 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.486 ' H ' ' C ' ' A' ' 54' ' ' ASP . 14.6 m -57.55 -142.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.329 0.585 . . . . 1.0 111.16 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.497 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . 30.75 -112.94 0.05 OUTLIER Glycine 0 N--CA 1.472 1.067 0 N-CA-C 111.121 -0.792 . . . . 1.0 111.121 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 1.9 p 154.55 -5.21 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 115.632 -0.284 . . . . 1.0 111.354 178.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.557 ' CD ' ' H ' ' A' ' 59' ' ' GLU . 8.6 mp0 -37.91 95.86 0.1 Allowed Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 111.762 0.282 . . . . 1.0 111.762 -178.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -62.64 138.47 70.02 Favored 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 122.483 2.122 . . . . 1.0 112.489 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 141.47 -117.54 1.22 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.608 -0.997 . . . . 1.0 110.608 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -137.53 73.77 1.46 Allowed 'General case' 0 N--CA 1.477 0.878 0 O-C-N 122.239 -0.565 . . . . 1.0 109.952 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -88.32 136.03 33.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.827 0.822 . . . . 1.0 112.247 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.406 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 32.7 p-10 -82.99 110.26 17.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.24 -0.891 . . . . 1.0 109.029 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -97.12 159.49 14.88 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.839 0.828 . . . . 1.0 111.626 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -104.58 141.39 36.49 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.934 -1.03 . . . . 1.0 111.296 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.7 t -80.01 124.47 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.43 0.634 . . . . 1.0 110.232 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -100.42 88.86 3.77 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.646 0.736 . . . . 1.0 110.297 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.5 t -86.71 134.75 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.044 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -74.35 146.54 84.23 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.51 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.58 154.72 64.31 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 122.371 2.047 . . . . 1.0 112.198 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.3 mt -112.43 123.25 34.52 Favored Pre-proline 0 N--CA 1.48 1.032 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.721 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.95 135.71 23.75 Favored 'Trans proline' 0 N--CA 1.504 2.098 0 C-N-CA 121.853 1.702 . . . . 1.0 112.392 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 79.48 -15.12 0.79 Allowed 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.39 0.676 . . . . 1.0 111.258 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.7 mm -120.8 146.17 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-O 122.077 0.941 . . . . 1.0 110.005 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -110.19 112.48 24.47 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 122.061 0.934 . . . . 1.0 111.167 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.8 tt -59.72 146.32 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-O 121.391 0.615 . . . . 1.0 110.094 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 68.6 t -103.66 -42.39 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 122.004 -0.435 . . . . 1.0 110.741 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -172.98 175.36 3.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.923 0.868 . . . . 1.0 110.776 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.422 ' O ' ' O ' ' A' ' 34' ' ' ARG . 61.9 mt -110.23 -77.61 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 115.648 -0.706 . . . . 1.0 109.767 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 80' ' ' ILE . 88.3 p 54.97 108.35 0.02 OUTLIER Pre-proline 0 CA--C 1.549 0.939 0 CA-C-O 118.228 -0.891 . . . . 1.0 112.213 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -68.93 122.02 5.38 Favored 'Cis proline' 0 N--CA 1.503 2.044 0 CA-C-N 120.373 1.169 . . . . 1.0 111.794 0.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 91.8 mtm180 -68.71 -34.21 75.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.929 0.871 . . . . 1.0 109.428 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.5 t -130.32 142.51 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.469 0.707 . . . . 1.0 109.117 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.4 m -135.51 153.61 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-O 121.766 0.793 . . . . 1.0 111.746 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 38.4 m -107.29 120.77 43.06 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.17 -0.923 . . . . 1.0 110.602 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 60.0 mt -126.75 134.64 50.58 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.349 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.534 ' H ' ' HG1' ' A' ' 28' ' ' THR . 57.4 tt0 -93.25 131.15 38.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.352 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.1 mt -112.98 140.27 47.94 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.362 0.601 . . . . 1.0 110.085 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -139.1 152.21 47.31 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.894 0.854 . . . . 1.0 111.067 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -69.12 139.74 54.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.153 -0.93 . . . . 1.0 110.826 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 121.666 0.746 . . . . 1.0 111.078 -179.751 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 . . . . . 0 CA--C 1.531 0.227 0 CA-C-O 121.187 0.518 . . . . 1.0 111.765 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 53.03 83.16 0.23 Allowed Pre-proline 0 CA--C 1.54 0.586 0 O-C-N 121.814 -0.554 . . . . 1.0 112.288 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.69 147.72 78.31 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 122.678 2.252 . . . . 1.0 112.834 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 81.9 m -119.27 107.15 13.06 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.578 0.704 . . . . 1.0 110.133 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.4 mt -117.91 152.79 34.73 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.18 0.991 . . . . 1.0 110.427 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.2 m -117.17 123.92 47.87 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.604 -0.725 . . . . 1.0 110.607 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.51 145.64 39.89 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.606 -0.724 . . . . 1.0 110.468 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 95.9 p -86.38 155.59 20.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.263 0.554 . . . . 1.0 109.908 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.7 tp -95.03 129.61 42.04 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.197 0.523 . . . . 1.0 110.755 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.0 pt -127.03 148.76 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-O 121.451 0.643 . . . . 1.0 110.958 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.9 104.64 16.86 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 121.841 -0.537 . . . . 1.0 110.971 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -82.68 59.68 4.86 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.33 0.586 . . . . 1.0 110.928 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.667 ' ND2' ' H ' ' A' ' 55' ' ' LEU . 1.8 p30 171.71 -79.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.356 0.598 . . . . 1.0 110.062 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.9 m 48.66 70.38 2.12 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 115.918 -0.583 . . . . 1.0 111.625 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 22' ' ' ALA . 40.0 Cg_endo -66.64 143.47 68.38 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 121.849 1.699 . . . . 1.0 111.557 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 24' ' ' SER . . . -48.36 -175.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.54 0.686 . . . . 1.0 111.727 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.6 m120 73.55 -25.68 0.19 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.089 0.471 . . . . 1.0 111.048 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.51 ' H ' ' C ' ' A' ' 22' ' ' ALA . 2.9 t -134.27 149.77 50.95 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 122.013 0.911 . . . . 1.0 110.614 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 17.0 ptm -143.62 142.79 31.2 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.613 -0.721 . . . . 1.0 110.414 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 80.5 mt -86.23 119.04 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 121.546 0.688 . . . . 1.0 110.833 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 12.3 ptm -98.69 -6.6 29.33 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.453 0.644 . . . . 1.0 109.571 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 91.5 m -84.47 136.25 33.91 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -67.95 123.31 20.24 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.316 -0.865 . . . . 1.0 110.334 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.416 ' N ' ' CD2' ' A' ' 30' ' ' LEU . 4.4 mm? -53.08 103.11 0.35 Allowed Pre-proline 0 CA--C 1.547 0.841 0 CA-C-O 118.68 -0.676 . . . . 1.0 112.096 -178.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -65.32 155.73 67.02 Favored 'Trans proline' 0 N--CA 1.506 2.256 0 C-N-CA 122.517 2.145 . . . . 1.0 113.144 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.6 p -93.17 165.58 12.75 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.646 -0.659 . . . . 1.0 110.994 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.6 m -137.8 135.43 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-O 121.141 0.496 . . . . 1.0 110.985 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -97.96 128.37 44.49 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.538 -0.542 . . . . 1.0 109.538 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 t -122.84 134.69 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 122.172 0.987 . . . . 1.0 111.473 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -109.4 155.85 20.76 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.357 -0.838 . . . . 1.0 110.412 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 76.0 p -138.02 124.9 21.2 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.247 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 39' ' ' GLY . 10.6 tm-20 -46.54 -67.17 0.31 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.859 0.838 . . . . 1.0 110.524 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 38' ' ' GLU . . . -58.74 -147.99 0.01 OUTLIER Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.017 -0.833 . . . . 1.0 111.017 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -141.97 122.9 14.48 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.651 0.739 . . . . 1.0 110.762 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.496 ' N ' ' CD ' ' A' ' 42' ' ' PRO . 6.7 p-10 -127.37 45.88 1.8 Allowed Pre-proline 0 N--CA 1.476 0.861 0 CA-C-N 116.024 -0.535 . . . . 1.0 111.164 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 41' ' ' ASN . 56.8 Cg_endo -67.72 -8.59 22.85 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.528 2.152 . . . . 1.0 111.667 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.6 t -143.58 77.02 1.54 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.169 0.509 . . . . 1.0 111.045 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.5 mt -144.06 156.17 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 121.932 0.873 . . . . 1.0 109.535 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.558 ' C ' ' H ' ' A' ' 47' ' ' ASN . 18.0 t-20 -68.16 55.51 0.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.447 -0.797 . . . . 1.0 110.67 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.4 m -70.56 24.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 121.023 0.44 . . . . 1.0 110.96 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.558 ' H ' ' C ' ' A' ' 45' ' ' ASN . 53.3 t30 -87.79 6.58 34.52 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.149 0.5 . . . . 1.0 110.413 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -126.29 8.34 7.19 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.208 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 16.2 mt -95.61 121.71 37.59 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.236 0.541 . . . . 1.0 109.707 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -148.51 163.54 36.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 122.466 1.127 . . . . 1.0 111.619 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -109.91 133.01 53.63 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.398 -1.274 . . . . 1.0 108.351 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.525 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 7.7 p90 -145.32 152.72 40.35 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 122.76 1.267 . . . . 1.0 112.164 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.8 m -111.75 138.61 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 114.214 -1.357 . . . . 1.0 109.068 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -88.35 87.05 7.17 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.625 -0.716 . . . . 1.0 110.519 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.667 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 4.1 mp -69.66 -10.59 58.88 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.079 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 55' ' ' LEU . 56.9 m 29.13 -108.93 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.655 0.613 . . . . 1.0 112.655 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.504 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -68.97 -76.33 0.47 Allowed Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.04 -0.824 . . . . 1.0 111.04 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 3.0 p 149.31 134.27 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.37 0.605 . . . . 1.0 111.663 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -132.98 77.03 69.18 Favored Pre-proline 0 N--CA 1.483 1.176 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.883 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.68 153.9 64.09 Favored 'Trans proline' 0 N--CA 1.507 2.308 0 C-N-CA 123.153 2.568 . . . . 1.0 112.953 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.558 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . 98.6 50.82 1.48 Allowed Glycine 0 N--CA 1.472 1.057 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.558 ' O ' ' O ' ' A' ' 61' ' ' GLY . 97.3 mt-10 54.79 137.3 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 O-C-N 122.245 -0.562 . . . . 1.0 110.217 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.702 ' CG ' ' H ' ' A' ' 64' ' ' ASP . 36.1 t60 -149.92 -166.0 2.43 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 122.595 1.188 . . . . 1.0 112.377 -178.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.702 ' H ' ' CG ' ' A' ' 63' ' ' HIS . 79.4 m-20 -143.35 97.89 3.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.58 -1.191 . . . . 1.0 109.155 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -99.76 135.83 40.58 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.791 0.805 . . . . 1.0 111.405 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.476 ' CD ' ' N ' ' A' ' 67' ' ' VAL . 10.2 tm-20 -72.08 152.87 42.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.992 -1.003 . . . . 1.0 111.326 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.476 ' N ' ' CD ' ' A' ' 66' ' ' GLU . 41.1 t -91.02 116.06 31.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.668 0.747 . . . . 1.0 110.119 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.432 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 28.1 ttmt -109.61 106.39 16.06 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 122.163 0.983 . . . . 1.0 110.443 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.1 t -99.05 139.61 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 115.689 -0.687 . . . . 1.0 111.242 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -68.37 117.65 51.83 Favored Pre-proline 0 CA--C 1.55 0.972 0 CA-C-O 118.719 -0.657 . . . . 1.0 110.56 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.58 141.29 19.66 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 C-N-CA 121.718 1.612 . . . . 1.0 112.701 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.7 mm -113.14 119.27 42.75 Favored Pre-proline 0 N--CA 1.484 1.229 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.07 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.23 89.09 0.93 Allowed 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 122.019 1.813 . . . . 1.0 112.585 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 166.25 -19.99 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 122.685 0.394 . . . . 1.0 110.573 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.8 mm -134.8 156.14 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 121.851 0.834 . . . . 1.0 110.244 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -101.03 144.51 29.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 122.755 1.264 . . . . 1.0 111.2 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.4 tt -108.59 114.86 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 115.208 -0.905 . . . . 1.0 110.148 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.9 t -66.05 -41.05 88.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 O-C-N 122.133 -0.355 . . . . 1.0 110.408 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.409 ' CD ' ' NH2' ' A' ' 83' ' ' ARG . 1.9 mt-10 -179.54 -175.53 0.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 122.177 0.989 . . . . 1.0 110.595 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.0 mt -107.56 -75.35 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 115.346 -0.843 . . . . 1.0 109.839 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.0 m 53.57 101.43 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.714 0 CA-C-O 118.219 -0.896 . . . . 1.0 111.848 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.52 172.35 35.49 Favored 'Cis proline' 0 N--CA 1.505 2.18 0 CA-C-N 120.287 1.138 . . . . 1.0 111.805 0.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.409 ' NH2' ' CD ' ' A' ' 79' ' ' GLU . 97.3 mtt180 -119.85 -12.97 9.12 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.679 0.752 . . . . 1.0 109.097 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.6 t -145.82 141.96 21.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.065 -0.717 . . . . 1.0 109.065 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.7 m -135.37 139.93 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-O 121.542 0.686 . . . . 1.0 111.662 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.9 t -103.04 119.86 39.62 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.387 -0.824 . . . . 1.0 110.753 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 62.1 mt -108.7 -178.22 3.53 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.658 0.742 . . . . 1.0 110.157 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -139.56 110.76 6.95 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.469 -0.787 . . . . 1.0 110.512 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.5 mt -105.01 139.43 39.71 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.493 -0.776 . . . . 1.0 110.086 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -145.43 144.21 30.5 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.741 0.781 . . . . 1.0 111.168 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -67.06 137.82 56.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.434 -0.803 . . . . 1.0 110.737 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.445 ' O ' ' CG ' ' A' ' 92' ' ' HIS . 7.9 p80 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 121.252 0.549 . . . . 1.0 111.358 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 74.4 mtp85 . . . . . 0 N--CA 1.469 0.524 0 CA-C-O 121.325 0.583 . . . . 1.0 112.194 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -165.3 107.59 0.78 Allowed Pre-proline 0 CA--C 1.545 0.757 0 O-C-N 121.927 -0.483 . . . . 1.0 111.273 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -77.04 161.72 32.48 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.484 1.456 . . . . 1.0 112.738 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.4 m -110.06 99.67 8.73 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.662 0.744 . . . . 1.0 110.122 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 57.8 mt -107.3 146.53 31.41 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.445 0.641 . . . . 1.0 110.287 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.9 t -124.03 127.72 48.3 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.274 0.559 . . . . 1.0 110.756 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 44.7 mt -110.46 137.42 48.18 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.602 -0.726 . . . . 1.0 110.221 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.1 t -63.36 171.17 2.58 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.865 -0.42 . . . . 1.0 109.865 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.9 tp -125.67 116.04 21.05 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.796 0.808 . . . . 1.0 110.805 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 38.2 pt -117.61 149.66 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-O 121.749 0.785 . . . . 1.0 110.67 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.56 124.73 39.72 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.87 -0.519 . . . . 1.0 110.689 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -120.64 -178.49 3.73 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.364 0.602 . . . . 1.0 110.0 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 45.03 37.02 2.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.373 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.479 ' H ' ' HG1' ' A' ' 20' ' ' THR . 0.6 OUTLIER -73.05 109.39 6.16 Favored Pre-proline 0 CA--C 1.561 1.402 0 CA-C-O 118.479 -0.772 . . . . 1.0 111.005 -178.844 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -59.05 -146.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.508 2.332 0 C-N-CA 121.141 1.228 . . . . 1.0 111.922 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.547 ' O ' ' C ' ' A' ' 23' ' ' ASN . . . -49.17 143.95 5.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 122.07 0.938 . . . . 1.0 111.544 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.547 ' C ' ' O ' ' A' ' 22' ' ' ALA . 12.2 m120 -13.91 84.84 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.483 0.659 . . . . 1.0 112.067 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 22' ' ' ALA . 40.5 t -96.06 149.12 21.95 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.644 0.735 . . . . 1.0 110.886 -178.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 26.2 ttt -144.44 103.64 3.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.558 0.694 . . . . 1.0 110.089 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.583 ' CD1' ' H ' ' A' ' 26' ' ' ILE . 2.7 mp -70.57 119.63 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.953 -0.567 . . . . 1.0 111.051 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -60.9 -45.26 95.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.261 0.553 . . . . 1.0 109.555 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.8 p -79.14 171.16 15.58 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -102.59 166.9 10.26 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.331 -0.856 . . . . 1.0 110.273 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 22.3 mt -102.56 94.21 4.84 Favored Pre-proline 0 CA--C 1.553 1.083 0 CA-C-N 115.553 -0.749 . . . . 1.0 112.104 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -80.79 157.6 21.23 Favored 'Trans proline' 0 N--CA 1.504 2.106 0 C-N-CA 121.819 1.679 . . . . 1.0 112.964 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 96.0 p -67.73 161.81 25.2 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 121.728 -0.608 . . . . 1.0 110.953 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.3 m -120.19 138.45 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.174 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 67.5 mtp85 -89.47 118.81 29.39 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.829 -0.434 . . . . 1.0 109.829 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.91 132.26 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 121.816 0.817 . . . . 1.0 111.534 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -102.52 150.99 22.84 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.66 -0.7 . . . . 1.0 110.211 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 72.6 p -134.96 136.86 42.56 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.057 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -53.34 -69.65 0.11 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.805 0.812 . . . . 1.0 110.428 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -49.04 172.45 0.06 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.252 -0.739 . . . . 1.0 111.252 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.442 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 68.2 t80 -96.92 -8.08 31.64 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.838 0.352 . . . . 1.0 111.308 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.7 m120 59.69 77.9 0.36 Allowed Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.749 -0.205 . . . . 1.0 111.294 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -45.69 -45.19 16.87 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 121.603 1.535 . . . . 1.0 112.371 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.4 p -169.86 21.77 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.785 0.326 . . . . 1.0 111.119 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.424 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 1.6 mp -53.39 133.59 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 121.657 0.742 . . . . 1.0 110.032 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -55.56 91.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.677 -0.692 . . . . 1.0 110.802 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 55.9 t -55.37 -16.68 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.44 -0.346 . . . . 1.0 110.621 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.5 ' O ' ' N ' ' A' ' 49' ' ' LEU . 10.2 p30 -80.58 -48.28 12.94 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.837 0.351 . . . . 1.0 110.308 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.462 ' N ' ' OD1' ' A' ' 47' ' ' ASN . 80.0 tt0 -43.99 -14.81 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 116.002 -0.545 . . . . 1.0 111.448 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.5 ' N ' ' O ' ' A' ' 47' ' ' ASN . 40.3 mt -95.02 139.53 31.26 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.455 ' CE2' ' O ' ' A' ' 47' ' ' ASN . 92.5 m-85 -150.86 159.43 44.56 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.768 0.794 . . . . 1.0 111.486 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -120.23 134.65 55.21 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.027 -0.988 . . . . 1.0 108.704 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 22.2 p90 -150.32 149.09 29.64 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.323 1.059 . . . . 1.0 112.104 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.0 m -105.62 147.44 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 114.648 -1.16 . . . . 1.0 109.083 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' A' ' 56' ' ' SER . 50.1 p-10 -101.23 81.03 2.17 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.305 0.574 . . . . 1.0 110.757 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.0 mt -56.29 -6.07 0.24 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.247 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.51 ' H ' ' C ' ' A' ' 54' ' ' ASP . 42.9 t 34.82 -95.49 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.25 0.62 . . . . 1.0 112.612 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.948 ' O ' ' O ' ' A' ' 58' ' ' SER . . . -114.55 62.39 0.33 Allowed Glycine 0 N--CA 1.472 1.094 0 N-CA-C 110.77 -0.932 . . . . 1.0 110.77 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.948 ' O ' ' O ' ' A' ' 57' ' ' GLY . 8.6 m 8.51 144.07 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.125 0 N-CA-C 113.707 1.003 . . . . 1.0 113.707 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.405 ' H ' HD11 ' A' ' 89' ' ' LEU . 73.5 mm-40 -133.64 82.02 52.13 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 110.07 -0.345 . . . . 1.0 110.07 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -49.36 139.97 27.71 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.133 1.889 . . . . 1.0 112.305 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.04 -97.37 0.81 Allowed Glycine 0 N--CA 1.47 0.959 0 N-CA-C 110.602 -0.999 . . . . 1.0 110.602 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -165.18 139.88 5.05 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 122.242 -0.563 . . . . 1.0 109.62 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.684 ' CG ' ' H ' ' A' ' 64' ' ' ASP . 32.5 t60 -154.94 -164.24 1.75 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 122.365 1.079 . . . . 1.0 112.167 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.684 ' H ' ' CG ' ' A' ' 63' ' ' HIS . 12.7 p-10 -122.79 145.04 48.78 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 114.607 -1.178 . . . . 1.0 109.134 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -142.56 138.12 30.6 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.309 0.576 . . . . 1.0 111.627 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -94.31 142.56 27.27 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.528 -0.76 . . . . 1.0 111.045 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.9 t -95.95 135.38 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.333 0.587 . . . . 1.0 110.175 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.72 151.24 52.03 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.881 0.848 . . . . 1.0 110.472 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.7 t -131.19 144.66 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 121.571 0.7 . . . . 1.0 111.131 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -68.08 128.49 93.27 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-N 115.422 -0.808 . . . . 1.0 110.445 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -39.51 153.9 0.05 OUTLIER 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.069 1.846 . . . . 1.0 113.433 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.449 ' O ' ' O ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -101.07 154.85 36.92 Favored Pre-proline 0 N--CA 1.483 1.202 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.582 -179.29 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 72' ' ' ILE . 61.1 Cg_exo -37.46 -106.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.509 2.415 0 C-N-CA 122.775 2.317 . . . . 1.0 113.698 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.407 ' H ' ' HB2' ' A' ' 73' ' ' PRO . 90.9 m-20 -105.99 18.25 22.37 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.036 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.433 ' CG2' ' N ' ' A' ' 76' ' ' LYS . 81.5 mt -103.53 166.1 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 121.351 0.596 . . . . 1.0 110.136 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.433 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 66.1 tttm -118.98 119.98 35.92 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.894 0.854 . . . . 1.0 111.533 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 19.3 tt -59.81 143.01 14.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.128 0.49 . . . . 1.0 110.323 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 85.1 t -96.14 -49.4 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 122.104 -0.373 . . . . 1.0 110.689 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -173.17 133.62 0.52 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.415 0.626 . . . . 1.0 111.031 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.8 tp -100.85 134.15 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-O 121.492 0.663 . . . . 1.0 109.381 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 61.8 p -145.45 143.06 19.03 Favored Pre-proline 0 N--CA 1.478 0.948 0 CA-C-O 118.939 -0.553 . . . . 1.0 111.795 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.6 138.66 56.2 Favored 'Cis proline' 0 N--CA 1.505 2.196 0 CA-C-N 119.602 0.894 . . . . 1.0 111.896 -1.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -67.87 -35.27 78.24 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.98 0.895 . . . . 1.0 109.947 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 t -134.89 145.6 32.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.178 -0.675 . . . . 1.0 109.178 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.65 161.44 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-O 122.431 1.11 . . . . 1.0 110.833 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 75.8 m -105.98 124.21 49.21 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.434 -1.257 . . . . 1.0 110.525 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 87.5 mt -130.62 116.98 18.84 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.192 0.52 . . . . 1.0 110.093 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -96.82 110.62 23.06 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.389 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.405 HD11 ' H ' ' A' ' 59' ' ' GLU . 51.5 mt -78.83 150.59 32.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.056 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -129.4 141.28 51.09 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 122.092 0.949 . . . . 1.0 111.045 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -65.63 126.59 28.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.009 -0.996 . . . . 1.0 110.584 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.447 ' CG ' ' O ' ' A' ' 92' ' ' HIS . 78.4 t60 . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.039 0.447 . . . . 1.0 111.095 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 . . . . . 0 N--CA 1.464 0.245 0 CA-C-O 121.432 0.634 . . . . 1.0 111.455 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 41.64 75.99 0.56 Allowed Pre-proline 0 C--N 1.327 -0.372 0 C-N-CA 122.975 0.51 . . . . 1.0 112.293 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.68 153.37 54.13 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.426 2.084 . . . . 1.0 113.019 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 75.3 m -106.15 99.24 8.84 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.408 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -94.02 146.73 23.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 122.13 0.967 . . . . 1.0 110.497 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.2 m -119.52 109.6 15.91 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.625 -0.716 . . . . 1.0 110.475 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.5 mt -110.36 134.14 52.58 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.318 -0.855 . . . . 1.0 109.696 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.0 m -79.74 164.95 23.29 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.91 -0.404 . . . . 1.0 109.91 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.2 tp -113.08 118.21 34.14 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.73 0.776 . . . . 1.0 110.648 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.8 pp -128.19 162.17 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 CA-C-O 121.751 0.786 . . . . 1.0 110.925 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.403 ' CB ' ' OG1' ' A' ' 20' ' ' THR . . . -79.69 157.99 27.08 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 121.769 -0.582 . . . . 1.0 111.001 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -66.94 -36.68 82.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.221 0.534 . . . . 1.0 111.282 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -166.45 -34.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.098 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.403 ' OG1' ' CB ' ' A' ' 17' ' ' ALA . 22.3 m 59.34 76.56 0.44 Allowed Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 116.343 -0.39 . . . . 1.0 111.463 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 22' ' ' ALA . 31.7 Cg_exo -57.88 148.96 72.82 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.249 1.966 . . . . 1.0 111.586 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.491 ' C ' ' H ' ' A' ' 24' ' ' SER . . . -51.37 -169.96 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.891 0.853 . . . . 1.0 111.74 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.638 HD22 ' NE2' ' A' ' 91' ' ' HIS . 0.4 OUTLIER 71.23 -38.68 0.43 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.141 -0.481 . . . . 1.0 111.001 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.491 ' H ' ' C ' ' A' ' 22' ' ' ALA . 13.3 p -109.02 149.58 29.05 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.699 0.761 . . . . 1.0 110.587 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 11.7 tmm? -141.88 120.26 12.35 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.553 0.692 . . . . 1.0 110.33 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 74.0 mt -72.74 116.13 14.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.592 0.71 . . . . 1.0 110.881 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 78.0 mtp -94.83 -16.41 22.96 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.925 -0.579 . . . . 1.0 109.669 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.9 m -78.71 134.5 37.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.262 0.553 . . . . 1.0 109.69 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.57 123.99 27.68 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 121.288 -0.883 . . . . 1.0 110.316 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.7 mt -70.43 114.71 28.18 Favored Pre-proline 0 CA--C 1.555 1.139 0 CA-C-N 115.748 -0.66 . . . . 1.0 112.05 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -84.68 152.59 11.62 Favored 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 121.77 1.647 . . . . 1.0 113.07 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.7 m -72.98 173.28 9.52 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.614 -0.679 . . . . 1.0 111.213 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.8 p -142.84 136.96 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-O 121.376 0.608 . . . . 1.0 111.046 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -97.54 129.33 44.7 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.4 0.619 . . . . 1.0 109.346 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -124.71 134.18 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-O 122.101 0.953 . . . . 1.0 111.576 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -107.81 149.02 28.73 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.465 -0.789 . . . . 1.0 110.289 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 72.1 p -127.78 132.04 49.55 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 116.045 -0.525 . . . . 1.0 111.294 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -58.04 -75.29 0.05 OUTLIER 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.827 0.823 . . . . 1.0 110.09 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.61 166.64 15.94 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.959 -0.856 . . . . 1.0 110.959 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 8.6 p90 -79.77 175.08 10.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.841 0.829 . . . . 1.0 110.683 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.493 ' N ' HD21 ' A' ' 41' ' ' ASN . 1.5 m-80 -124.0 92.77 47.98 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 115.71 -0.677 . . . . 1.0 110.65 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -52.36 -40.9 69.66 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 121.893 1.729 . . . . 1.0 112.13 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 44' ' ' ILE . 73.8 m -165.51 -96.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.63 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 43' ' ' SER . 65.7 mt 57.76 141.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.128 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -85.44 96.95 9.75 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.165 0.507 . . . . 1.0 110.806 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.4 m -86.13 5.92 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 120.942 0.401 . . . . 1.0 110.782 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -97.13 -1.13 45.78 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.107 0.48 . . . . 1.0 110.262 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.482 ' OE1' ' N ' ' A' ' 48' ' ' GLU . 18.8 mp0 -120.25 6.27 10.72 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.662 -0.699 . . . . 1.0 110.145 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.0 mt -122.26 128.44 51.12 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.635 0.731 . . . . 1.0 109.557 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -133.67 -168.45 2.11 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.248 1.023 . . . . 1.0 111.544 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -115.41 139.74 49.75 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.626 -1.17 . . . . 1.0 108.989 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.475 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 16.8 p90 -141.37 153.42 45.08 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 122.34 1.067 . . . . 1.0 112.36 -178.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.3 m -110.56 140.09 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 114.647 -1.16 . . . . 1.0 109.27 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -77.44 88.57 3.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.502 0.668 . . . . 1.0 110.328 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 57' ' ' GLY . 0.8 OUTLIER -90.39 -26.52 19.86 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.623 -0.717 . . . . 1.0 109.848 -179.735 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 55' ' ' LEU . 35.4 t 28.18 -89.86 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.004 0.521 . . . . 1.0 112.353 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . -62.55 -75.01 0.35 Allowed Glycine 0 CA--C 1.531 1.093 0 N-CA-C 111.029 -0.828 . . . . 1.0 111.029 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.0 t 75.56 95.82 0.07 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 122.879 0.471 . . . . 1.0 111.469 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -123.61 147.95 54.57 Favored Pre-proline 0 N--CA 1.482 1.16 0 CA-C-O 119.514 -0.279 . . . . 1.0 111.67 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -47.82 139.0 19.92 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 121.724 1.616 . . . . 1.0 113.304 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 139.66 -135.59 7.3 Favored Glycine 0 N--CA 1.472 1.086 0 N-CA-C 110.532 -1.027 . . . . 1.0 110.532 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -170.65 144.02 2.27 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -154.62 -164.66 1.87 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.708 1.242 . . . . 1.0 112.451 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 32.8 p-10 -111.74 91.84 3.81 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 114.33 -1.305 . . . . 1.0 108.942 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -82.56 132.16 35.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.679 0.752 . . . . 1.0 111.36 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.51 153.63 37.38 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.057 -0.974 . . . . 1.0 111.171 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 65.4 t -94.09 110.29 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 121.59 0.71 . . . . 1.0 110.152 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' A' ' 52' ' ' TYR . 1.6 tmtp? -112.01 118.6 35.87 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 122.039 0.923 . . . . 1.0 110.137 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.3 m -126.43 149.89 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 115.783 -0.644 . . . . 1.0 111.203 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -74.84 125.77 89.09 Favored Pre-proline 0 CA--C 1.549 0.92 0 CA-C-O 118.387 -0.816 . . . . 1.0 110.311 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.01 137.76 19.91 Favored 'Trans proline' 0 N--CA 1.5 1.892 0 C-N-CA 121.619 1.546 . . . . 1.0 112.357 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.5 mm -79.8 128.74 73.29 Favored Pre-proline 0 CA--C 1.554 1.131 0 CA-C-N 116.456 -0.338 . . . . 1.0 111.314 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.417 ' C ' ' H ' ' A' ' 75' ' ' ILE . 61.5 Cg_endo -70.3 152.82 66.74 Favored 'Trans proline' 0 N--CA 1.502 2.024 0 C-N-CA 121.506 1.471 . . . . 1.0 112.818 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.9 t30 65.63 -1.27 1.06 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.295 0.638 . . . . 1.0 111.29 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.417 ' H ' ' C ' ' A' ' 73' ' ' PRO . 66.5 mt -133.58 155.48 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 121.64 0.733 . . . . 1.0 110.191 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -107.93 149.82 27.86 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 122.267 1.032 . . . . 1.0 111.236 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.1 tt -100.41 101.54 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 115.732 -0.667 . . . . 1.0 109.995 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.2 t -46.02 -58.18 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 O-C-N 122.121 -0.362 . . . . 1.0 110.636 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -175.62 141.68 0.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.685 0.755 . . . . 1.0 110.686 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.6 tp -104.18 138.85 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.399 0.619 . . . . 1.0 109.579 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.2 m -147.32 134.93 10.48 Favored Pre-proline 0 N--CA 1.481 1.079 0 CA-C-O 118.481 -0.771 . . . . 1.0 112.293 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.84 -174.49 10.77 Favored 'Cis proline' 0 N--CA 1.503 2.037 0 CA-C-N 120.133 1.083 . . . . 1.0 111.701 -0.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -121.2 -18.31 7.45 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.927 0.87 . . . . 1.0 109.312 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.6 t -138.61 136.94 43.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.029 -0.73 . . . . 1.0 109.029 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.2 m -137.19 174.74 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 CA-C-O 121.771 0.796 . . . . 1.0 111.476 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.0 t -133.07 128.31 35.95 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.137 -0.938 . . . . 1.0 110.465 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 50.2 mt -130.74 120.95 24.58 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 120.954 0.407 . . . . 1.0 110.207 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -86.16 112.12 21.02 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.582 0.706 . . . . 1.0 110.281 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.6 mt -80.68 165.87 21.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.673 -0.694 . . . . 1.0 110.085 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -140.27 130.32 24.86 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.9 0.857 . . . . 1.0 110.971 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.638 ' NE2' HD22 ' A' ' 23' ' ' ASN . 60.5 t-80 -76.19 129.57 36.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.194 -0.912 . . . . 1.0 110.522 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 . . . . . 0 CA--C 1.534 0.328 0 CA-C-O 121.202 0.525 . . . . 1.0 111.145 -179.658 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.534 ' NH2' ' CZ ' ' A' ' 40' ' ' TYR . 88.6 mtm180 . . . . . 0 N--CA 1.468 0.432 0 CA-C-O 122.263 1.03 . . . . 1.0 111.381 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -152.28 86.27 4.44 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 115.9 -0.591 . . . . 1.0 111.509 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.95 119.83 6.93 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 122.166 1.911 . . . . 1.0 113.227 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 42.0 m -117.25 87.15 2.65 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 121.312 0.577 . . . . 1.0 110.739 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.528 ' N ' ' CD2' ' A' ' 11' ' ' LEU . 0.9 OUTLIER -98.6 147.15 25.1 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 122.122 0.963 . . . . 1.0 110.615 -179.462 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.5 m -106.79 124.28 49.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.717 0.77 . . . . 1.0 110.338 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.8 mt -112.99 130.53 56.1 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.107 -0.951 . . . . 1.0 110.131 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.9 m -69.19 161.07 29.94 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.0 tp -113.47 116.89 30.31 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.449 0.643 . . . . 1.0 111.055 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.7 pt -119.04 140.5 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-O 121.877 0.846 . . . . 1.0 110.694 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.27 117.91 17.61 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.22 0.533 . . . . 1.0 110.918 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.2 tptt -112.86 159.3 19.17 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.357 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 53.37 31.15 11.44 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.96 -0.385 . . . . 1.0 109.96 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.0 m -68.93 129.7 92.1 Favored Pre-proline 0 CA--C 1.546 0.823 0 CA-C-O 119.051 -0.499 . . . . 1.0 111.704 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -71.92 117.31 5.08 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 121.245 1.297 . . . . 1.0 111.431 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -42.83 158.15 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.87 0.843 . . . . 1.0 111.617 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.4 m120 73.2 9.71 5.22 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.958 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 90.3 p -112.44 145.13 40.73 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.738 0.78 . . . . 1.0 110.701 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.408 ' SD ' ' O ' ' A' ' 26' ' ' ILE . 12.5 tmm? -139.31 121.07 15.38 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.722 -0.672 . . . . 1.0 110.258 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.408 ' O ' ' SD ' ' A' ' 25' ' ' MET . 54.6 mt -73.8 144.98 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.888 0.851 . . . . 1.0 110.979 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 10.7 tpp -107.34 -26.78 10.85 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.571 -0.741 . . . . 1.0 109.596 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.9 m -81.09 156.49 25.78 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.203 -0.666 . . . . 1.0 109.203 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -84.18 157.89 21.5 Favored 'General case' 0 CA--C 1.516 -0.362 0 O-C-N 121.273 -0.892 . . . . 1.0 110.19 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.406 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 4.3 mm? -100.26 97.84 6.89 Favored Pre-proline 0 N--CA 1.484 1.262 0 CA-C-N 115.958 -0.565 . . . . 1.0 112.42 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -86.1 157.38 9.88 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.486 2.124 . . . . 1.0 112.714 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.4 m -77.35 -178.21 5.04 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.594 -0.691 . . . . 1.0 110.991 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.7 p -140.78 149.82 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 121.31 0.576 . . . . 1.0 111.146 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -102.87 123.83 47.24 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.49 0.662 . . . . 1.0 109.423 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 t -120.29 133.14 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-O 122.265 1.031 . . . . 1.0 111.52 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -103.45 146.29 28.73 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.293 -0.867 . . . . 1.0 110.076 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 43.8 p -131.24 130.63 43.13 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.099 -0.501 . . . . 1.0 111.469 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.431 ' O ' ' O ' ' A' ' 39' ' ' GLY . 83.9 tt0 -57.36 -74.72 0.05 Allowed 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.648 0.737 . . . . 1.0 110.159 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 38' ' ' GLU . . . -50.17 -173.72 0.01 OUTLIER Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.347 -0.701 . . . . 1.0 111.347 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.534 ' CZ ' ' NH2' ' A' ' 7' ' ' ARG . 3.0 m-85 -104.92 167.9 9.41 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.494 0.664 . . . . 1.0 110.411 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -120.67 83.88 36.17 Favored Pre-proline 0 N--CA 1.476 0.831 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.412 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.56 -41.26 69.42 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.132 1.888 . . . . 1.0 112.162 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.515 ' O ' ' O ' ' A' ' 44' ' ' ILE . 73.7 m -161.17 -88.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.246 0.546 . . . . 1.0 110.401 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.515 ' O ' ' O ' ' A' ' 43' ' ' SER . 2.8 tt 31.56 100.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.352 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.62 ' C ' ' H ' ' A' ' 47' ' ' ASN . 87.9 m-20 -63.65 96.85 0.13 Allowed 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 120.969 0.414 . . . . 1.0 110.815 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.8 m -66.63 20.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.331 0.586 . . . . 1.0 110.718 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.62 ' H ' ' C ' ' A' ' 45' ' ' ASN . 94.1 m-20 -92.26 12.2 23.22 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.14 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -125.32 -1.23 7.61 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.694 -0.685 . . . . 1.0 110.288 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.8 mt -123.01 133.38 54.35 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -141.09 -166.57 2.2 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.009 0.909 . . . . 1.0 111.592 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -118.7 140.51 49.81 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.798 -1.092 . . . . 1.0 108.389 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -120.36 166.73 13.14 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 122.413 1.101 . . . . 1.0 112.084 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.3 m -133.73 145.49 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 114.475 -1.239 . . . . 1.0 109.305 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -94.92 81.83 3.78 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.709 0.766 . . . . 1.0 110.663 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.2 mp -75.11 -4.09 36.56 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.445 -0.798 . . . . 1.0 110.176 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.8 t -79.06 5.33 12.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.371 -0.377 . . . . 1.0 111.329 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -132.59 52.04 0.84 Allowed Glycine 0 N--CA 1.474 1.213 0 N-CA-C 111.344 -0.702 . . . . 1.0 111.344 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.7 t -153.45 -63.92 0.15 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.536 0.208 . . . . 1.0 111.316 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 66.36 151.92 0.12 Allowed Pre-proline 0 N--CA 1.472 0.625 0 C-N-CA 122.562 0.345 . . . . 1.0 111.443 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -35.06 143.29 0.08 OUTLIER 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 122.866 2.377 . . . . 1.0 113.369 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.513 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . 120.24 16.16 4.86 Favored Glycine 0 N--CA 1.472 1.057 0 N-CA-C 110.935 -0.866 . . . . 1.0 110.935 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.513 ' O ' ' O ' ' A' ' 61' ' ' GLY . 81.6 tt0 57.17 141.07 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 O-C-N 122.12 -0.635 . . . . 1.0 109.9 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.752 ' CG ' ' H ' ' A' ' 64' ' ' ASP . 39.5 t60 -155.55 -163.65 1.57 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 122.883 1.325 . . . . 1.0 112.289 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.752 ' H ' ' CG ' ' A' ' 63' ' ' HIS . 95.6 m-20 -114.58 144.27 43.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.285 -1.325 . . . . 1.0 108.652 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.416 ' N ' ' CD1' ' A' ' 65' ' ' TYR . 48.7 m-85 -134.76 139.15 44.93 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.426 0.631 . . . . 1.0 111.388 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -104.44 149.29 25.56 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.345 -0.843 . . . . 1.0 111.15 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 48.4 t -103.28 116.45 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 121.726 0.774 . . . . 1.0 110.203 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -123.51 139.74 53.71 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.293 1.044 . . . . 1.0 110.344 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.7 t -109.0 136.89 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 115.553 -0.748 . . . . 1.0 110.874 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -72.13 117.26 56.73 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-O 118.557 -0.735 . . . . 1.0 110.091 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -44.96 119.22 2.29 Favored 'Trans proline' 0 N--CA 1.505 2.167 0 C-N-CA 121.754 1.636 . . . . 1.0 113.157 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 33.9 mm -105.93 123.0 40.57 Favored Pre-proline 0 N--CA 1.487 1.39 0 CA-C-O 119.103 -0.475 . . . . 1.0 111.235 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.64 157.86 54.81 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.32 2.014 . . . . 1.0 112.092 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 33.6 t30 80.67 -26.27 0.16 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.481 0.712 . . . . 1.0 110.826 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.7 mm -132.81 148.46 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 122.206 1.003 . . . . 1.0 110.489 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -113.77 149.6 34.65 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 122.762 1.268 . . . . 1.0 110.961 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.6 tt -91.97 142.99 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.209 -0.905 . . . . 1.0 110.112 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.8 t -120.72 -45.48 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 122.089 -0.382 . . . . 1.0 110.901 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -96.17 139.4 32.39 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 122.127 0.965 . . . . 1.0 110.667 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.5 mp -135.25 80.82 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 115.435 -0.802 . . . . 1.0 109.723 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.7 m -148.61 148.84 29.47 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 120.281 -0.568 . . . . 1.0 112.018 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.82 141.73 72.64 Favored 'Cis proline' 0 N--CA 1.509 2.423 0 C-N-CA 124.685 -0.964 . . . . 1.0 112.3 -1.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 90.8 mtm180 -61.76 -56.48 19.11 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.567 0.698 . . . . 1.0 109.368 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.1 t -135.21 149.25 28.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.231 -0.655 . . . . 1.0 109.231 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.2 m -144.75 163.73 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 121.647 0.737 . . . . 1.0 111.764 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 74.3 m -111.6 122.82 48.83 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.299 -0.864 . . . . 1.0 110.658 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.4 mt -107.99 -170.13 1.63 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.426 0.632 . . . . 1.0 110.204 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -146.56 112.6 5.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.47 0.652 . . . . 1.0 110.55 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.8 mt -107.33 143.16 36.01 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.555 0.693 . . . . 1.0 110.033 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -132.44 143.71 49.98 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.971 0.891 . . . . 1.0 111.036 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -68.65 131.16 44.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.165 -0.925 . . . . 1.0 110.547 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.474 0.736 0 CA-C-O 121.701 0.762 . . . . 1.0 111.071 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 . . . . . 0 CA--C 1.538 0.516 0 N-CA-C 112.558 0.577 . . . . 1.0 112.558 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -139.21 81.82 20.34 Favored Pre-proline 0 N--CA 1.476 0.867 0 O-C-N 121.942 -0.474 . . . . 1.0 111.329 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.94 134.5 55.53 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.794 2.329 . . . . 1.0 112.739 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.7 m -104.51 85.92 2.42 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.409 0.623 . . . . 1.0 110.143 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.8 mt -86.01 145.52 27.06 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.814 0.816 . . . . 1.0 110.544 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.3 m -109.57 119.56 39.79 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.531 0.682 . . . . 1.0 110.599 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.8 mp -102.54 135.36 44.31 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.39 -0.823 . . . . 1.0 109.879 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 59.3 m -79.33 105.8 10.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.895 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.5 tp -68.52 95.94 0.66 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.591 0.71 . . . . 1.0 110.938 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.3 pt -118.69 165.05 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 121.571 0.701 . . . . 1.0 111.038 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.99 164.34 23.54 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.792 -0.568 . . . . 1.0 111.12 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.1 mmtp -104.11 -56.85 2.13 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.221 0.534 . . . . 1.0 111.402 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -92.89 -54.54 3.7 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.547 0.689 . . . . 1.0 110.144 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 45.66 80.91 0.27 Allowed Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 115.831 -0.622 . . . . 1.0 111.592 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.38 134.72 65.52 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.302 2.001 . . . . 1.0 111.238 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.45 -14.4 3.01 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 122.001 -0.437 . . . . 1.0 111.859 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -91.53 -15.34 28.87 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.957 -0.464 . . . . 1.0 111.161 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.4 t -108.3 153.48 23.18 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.524 0.678 . . . . 1.0 110.779 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 45.0 ttp -144.66 115.51 7.8 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.706 0.765 . . . . 1.0 110.086 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.57 ' H ' ' CD1' ' A' ' 26' ' ' ILE . 2.2 mp -68.11 115.39 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.862 0.839 . . . . 1.0 111.095 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 44.3 ttm -67.67 -28.07 67.38 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.685 -0.689 . . . . 1.0 109.44 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.9 m -68.88 135.74 51.56 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -68.85 -13.99 62.76 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 121.279 -0.888 . . . . 1.0 111.097 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.1 mt 61.95 91.81 0.07 OUTLIER Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 115.828 -0.624 . . . . 1.0 112.31 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -86.57 158.47 9.27 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.854 2.369 . . . . 1.0 112.755 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 95.4 p -69.13 178.07 2.45 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.666 -0.646 . . . . 1.0 111.268 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.0 p -139.7 151.04 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-O 121.408 0.623 . . . . 1.0 111.053 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 100.0 mtt180 -98.96 129.19 45.26 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.6 t -127.03 154.66 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 122.384 1.087 . . . . 1.0 111.396 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -124.7 142.67 51.23 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.108 -0.951 . . . . 1.0 110.591 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 60.3 p -130.08 136.57 49.49 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.33 0.586 . . . . 1.0 111.264 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -109.84 41.62 1.67 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.526 0.679 . . . . 1.0 109.798 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -125.3 -9.45 5.03 Favored Glycine 0 N--CA 1.472 1.093 0 N-CA-C 111.039 -0.824 . . . . 1.0 111.039 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 59.73 153.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.234 0.54 . . . . 1.0 111.13 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.468 ' ND2' ' N ' ' A' ' 41' ' ' ASN . 0.1 OUTLIER -175.4 148.11 1.02 Allowed Pre-proline 0 CA--C 1.547 0.835 0 O-C-N 122.212 -0.305 . . . . 1.0 110.451 179.854 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.29 -58.97 0.11 Allowed 'Trans proline' 0 N--CA 1.509 2.429 0 C-N-CA 121.507 1.471 . . . . 1.0 112.599 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.455 ' O ' ' HB ' ' A' ' 44' ' ' ILE . 40.2 t -159.42 -56.8 0.06 Allowed 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.71 0.767 . . . . 1.0 110.71 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.455 ' HB ' ' O ' ' A' ' 43' ' ' SER . 42.3 mt 91.92 -113.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-N 115.39 -0.823 . . . . 1.0 109.73 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.6 ' ND2' HD22 ' A' ' 47' ' ' ASN . 11.2 t-20 -175.87 -19.47 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.653 0.74 . . . . 1.0 110.383 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.444 ' C ' ' O ' ' A' ' 45' ' ' ASN . 17.7 m 28.18 43.58 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-O 121.827 0.822 . . . . 1.0 112.036 -178.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.6 HD22 ' ND2' ' A' ' 45' ' ' ASN . 99.3 m-20 -69.93 -40.92 75.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.577 -0.738 . . . . 1.0 110.754 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -127.95 13.08 6.78 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.617 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 28.5 mt -96.42 110.84 23.12 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.974 0.893 . . . . 1.0 109.597 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -148.24 -160.87 1.23 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 122.191 0.996 . . . . 1.0 111.533 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -117.2 142.49 46.97 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.703 -1.135 . . . . 1.0 108.263 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -134.57 175.12 9.82 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 122.03 0.919 . . . . 1.0 112.345 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.4 m -138.87 146.0 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 114.834 -1.075 . . . . 1.0 109.393 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -86.9 83.02 7.61 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.588 0.709 . . . . 1.0 110.318 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 56' ' ' SER . 0.7 OUTLIER -81.89 -13.79 57.09 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.0 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.454 ' C ' ' O ' ' A' ' 55' ' ' LEU . 77.3 p 20.18 -97.93 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 112.829 0.678 . . . . 1.0 112.829 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.493 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -60.57 -74.53 0.36 Allowed Glycine 0 CA--C 1.531 1.073 0 N-CA-C 110.583 -1.007 . . . . 1.0 110.583 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 3.9 m 101.94 45.24 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 123.94 0.896 . . . . 1.0 111.444 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 60' ' ' PRO . 12.3 mp0 -76.0 130.65 77.68 Favored Pre-proline 0 CA--C 1.548 0.902 0 CA-C-O 119.23 -0.414 . . . . 1.0 111.586 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 59' ' ' GLU . 88.7 Cg_exo -44.11 -179.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.506 2.251 0 C-N-CA 122.076 1.851 . . . . 1.0 113.044 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.54 -141.15 15.16 Favored Glycine 0 N--CA 1.472 1.093 0 N-CA-C 110.713 -0.955 . . . . 1.0 110.713 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.3 mp0 -138.19 75.1 1.5 Allowed 'General case' 0 N--CA 1.471 0.58 0 O-C-N 122.135 -0.626 . . . . 1.0 109.724 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -93.54 137.67 32.59 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.712 0.768 . . . . 1.0 112.013 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -85.37 139.19 31.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.282 -0.872 . . . . 1.0 109.072 178.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -132.11 127.94 37.09 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.718 0.77 . . . . 1.0 111.664 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.428 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 32.6 mp0 -67.87 132.81 48.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.091 -0.959 . . . . 1.0 111.318 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.6 t -76.27 124.96 35.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.507 0.67 . . . . 1.0 110.207 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -109.39 121.16 44.57 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.973 0.892 . . . . 1.0 110.196 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.3 m -109.75 129.61 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 115.833 -0.622 . . . . 1.0 111.008 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -50.35 127.76 23.49 Favored Pre-proline 0 CA--C 1.554 1.133 0 CA-C-O 118.87 -0.586 . . . . 1.0 110.554 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.3 112.01 3.42 Favored 'Trans proline' 0 N--CA 1.505 2.178 0 C-N-CA 121.684 1.59 . . . . 1.0 112.218 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.8 mp -82.02 129.71 63.27 Favored Pre-proline 0 CA--C 1.556 1.198 0 CA-C-O 119.411 -0.328 . . . . 1.0 110.795 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -67.15 140.98 55.63 Favored 'Trans proline' 0 N--CA 1.506 2.218 0 C-N-CA 121.755 1.637 . . . . 1.0 112.662 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.9 t30 66.93 10.32 7.55 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.271 0.629 . . . . 1.0 111.476 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mm -124.04 137.13 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-O 122.367 1.079 . . . . 1.0 109.746 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.33 121.14 38.89 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 122.145 0.974 . . . . 1.0 111.013 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.402 ' O ' ' CG2' ' A' ' 77' ' ' ILE . 7.4 tp -84.12 93.34 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.879 -0.601 . . . . 1.0 110.053 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.8 t -46.9 -53.65 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 O-C-N 121.97 -0.456 . . . . 1.0 110.835 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -170.42 -127.19 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.819 0.819 . . . . 1.0 110.408 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.8 mt -154.23 -77.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.131 -0.692 . . . . 1.0 109.131 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.6 t 58.71 101.94 0.04 OUTLIER Pre-proline 0 CA--C 1.549 0.907 0 CA-C-O 117.544 -1.217 . . . . 1.0 111.778 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -67.74 134.11 24.28 Favored 'Cis proline' 0 N--CA 1.512 2.598 0 CA-C-N 121.028 1.403 . . . . 1.0 111.831 0.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -66.26 -43.53 86.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.761 0.791 . . . . 1.0 109.661 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -130.08 153.21 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 109.377 -0.601 . . . . 1.0 109.377 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.5 p -145.38 136.06 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.604 0.716 . . . . 1.0 111.5 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 37.2 m -81.39 130.36 35.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.282 -0.872 . . . . 1.0 110.441 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 33.5 mt -133.45 124.47 27.12 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.104 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.409 ' N ' ' CD ' ' A' ' 88' ' ' GLN . 18.3 mp0 -93.28 121.43 34.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.687 0.756 . . . . 1.0 110.525 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.0 mt -96.98 162.06 13.56 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.445 -0.798 . . . . 1.0 109.802 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -152.81 151.62 30.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.642 0.734 . . . . 1.0 110.992 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.625 ' HD1' ' H ' ' A' ' 91' ' ' HIS . 19.3 p-80 -66.2 139.44 58.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.427 -0.806 . . . . 1.0 110.687 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 . . . . . 0 C--N 1.328 -0.342 0 CA-C-O 121.325 0.583 . . . . 1.0 111.165 -179.504 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 56.5 mmt-85 . . . . . 0 CA--C 1.529 0.139 0 CA-C-O 120.918 0.39 . . . . 1.0 111.51 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.463 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 4.9 p-10 44.3 54.35 11.92 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 112.935 0.717 . . . . 1.0 112.935 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.463 ' HD3' ' N ' ' A' ' 8' ' ' ASP . 57.6 Cg_endo -89.8 -178.03 1.54 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.806 2.337 . . . . 1.0 112.801 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.493 ' HG1' ' NZ ' ' A' ' 36' ' ' LYS . 53.9 m -85.51 113.61 21.9 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.647 0.737 . . . . 1.0 110.423 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 74.9 mt -105.85 139.32 40.59 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.673 0.749 . . . . 1.0 110.572 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.0 m -101.14 124.57 47.04 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.379 0.609 . . . . 1.0 110.428 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.3 mp -108.19 131.15 54.96 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.651 -0.704 . . . . 1.0 109.944 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.6 t -75.83 114.85 14.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.196 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 41.4 tp -69.37 105.99 2.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.246 0.546 . . . . 1.0 110.88 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.7 pt -118.08 142.6 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 121.692 0.758 . . . . 1.0 111.117 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.49 121.5 24.64 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.351 0.596 . . . . 1.0 110.76 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -114.03 50.4 0.93 Allowed 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.404 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 172.81 34.35 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.326 -0.62 . . . . 1.0 109.326 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.0 m -70.17 112.5 12.85 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-O 119.022 -0.513 . . . . 1.0 111.466 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -57.66 145.64 88.62 Favored 'Trans proline' 0 N--CA 1.501 1.948 0 C-N-CA 121.876 1.718 . . . . 1.0 111.832 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.93 150.38 49.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 122.155 0.979 . . . . 1.0 111.388 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 68.06 7.93 6.17 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.129 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.3 p -114.1 152.09 31.61 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.791 0.805 . . . . 1.0 110.521 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 49.0 ttp -141.47 120.27 12.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.704 -0.68 . . . . 1.0 110.082 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 72.2 mt -72.04 117.95 16.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.456 0.645 . . . . 1.0 110.665 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.417 ' SD ' ' OE1' ' A' ' 90' ' ' GLU . 76.4 mtp -83.79 58.64 4.75 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.806 0.812 . . . . 1.0 109.83 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.7 m -165.18 128.29 2.25 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.358 -0.608 . . . . 1.0 109.358 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.476 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 38.2 ttpt -68.2 158.44 33.24 Favored 'General case' 0 CA--C 1.515 -0.393 0 O-C-N 121.229 -0.92 . . . . 1.0 110.682 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.427 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 4.3 mm? -98.55 96.86 4.12 Favored Pre-proline 0 CA--C 1.557 1.213 0 N-CA-C 112.374 0.509 . . . . 1.0 112.374 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 29' ' ' LYS . 39.7 Cg_endo -86.51 152.05 9.02 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.485 2.123 . . . . 1.0 112.635 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.5 p -68.17 177.55 2.22 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.698 -0.626 . . . . 1.0 111.098 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -145.14 154.27 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.557 0.694 . . . . 1.0 111.079 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -104.42 127.0 52.02 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.5 m -131.6 161.75 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 122.169 0.985 . . . . 1.0 111.28 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.493 ' NZ ' ' HG1' ' A' ' 10' ' ' THR . 64.5 mmtt -125.25 134.03 52.46 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.423 -0.808 . . . . 1.0 110.939 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 30.1 p -141.1 -175.27 4.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.647 0.736 . . . . 1.0 111.211 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -124.37 -138.17 0.29 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.727 -0.67 . . . . 1.0 110.089 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.66 -150.61 38.33 Favored Glycine 0 N--CA 1.458 0.161 0 N-CA-C 110.911 -0.876 . . . . 1.0 110.911 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -144.32 -25.96 0.52 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.252 0.549 . . . . 1.0 111.321 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 61.97 67.43 1.27 Allowed Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.451 -0.341 . . . . 1.0 111.128 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -58.64 -41.12 67.16 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 122.171 1.914 . . . . 1.0 111.92 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 55.4 p -172.07 55.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.614 -0.266 . . . . 1.0 110.533 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.8 mm -90.06 125.52 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.39 0.614 . . . . 1.0 110.062 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.534 ' C ' ' H ' ' A' ' 47' ' ' ASN . 12.0 m120 -75.59 100.89 4.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.459 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.1 m -46.72 -9.54 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.234 0.54 . . . . 1.0 111.817 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.534 ' H ' ' C ' ' A' ' 45' ' ' ASN . 33.6 m120 -63.02 -36.14 82.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.228 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -102.98 55.79 0.76 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.001 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.524 ' O ' ' CG ' ' A' ' 50' ' ' PHE . 20.1 mt -152.28 118.97 5.7 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.225 0.536 . . . . 1.0 110.071 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.524 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 59.1 m-85 -161.64 173.91 14.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 122.513 1.149 . . . . 1.0 111.675 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.463 ' C ' ' CG ' ' A' ' 52' ' ' TYR . . . -100.47 170.14 8.6 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 114.219 -1.355 . . . . 1.0 108.728 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.463 ' CG ' ' C ' ' A' ' 51' ' ' ALA . 25.3 m-85 -151.57 163.77 38.33 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 122.221 1.01 . . . . 1.0 111.913 -178.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.1 m -137.19 145.74 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 114.735 -1.12 . . . . 1.0 109.443 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -98.76 81.91 2.72 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.504 0.668 . . . . 1.0 110.643 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.491 ' O ' ' C ' ' A' ' 56' ' ' SER . 70.1 mt -74.71 4.75 5.78 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.577 -0.738 . . . . 1.0 110.197 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.491 ' C ' ' O ' ' A' ' 55' ' ' LEU . 84.2 p 15.02 -113.75 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 115.593 -0.731 . . . . 1.0 112.88 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.41 -143.22 0.01 OUTLIER Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.791 -0.924 . . . . 1.0 110.791 178.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.4 m -151.08 32.25 0.6 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 121.324 -0.15 . . . . 1.0 111.047 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -41.96 101.7 0.25 Allowed Pre-proline 0 CA--C 1.543 0.698 0 CA-C-O 119.625 -0.226 . . . . 1.0 111.394 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -56.02 118.61 5.42 Favored 'Trans proline' 0 N--CA 1.502 2.01 0 C-N-CA 122.607 2.205 . . . . 1.0 112.736 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 149.71 -168.07 29.87 Favored Glycine 0 N--CA 1.465 0.575 0 N-CA-C 110.22 -1.152 . . . . 1.0 110.22 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.47 ' CD ' ' H ' ' A' ' 62' ' ' GLU . 1.2 pm0 -102.62 80.2 1.89 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.375 0.607 . . . . 1.0 109.735 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.438 ' CD2' ' O ' ' A' ' 64' ' ' ASP . 83.7 t60 -90.69 161.37 15.39 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.911 0.862 . . . . 1.0 111.895 -178.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.438 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 69.2 m-20 -88.34 128.1 35.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.126 -0.943 . . . . 1.0 109.432 178.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -122.37 97.7 5.59 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.8 0.81 . . . . 1.0 111.546 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.465 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 39.1 mp0 -59.25 131.72 51.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.969 -1.014 . . . . 1.0 111.463 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.8 t -77.81 128.18 38.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.702 0.763 . . . . 1.0 110.269 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -117.73 137.91 52.38 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.993 0.901 . . . . 1.0 110.346 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.1 t -110.71 129.92 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.038 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -51.14 123.28 19.74 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.45 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.38 88.68 1.13 Allowed 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 122.09 1.86 . . . . 1.0 112.656 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.3 mp -79.72 128.21 75.26 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 120.935 -0.306 . . . . 1.0 110.735 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.404 ' O ' ' ND2' ' A' ' 74' ' ' ASN . 56.3 Cg_endo -71.33 80.99 1.27 Allowed 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 122.151 1.901 . . . . 1.0 112.782 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.404 ' ND2' ' O ' ' A' ' 73' ' ' PRO . 6.2 m-20 167.78 -52.19 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.844 0.354 . . . . 1.0 110.498 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.3 mm -91.23 136.87 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-O 121.879 0.847 . . . . 1.0 110.201 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -96.41 140.38 31.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 122.288 1.042 . . . . 1.0 111.343 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.8 tt -94.93 135.91 27.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.641 -0.709 . . . . 1.0 110.327 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.7 t -105.47 -52.38 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 O-C-N 122.074 -0.391 . . . . 1.0 110.354 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -148.05 -152.41 0.44 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.998 0.904 . . . . 1.0 110.63 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.417 ' O ' ' O ' ' A' ' 81' ' ' SER . 34.2 mt -144.1 -48.24 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.582 -0.735 . . . . 1.0 109.617 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 80' ' ' ILE . 79.3 p 31.04 96.38 0.04 OUTLIER Pre-proline 0 CA--C 1.557 1.219 0 CA-C-O 118.39 -0.814 . . . . 1.0 112.354 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -68.29 -172.15 6.19 Favored 'Cis proline' 0 N--CA 1.501 1.94 0 CA-C-N 120.2 1.107 . . . . 1.0 111.757 1.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -112.09 -30.93 7.05 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.591 -0.731 . . . . 1.0 109.788 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.3 t -149.04 152.57 11.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.162 -0.681 . . . . 1.0 109.162 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.1 p -143.43 140.56 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.604 0.716 . . . . 1.0 111.664 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 60.4 m -95.76 128.96 43.08 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.281 -0.872 . . . . 1.0 110.789 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.6 mt -116.93 167.17 11.36 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.617 -0.719 . . . . 1.0 110.235 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -118.07 116.7 27.4 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.854 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -105.25 130.26 53.43 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.889 0.852 . . . . 1.0 110.253 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.417 ' OE1' ' SD ' ' A' ' 27' ' ' MET . 39.0 tt0 -134.2 136.64 43.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 122.346 1.07 . . . . 1.0 111.149 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.528 ' HD1' ' H ' ' A' ' 91' ' ' HIS . 29.0 p-80 -68.76 116.96 9.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.735 -1.12 . . . . 1.0 110.685 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 85.3 t60 . . . . . 0 N--CA 1.469 0.511 0 CA-C-O 121.027 0.441 . . . . 1.0 110.822 -179.6 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 75.0 p . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 109.674 -0.491 . . . . 1.0 109.674 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.5 m -149.37 149.35 30.72 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.698 -0.482 . . . . 1.0 109.698 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.412 ' N ' ' CD ' ' A' ' 3' ' ' GLN . 27.2 mp0 -75.8 -87.14 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 O-C-N 121.912 -0.493 . . . . 1.0 110.236 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 35.1 p -81.08 -151.12 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.589 0.709 . . . . 1.0 109.27 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 73.07 78.52 0.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 O-C-N 121.92 -0.487 . . . . 1.0 111.315 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.405 ' OD1' ' CD1' ' A' ' 40' ' ' TYR . 52.1 p-10 -137.08 149.12 47.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.44 0.638 . . . . 1.0 109.789 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -39.18 147.15 0.07 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.923 -0.581 . . . . 1.0 111.822 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -55.73 137.32 71.32 Favored Pre-proline 0 CA--C 1.549 0.926 0 O-C-N 121.848 -0.532 . . . . 1.0 112.007 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -72.82 142.0 34.61 Favored 'Trans proline' 0 N--CA 1.503 2.039 0 C-N-CA 122.347 2.031 . . . . 1.0 112.953 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.5 m -113.92 94.78 4.98 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 121.514 0.673 . . . . 1.0 110.013 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 66.4 mt -109.73 143.43 39.52 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.791 0.805 . . . . 1.0 110.394 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.9 t -102.08 133.26 47.19 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.949 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.522 ' N ' ' CD2' ' A' ' 13' ' ' LEU . 0.9 OUTLIER -108.87 139.9 43.08 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.618 0.723 . . . . 1.0 110.457 -179.695 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.1 m -74.55 109.8 8.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.899 -0.591 . . . . 1.0 109.869 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.7 tp -69.41 106.56 2.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.406 0.622 . . . . 1.0 110.878 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.4 pt -111.04 142.29 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-O 121.811 0.815 . . . . 1.0 110.857 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.67 127.13 33.93 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.85 -0.531 . . . . 1.0 111.058 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -115.73 162.13 17.72 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 120.952 0.406 . . . . 1.0 110.201 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 22.4 m120 57.47 34.77 25.07 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.94 -0.393 . . . . 1.0 109.94 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 49.4 m -60.21 114.68 10.54 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-O 119.089 -0.482 . . . . 1.0 111.528 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.8 149.83 18.79 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 121.533 1.489 . . . . 1.0 112.01 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.91 145.1 42.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 122.041 0.924 . . . . 1.0 111.374 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.2 m-20 64.14 18.48 11.28 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.945 -0.571 . . . . 1.0 111.093 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.5 t -110.66 147.17 34.86 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.948 0.88 . . . . 1.0 110.658 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 61.4 ttp -139.12 116.15 10.96 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.624 -0.716 . . . . 1.0 109.982 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 59.0 mt -69.71 149.4 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.978 0.894 . . . . 1.0 110.532 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.515 ' O ' ' OG1' ' A' ' 28' ' ' THR . 1.1 tpt -118.74 63.78 0.77 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.766 0.793 . . . . 1.0 109.58 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.515 ' OG1' ' O ' ' A' ' 27' ' ' MET . 33.7 m -178.02 146.59 0.42 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.104 -0.702 . . . . 1.0 109.104 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -85.04 151.41 24.18 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.295 -0.878 . . . . 1.0 110.444 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 mp -103.79 105.41 47.82 Favored Pre-proline 0 N--CA 1.482 1.166 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.894 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -87.78 152.09 7.36 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.374 2.05 . . . . 1.0 112.688 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 63.0 p -59.19 -179.02 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.653 -0.655 . . . . 1.0 111.19 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.6 p -139.65 144.93 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-O 121.264 0.554 . . . . 1.0 111.077 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 82.3 mtt85 -99.99 125.18 45.98 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.385 -0.598 . . . . 1.0 109.385 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 t -124.23 153.47 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-O 122.557 1.17 . . . . 1.0 111.189 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -124.7 138.16 54.31 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 114.968 -1.015 . . . . 1.0 110.6 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 51.5 p -125.51 131.85 52.73 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.754 -0.657 . . . . 1.0 111.3 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -77.99 47.53 0.65 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.473 0.654 . . . . 1.0 109.886 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.401 ' O ' ' CD1' ' A' ' 40' ' ' TYR . . . -149.53 -169.24 15.72 Favored Glycine 0 N--CA 1.466 0.645 0 N-CA-C 110.572 -1.011 . . . . 1.0 110.572 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.405 ' CD1' ' OD1' ' A' ' 6' ' ' ASP . 0.8 OUTLIER -142.36 108.73 5.29 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.264 0.554 . . . . 1.0 110.232 -179.499 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -119.69 84.35 30.64 Favored Pre-proline 0 N--CA 1.474 0.733 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.475 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -56.3 -19.3 27.49 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.305 2.003 . . . . 1.0 111.862 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.2 t -145.31 -101.71 0.1 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.997 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.1 mm 58.8 37.97 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.856 -0.424 . . . . 1.0 109.856 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 39.45 70.9 0.19 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.89 0.376 . . . . 1.0 111.266 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.1 m -56.23 -14.52 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.048 0.452 . . . . 1.0 110.784 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 48' ' ' GLU . 22.2 p30 -58.94 -33.81 71.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.312 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.494 ' N ' ' OD1' ' A' ' 47' ' ' ASN . 74.6 tt0 -91.0 63.64 5.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.996 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 69.1 mt -148.37 110.68 4.65 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.441 0.638 . . . . 1.0 109.995 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -143.31 156.55 44.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 122.054 0.93 . . . . 1.0 111.865 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -115.78 140.87 48.8 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.82 -1.082 . . . . 1.0 108.416 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 16.7 p90 -141.24 144.62 34.81 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 122.082 0.944 . . . . 1.0 112.24 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.4 m -105.53 156.09 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 114.857 -1.065 . . . . 1.0 108.947 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -97.19 142.8 28.67 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.454 0.645 . . . . 1.0 110.523 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.617 ' C ' ' H ' ' A' ' 57' ' ' GLY . 79.6 mt -131.35 40.46 3.43 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.648 -0.705 . . . . 1.0 110.377 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.7 m -60.01 14.24 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.901 -0.59 . . . . 1.0 111.982 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.617 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . -148.3 159.17 27.94 Favored Glycine 0 N--CA 1.466 0.689 0 N-CA-C 110.444 -1.062 . . . . 1.0 110.444 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.5 t -148.24 130.5 15.57 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.577 0.703 . . . . 1.0 110.976 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.638 ' O ' ' N ' ' A' ' 61' ' ' GLY . 2.1 mt-10 179.91 123.1 0.22 Allowed Pre-proline 0 CA--C 1.55 0.943 0 CA-C-N 115.677 -0.692 . . . . 1.0 110.657 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -45.57 71.42 0.01 OUTLIER 'Trans proline' 0 N--CA 1.511 2.531 0 C-N-CA 122.524 2.149 . . . . 1.0 113.939 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.638 ' N ' ' O ' ' A' ' 59' ' ' GLU . . . -145.27 155.68 26.6 Favored Glycine 0 N--CA 1.47 0.951 0 N-CA-C 110.349 -1.1 . . . . 1.0 110.349 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -86.09 87.1 7.36 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 122.302 -0.529 . . . . 1.0 109.768 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.505 ' ND1' ' CE1' ' A' ' 65' ' ' TYR . 61.1 t-80 -92.38 137.51 32.31 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.548 0.69 . . . . 1.0 112.342 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -90.42 115.93 27.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.623 -0.717 . . . . 1.0 109.212 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.505 ' CE1' ' ND1' ' A' ' 63' ' ' HIS . 71.1 m-85 -104.75 135.22 46.54 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.878 0.847 . . . . 1.0 111.455 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -81.06 142.09 33.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.899 -1.046 . . . . 1.0 111.252 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.9 t -74.94 117.5 19.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.373 0.606 . . . . 1.0 110.417 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -106.73 114.8 29.12 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 122.334 1.064 . . . . 1.0 109.886 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.3 t -85.52 169.27 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 115.57 -0.741 . . . . 1.0 110.871 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -94.4 111.8 55.11 Favored Pre-proline 0 CA--C 1.553 1.09 0 CA-C-N 115.668 -0.696 . . . . 1.0 109.833 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -48.09 131.3 21.53 Favored 'Trans proline' 0 N--CA 1.506 2.217 0 C-N-CA 121.782 1.654 . . . . 1.0 112.859 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.8 mt -99.54 109.51 55.42 Favored Pre-proline 0 CA--C 1.554 1.099 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.792 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.97 55.63 3.43 Favored 'Trans proline' 0 N--CA 1.506 2.246 0 C-N-CA 122.069 1.846 . . . . 1.0 113.095 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -175.09 -44.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.242 0.544 . . . . 1.0 110.882 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.545 ' CG2' ' H ' ' A' ' 76' ' ' LYS . 63.7 mt -112.63 174.22 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-O 121.559 0.695 . . . . 1.0 110.114 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.545 ' H ' ' CG2' ' A' ' 75' ' ' ILE . 60.5 tttp -117.83 156.44 28.37 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 122.583 1.182 . . . . 1.0 111.238 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.9 tt -99.39 153.17 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 115.367 -0.833 . . . . 1.0 109.966 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.9 t -108.14 -49.68 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 122.142 -0.349 . . . . 1.0 110.665 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -179.69 -175.99 0.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 122.316 1.055 . . . . 1.0 110.52 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.404 HG23 ' H ' ' A' ' 81' ' ' SER . 3.4 mt -129.86 167.42 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 122.15 0.976 . . . . 1.0 109.307 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.404 ' H ' HG23 ' A' ' 80' ' ' ILE . 33.7 t -167.04 106.09 0.63 Allowed Pre-proline 0 CA--C 1.554 1.131 0 CA-C-O 118.438 -0.791 . . . . 1.0 111.452 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -62.39 -173.78 2.74 Favored 'Cis proline' 0 N--CA 1.507 2.283 0 CA-C-N 120.191 1.104 . . . . 1.0 111.528 -0.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -118.54 -23.51 7.11 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.516 0.674 . . . . 1.0 109.191 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 t -144.36 149.85 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.1 m -136.39 157.11 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-O 121.75 0.786 . . . . 1.0 111.567 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 71.7 m -109.1 119.13 38.6 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.174 -0.921 . . . . 1.0 110.613 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.8 mt -122.7 126.22 47.14 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.701 -0.682 . . . . 1.0 110.222 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -83.64 130.52 34.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.587 0.708 . . . . 1.0 110.255 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -104.02 136.15 44.19 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.652 0.739 . . . . 1.0 110.297 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -138.1 140.45 39.97 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.331 1.063 . . . . 1.0 111.053 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -67.18 167.33 12.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.842 -1.072 . . . . 1.0 110.644 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.452 ' CG ' ' N ' ' A' ' 93' ' ' HIS . 57.8 t-80 -142.57 164.47 30.03 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.653 0.739 . . . . 1.0 110.972 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.452 ' N ' ' CG ' ' A' ' 92' ' ' HIS . 84.8 t60 55.07 93.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.286 0.565 . . . . 1.0 110.392 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -63.4 75.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.485 . . . . 1.0 111.214 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.433 ' N ' ' O ' ' A' ' 93' ' ' HIS . 60.8 m80 52.62 -174.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.631 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.988 -1.006 . . . . 1.0 110.48 179.839 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 43.2 t . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.504 -0.554 . . . . 1.0 109.504 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.7 m -68.27 138.58 55.63 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.846 -0.427 . . . . 1.0 109.846 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.464 ' NE2' ' OH ' ' A' ' 40' ' ' TYR . 1.1 pt20 -84.15 -68.88 0.68 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.08 0.467 . . . . 1.0 109.827 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.5 p -75.62 168.86 19.22 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.857 -0.423 . . . . 1.0 109.857 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 51.4 mt -62.65 -45.86 90.88 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 121.938 -0.476 . . . . 1.0 111.065 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 53.4 p-10 -169.12 171.41 8.13 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.818 -0.438 . . . . 1.0 109.818 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -36.24 -64.96 0.29 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.793 0.664 . . . . 1.0 112.793 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.32 118.14 50.36 Favored Pre-proline 0 CA--C 1.549 0.908 0 O-C-N 121.85 -0.531 . . . . 1.0 112.159 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.47 141.79 35.57 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 CA-C-N 120.404 1.18 . . . . 1.0 113.392 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.1 m -107.36 157.4 17.98 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.575 0.702 . . . . 1.0 110.024 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.09 139.41 28.89 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.445 0.64 . . . . 1.0 110.428 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.3 m -123.5 120.19 32.16 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.509 0.671 . . . . 1.0 110.571 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 35.7 mt -130.52 134.08 46.77 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.454 -0.794 . . . . 1.0 110.027 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.5 m -58.67 179.58 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.6 tp -120.33 112.99 19.71 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-O 121.602 0.715 . . . . 1.0 111.043 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.5 pt -116.78 154.26 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-O 121.809 0.814 . . . . 1.0 110.763 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.82 125.56 41.35 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.806 -0.559 . . . . 1.0 110.536 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.483 ' O ' ' O ' ' A' ' 19' ' ' ASN . 63.9 tttm -119.7 137.68 53.76 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.615 0.721 . . . . 1.0 109.707 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 18' ' ' LYS . 82.3 m-20 43.53 100.84 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.993 -0.549 . . . . 1.0 110.876 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.3 m -136.55 132.43 18.7 Favored Pre-proline 0 N--CA 1.479 0.979 0 CA-C-O 119.45 -0.31 . . . . 1.0 111.577 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -36.84 95.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 121.641 1.561 . . . . 1.0 112.541 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -39.33 161.79 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.53 0.681 . . . . 1.0 111.869 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 72.61 12.19 5.47 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 122.006 -0.433 . . . . 1.0 110.746 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.7 p -133.51 153.75 51.38 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.745 0.783 . . . . 1.0 110.661 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 47.8 ttp -143.74 138.6 28.93 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.46 0.647 . . . . 1.0 110.184 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 69.9 mt -75.02 154.12 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.611 0.72 . . . . 1.0 111.047 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.6 ttt -107.13 -28.01 10.24 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 121.391 0.615 . . . . 1.0 109.859 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.0 m -64.75 138.2 58.24 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.575 -0.528 . . . . 1.0 109.575 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -66.99 -6.74 18.14 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.287 -0.883 . . . . 1.0 111.261 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.2 mt 59.38 95.24 0.05 OUTLIER Pre-proline 0 CA--C 1.548 0.868 0 CA-C-O 118.736 -0.649 . . . . 1.0 111.864 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -85.99 154.91 9.87 Favored 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 122.649 2.233 . . . . 1.0 112.744 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.6 m -57.89 175.59 0.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.614 -0.679 . . . . 1.0 111.26 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.6 m -132.59 133.46 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-O 121.317 0.58 . . . . 1.0 111.091 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -104.98 126.84 52.48 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -130.07 155.63 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 122.163 0.982 . . . . 1.0 111.2 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -119.52 138.8 52.94 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.426 -0.807 . . . . 1.0 110.165 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.5 p -129.97 141.93 50.7 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 115.855 -0.611 . . . . 1.0 110.723 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -82.77 164.23 20.75 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.719 -0.474 . . . . 1.0 109.719 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.51 -157.88 18.13 Favored Glycine 0 N--CA 1.472 1.07 0 N-CA-C 110.827 -0.909 . . . . 1.0 110.827 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.464 ' OH ' ' NE2' ' A' ' 3' ' ' GLN . 68.1 t80 -152.77 98.79 2.38 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.471 0.653 . . . . 1.0 110.829 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.46 ' C ' ' H ' ' A' ' 43' ' ' SER . 0.1 OUTLIER -174.42 75.08 0.34 Allowed Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.497 179.743 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.4 38.88 0.35 Allowed 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 121.691 1.594 . . . . 1.0 111.86 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.46 ' H ' ' C ' ' A' ' 41' ' ' ASN . 38.7 m -170.11 97.14 0.28 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.413 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.1 mt -127.96 53.56 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 109.805 -0.442 . . . . 1.0 109.805 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.552 ' C ' ' H ' ' A' ' 47' ' ' ASN . 4.7 p-10 39.43 56.98 2.17 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.499 -0.319 . . . . 1.0 111.235 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.3 m -70.14 35.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.052 0.453 . . . . 1.0 111.098 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.552 ' H ' ' C ' ' A' ' 45' ' ' ASN . 70.9 m-20 -59.97 -24.18 64.2 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.295 -0.412 . . . . 1.0 110.577 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.513 ' O ' ' C ' ' A' ' 49' ' ' LEU . 96.4 mt-10 -124.38 -54.85 1.67 Allowed 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.934 -0.576 . . . . 1.0 110.009 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.513 ' C ' ' O ' ' A' ' 48' ' ' GLU . 9.1 mp -25.42 113.7 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.074 0.464 . . . . 1.0 110.845 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -141.76 -171.86 3.43 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.898 0.856 . . . . 1.0 111.551 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.455 ' O ' ' CG ' ' A' ' 52' ' ' TYR . . . -93.19 158.02 15.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.928 -1.033 . . . . 1.0 108.321 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.455 ' CG ' ' O ' ' A' ' 51' ' ' ALA . 91.8 m-85 -153.6 157.84 40.29 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 122.273 1.035 . . . . 1.0 111.889 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.3 147.22 22.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 114.64 -1.164 . . . . 1.0 109.357 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.402 ' N ' ' OD1' ' A' ' 54' ' ' ASP . 23.0 p-10 -115.88 106.23 13.58 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.452 0.644 . . . . 1.0 110.606 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.524 ' C ' ' H ' ' A' ' 57' ' ' GLY . 24.4 mt -104.77 32.77 3.93 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.802 -0.635 . . . . 1.0 110.179 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 88.9 p -62.4 8.71 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.849 -0.614 . . . . 1.0 111.859 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.524 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . -88.88 -168.73 44.18 Favored Glycine 0 N--CA 1.47 0.959 0 N-CA-C 110.84 -0.904 . . . . 1.0 110.84 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 82.0 p -162.41 76.71 0.47 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.413 0.625 . . . . 1.0 111.446 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -138.13 88.03 15.68 Favored Pre-proline 0 N--CA 1.472 0.666 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.589 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -48.09 108.76 0.19 Allowed 'Trans proline' 0 N--CA 1.504 2.11 0 C-N-CA 122.364 2.043 . . . . 1.0 112.775 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.74 -165.04 25.41 Favored Glycine 0 N--CA 1.47 0.909 0 N-CA-C 110.343 -1.103 . . . . 1.0 110.343 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.477 ' CD ' ' H ' ' A' ' 62' ' ' GLU . 0.9 OUTLIER -71.77 142.89 49.7 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.261 -0.552 . . . . 1.0 109.641 179.477 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.45 ' O ' ' CD1' ' A' ' 65' ' ' TYR . 62.7 t-80 -161.12 126.02 3.6 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.149 -0.62 . . . . 1.0 112.45 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -77.24 117.32 18.65 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.806 -0.813 . . . . 1.0 108.806 178.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.45 ' CD1' ' O ' ' A' ' 63' ' ' HIS . 91.4 m-85 -94.38 -122.77 0.1 Allowed 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.985 -0.447 . . . . 1.0 111.821 -178.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -160.3 130.68 5.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.127 0.489 . . . . 1.0 110.732 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.7 t -92.94 115.94 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.122 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -142.27 151.83 42.42 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.742 0.782 . . . . 1.0 110.487 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.6 t -134.63 157.39 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-O 121.405 0.622 . . . . 1.0 111.201 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -58.26 147.28 67.6 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 115.575 -0.738 . . . . 1.0 110.681 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -73.64 162.08 40.56 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 121.892 1.728 . . . . 1.0 112.417 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.84 101.41 12.82 Favored Pre-proline 0 N--CA 1.48 1.048 0 CA-C-N 115.3 -0.864 . . . . 1.0 110.526 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -50.04 140.33 32.33 Favored 'Trans proline' 0 N--CA 1.502 2.026 0 C-N-CA 121.31 1.34 . . . . 1.0 113.064 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.432 ' N ' ' ND2' ' A' ' 74' ' ' ASN . 1.1 m120 78.88 -11.9 1.15 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.555 0.742 . . . . 1.0 111.318 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 42.9 mm -125.96 153.17 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 122.276 1.036 . . . . 1.0 110.006 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -121.65 158.5 28.53 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 122.751 1.262 . . . . 1.0 110.735 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.6 tt -99.3 95.88 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 115.125 -0.943 . . . . 1.0 109.813 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.7 t -44.91 -53.48 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 O-C-N 121.975 -0.453 . . . . 1.0 110.893 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -167.8 -146.2 0.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.685 0.755 . . . . 1.0 110.559 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.9 mt -148.63 157.18 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 109.238 -0.653 . . . . 1.0 109.238 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 82' ' ' PRO . 43.3 t -163.17 101.05 1.0 Allowed Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 118.434 -0.793 . . . . 1.0 111.672 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.474 ' O ' ' N ' ' A' ' 81' ' ' SER . 24.0 Cg_exo -63.97 -166.31 1.35 Allowed 'Cis proline' 0 N--CA 1.511 2.541 0 CA-C-N 120.134 1.083 . . . . 1.0 111.393 -0.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -129.81 -18.7 3.4 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.446 0.641 . . . . 1.0 109.512 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.2 t -142.86 135.7 25.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.889 -0.782 . . . . 1.0 108.889 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.9 m -130.65 146.34 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-O 121.841 0.829 . . . . 1.0 111.376 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.0 t -106.29 131.99 52.86 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.071 -0.968 . . . . 1.0 110.49 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 35.1 mt -134.26 126.2 29.32 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.056 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -91.7 122.11 33.96 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.484 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.7 mt -93.43 140.69 29.3 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.415 0.626 . . . . 1.0 109.972 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -133.06 144.68 50.17 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.954 0.883 . . . . 1.0 111.2 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -69.67 144.56 52.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.195 -0.911 . . . . 1.0 110.809 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -73.64 96.6 2.5 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.634 0.73 . . . . 1.0 110.81 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -85.59 -9.0 57.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 1.0 109.948 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -66.64 -30.28 70.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.795 0.331 . . . . 1.0 110.887 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.45 ' O ' ' ND1' ' A' ' 96' ' ' HIS . 28.2 t60 -59.02 -40.67 85.7 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.83 -0.433 . . . . 1.0 109.83 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.45 ' ND1' ' O ' ' A' ' 95' ' ' HIS . 73.1 m-70 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 117.927 -1.035 . . . . 1.0 109.82 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 93.4 p . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.51 -0.552 . . . . 1.0 109.51 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.3 m -61.03 -74.42 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.089 0.471 . . . . 1.0 110.828 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -135.5 -174.13 3.55 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.252 0.549 . . . . 1.0 110.17 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.9 p 49.97 38.39 16.26 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.848 0.832 . . . . 1.0 110.124 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 55.9 tp -59.31 -59.21 5.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 1.0 111.116 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 53.3 p-10 -75.74 50.53 0.57 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.313 0.578 . . . . 1.0 110.442 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 42.69 -125.1 0.73 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.064 -0.516 . . . . 1.0 111.641 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 40.03 84.36 0.18 Allowed Pre-proline 0 CA--C 1.538 0.499 0 O-C-N 121.833 -0.542 . . . . 1.0 112.119 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.35 135.17 64.53 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.3 2.0 . . . . 1.0 112.954 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 68.2 m -127.96 122.56 32.65 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.679 0.752 . . . . 1.0 109.827 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.4 mt -137.02 164.66 27.84 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.647 0.737 . . . . 1.0 110.509 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.2 m -101.54 128.35 47.83 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.348 0.594 . . . . 1.0 110.282 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 tp -123.4 153.56 40.22 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.61 -0.723 . . . . 1.0 110.227 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.442 ' HG ' ' N ' ' A' ' 15' ' ' LEU . 47.1 t -106.18 152.24 23.72 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.03 0.443 . . . . 1.0 109.906 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.442 ' N ' ' HG ' ' A' ' 14' ' ' SER . 1.5 pp -119.71 117.48 28.36 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.353 0.596 . . . . 1.0 111.035 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.3 pt -110.99 163.08 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-O 121.724 0.773 . . . . 1.0 110.713 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.76 116.46 24.04 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.89 -0.506 . . . . 1.0 110.944 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.5 mmtt -61.15 -32.67 72.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.91 0.386 . . . . 1.0 110.68 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -144.54 76.06 1.48 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.133 0.492 . . . . 1.0 110.252 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.1 m -60.47 116.07 16.33 Favored Pre-proline 0 CA--C 1.554 1.119 0 CA-C-O 118.873 -0.584 . . . . 1.0 111.385 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.96 138.17 52.35 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 120.926 1.084 . . . . 1.0 111.846 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.47 152.5 43.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.922 0.868 . . . . 1.0 111.592 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.4 m-20 69.08 6.28 5.56 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.097 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.0 p -100.73 145.64 28.22 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.61 0.719 . . . . 1.0 110.785 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -136.61 116.4 13.09 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.506 0.67 . . . . 1.0 110.332 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 65.7 mt -69.32 148.43 11.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.828 0.823 . . . . 1.0 110.828 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 46.9 mtt -114.23 -35.67 4.93 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.677 -0.692 . . . . 1.0 109.935 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.6 m -79.78 147.92 31.64 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.498 -0.556 . . . . 1.0 109.498 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -78.68 150.9 32.47 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.289 -0.882 . . . . 1.0 110.069 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 tp -76.39 112.7 22.84 Favored Pre-proline 0 CA--C 1.557 1.214 0 CA-C-N 115.678 -0.692 . . . . 1.0 111.983 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -90.53 151.7 4.33 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 121.456 1.437 . . . . 1.0 112.567 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.3 p -84.03 170.16 14.2 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.618 -0.676 . . . . 1.0 110.834 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.2 p -135.88 136.54 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 121.558 0.694 . . . . 1.0 110.949 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 42.4 mtm105 -98.24 130.99 44.95 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.929 -0.578 . . . . 1.0 109.464 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 t -124.24 128.59 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 121.963 0.887 . . . . 1.0 111.428 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -97.43 153.33 18.18 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.534 -0.757 . . . . 1.0 110.341 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 16.1 p -131.9 133.08 44.19 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.166 0.507 . . . . 1.0 111.315 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -80.75 47.04 0.93 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.245 0.545 . . . . 1.0 109.648 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.54 -171.71 34.65 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 110.558 -1.017 . . . . 1.0 110.558 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.53 ' CD2' ' N ' ' A' ' 41' ' ' ASN . 62.4 t80 -107.6 164.36 12.29 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.473 0.654 . . . . 1.0 110.636 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.53 ' N ' ' CD2' ' A' ' 40' ' ' TYR . 4.8 p30 -114.3 90.76 21.47 Favored Pre-proline 0 N--CA 1.477 0.923 0 CA-C-N 116.147 -0.478 . . . . 1.0 111.056 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -50.78 -41.5 54.49 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 121.746 1.631 . . . . 1.0 112.025 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.9 t -171.27 42.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.576 0.227 . . . . 1.0 110.732 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.7 tt -58.64 126.77 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.978 0.418 . . . . 1.0 110.415 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.522 ' C ' ' H ' ' A' ' 47' ' ' ASN . 44.6 p-10 -99.96 86.13 3.2 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.947 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.9 m -72.25 33.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.99 0.424 . . . . 1.0 110.675 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.522 ' H ' ' C ' ' A' ' 45' ' ' ASN . 71.5 m-80 -100.99 -10.22 20.76 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.311 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -131.53 1.84 4.11 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.469 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.608 ' O ' ' CG ' ' A' ' 50' ' ' PHE . 51.1 mt -95.81 154.85 17.01 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.608 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 70.3 m-85 -165.72 174.21 9.96 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.795 0.807 . . . . 1.0 111.694 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.432 ' C ' ' CG ' ' A' ' 52' ' ' TYR . . . -111.64 169.94 8.47 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.052 -0.976 . . . . 1.0 108.431 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.432 ' CG ' ' C ' ' A' ' 51' ' ' ALA . 22.8 m-85 -151.23 169.58 21.58 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 122.181 0.991 . . . . 1.0 112.134 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.3 m -136.26 144.77 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 114.73 -1.123 . . . . 1.0 109.496 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -85.58 83.49 7.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.404 0.621 . . . . 1.0 110.374 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 57' ' ' GLY . 1.2 mp -94.15 -26.8 16.54 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.603 -0.726 . . . . 1.0 109.769 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 55' ' ' LEU . 47.5 t 29.61 -90.26 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.644 0.735 . . . . 1.0 112.336 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . -129.07 71.49 0.49 Allowed Glycine 0 N--CA 1.472 1.06 0 N-CA-C 111.039 -0.824 . . . . 1.0 111.039 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.479 ' HG ' ' N ' ' A' ' 59' ' ' GLU . 27.8 t -83.26 163.41 20.74 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.728 0.775 . . . . 1.0 111.343 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.479 ' N ' ' HG ' ' A' ' 58' ' ' SER . 36.5 mp0 -130.93 148.75 71.5 Favored Pre-proline 0 N--CA 1.48 1.062 0 CA-C-N 115.593 -0.73 . . . . 1.0 111.255 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -39.79 144.06 0.37 Allowed 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 122.064 1.843 . . . . 1.0 113.387 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 142.27 -137.68 8.02 Favored Glycine 0 N--CA 1.468 0.809 0 N-CA-C 110.517 -1.033 . . . . 1.0 110.517 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -140.09 69.93 1.36 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.322 0.582 . . . . 1.0 109.553 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -93.03 130.84 38.48 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.09 -0.505 . . . . 1.0 112.124 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -82.41 142.01 32.3 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.117 -0.697 . . . . 1.0 109.117 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -133.2 136.45 45.66 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.753 0.787 . . . . 1.0 111.675 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -73.19 135.78 44.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.07 -0.968 . . . . 1.0 111.485 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.83 129.02 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.173 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -121.01 149.58 42.45 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.816 0.817 . . . . 1.0 110.513 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.1 t -124.54 137.54 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 115.978 -0.555 . . . . 1.0 111.316 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -63.05 115.24 16.08 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-O 118.483 -0.77 . . . . 1.0 110.26 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.8 136.17 42.82 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 CA-C-N 120.281 1.136 . . . . 1.0 113.032 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.5 mp -91.73 115.99 65.61 Favored Pre-proline 0 CA--C 1.553 1.07 0 CA-C-N 115.481 -0.781 . . . . 1.0 110.442 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -50.41 134.66 39.07 Favored 'Trans proline' 0 N--CA 1.506 2.226 0 C-N-CA 120.968 1.112 . . . . 1.0 113.496 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 67.59 4.87 4.05 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.417 0.687 . . . . 1.0 111.436 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.4 mm -138.26 154.36 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 122.319 1.057 . . . . 1.0 109.721 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -127.34 165.47 19.67 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 122.425 1.107 . . . . 1.0 111.074 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.8 pt -118.49 121.5 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 115.471 -0.786 . . . . 1.0 109.887 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 80.2 t -56.1 -50.58 69.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 O-C-N 122.086 -0.384 . . . . 1.0 110.378 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 177.67 147.61 0.14 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 122.198 0.999 . . . . 1.0 110.418 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 16.3 pt -84.52 172.1 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.347 -0.842 . . . . 1.0 109.789 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 t -178.26 119.13 0.25 Allowed Pre-proline 0 CA--C 1.552 1.027 0 CA-C-O 117.941 -1.028 . . . . 1.0 111.438 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -65.38 141.22 48.09 Favored 'Cis proline' 0 N--CA 1.509 2.411 0 CA-C-N 120.657 1.27 . . . . 1.0 111.444 -1.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -76.58 -18.02 58.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.769 0.795 . . . . 1.0 109.546 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.2 t -137.01 143.96 33.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.937 -0.764 . . . . 1.0 108.937 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.9 m -135.24 160.15 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.832 0.825 . . . . 1.0 111.469 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 58.1 m -116.08 130.2 56.69 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.021 -0.99 . . . . 1.0 110.365 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 83.0 mt -134.62 123.15 23.33 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.681 -0.691 . . . . 1.0 110.034 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -93.69 123.9 37.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.497 0.665 . . . . 1.0 110.145 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 64.9 mt -105.76 157.61 17.32 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.657 -0.701 . . . . 1.0 110.129 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -145.89 138.13 25.4 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.606 0.717 . . . . 1.0 111.023 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -69.49 143.46 53.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.564 -0.744 . . . . 1.0 110.324 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -56.2 136.63 52.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.53 0.681 . . . . 1.0 111.019 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -70.13 127.28 32.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.264 0.554 . . . . 1.0 110.374 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 46.8 m170 -87.83 133.41 33.9 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.285 0.565 . . . . 1.0 111.066 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.444 ' CD2' ' N ' ' A' ' 95' ' ' HIS . 0.4 OUTLIER -170.84 33.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 1.0 109.824 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.476 ' N ' ' HD1' ' A' ' 96' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 117.951 -1.023 . . . . 1.0 110.262 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.7 p . . . . . 0 N--CA 1.487 1.411 0 N-CA-C 109.452 -0.573 . . . . 1.0 109.452 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.8 t -165.61 -57.14 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.727 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 54.31 75.74 0.27 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.303 0.573 . . . . 1.0 110.222 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.8 m 56.41 105.09 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.668 -0.493 . . . . 1.0 109.668 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 53.6 tp -145.53 -60.45 0.34 Allowed 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.973 -0.455 . . . . 1.0 110.839 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.456 ' CG ' ' H ' ' A' ' 7' ' ' ARG . 26.2 t0 57.41 175.31 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.987 0.422 . . . . 1.0 110.369 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.456 ' H ' ' CG ' ' A' ' 6' ' ' ASP . 54.8 mmm-85 -136.05 139.04 42.76 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.661 0.743 . . . . 1.0 111.702 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 41.57 97.23 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 123.36 0.664 . . . . 1.0 112.0 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.6 140.98 54.32 Favored 'Trans proline' 0 N--CA 1.498 1.783 0 C-N-CA 122.403 2.069 . . . . 1.0 113.111 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 71.4 m -129.52 107.85 9.79 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.528 0.68 . . . . 1.0 110.228 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 60.5 mt -110.61 159.67 17.36 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.795 0.807 . . . . 1.0 110.439 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.9 m -119.58 120.67 37.4 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.538 0.685 . . . . 1.0 110.72 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.8 132.56 53.33 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.419 -0.81 . . . . 1.0 110.093 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.0 m -65.33 160.04 22.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.075 -0.511 . . . . 1.0 109.863 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.2 tp -113.44 126.91 55.86 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.5 0.667 . . . . 1.0 110.856 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.5 pt -117.53 179.75 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.707 0.765 . . . . 1.0 111.017 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.69 115.27 29.27 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.284 0.564 . . . . 1.0 111.197 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -113.44 166.23 11.7 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.321 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 48.8 26.83 1.38 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.875 0.369 . . . . 1.0 110.015 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.9 m -63.94 129.7 94.04 Favored Pre-proline 0 CA--C 1.547 0.843 0 CA-C-O 119.057 -0.497 . . . . 1.0 112.175 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.28 141.28 56.18 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 121.753 1.635 . . . . 1.0 111.427 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.41 149.08 49.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 122.125 0.964 . . . . 1.0 111.232 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 74.41 6.22 4.59 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.881 -0.6 . . . . 1.0 111.195 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.6 p -113.21 146.4 39.37 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.794 0.807 . . . . 1.0 110.745 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 24.6 ptm -142.6 139.9 31.49 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.518 0.675 . . . . 1.0 110.14 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 75.6 mt -88.33 145.81 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.697 0.761 . . . . 1.0 111.027 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 20.8 ttt -111.83 -23.5 10.54 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.781 -0.645 . . . . 1.0 109.511 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.534 ' HG1' ' H ' ' A' ' 88' ' ' GLN . 24.1 p -87.7 121.95 30.76 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.501 0.667 . . . . 1.0 109.242 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -63.84 141.47 58.76 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.271 -0.893 . . . . 1.0 110.869 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.401 ' N ' ' CD1' ' A' ' 30' ' ' LEU . 10.7 mp -81.56 118.09 70.8 Favored Pre-proline 0 CA--C 1.554 1.123 0 N-CA-C 112.238 0.459 . . . . 1.0 112.238 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -86.2 162.79 9.98 Favored 'Trans proline' 0 N--CA 1.501 1.957 0 C-N-CA 122.383 2.056 . . . . 1.0 112.793 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 56.5 m -70.44 168.52 15.97 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.563 -0.711 . . . . 1.0 111.259 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.9 p -136.82 139.11 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-O 121.427 0.632 . . . . 1.0 111.116 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 80' ' ' ILE . 1.6 mpt_? -102.38 124.41 47.89 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.134 -0.691 . . . . 1.0 109.134 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.5 t -120.33 125.69 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 122.0 0.905 . . . . 1.0 111.132 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -98.59 147.04 25.21 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.288 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 70.4 p -129.39 131.28 46.78 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.492 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -53.78 -72.52 0.06 Allowed 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.723 0.773 . . . . 1.0 110.139 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.21 -171.93 0.09 OUTLIER Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.009 -0.837 . . . . 1.0 111.009 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -106.24 175.89 5.35 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.658 0.742 . . . . 1.0 110.944 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -136.42 74.28 54.4 Favored Pre-proline 0 N--CA 1.472 0.644 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.644 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -52.09 -37.72 69.17 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 C-N-CA 122.29 1.993 . . . . 1.0 111.892 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 44' ' ' ILE . 70.8 m -146.55 -97.69 0.09 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.383 -0.372 . . . . 1.0 110.832 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 43' ' ' SER . 68.7 mt 59.12 128.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.897 0.38 . . . . 1.0 110.086 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.524 ' ND2' ' N ' ' A' ' 45' ' ' ASN . 0.1 OUTLIER -56.34 90.64 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.194 0.521 . . . . 1.0 110.772 -179.847 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.1 t -57.11 -17.05 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.017 0.437 . . . . 1.0 110.867 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -83.17 12.22 5.46 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.395 0.617 . . . . 1.0 110.182 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -132.93 54.86 1.93 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.205 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 85.4 mt -144.03 110.33 5.47 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.974 -0.557 . . . . 1.0 109.721 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -147.79 157.4 43.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 122.022 0.915 . . . . 1.0 111.791 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -119.25 139.39 51.96 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.871 -1.059 . . . . 1.0 108.433 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -117.56 168.39 10.45 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 122.536 1.16 . . . . 1.0 112.1 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.3 m -123.93 139.32 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 114.458 -1.246 . . . . 1.0 109.367 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.486 ' C ' ' H ' ' A' ' 56' ' ' SER . 40.0 p-10 -99.79 78.49 2.14 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.565 0.697 . . . . 1.0 110.484 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 56' ' ' SER . 23.9 mt -71.86 45.94 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.539 -0.755 . . . . 1.0 109.844 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.486 ' H ' ' C ' ' A' ' 54' ' ' ASP . 14.6 m -57.55 -142.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.329 0.585 . . . . 1.0 111.16 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.497 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . 30.75 -112.94 0.05 OUTLIER Glycine 0 N--CA 1.472 1.067 0 N-CA-C 111.121 -0.792 . . . . 1.0 111.121 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 1.9 p 154.55 -5.21 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 115.632 -0.284 . . . . 1.0 111.354 178.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.557 ' CD ' ' H ' ' A' ' 59' ' ' GLU . 8.6 mp0 -37.91 95.86 0.1 Allowed Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 111.762 0.282 . . . . 1.0 111.762 -178.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -62.64 138.47 70.02 Favored 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 122.483 2.122 . . . . 1.0 112.489 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 141.47 -117.54 1.22 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.608 -0.997 . . . . 1.0 110.608 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -137.53 73.77 1.46 Allowed 'General case' 0 N--CA 1.477 0.878 0 O-C-N 122.239 -0.565 . . . . 1.0 109.952 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -88.32 136.03 33.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.827 0.822 . . . . 1.0 112.247 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.406 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 32.7 p-10 -82.99 110.26 17.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.24 -0.891 . . . . 1.0 109.029 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -97.12 159.49 14.88 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.839 0.828 . . . . 1.0 111.626 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -104.58 141.39 36.49 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.934 -1.03 . . . . 1.0 111.296 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.7 t -80.01 124.47 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.43 0.634 . . . . 1.0 110.232 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -100.42 88.86 3.77 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.646 0.736 . . . . 1.0 110.297 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.5 t -86.71 134.75 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.044 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -74.35 146.54 84.23 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.51 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.58 154.72 64.31 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 122.371 2.047 . . . . 1.0 112.198 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.3 mt -112.43 123.25 34.52 Favored Pre-proline 0 N--CA 1.48 1.032 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.721 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.95 135.71 23.75 Favored 'Trans proline' 0 N--CA 1.504 2.098 0 C-N-CA 121.853 1.702 . . . . 1.0 112.392 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 79.48 -15.12 0.79 Allowed 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.39 0.676 . . . . 1.0 111.258 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.7 mm -120.8 146.17 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-O 122.077 0.941 . . . . 1.0 110.005 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -110.19 112.48 24.47 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 122.061 0.934 . . . . 1.0 111.167 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.8 tt -59.72 146.32 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-O 121.391 0.615 . . . . 1.0 110.094 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 68.6 t -103.66 -42.39 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 122.004 -0.435 . . . . 1.0 110.741 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -172.98 175.36 3.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.923 0.868 . . . . 1.0 110.776 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.422 ' O ' ' O ' ' A' ' 34' ' ' ARG . 61.9 mt -110.23 -77.61 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 115.648 -0.706 . . . . 1.0 109.767 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 80' ' ' ILE . 88.3 p 54.97 108.35 0.02 OUTLIER Pre-proline 0 CA--C 1.549 0.939 0 CA-C-O 118.228 -0.891 . . . . 1.0 112.213 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -68.93 122.02 5.38 Favored 'Cis proline' 0 N--CA 1.503 2.044 0 CA-C-N 120.373 1.169 . . . . 1.0 111.794 0.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 91.8 mtm180 -68.71 -34.21 75.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.929 0.871 . . . . 1.0 109.428 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.5 t -130.32 142.51 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.469 0.707 . . . . 1.0 109.117 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.4 m -135.51 153.61 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-O 121.766 0.793 . . . . 1.0 111.746 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 38.4 m -107.29 120.77 43.06 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.17 -0.923 . . . . 1.0 110.602 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 60.0 mt -126.75 134.64 50.58 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.349 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.534 ' H ' ' HG1' ' A' ' 28' ' ' THR . 57.4 tt0 -93.25 131.15 38.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.352 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.1 mt -112.98 140.27 47.94 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.362 0.601 . . . . 1.0 110.085 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -139.1 152.21 47.31 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.894 0.854 . . . . 1.0 111.067 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -69.12 139.74 54.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.153 -0.93 . . . . 1.0 110.826 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -69.18 98.32 1.01 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.666 0.746 . . . . 1.0 111.078 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -76.24 101.99 5.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.225 0.536 . . . . 1.0 110.382 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -165.21 128.98 2.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.815 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.464 ' CG ' ' N ' ' A' ' 96' ' ' HIS . 39.3 p-80 -58.83 -49.08 79.04 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.033 -0.358 . . . . 1.0 110.033 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.464 ' N ' ' CG ' ' A' ' 95' ' ' HIS . 81.3 t60 . . . . . 0 C--O 1.219 -0.526 0 CA-C-O 117.915 -1.041 . . . . 1.0 109.807 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.4 t . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 109.47 -0.567 . . . . 1.0 109.47 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.9 t 55.37 -174.49 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.954 -0.387 . . . . 1.0 109.954 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -71.41 123.22 21.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.554 0.692 . . . . 1.0 110.116 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.9 m -155.91 74.64 0.87 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.584 0.707 . . . . 1.0 109.626 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.565 ' C ' ' H ' ' A' ' 7' ' ' ARG . 0.6 OUTLIER -156.16 -163.71 1.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.125 0.488 . . . . 1.0 110.669 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.8 t0 71.27 -34.15 0.29 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.064 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.565 ' H ' ' C ' ' A' ' 5' ' ' LEU . 88.5 mtm180 46.22 103.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.187 0.518 . . . . 1.0 111.765 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 53.03 83.16 0.23 Allowed Pre-proline 0 CA--C 1.54 0.586 0 O-C-N 121.814 -0.554 . . . . 1.0 112.288 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.69 147.72 78.31 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 122.678 2.252 . . . . 1.0 112.834 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 81.9 m -119.27 107.15 13.06 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.578 0.704 . . . . 1.0 110.133 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.4 mt -117.91 152.79 34.73 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.18 0.991 . . . . 1.0 110.427 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.2 m -117.17 123.92 47.87 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.604 -0.725 . . . . 1.0 110.607 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.51 145.64 39.89 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.606 -0.724 . . . . 1.0 110.468 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 95.9 p -86.38 155.59 20.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.263 0.554 . . . . 1.0 109.908 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.7 tp -95.03 129.61 42.04 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.197 0.523 . . . . 1.0 110.755 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.0 pt -127.03 148.76 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-O 121.451 0.643 . . . . 1.0 110.958 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.9 104.64 16.86 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 121.841 -0.537 . . . . 1.0 110.971 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -82.68 59.68 4.86 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.33 0.586 . . . . 1.0 110.928 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.667 ' ND2' ' H ' ' A' ' 55' ' ' LEU . 1.8 p30 171.71 -79.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.356 0.598 . . . . 1.0 110.062 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.9 m 48.66 70.38 2.12 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 115.918 -0.583 . . . . 1.0 111.625 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 22' ' ' ALA . 40.0 Cg_endo -66.64 143.47 68.38 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 121.849 1.699 . . . . 1.0 111.557 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 24' ' ' SER . . . -48.36 -175.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.54 0.686 . . . . 1.0 111.727 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.6 m120 73.55 -25.68 0.19 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.089 0.471 . . . . 1.0 111.048 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.51 ' H ' ' C ' ' A' ' 22' ' ' ALA . 2.9 t -134.27 149.77 50.95 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 122.013 0.911 . . . . 1.0 110.614 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 17.0 ptm -143.62 142.79 31.2 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.613 -0.721 . . . . 1.0 110.414 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 80.5 mt -86.23 119.04 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 121.546 0.688 . . . . 1.0 110.833 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 12.3 ptm -98.69 -6.6 29.33 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.453 0.644 . . . . 1.0 109.571 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 91.5 m -84.47 136.25 33.91 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -67.95 123.31 20.24 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.316 -0.865 . . . . 1.0 110.334 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.416 ' N ' ' CD2' ' A' ' 30' ' ' LEU . 4.4 mm? -53.08 103.11 0.35 Allowed Pre-proline 0 CA--C 1.547 0.841 0 CA-C-O 118.68 -0.676 . . . . 1.0 112.096 -178.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -65.32 155.73 67.02 Favored 'Trans proline' 0 N--CA 1.506 2.256 0 C-N-CA 122.517 2.145 . . . . 1.0 113.144 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.6 p -93.17 165.58 12.75 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.646 -0.659 . . . . 1.0 110.994 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.6 m -137.8 135.43 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-O 121.141 0.496 . . . . 1.0 110.985 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -97.96 128.37 44.49 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.538 -0.542 . . . . 1.0 109.538 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 t -122.84 134.69 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 122.172 0.987 . . . . 1.0 111.473 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -109.4 155.85 20.76 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.357 -0.838 . . . . 1.0 110.412 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 76.0 p -138.02 124.9 21.2 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.247 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 39' ' ' GLY . 10.6 tm-20 -46.54 -67.17 0.31 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.859 0.838 . . . . 1.0 110.524 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 38' ' ' GLU . . . -58.74 -147.99 0.01 OUTLIER Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.017 -0.833 . . . . 1.0 111.017 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -141.97 122.9 14.48 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.651 0.739 . . . . 1.0 110.762 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.496 ' N ' ' CD ' ' A' ' 42' ' ' PRO . 6.7 p-10 -127.37 45.88 1.8 Allowed Pre-proline 0 N--CA 1.476 0.861 0 CA-C-N 116.024 -0.535 . . . . 1.0 111.164 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 41' ' ' ASN . 56.8 Cg_endo -67.72 -8.59 22.85 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.528 2.152 . . . . 1.0 111.667 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.6 t -143.58 77.02 1.54 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.169 0.509 . . . . 1.0 111.045 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.5 mt -144.06 156.17 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 121.932 0.873 . . . . 1.0 109.535 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.558 ' C ' ' H ' ' A' ' 47' ' ' ASN . 18.0 t-20 -68.16 55.51 0.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.447 -0.797 . . . . 1.0 110.67 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.4 m -70.56 24.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 121.023 0.44 . . . . 1.0 110.96 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.558 ' H ' ' C ' ' A' ' 45' ' ' ASN . 53.3 t30 -87.79 6.58 34.52 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.149 0.5 . . . . 1.0 110.413 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -126.29 8.34 7.19 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.208 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 16.2 mt -95.61 121.71 37.59 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.236 0.541 . . . . 1.0 109.707 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -148.51 163.54 36.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 122.466 1.127 . . . . 1.0 111.619 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -109.91 133.01 53.63 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.398 -1.274 . . . . 1.0 108.351 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.525 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 7.7 p90 -145.32 152.72 40.35 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 122.76 1.267 . . . . 1.0 112.164 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.8 m -111.75 138.61 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 114.214 -1.357 . . . . 1.0 109.068 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -88.35 87.05 7.17 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.625 -0.716 . . . . 1.0 110.519 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.667 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 4.1 mp -69.66 -10.59 58.88 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.079 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 55' ' ' LEU . 56.9 m 29.13 -108.93 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.655 0.613 . . . . 1.0 112.655 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.504 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -68.97 -76.33 0.47 Allowed Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.04 -0.824 . . . . 1.0 111.04 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 3.0 p 149.31 134.27 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.37 0.605 . . . . 1.0 111.663 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -132.98 77.03 69.18 Favored Pre-proline 0 N--CA 1.483 1.176 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.883 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.68 153.9 64.09 Favored 'Trans proline' 0 N--CA 1.507 2.308 0 C-N-CA 123.153 2.568 . . . . 1.0 112.953 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.558 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . 98.6 50.82 1.48 Allowed Glycine 0 N--CA 1.472 1.057 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.558 ' O ' ' O ' ' A' ' 61' ' ' GLY . 97.3 mt-10 54.79 137.3 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 O-C-N 122.245 -0.562 . . . . 1.0 110.217 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.702 ' CG ' ' H ' ' A' ' 64' ' ' ASP . 36.1 t60 -149.92 -166.0 2.43 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 122.595 1.188 . . . . 1.0 112.377 -178.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.702 ' H ' ' CG ' ' A' ' 63' ' ' HIS . 79.4 m-20 -143.35 97.89 3.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.58 -1.191 . . . . 1.0 109.155 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -99.76 135.83 40.58 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.791 0.805 . . . . 1.0 111.405 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.476 ' CD ' ' N ' ' A' ' 67' ' ' VAL . 10.2 tm-20 -72.08 152.87 42.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.992 -1.003 . . . . 1.0 111.326 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.476 ' N ' ' CD ' ' A' ' 66' ' ' GLU . 41.1 t -91.02 116.06 31.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.668 0.747 . . . . 1.0 110.119 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.432 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 28.1 ttmt -109.61 106.39 16.06 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 122.163 0.983 . . . . 1.0 110.443 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.1 t -99.05 139.61 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 115.689 -0.687 . . . . 1.0 111.242 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -68.37 117.65 51.83 Favored Pre-proline 0 CA--C 1.55 0.972 0 CA-C-O 118.719 -0.657 . . . . 1.0 110.56 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.58 141.29 19.66 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 C-N-CA 121.718 1.612 . . . . 1.0 112.701 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.7 mm -113.14 119.27 42.75 Favored Pre-proline 0 N--CA 1.484 1.229 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.07 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.23 89.09 0.93 Allowed 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 122.019 1.813 . . . . 1.0 112.585 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 166.25 -19.99 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 122.685 0.394 . . . . 1.0 110.573 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.8 mm -134.8 156.14 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 121.851 0.834 . . . . 1.0 110.244 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -101.03 144.51 29.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 122.755 1.264 . . . . 1.0 111.2 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.4 tt -108.59 114.86 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 115.208 -0.905 . . . . 1.0 110.148 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.9 t -66.05 -41.05 88.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 O-C-N 122.133 -0.355 . . . . 1.0 110.408 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.409 ' CD ' ' NH2' ' A' ' 83' ' ' ARG . 1.9 mt-10 -179.54 -175.53 0.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 122.177 0.989 . . . . 1.0 110.595 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.0 mt -107.56 -75.35 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 115.346 -0.843 . . . . 1.0 109.839 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.0 m 53.57 101.43 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.714 0 CA-C-O 118.219 -0.896 . . . . 1.0 111.848 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.52 172.35 35.49 Favored 'Cis proline' 0 N--CA 1.505 2.18 0 CA-C-N 120.287 1.138 . . . . 1.0 111.805 0.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.409 ' NH2' ' CD ' ' A' ' 79' ' ' GLU . 97.3 mtt180 -119.85 -12.97 9.12 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.679 0.752 . . . . 1.0 109.097 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.6 t -145.82 141.96 21.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.065 -0.717 . . . . 1.0 109.065 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.7 m -135.37 139.93 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-O 121.542 0.686 . . . . 1.0 111.662 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.9 t -103.04 119.86 39.62 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.387 -0.824 . . . . 1.0 110.753 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 62.1 mt -108.7 -178.22 3.53 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.658 0.742 . . . . 1.0 110.157 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -139.56 110.76 6.95 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.469 -0.787 . . . . 1.0 110.512 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.5 mt -105.01 139.43 39.71 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.493 -0.776 . . . . 1.0 110.086 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -145.43 144.21 30.5 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.741 0.781 . . . . 1.0 111.168 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.467 ' O ' ' N ' ' A' ' 93' ' ' HIS . 13.8 p80 -67.06 137.82 56.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.434 -0.803 . . . . 1.0 110.737 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.445 ' CG ' ' O ' ' A' ' 92' ' ' HIS . 7.9 p80 -61.99 72.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.252 0.549 . . . . 1.0 111.358 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.467 ' N ' ' O ' ' A' ' 91' ' ' HIS . 86.5 t60 -61.89 -45.06 95.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.951 0.405 . . . . 1.0 110.36 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -71.46 123.81 23.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.205 0.526 . . . . 1.0 110.922 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.445 ' ND1' ' H ' ' A' ' 95' ' ' HIS . 37.7 p-80 -71.24 134.35 46.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.327 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 . . . . . 0 C--O 1.219 -0.528 0 CA-C-O 118.082 -0.961 . . . . 1.0 110.545 -179.853 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.9 p . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.552 -0.536 . . . . 1.0 109.552 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.0 m -70.22 144.19 51.96 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.797 -0.446 . . . . 1.0 109.797 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -84.66 177.41 8.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.389 0.614 . . . . 1.0 110.171 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.0 p 49.81 80.82 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.562 0.696 . . . . 1.0 110.074 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.425 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 9.1 mp -84.63 87.31 7.27 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.075 0.464 . . . . 1.0 110.699 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -138.03 -112.85 0.17 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.832 -0.433 . . . . 1.0 109.832 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 74.4 mtp85 39.73 66.2 0.61 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.325 0.583 . . . . 1.0 112.194 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -165.3 107.59 0.78 Allowed Pre-proline 0 CA--C 1.545 0.757 0 O-C-N 121.927 -0.483 . . . . 1.0 111.273 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -77.04 161.72 32.48 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.484 1.456 . . . . 1.0 112.738 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.4 m -110.06 99.67 8.73 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.662 0.744 . . . . 1.0 110.122 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 57.8 mt -107.3 146.53 31.41 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.445 0.641 . . . . 1.0 110.287 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.9 t -124.03 127.72 48.3 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.274 0.559 . . . . 1.0 110.756 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 44.7 mt -110.46 137.42 48.18 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.602 -0.726 . . . . 1.0 110.221 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.1 t -63.36 171.17 2.58 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.865 -0.42 . . . . 1.0 109.865 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.9 tp -125.67 116.04 21.05 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.796 0.808 . . . . 1.0 110.805 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 38.2 pt -117.61 149.66 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-O 121.749 0.785 . . . . 1.0 110.67 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.56 124.73 39.72 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.87 -0.519 . . . . 1.0 110.689 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -120.64 -178.49 3.73 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.364 0.602 . . . . 1.0 110.0 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 45.03 37.02 2.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.373 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.479 ' H ' ' HG1' ' A' ' 20' ' ' THR . 0.6 OUTLIER -73.05 109.39 6.16 Favored Pre-proline 0 CA--C 1.561 1.402 0 CA-C-O 118.479 -0.772 . . . . 1.0 111.005 -178.844 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -59.05 -146.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.508 2.332 0 C-N-CA 121.141 1.228 . . . . 1.0 111.922 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.547 ' O ' ' C ' ' A' ' 23' ' ' ASN . . . -49.17 143.95 5.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 122.07 0.938 . . . . 1.0 111.544 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.547 ' C ' ' O ' ' A' ' 22' ' ' ALA . 12.2 m120 -13.91 84.84 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.483 0.659 . . . . 1.0 112.067 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 22' ' ' ALA . 40.5 t -96.06 149.12 21.95 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.644 0.735 . . . . 1.0 110.886 -178.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 26.2 ttt -144.44 103.64 3.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.558 0.694 . . . . 1.0 110.089 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.583 ' CD1' ' H ' ' A' ' 26' ' ' ILE . 2.7 mp -70.57 119.63 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.953 -0.567 . . . . 1.0 111.051 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -60.9 -45.26 95.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.261 0.553 . . . . 1.0 109.555 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.8 p -79.14 171.16 15.58 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -102.59 166.9 10.26 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.331 -0.856 . . . . 1.0 110.273 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 22.3 mt -102.56 94.21 4.84 Favored Pre-proline 0 CA--C 1.553 1.083 0 CA-C-N 115.553 -0.749 . . . . 1.0 112.104 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -80.79 157.6 21.23 Favored 'Trans proline' 0 N--CA 1.504 2.106 0 C-N-CA 121.819 1.679 . . . . 1.0 112.964 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 96.0 p -67.73 161.81 25.2 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 121.728 -0.608 . . . . 1.0 110.953 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.3 m -120.19 138.45 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.174 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 67.5 mtp85 -89.47 118.81 29.39 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.829 -0.434 . . . . 1.0 109.829 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.91 132.26 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 121.816 0.817 . . . . 1.0 111.534 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -102.52 150.99 22.84 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.66 -0.7 . . . . 1.0 110.211 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 72.6 p -134.96 136.86 42.56 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.057 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -53.34 -69.65 0.11 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.805 0.812 . . . . 1.0 110.428 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -49.04 172.45 0.06 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.252 -0.739 . . . . 1.0 111.252 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.442 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 68.2 t80 -96.92 -8.08 31.64 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.838 0.352 . . . . 1.0 111.308 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.7 m120 59.69 77.9 0.36 Allowed Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.749 -0.205 . . . . 1.0 111.294 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -45.69 -45.19 16.87 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 121.603 1.535 . . . . 1.0 112.371 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.4 p -169.86 21.77 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.785 0.326 . . . . 1.0 111.119 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.424 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 1.6 mp -53.39 133.59 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 121.657 0.742 . . . . 1.0 110.032 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -55.56 91.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.677 -0.692 . . . . 1.0 110.802 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 55.9 t -55.37 -16.68 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.44 -0.346 . . . . 1.0 110.621 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.5 ' O ' ' N ' ' A' ' 49' ' ' LEU . 10.2 p30 -80.58 -48.28 12.94 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.837 0.351 . . . . 1.0 110.308 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.462 ' N ' ' OD1' ' A' ' 47' ' ' ASN . 80.0 tt0 -43.99 -14.81 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 116.002 -0.545 . . . . 1.0 111.448 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.5 ' N ' ' O ' ' A' ' 47' ' ' ASN . 40.3 mt -95.02 139.53 31.26 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.455 ' CE2' ' O ' ' A' ' 47' ' ' ASN . 92.5 m-85 -150.86 159.43 44.56 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.768 0.794 . . . . 1.0 111.486 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -120.23 134.65 55.21 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.027 -0.988 . . . . 1.0 108.704 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 22.2 p90 -150.32 149.09 29.64 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.323 1.059 . . . . 1.0 112.104 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.0 m -105.62 147.44 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 114.648 -1.16 . . . . 1.0 109.083 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' A' ' 56' ' ' SER . 50.1 p-10 -101.23 81.03 2.17 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.305 0.574 . . . . 1.0 110.757 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.0 mt -56.29 -6.07 0.24 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.247 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.51 ' H ' ' C ' ' A' ' 54' ' ' ASP . 42.9 t 34.82 -95.49 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.25 0.62 . . . . 1.0 112.612 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.948 ' O ' ' O ' ' A' ' 58' ' ' SER . . . -114.55 62.39 0.33 Allowed Glycine 0 N--CA 1.472 1.094 0 N-CA-C 110.77 -0.932 . . . . 1.0 110.77 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.948 ' O ' ' O ' ' A' ' 57' ' ' GLY . 8.6 m 8.51 144.07 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.125 0 N-CA-C 113.707 1.003 . . . . 1.0 113.707 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.405 ' H ' HD11 ' A' ' 89' ' ' LEU . 73.5 mm-40 -133.64 82.02 52.13 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 110.07 -0.345 . . . . 1.0 110.07 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -49.36 139.97 27.71 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.133 1.889 . . . . 1.0 112.305 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.04 -97.37 0.81 Allowed Glycine 0 N--CA 1.47 0.959 0 N-CA-C 110.602 -0.999 . . . . 1.0 110.602 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -165.18 139.88 5.05 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 122.242 -0.563 . . . . 1.0 109.62 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.684 ' CG ' ' H ' ' A' ' 64' ' ' ASP . 32.5 t60 -154.94 -164.24 1.75 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 122.365 1.079 . . . . 1.0 112.167 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.684 ' H ' ' CG ' ' A' ' 63' ' ' HIS . 12.7 p-10 -122.79 145.04 48.78 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 114.607 -1.178 . . . . 1.0 109.134 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -142.56 138.12 30.6 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.309 0.576 . . . . 1.0 111.627 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -94.31 142.56 27.27 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.528 -0.76 . . . . 1.0 111.045 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.9 t -95.95 135.38 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.333 0.587 . . . . 1.0 110.175 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.72 151.24 52.03 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.881 0.848 . . . . 1.0 110.472 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.7 t -131.19 144.66 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 121.571 0.7 . . . . 1.0 111.131 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -68.08 128.49 93.27 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-N 115.422 -0.808 . . . . 1.0 110.445 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -39.51 153.9 0.05 OUTLIER 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.069 1.846 . . . . 1.0 113.433 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.449 ' O ' ' O ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -101.07 154.85 36.92 Favored Pre-proline 0 N--CA 1.483 1.202 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.582 -179.29 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 72' ' ' ILE . 61.1 Cg_exo -37.46 -106.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.509 2.415 0 C-N-CA 122.775 2.317 . . . . 1.0 113.698 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.407 ' H ' ' HB2' ' A' ' 73' ' ' PRO . 90.9 m-20 -105.99 18.25 22.37 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.036 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.433 ' CG2' ' N ' ' A' ' 76' ' ' LYS . 81.5 mt -103.53 166.1 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 121.351 0.596 . . . . 1.0 110.136 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.433 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 66.1 tttm -118.98 119.98 35.92 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.894 0.854 . . . . 1.0 111.533 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 19.3 tt -59.81 143.01 14.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.128 0.49 . . . . 1.0 110.323 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 85.1 t -96.14 -49.4 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 122.104 -0.373 . . . . 1.0 110.689 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -173.17 133.62 0.52 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.415 0.626 . . . . 1.0 111.031 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.8 tp -100.85 134.15 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-O 121.492 0.663 . . . . 1.0 109.381 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 61.8 p -145.45 143.06 19.03 Favored Pre-proline 0 N--CA 1.478 0.948 0 CA-C-O 118.939 -0.553 . . . . 1.0 111.795 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.6 138.66 56.2 Favored 'Cis proline' 0 N--CA 1.505 2.196 0 CA-C-N 119.602 0.894 . . . . 1.0 111.896 -1.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -67.87 -35.27 78.24 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.98 0.895 . . . . 1.0 109.947 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 t -134.89 145.6 32.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.178 -0.675 . . . . 1.0 109.178 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.65 161.44 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-O 122.431 1.11 . . . . 1.0 110.833 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 75.8 m -105.98 124.21 49.21 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.434 -1.257 . . . . 1.0 110.525 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 87.5 mt -130.62 116.98 18.84 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.192 0.52 . . . . 1.0 110.093 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -96.82 110.62 23.06 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.389 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.405 HD11 ' H ' ' A' ' 59' ' ' GLU . 51.5 mt -78.83 150.59 32.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.056 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -129.4 141.28 51.09 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 122.092 0.949 . . . . 1.0 111.045 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.404 ' C ' ' H ' ' A' ' 93' ' ' HIS . 2.0 t60 -65.63 126.59 28.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.009 -0.996 . . . . 1.0 110.584 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.447 ' CG ' ' O ' ' A' ' 92' ' ' HIS . 78.4 t60 -72.18 43.62 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.039 0.447 . . . . 1.0 111.095 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.547 ' N ' ' HD1' ' A' ' 93' ' ' HIS . 0.2 OUTLIER -73.01 1.44 8.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.232 0.539 . . . . 1.0 110.291 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -61.26 -49.28 77.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 1.0 111.156 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.424 ' O ' ' NE2' ' A' ' 92' ' ' HIS . 86.3 t60 -170.3 132.07 1.0 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.034 -0.358 . . . . 1.0 110.034 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 . . . . . 0 C--O 1.219 -0.524 0 CA-C-O 118.171 -0.919 . . . . 1.0 110.606 179.826 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.436 -0.579 . . . . 1.0 109.436 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.2 t 54.48 173.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.917 -0.401 . . . . 1.0 109.917 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -156.72 158.29 36.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.387 0.613 . . . . 1.0 110.121 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 51.2 p -71.08 137.85 49.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.121 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.8 mp 53.29 -177.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.198 0.523 . . . . 1.0 110.755 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -166.12 162.61 17.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.238 0.542 . . . . 1.0 109.852 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -73.45 151.25 41.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.432 0.634 . . . . 1.0 111.455 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 41.64 75.99 0.56 Allowed Pre-proline 0 C--N 1.327 -0.372 0 C-N-CA 122.975 0.51 . . . . 1.0 112.293 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.68 153.37 54.13 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.426 2.084 . . . . 1.0 113.019 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 75.3 m -106.15 99.24 8.84 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.408 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -94.02 146.73 23.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 122.13 0.967 . . . . 1.0 110.497 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.2 m -119.52 109.6 15.91 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.625 -0.716 . . . . 1.0 110.475 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.5 mt -110.36 134.14 52.58 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.318 -0.855 . . . . 1.0 109.696 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.0 m -79.74 164.95 23.29 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.91 -0.404 . . . . 1.0 109.91 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.2 tp -113.08 118.21 34.14 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.73 0.776 . . . . 1.0 110.648 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.8 pp -128.19 162.17 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 CA-C-O 121.751 0.786 . . . . 1.0 110.925 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.403 ' CB ' ' OG1' ' A' ' 20' ' ' THR . . . -79.69 157.99 27.08 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 121.769 -0.582 . . . . 1.0 111.001 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -66.94 -36.68 82.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.221 0.534 . . . . 1.0 111.282 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -166.45 -34.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.098 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.403 ' OG1' ' CB ' ' A' ' 17' ' ' ALA . 22.3 m 59.34 76.56 0.44 Allowed Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 116.343 -0.39 . . . . 1.0 111.463 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 22' ' ' ALA . 31.7 Cg_exo -57.88 148.96 72.82 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.249 1.966 . . . . 1.0 111.586 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.491 ' C ' ' H ' ' A' ' 24' ' ' SER . . . -51.37 -169.96 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.891 0.853 . . . . 1.0 111.74 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.638 HD22 ' NE2' ' A' ' 91' ' ' HIS . 0.4 OUTLIER 71.23 -38.68 0.43 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.141 -0.481 . . . . 1.0 111.001 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.491 ' H ' ' C ' ' A' ' 22' ' ' ALA . 13.3 p -109.02 149.58 29.05 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.699 0.761 . . . . 1.0 110.587 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 11.7 tmm? -141.88 120.26 12.35 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.553 0.692 . . . . 1.0 110.33 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 74.0 mt -72.74 116.13 14.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.592 0.71 . . . . 1.0 110.881 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 78.0 mtp -94.83 -16.41 22.96 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.925 -0.579 . . . . 1.0 109.669 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.9 m -78.71 134.5 37.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.262 0.553 . . . . 1.0 109.69 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.57 123.99 27.68 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 121.288 -0.883 . . . . 1.0 110.316 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.7 mt -70.43 114.71 28.18 Favored Pre-proline 0 CA--C 1.555 1.139 0 CA-C-N 115.748 -0.66 . . . . 1.0 112.05 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -84.68 152.59 11.62 Favored 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 121.77 1.647 . . . . 1.0 113.07 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.7 m -72.98 173.28 9.52 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.614 -0.679 . . . . 1.0 111.213 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.8 p -142.84 136.96 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-O 121.376 0.608 . . . . 1.0 111.046 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -97.54 129.33 44.7 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.4 0.619 . . . . 1.0 109.346 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -124.71 134.18 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-O 122.101 0.953 . . . . 1.0 111.576 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -107.81 149.02 28.73 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.465 -0.789 . . . . 1.0 110.289 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 72.1 p -127.78 132.04 49.55 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 116.045 -0.525 . . . . 1.0 111.294 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -58.04 -75.29 0.05 OUTLIER 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.827 0.823 . . . . 1.0 110.09 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.61 166.64 15.94 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.959 -0.856 . . . . 1.0 110.959 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 8.6 p90 -79.77 175.08 10.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.841 0.829 . . . . 1.0 110.683 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.493 ' N ' HD21 ' A' ' 41' ' ' ASN . 1.5 m-80 -124.0 92.77 47.98 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 115.71 -0.677 . . . . 1.0 110.65 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -52.36 -40.9 69.66 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 121.893 1.729 . . . . 1.0 112.13 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 44' ' ' ILE . 73.8 m -165.51 -96.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.63 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 43' ' ' SER . 65.7 mt 57.76 141.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.128 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -85.44 96.95 9.75 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.165 0.507 . . . . 1.0 110.806 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.4 m -86.13 5.92 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 120.942 0.401 . . . . 1.0 110.782 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -97.13 -1.13 45.78 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.107 0.48 . . . . 1.0 110.262 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.482 ' OE1' ' N ' ' A' ' 48' ' ' GLU . 18.8 mp0 -120.25 6.27 10.72 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.662 -0.699 . . . . 1.0 110.145 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.0 mt -122.26 128.44 51.12 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.635 0.731 . . . . 1.0 109.557 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -133.67 -168.45 2.11 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.248 1.023 . . . . 1.0 111.544 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -115.41 139.74 49.75 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.626 -1.17 . . . . 1.0 108.989 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.475 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 16.8 p90 -141.37 153.42 45.08 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 122.34 1.067 . . . . 1.0 112.36 -178.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.3 m -110.56 140.09 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 114.647 -1.16 . . . . 1.0 109.27 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -77.44 88.57 3.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.502 0.668 . . . . 1.0 110.328 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 57' ' ' GLY . 0.8 OUTLIER -90.39 -26.52 19.86 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.623 -0.717 . . . . 1.0 109.848 -179.735 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 55' ' ' LEU . 35.4 t 28.18 -89.86 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.004 0.521 . . . . 1.0 112.353 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . -62.55 -75.01 0.35 Allowed Glycine 0 CA--C 1.531 1.093 0 N-CA-C 111.029 -0.828 . . . . 1.0 111.029 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.0 t 75.56 95.82 0.07 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 122.879 0.471 . . . . 1.0 111.469 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -123.61 147.95 54.57 Favored Pre-proline 0 N--CA 1.482 1.16 0 CA-C-O 119.514 -0.279 . . . . 1.0 111.67 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -47.82 139.0 19.92 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 121.724 1.616 . . . . 1.0 113.304 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 139.66 -135.59 7.3 Favored Glycine 0 N--CA 1.472 1.086 0 N-CA-C 110.532 -1.027 . . . . 1.0 110.532 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -170.65 144.02 2.27 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -154.62 -164.66 1.87 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.708 1.242 . . . . 1.0 112.451 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 32.8 p-10 -111.74 91.84 3.81 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 114.33 -1.305 . . . . 1.0 108.942 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -82.56 132.16 35.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.679 0.752 . . . . 1.0 111.36 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.51 153.63 37.38 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.057 -0.974 . . . . 1.0 111.171 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 65.4 t -94.09 110.29 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 121.59 0.71 . . . . 1.0 110.152 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' A' ' 52' ' ' TYR . 1.6 tmtp? -112.01 118.6 35.87 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 122.039 0.923 . . . . 1.0 110.137 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.3 m -126.43 149.89 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 115.783 -0.644 . . . . 1.0 111.203 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -74.84 125.77 89.09 Favored Pre-proline 0 CA--C 1.549 0.92 0 CA-C-O 118.387 -0.816 . . . . 1.0 110.311 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.01 137.76 19.91 Favored 'Trans proline' 0 N--CA 1.5 1.892 0 C-N-CA 121.619 1.546 . . . . 1.0 112.357 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.5 mm -79.8 128.74 73.29 Favored Pre-proline 0 CA--C 1.554 1.131 0 CA-C-N 116.456 -0.338 . . . . 1.0 111.314 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.417 ' C ' ' H ' ' A' ' 75' ' ' ILE . 61.5 Cg_endo -70.3 152.82 66.74 Favored 'Trans proline' 0 N--CA 1.502 2.024 0 C-N-CA 121.506 1.471 . . . . 1.0 112.818 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.9 t30 65.63 -1.27 1.06 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.295 0.638 . . . . 1.0 111.29 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.417 ' H ' ' C ' ' A' ' 73' ' ' PRO . 66.5 mt -133.58 155.48 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 121.64 0.733 . . . . 1.0 110.191 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -107.93 149.82 27.86 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 122.267 1.032 . . . . 1.0 111.236 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.1 tt -100.41 101.54 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 115.732 -0.667 . . . . 1.0 109.995 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.2 t -46.02 -58.18 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 O-C-N 122.121 -0.362 . . . . 1.0 110.636 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -175.62 141.68 0.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.685 0.755 . . . . 1.0 110.686 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.6 tp -104.18 138.85 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.399 0.619 . . . . 1.0 109.579 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.2 m -147.32 134.93 10.48 Favored Pre-proline 0 N--CA 1.481 1.079 0 CA-C-O 118.481 -0.771 . . . . 1.0 112.293 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.84 -174.49 10.77 Favored 'Cis proline' 0 N--CA 1.503 2.037 0 CA-C-N 120.133 1.083 . . . . 1.0 111.701 -0.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -121.2 -18.31 7.45 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.927 0.87 . . . . 1.0 109.312 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.6 t -138.61 136.94 43.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.029 -0.73 . . . . 1.0 109.029 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.2 m -137.19 174.74 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 CA-C-O 121.771 0.796 . . . . 1.0 111.476 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.0 t -133.07 128.31 35.95 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.137 -0.938 . . . . 1.0 110.465 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 50.2 mt -130.74 120.95 24.58 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 120.954 0.407 . . . . 1.0 110.207 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -86.16 112.12 21.02 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.582 0.706 . . . . 1.0 110.281 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.6 mt -80.68 165.87 21.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.673 -0.694 . . . . 1.0 110.085 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -140.27 130.32 24.86 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.9 0.857 . . . . 1.0 110.971 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.638 ' NE2' HD22 ' A' ' 23' ' ' ASN . 60.5 t-80 -76.19 129.57 36.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.194 -0.912 . . . . 1.0 110.522 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.59 ' CG ' ' H ' ' A' ' 93' ' ' HIS . 12.0 t-80 -73.16 -122.76 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.202 0.525 . . . . 1.0 111.145 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.59 ' H ' ' CG ' ' A' ' 92' ' ' HIS . 79.2 m80 -154.59 155.45 34.76 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.216 0.531 . . . . 1.0 110.494 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.428 ' O ' ' CG ' ' A' ' 95' ' ' HIS . 92.1 m-70 -80.09 121.19 25.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.276 0.56 . . . . 1.0 111.046 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.428 ' CG ' ' O ' ' A' ' 94' ' ' HIS . 38.4 m80 -156.9 4.44 0.15 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.183 -0.462 . . . . 1.0 109.839 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 79.4 m80 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.988 -1.006 . . . . 1.0 110.354 179.788 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 40.6 t . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.548 -0.538 . . . . 1.0 109.548 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.487 ' HG ' ' N ' ' A' ' 3' ' ' GLN . 44.1 t -161.26 162.27 31.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.107 -0.497 . . . . 1.0 109.724 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.487 ' N ' ' HG ' ' A' ' 2' ' ' SER . 5.0 pp0? -67.4 -18.74 65.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.287 0.565 . . . . 1.0 110.124 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.4 p -65.11 130.87 44.93 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.463 -0.569 . . . . 1.0 109.463 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 51.3 tp -64.72 -54.61 28.87 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 122.057 -0.402 . . . . 1.0 111.304 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 7' ' ' ARG . 14.4 p30 177.12 -41.2 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.095 0.474 . . . . 1.0 109.874 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.534 ' NH2' ' CZ ' ' A' ' 40' ' ' TYR . 88.6 mtm180 -72.44 146.65 46.78 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 122.263 1.03 . . . . 1.0 111.381 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -152.28 86.27 4.44 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 115.9 -0.591 . . . . 1.0 111.509 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.95 119.83 6.93 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 122.166 1.911 . . . . 1.0 113.227 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 42.0 m -117.25 87.15 2.65 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 121.312 0.577 . . . . 1.0 110.739 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.528 ' CD2' ' N ' ' A' ' 11' ' ' LEU . 0.9 OUTLIER -98.6 147.15 25.1 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 122.122 0.963 . . . . 1.0 110.615 -179.462 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.5 m -106.79 124.28 49.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.717 0.77 . . . . 1.0 110.338 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.8 mt -112.99 130.53 56.1 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.107 -0.951 . . . . 1.0 110.131 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.9 m -69.19 161.07 29.94 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.0 tp -113.47 116.89 30.31 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.449 0.643 . . . . 1.0 111.055 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.7 pt -119.04 140.5 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-O 121.877 0.846 . . . . 1.0 110.694 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.27 117.91 17.61 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.22 0.533 . . . . 1.0 110.918 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.2 tptt -112.86 159.3 19.17 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.357 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 53.37 31.15 11.44 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.96 -0.385 . . . . 1.0 109.96 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.0 m -68.93 129.7 92.1 Favored Pre-proline 0 CA--C 1.546 0.823 0 CA-C-O 119.051 -0.499 . . . . 1.0 111.704 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -71.92 117.31 5.08 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 121.245 1.297 . . . . 1.0 111.431 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -42.83 158.15 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.87 0.843 . . . . 1.0 111.617 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.4 m120 73.2 9.71 5.22 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.958 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 90.3 p -112.44 145.13 40.73 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.738 0.78 . . . . 1.0 110.701 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.408 ' SD ' ' O ' ' A' ' 26' ' ' ILE . 12.5 tmm? -139.31 121.07 15.38 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.722 -0.672 . . . . 1.0 110.258 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.408 ' O ' ' SD ' ' A' ' 25' ' ' MET . 54.6 mt -73.8 144.98 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.888 0.851 . . . . 1.0 110.979 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 10.7 tpp -107.34 -26.78 10.85 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.571 -0.741 . . . . 1.0 109.596 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.9 m -81.09 156.49 25.78 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.203 -0.666 . . . . 1.0 109.203 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -84.18 157.89 21.5 Favored 'General case' 0 CA--C 1.516 -0.362 0 O-C-N 121.273 -0.892 . . . . 1.0 110.19 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.406 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 4.3 mm? -100.26 97.84 6.89 Favored Pre-proline 0 N--CA 1.484 1.262 0 CA-C-N 115.958 -0.565 . . . . 1.0 112.42 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -86.1 157.38 9.88 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.486 2.124 . . . . 1.0 112.714 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.4 m -77.35 -178.21 5.04 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.594 -0.691 . . . . 1.0 110.991 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.7 p -140.78 149.82 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 121.31 0.576 . . . . 1.0 111.146 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -102.87 123.83 47.24 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.49 0.662 . . . . 1.0 109.423 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 t -120.29 133.14 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-O 122.265 1.031 . . . . 1.0 111.52 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -103.45 146.29 28.73 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.293 -0.867 . . . . 1.0 110.076 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 43.8 p -131.24 130.63 43.13 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.099 -0.501 . . . . 1.0 111.469 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.431 ' O ' ' O ' ' A' ' 39' ' ' GLY . 83.9 tt0 -57.36 -74.72 0.05 Allowed 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.648 0.737 . . . . 1.0 110.159 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 38' ' ' GLU . . . -50.17 -173.72 0.01 OUTLIER Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.347 -0.701 . . . . 1.0 111.347 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.534 ' CZ ' ' NH2' ' A' ' 7' ' ' ARG . 3.0 m-85 -104.92 167.9 9.41 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.494 0.664 . . . . 1.0 110.411 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -120.67 83.88 36.17 Favored Pre-proline 0 N--CA 1.476 0.831 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.412 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.56 -41.26 69.42 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.132 1.888 . . . . 1.0 112.162 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.515 ' O ' ' O ' ' A' ' 44' ' ' ILE . 73.7 m -161.17 -88.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.246 0.546 . . . . 1.0 110.401 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.515 ' O ' ' O ' ' A' ' 43' ' ' SER . 2.8 tt 31.56 100.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.352 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.62 ' C ' ' H ' ' A' ' 47' ' ' ASN . 87.9 m-20 -63.65 96.85 0.13 Allowed 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 120.969 0.414 . . . . 1.0 110.815 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.8 m -66.63 20.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.331 0.586 . . . . 1.0 110.718 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.62 ' H ' ' C ' ' A' ' 45' ' ' ASN . 94.1 m-20 -92.26 12.2 23.22 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.14 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -125.32 -1.23 7.61 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.694 -0.685 . . . . 1.0 110.288 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.8 mt -123.01 133.38 54.35 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -141.09 -166.57 2.2 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.009 0.909 . . . . 1.0 111.592 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -118.7 140.51 49.81 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.798 -1.092 . . . . 1.0 108.389 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -120.36 166.73 13.14 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 122.413 1.101 . . . . 1.0 112.084 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.3 m -133.73 145.49 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 114.475 -1.239 . . . . 1.0 109.305 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -94.92 81.83 3.78 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.709 0.766 . . . . 1.0 110.663 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.2 mp -75.11 -4.09 36.56 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.445 -0.798 . . . . 1.0 110.176 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.8 t -79.06 5.33 12.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.371 -0.377 . . . . 1.0 111.329 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -132.59 52.04 0.84 Allowed Glycine 0 N--CA 1.474 1.213 0 N-CA-C 111.344 -0.702 . . . . 1.0 111.344 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.7 t -153.45 -63.92 0.15 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.536 0.208 . . . . 1.0 111.316 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 66.36 151.92 0.12 Allowed Pre-proline 0 N--CA 1.472 0.625 0 C-N-CA 122.562 0.345 . . . . 1.0 111.443 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -35.06 143.29 0.08 OUTLIER 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 122.866 2.377 . . . . 1.0 113.369 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.513 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . 120.24 16.16 4.86 Favored Glycine 0 N--CA 1.472 1.057 0 N-CA-C 110.935 -0.866 . . . . 1.0 110.935 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.513 ' O ' ' O ' ' A' ' 61' ' ' GLY . 81.6 tt0 57.17 141.07 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 O-C-N 122.12 -0.635 . . . . 1.0 109.9 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.752 ' CG ' ' H ' ' A' ' 64' ' ' ASP . 39.5 t60 -155.55 -163.65 1.57 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 122.883 1.325 . . . . 1.0 112.289 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.752 ' H ' ' CG ' ' A' ' 63' ' ' HIS . 95.6 m-20 -114.58 144.27 43.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.285 -1.325 . . . . 1.0 108.652 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' A' ' 65' ' ' TYR . 48.7 m-85 -134.76 139.15 44.93 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.426 0.631 . . . . 1.0 111.388 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -104.44 149.29 25.56 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.345 -0.843 . . . . 1.0 111.15 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 48.4 t -103.28 116.45 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 121.726 0.774 . . . . 1.0 110.203 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -123.51 139.74 53.71 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.293 1.044 . . . . 1.0 110.344 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.7 t -109.0 136.89 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 115.553 -0.748 . . . . 1.0 110.874 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -72.13 117.26 56.73 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-O 118.557 -0.735 . . . . 1.0 110.091 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -44.96 119.22 2.29 Favored 'Trans proline' 0 N--CA 1.505 2.167 0 C-N-CA 121.754 1.636 . . . . 1.0 113.157 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 33.9 mm -105.93 123.0 40.57 Favored Pre-proline 0 N--CA 1.487 1.39 0 CA-C-O 119.103 -0.475 . . . . 1.0 111.235 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.64 157.86 54.81 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.32 2.014 . . . . 1.0 112.092 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 33.6 t30 80.67 -26.27 0.16 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.481 0.712 . . . . 1.0 110.826 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.7 mm -132.81 148.46 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 122.206 1.003 . . . . 1.0 110.489 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -113.77 149.6 34.65 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 122.762 1.268 . . . . 1.0 110.961 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.6 tt -91.97 142.99 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.209 -0.905 . . . . 1.0 110.112 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.8 t -120.72 -45.48 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 122.089 -0.382 . . . . 1.0 110.901 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -96.17 139.4 32.39 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 122.127 0.965 . . . . 1.0 110.667 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.5 mp -135.25 80.82 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 115.435 -0.802 . . . . 1.0 109.723 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.7 m -148.61 148.84 29.47 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 120.281 -0.568 . . . . 1.0 112.018 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.82 141.73 72.64 Favored 'Cis proline' 0 N--CA 1.509 2.423 0 C-N-CA 124.685 -0.964 . . . . 1.0 112.3 -1.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 90.8 mtm180 -61.76 -56.48 19.11 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.567 0.698 . . . . 1.0 109.368 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.1 t -135.21 149.25 28.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.231 -0.655 . . . . 1.0 109.231 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.2 m -144.75 163.73 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 121.647 0.737 . . . . 1.0 111.764 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 74.3 m -111.6 122.82 48.83 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.299 -0.864 . . . . 1.0 110.658 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.4 mt -107.99 -170.13 1.63 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.426 0.632 . . . . 1.0 110.204 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -146.56 112.6 5.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.47 0.652 . . . . 1.0 110.55 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.8 mt -107.33 143.16 36.01 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.555 0.693 . . . . 1.0 110.033 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -132.44 143.71 49.98 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.971 0.891 . . . . 1.0 111.036 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -68.65 131.16 44.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.165 -0.925 . . . . 1.0 110.547 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.623 ' HD1' ' N ' ' A' ' 93' ' ' HIS . 0.7 OUTLIER -133.19 128.22 35.49 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.701 0.762 . . . . 1.0 111.071 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.623 ' N ' ' HD1' ' A' ' 92' ' ' HIS . 84.0 t60 -78.46 89.43 4.43 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.328 0.585 . . . . 1.0 110.317 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.605 ' CG ' ' H ' ' A' ' 95' ' ' HIS . 82.1 t60 52.76 173.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.211 0.529 . . . . 1.0 111.225 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.605 ' H ' ' CG ' ' A' ' 94' ' ' HIS . 83.3 t60 55.68 97.15 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.207 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 . . . . . 0 C--O 1.221 -0.414 0 CA-C-O 117.954 -1.022 . . . . 1.0 110.753 -179.723 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.49 ' H1 ' ' CG2' ' A' ' 4' ' ' THR . 45.9 t . . . . . 0 N--CA 1.484 1.255 0 N-CA-C 109.418 -0.586 . . . . 1.0 109.418 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.3 t -66.25 -51.72 54.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.874 0.369 . . . . 1.0 111.178 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -173.45 17.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.635 0.731 . . . . 1.0 110.062 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.49 ' CG2' ' H1 ' ' A' ' 1' ' ' SER . 0.1 OUTLIER -62.21 -43.66 98.34 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.741 0.782 . . . . 1.0 109.658 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 11.1 mp -65.79 167.16 9.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.7 0.762 . . . . 1.0 110.296 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.478 ' C ' ' H ' ' A' ' 8' ' ' ASP . 51.6 p-10 -151.17 146.46 26.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.591 -0.732 . . . . 1.0 109.662 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -48.98 -8.82 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.808 -0.633 . . . . 1.0 112.558 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.478 ' H ' ' C ' ' A' ' 6' ' ' ASP . 12.2 p-10 -139.21 81.82 20.34 Favored Pre-proline 0 N--CA 1.476 0.867 0 O-C-N 121.942 -0.474 . . . . 1.0 111.329 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.94 134.5 55.53 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.794 2.329 . . . . 1.0 112.739 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.7 m -104.51 85.92 2.42 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.409 0.623 . . . . 1.0 110.143 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.8 mt -86.01 145.52 27.06 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.814 0.816 . . . . 1.0 110.544 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.3 m -109.57 119.56 39.79 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.531 0.682 . . . . 1.0 110.599 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.8 mp -102.54 135.36 44.31 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.39 -0.823 . . . . 1.0 109.879 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 59.3 m -79.33 105.8 10.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.895 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.5 tp -68.52 95.94 0.66 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.591 0.71 . . . . 1.0 110.938 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.3 pt -118.69 165.05 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 121.571 0.701 . . . . 1.0 111.038 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.99 164.34 23.54 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.792 -0.568 . . . . 1.0 111.12 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.1 mmtp -104.11 -56.85 2.13 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.221 0.534 . . . . 1.0 111.402 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -92.89 -54.54 3.7 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.547 0.689 . . . . 1.0 110.144 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 45.66 80.91 0.27 Allowed Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 115.831 -0.622 . . . . 1.0 111.592 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.38 134.72 65.52 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.302 2.001 . . . . 1.0 111.238 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.45 -14.4 3.01 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 122.001 -0.437 . . . . 1.0 111.859 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -91.53 -15.34 28.87 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.957 -0.464 . . . . 1.0 111.161 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.4 t -108.3 153.48 23.18 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.524 0.678 . . . . 1.0 110.779 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 45.0 ttp -144.66 115.51 7.8 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.706 0.765 . . . . 1.0 110.086 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.57 ' CD1' ' H ' ' A' ' 26' ' ' ILE . 2.2 mp -68.11 115.39 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.862 0.839 . . . . 1.0 111.095 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 44.3 ttm -67.67 -28.07 67.38 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.685 -0.689 . . . . 1.0 109.44 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.9 m -68.88 135.74 51.56 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -68.85 -13.99 62.76 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 121.279 -0.888 . . . . 1.0 111.097 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.1 mt 61.95 91.81 0.07 OUTLIER Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 115.828 -0.624 . . . . 1.0 112.31 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -86.57 158.47 9.27 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.854 2.369 . . . . 1.0 112.755 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 95.4 p -69.13 178.07 2.45 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.666 -0.646 . . . . 1.0 111.268 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.0 p -139.7 151.04 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-O 121.408 0.623 . . . . 1.0 111.053 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 100.0 mtt180 -98.96 129.19 45.26 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.6 t -127.03 154.66 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 122.384 1.087 . . . . 1.0 111.396 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -124.7 142.67 51.23 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.108 -0.951 . . . . 1.0 110.591 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 60.3 p -130.08 136.57 49.49 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.33 0.586 . . . . 1.0 111.264 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -109.84 41.62 1.67 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.526 0.679 . . . . 1.0 109.798 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -125.3 -9.45 5.03 Favored Glycine 0 N--CA 1.472 1.093 0 N-CA-C 111.039 -0.824 . . . . 1.0 111.039 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 59.73 153.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.234 0.54 . . . . 1.0 111.13 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.468 ' ND2' ' N ' ' A' ' 41' ' ' ASN . 0.1 OUTLIER -175.4 148.11 1.02 Allowed Pre-proline 0 CA--C 1.547 0.835 0 O-C-N 122.212 -0.305 . . . . 1.0 110.451 179.854 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.29 -58.97 0.11 Allowed 'Trans proline' 0 N--CA 1.509 2.429 0 C-N-CA 121.507 1.471 . . . . 1.0 112.599 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.455 ' O ' ' HB ' ' A' ' 44' ' ' ILE . 40.2 t -159.42 -56.8 0.06 Allowed 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.71 0.767 . . . . 1.0 110.71 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.455 ' HB ' ' O ' ' A' ' 43' ' ' SER . 42.3 mt 91.92 -113.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-N 115.39 -0.823 . . . . 1.0 109.73 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.6 ' ND2' HD22 ' A' ' 47' ' ' ASN . 11.2 t-20 -175.87 -19.47 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.653 0.74 . . . . 1.0 110.383 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.444 ' C ' ' O ' ' A' ' 45' ' ' ASN . 17.7 m 28.18 43.58 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-O 121.827 0.822 . . . . 1.0 112.036 -178.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.6 HD22 ' ND2' ' A' ' 45' ' ' ASN . 99.3 m-20 -69.93 -40.92 75.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.577 -0.738 . . . . 1.0 110.754 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -127.95 13.08 6.78 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.617 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 28.5 mt -96.42 110.84 23.12 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.974 0.893 . . . . 1.0 109.597 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -148.24 -160.87 1.23 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 122.191 0.996 . . . . 1.0 111.533 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -117.2 142.49 46.97 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.703 -1.135 . . . . 1.0 108.263 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -134.57 175.12 9.82 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 122.03 0.919 . . . . 1.0 112.345 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.4 m -138.87 146.0 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 114.834 -1.075 . . . . 1.0 109.393 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -86.9 83.02 7.61 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.588 0.709 . . . . 1.0 110.318 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 56' ' ' SER . 0.7 OUTLIER -81.89 -13.79 57.09 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.0 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.454 ' C ' ' O ' ' A' ' 55' ' ' LEU . 77.3 p 20.18 -97.93 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 112.829 0.678 . . . . 1.0 112.829 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.493 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -60.57 -74.53 0.36 Allowed Glycine 0 CA--C 1.531 1.073 0 N-CA-C 110.583 -1.007 . . . . 1.0 110.583 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 3.9 m 101.94 45.24 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 123.94 0.896 . . . . 1.0 111.444 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 60' ' ' PRO . 12.3 mp0 -76.0 130.65 77.68 Favored Pre-proline 0 CA--C 1.548 0.902 0 CA-C-O 119.23 -0.414 . . . . 1.0 111.586 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 59' ' ' GLU . 88.7 Cg_exo -44.11 -179.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.506 2.251 0 C-N-CA 122.076 1.851 . . . . 1.0 113.044 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.54 -141.15 15.16 Favored Glycine 0 N--CA 1.472 1.093 0 N-CA-C 110.713 -0.955 . . . . 1.0 110.713 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.3 mp0 -138.19 75.1 1.5 Allowed 'General case' 0 N--CA 1.471 0.58 0 O-C-N 122.135 -0.626 . . . . 1.0 109.724 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -93.54 137.67 32.59 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.712 0.768 . . . . 1.0 112.013 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -85.37 139.19 31.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.282 -0.872 . . . . 1.0 109.072 178.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -132.11 127.94 37.09 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.718 0.77 . . . . 1.0 111.664 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.428 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 32.6 mp0 -67.87 132.81 48.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.091 -0.959 . . . . 1.0 111.318 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.6 t -76.27 124.96 35.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.507 0.67 . . . . 1.0 110.207 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -109.39 121.16 44.57 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.973 0.892 . . . . 1.0 110.196 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.3 m -109.75 129.61 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 115.833 -0.622 . . . . 1.0 111.008 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -50.35 127.76 23.49 Favored Pre-proline 0 CA--C 1.554 1.133 0 CA-C-O 118.87 -0.586 . . . . 1.0 110.554 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.3 112.01 3.42 Favored 'Trans proline' 0 N--CA 1.505 2.178 0 C-N-CA 121.684 1.59 . . . . 1.0 112.218 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.8 mp -82.02 129.71 63.27 Favored Pre-proline 0 CA--C 1.556 1.198 0 CA-C-O 119.411 -0.328 . . . . 1.0 110.795 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -67.15 140.98 55.63 Favored 'Trans proline' 0 N--CA 1.506 2.218 0 C-N-CA 121.755 1.637 . . . . 1.0 112.662 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.9 t30 66.93 10.32 7.55 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.271 0.629 . . . . 1.0 111.476 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mm -124.04 137.13 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-O 122.367 1.079 . . . . 1.0 109.746 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.33 121.14 38.89 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 122.145 0.974 . . . . 1.0 111.013 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.402 ' O ' ' CG2' ' A' ' 77' ' ' ILE . 7.4 tp -84.12 93.34 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.879 -0.601 . . . . 1.0 110.053 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.8 t -46.9 -53.65 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 O-C-N 121.97 -0.456 . . . . 1.0 110.835 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -170.42 -127.19 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.819 0.819 . . . . 1.0 110.408 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.8 mt -154.23 -77.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.131 -0.692 . . . . 1.0 109.131 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.6 t 58.71 101.94 0.04 OUTLIER Pre-proline 0 CA--C 1.549 0.907 0 CA-C-O 117.544 -1.217 . . . . 1.0 111.778 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -67.74 134.11 24.28 Favored 'Cis proline' 0 N--CA 1.512 2.598 0 CA-C-N 121.028 1.403 . . . . 1.0 111.831 0.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -66.26 -43.53 86.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.761 0.791 . . . . 1.0 109.661 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -130.08 153.21 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 109.377 -0.601 . . . . 1.0 109.377 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.5 p -145.38 136.06 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.604 0.716 . . . . 1.0 111.5 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 37.2 m -81.39 130.36 35.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.282 -0.872 . . . . 1.0 110.441 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 33.5 mt -133.45 124.47 27.12 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.104 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.409 ' CD ' ' N ' ' A' ' 88' ' ' GLN . 18.3 mp0 -93.28 121.43 34.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.687 0.756 . . . . 1.0 110.525 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.0 mt -96.98 162.06 13.56 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.445 -0.798 . . . . 1.0 109.802 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -152.81 151.62 30.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.642 0.734 . . . . 1.0 110.992 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.625 ' HD1' ' H ' ' A' ' 91' ' ' HIS . 19.3 p-80 -66.2 139.44 58.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.427 -0.806 . . . . 1.0 110.687 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -65.12 69.52 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.325 0.583 . . . . 1.0 111.165 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.401 ' N ' ' O ' ' A' ' 91' ' ' HIS . 84.7 t60 -67.31 -44.73 78.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.099 0.476 . . . . 1.0 110.402 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -61.97 85.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.123 0.487 . . . . 1.0 110.976 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -76.63 55.84 1.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.055 0.455 . . . . 1.0 109.776 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.936 -1.031 . . . . 1.0 110.838 -179.816 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.7 t . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.675 -0.491 . . . . 1.0 109.675 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.9 p -73.65 157.43 36.61 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.487 -0.56 . . . . 1.0 109.487 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 53.72 88.21 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.397 0.618 . . . . 1.0 110.249 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.4 t -91.35 156.03 18.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.636 0.732 . . . . 1.0 109.572 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.12 136.17 53.4 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.705 0.764 . . . . 1.0 110.54 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.493 ' CG ' ' H ' ' A' ' 7' ' ' ARG . 51.9 t0 178.8 -118.69 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.609 -0.723 . . . . 1.0 109.717 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.493 ' H ' ' CG ' ' A' ' 6' ' ' ASP . 56.5 mmt-85 60.43 -122.56 0.98 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.51 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.463 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 4.9 p-10 44.3 54.35 11.92 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 112.935 0.717 . . . . 1.0 112.935 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.463 ' HD3' ' N ' ' A' ' 8' ' ' ASP . 57.6 Cg_endo -89.8 -178.03 1.54 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.806 2.337 . . . . 1.0 112.801 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.493 ' HG1' ' NZ ' ' A' ' 36' ' ' LYS . 53.9 m -85.51 113.61 21.9 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.647 0.737 . . . . 1.0 110.423 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 74.9 mt -105.85 139.32 40.59 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.673 0.749 . . . . 1.0 110.572 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.0 m -101.14 124.57 47.04 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.379 0.609 . . . . 1.0 110.428 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.3 mp -108.19 131.15 54.96 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.651 -0.704 . . . . 1.0 109.944 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.6 t -75.83 114.85 14.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.196 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 41.4 tp -69.37 105.99 2.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.246 0.546 . . . . 1.0 110.88 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.7 pt -118.08 142.6 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 121.692 0.758 . . . . 1.0 111.117 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.49 121.5 24.64 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.351 0.596 . . . . 1.0 110.76 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -114.03 50.4 0.93 Allowed 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.404 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 172.81 34.35 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.326 -0.62 . . . . 1.0 109.326 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.0 m -70.17 112.5 12.85 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-O 119.022 -0.513 . . . . 1.0 111.466 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -57.66 145.64 88.62 Favored 'Trans proline' 0 N--CA 1.501 1.948 0 C-N-CA 121.876 1.718 . . . . 1.0 111.832 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.93 150.38 49.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 122.155 0.979 . . . . 1.0 111.388 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 68.06 7.93 6.17 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.129 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.3 p -114.1 152.09 31.61 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.791 0.805 . . . . 1.0 110.521 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 49.0 ttp -141.47 120.27 12.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.704 -0.68 . . . . 1.0 110.082 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 72.2 mt -72.04 117.95 16.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.456 0.645 . . . . 1.0 110.665 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.417 ' SD ' ' OE1' ' A' ' 90' ' ' GLU . 76.4 mtp -83.79 58.64 4.75 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.806 0.812 . . . . 1.0 109.83 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.7 m -165.18 128.29 2.25 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.358 -0.608 . . . . 1.0 109.358 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.476 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 38.2 ttpt -68.2 158.44 33.24 Favored 'General case' 0 CA--C 1.515 -0.393 0 O-C-N 121.229 -0.92 . . . . 1.0 110.682 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.427 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 4.3 mm? -98.55 96.86 4.12 Favored Pre-proline 0 CA--C 1.557 1.213 0 N-CA-C 112.374 0.509 . . . . 1.0 112.374 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 29' ' ' LYS . 39.7 Cg_endo -86.51 152.05 9.02 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.485 2.123 . . . . 1.0 112.635 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.5 p -68.17 177.55 2.22 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.698 -0.626 . . . . 1.0 111.098 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -145.14 154.27 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.557 0.694 . . . . 1.0 111.079 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -104.42 127.0 52.02 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.5 m -131.6 161.75 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 122.169 0.985 . . . . 1.0 111.28 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.493 ' NZ ' ' HG1' ' A' ' 10' ' ' THR . 64.5 mmtt -125.25 134.03 52.46 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.423 -0.808 . . . . 1.0 110.939 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 30.1 p -141.1 -175.27 4.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.647 0.736 . . . . 1.0 111.211 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -124.37 -138.17 0.29 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.727 -0.67 . . . . 1.0 110.089 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.66 -150.61 38.33 Favored Glycine 0 N--CA 1.458 0.161 0 N-CA-C 110.911 -0.876 . . . . 1.0 110.911 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -144.32 -25.96 0.52 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.252 0.549 . . . . 1.0 111.321 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 61.97 67.43 1.27 Allowed Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.451 -0.341 . . . . 1.0 111.128 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -58.64 -41.12 67.16 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 122.171 1.914 . . . . 1.0 111.92 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 55.4 p -172.07 55.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.614 -0.266 . . . . 1.0 110.533 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.8 mm -90.06 125.52 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.39 0.614 . . . . 1.0 110.062 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.534 ' C ' ' H ' ' A' ' 47' ' ' ASN . 12.0 m120 -75.59 100.89 4.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.459 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.1 m -46.72 -9.54 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.234 0.54 . . . . 1.0 111.817 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.534 ' H ' ' C ' ' A' ' 45' ' ' ASN . 33.6 m120 -63.02 -36.14 82.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.228 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -102.98 55.79 0.76 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.001 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.524 ' O ' ' CG ' ' A' ' 50' ' ' PHE . 20.1 mt -152.28 118.97 5.7 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.225 0.536 . . . . 1.0 110.071 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.524 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 59.1 m-85 -161.64 173.91 14.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 122.513 1.149 . . . . 1.0 111.675 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.463 ' C ' ' CG ' ' A' ' 52' ' ' TYR . . . -100.47 170.14 8.6 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 114.219 -1.355 . . . . 1.0 108.728 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.463 ' CG ' ' C ' ' A' ' 51' ' ' ALA . 25.3 m-85 -151.57 163.77 38.33 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 122.221 1.01 . . . . 1.0 111.913 -178.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.1 m -137.19 145.74 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 114.735 -1.12 . . . . 1.0 109.443 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -98.76 81.91 2.72 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.504 0.668 . . . . 1.0 110.643 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.491 ' O ' ' C ' ' A' ' 56' ' ' SER . 70.1 mt -74.71 4.75 5.78 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.577 -0.738 . . . . 1.0 110.197 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.491 ' C ' ' O ' ' A' ' 55' ' ' LEU . 84.2 p 15.02 -113.75 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 115.593 -0.731 . . . . 1.0 112.88 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.41 -143.22 0.01 OUTLIER Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.791 -0.924 . . . . 1.0 110.791 178.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.4 m -151.08 32.25 0.6 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 121.324 -0.15 . . . . 1.0 111.047 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -41.96 101.7 0.25 Allowed Pre-proline 0 CA--C 1.543 0.698 0 CA-C-O 119.625 -0.226 . . . . 1.0 111.394 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -56.02 118.61 5.42 Favored 'Trans proline' 0 N--CA 1.502 2.01 0 C-N-CA 122.607 2.205 . . . . 1.0 112.736 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 149.71 -168.07 29.87 Favored Glycine 0 N--CA 1.465 0.575 0 N-CA-C 110.22 -1.152 . . . . 1.0 110.22 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.47 ' CD ' ' H ' ' A' ' 62' ' ' GLU . 1.2 pm0 -102.62 80.2 1.89 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.375 0.607 . . . . 1.0 109.735 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.438 ' CD2' ' O ' ' A' ' 64' ' ' ASP . 83.7 t60 -90.69 161.37 15.39 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.911 0.862 . . . . 1.0 111.895 -178.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.438 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 69.2 m-20 -88.34 128.1 35.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.126 -0.943 . . . . 1.0 109.432 178.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -122.37 97.7 5.59 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.8 0.81 . . . . 1.0 111.546 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.465 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 39.1 mp0 -59.25 131.72 51.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.969 -1.014 . . . . 1.0 111.463 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.8 t -77.81 128.18 38.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.702 0.763 . . . . 1.0 110.269 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -117.73 137.91 52.38 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.993 0.901 . . . . 1.0 110.346 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.1 t -110.71 129.92 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.038 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -51.14 123.28 19.74 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.45 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.38 88.68 1.13 Allowed 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 122.09 1.86 . . . . 1.0 112.656 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.3 mp -79.72 128.21 75.26 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 120.935 -0.306 . . . . 1.0 110.735 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.404 ' O ' ' ND2' ' A' ' 74' ' ' ASN . 56.3 Cg_endo -71.33 80.99 1.27 Allowed 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 122.151 1.901 . . . . 1.0 112.782 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.404 ' ND2' ' O ' ' A' ' 73' ' ' PRO . 6.2 m-20 167.78 -52.19 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.844 0.354 . . . . 1.0 110.498 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.3 mm -91.23 136.87 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-O 121.879 0.847 . . . . 1.0 110.201 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -96.41 140.38 31.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 122.288 1.042 . . . . 1.0 111.343 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.8 tt -94.93 135.91 27.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.641 -0.709 . . . . 1.0 110.327 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.7 t -105.47 -52.38 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 O-C-N 122.074 -0.391 . . . . 1.0 110.354 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -148.05 -152.41 0.44 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.998 0.904 . . . . 1.0 110.63 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.417 ' O ' ' O ' ' A' ' 81' ' ' SER . 34.2 mt -144.1 -48.24 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.582 -0.735 . . . . 1.0 109.617 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 80' ' ' ILE . 79.3 p 31.04 96.38 0.04 OUTLIER Pre-proline 0 CA--C 1.557 1.219 0 CA-C-O 118.39 -0.814 . . . . 1.0 112.354 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -68.29 -172.15 6.19 Favored 'Cis proline' 0 N--CA 1.501 1.94 0 CA-C-N 120.2 1.107 . . . . 1.0 111.757 1.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -112.09 -30.93 7.05 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.591 -0.731 . . . . 1.0 109.788 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.3 t -149.04 152.57 11.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.162 -0.681 . . . . 1.0 109.162 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.1 p -143.43 140.56 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.604 0.716 . . . . 1.0 111.664 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 60.4 m -95.76 128.96 43.08 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.281 -0.872 . . . . 1.0 110.789 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.6 mt -116.93 167.17 11.36 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.617 -0.719 . . . . 1.0 110.235 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -118.07 116.7 27.4 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.854 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -105.25 130.26 53.43 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.889 0.852 . . . . 1.0 110.253 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.417 ' OE1' ' SD ' ' A' ' 27' ' ' MET . 39.0 tt0 -134.2 136.64 43.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 122.346 1.07 . . . . 1.0 111.149 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.528 ' HD1' ' H ' ' A' ' 91' ' ' HIS . 29.0 p-80 -68.76 116.96 9.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.735 -1.12 . . . . 1.0 110.685 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -91.62 68.43 5.61 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.027 0.441 . . . . 1.0 110.822 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.406 ' CG ' ' O ' ' A' ' 93' ' ' HIS . 14.4 p80 -62.07 99.46 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.426 0.631 . . . . 1.0 110.416 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.516 ' CG ' ' N ' ' A' ' 95' ' ' HIS . 78.3 t60 -164.25 168.07 19.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.607 0.717 . . . . 1.0 110.531 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.516 ' N ' ' CG ' ' A' ' 94' ' ' HIS . 58.6 t-80 -138.38 97.34 3.35 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.835 -0.621 . . . . 1.0 110.066 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 79.1 t60 . . . . . 0 C--O 1.219 -0.549 0 CA-C-O 117.936 -1.031 . . . . 1.0 110.362 -179.888 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 . . . . . 0 N--CA 1.471 0.621 0 CA-C-O 121.213 0.53 . . . . 1.0 111.822 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -55.73 137.32 71.32 Favored Pre-proline 0 CA--C 1.549 0.926 0 O-C-N 121.848 -0.532 . . . . 1.0 112.007 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -72.82 142.0 34.61 Favored 'Trans proline' 0 N--CA 1.503 2.039 0 C-N-CA 122.347 2.031 . . . . 1.0 112.953 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.5 m -113.92 94.78 4.98 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 121.514 0.673 . . . . 1.0 110.013 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 66.4 mt -109.73 143.43 39.52 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.791 0.805 . . . . 1.0 110.394 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.9 t -102.08 133.26 47.19 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.949 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.763 HD22 ' N ' ' A' ' 13' ' ' LEU . 0.9 OUTLIER -108.87 139.9 43.08 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.618 0.723 . . . . 1.0 110.457 -179.695 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.1 m -74.55 109.8 8.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.899 -0.591 . . . . 1.0 109.869 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.7 tp -69.41 106.56 2.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.406 0.622 . . . . 1.0 110.878 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.4 pt -111.04 142.29 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-O 121.811 0.815 . . . . 1.0 110.857 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.67 127.13 33.93 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.85 -0.531 . . . . 1.0 111.058 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -115.73 162.13 17.72 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 120.952 0.406 . . . . 1.0 110.201 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 22.4 m120 57.47 34.77 25.07 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.94 -0.393 . . . . 1.0 109.94 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 49.4 m -60.21 114.68 10.54 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-O 119.089 -0.482 . . . . 1.0 111.528 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.8 149.83 18.79 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 121.533 1.489 . . . . 1.0 112.01 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.91 145.1 42.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 122.041 0.924 . . . . 1.0 111.374 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.2 m-20 64.14 18.48 11.28 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.945 -0.571 . . . . 1.0 111.093 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.5 t -110.66 147.17 34.86 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.948 0.88 . . . . 1.0 110.658 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 61.4 ttp -139.12 116.15 10.96 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.624 -0.716 . . . . 1.0 109.982 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 59.0 mt -69.71 149.4 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.978 0.894 . . . . 1.0 110.532 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.515 ' O ' ' OG1' ' A' ' 28' ' ' THR . 1.1 tpt -118.74 63.78 0.77 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.766 0.793 . . . . 1.0 109.58 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.515 ' OG1' ' O ' ' A' ' 27' ' ' MET . 33.7 m -178.02 146.59 0.42 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.104 -0.702 . . . . 1.0 109.104 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -85.04 151.41 24.18 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.295 -0.878 . . . . 1.0 110.444 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 mp -103.79 105.41 47.82 Favored Pre-proline 0 N--CA 1.482 1.166 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.894 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -87.78 152.09 7.36 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.374 2.05 . . . . 1.0 112.688 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 63.0 p -59.19 -179.02 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.653 -0.655 . . . . 1.0 111.19 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.6 p -139.65 144.93 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-O 121.264 0.554 . . . . 1.0 111.077 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 82.3 mtt85 -99.99 125.18 45.98 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.385 -0.598 . . . . 1.0 109.385 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 t -124.23 153.47 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-O 122.557 1.17 . . . . 1.0 111.189 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -124.7 138.16 54.31 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 114.968 -1.015 . . . . 1.0 110.6 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 51.5 p -125.51 131.85 52.73 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.754 -0.657 . . . . 1.0 111.3 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -77.99 47.53 0.65 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.473 0.654 . . . . 1.0 109.886 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.401 ' O ' ' CD1' ' A' ' 40' ' ' TYR . . . -149.53 -169.24 15.72 Favored Glycine 0 N--CA 1.466 0.645 0 N-CA-C 110.572 -1.011 . . . . 1.0 110.572 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.401 ' CD1' ' O ' ' A' ' 39' ' ' GLY . 0.8 OUTLIER -142.36 108.73 5.29 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.264 0.554 . . . . 1.0 110.232 -179.499 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -119.69 84.35 30.64 Favored Pre-proline 0 N--CA 1.474 0.733 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.475 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -56.3 -19.3 27.49 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.305 2.003 . . . . 1.0 111.862 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.2 t -145.31 -101.71 0.1 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.997 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.429 HG22 ' O ' ' A' ' 44' ' ' ILE . 27.1 mm 58.8 37.97 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.856 -0.424 . . . . 1.0 109.856 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 39.45 70.9 0.19 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.89 0.376 . . . . 1.0 111.266 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.1 m -56.23 -14.52 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.048 0.452 . . . . 1.0 110.784 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 48' ' ' GLU . 22.2 p30 -58.94 -33.81 71.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.312 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.494 ' N ' ' OD1' ' A' ' 47' ' ' ASN . 74.6 tt0 -91.0 63.64 5.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.996 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 69.1 mt -148.37 110.68 4.65 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.441 0.638 . . . . 1.0 109.995 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -143.31 156.55 44.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 122.054 0.93 . . . . 1.0 111.865 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -115.78 140.87 48.8 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.82 -1.082 . . . . 1.0 108.416 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 16.7 p90 -141.24 144.62 34.81 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 122.082 0.944 . . . . 1.0 112.24 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.4 m -105.53 156.09 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 114.857 -1.065 . . . . 1.0 108.947 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -97.19 142.8 28.67 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.454 0.645 . . . . 1.0 110.523 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.593 ' C ' ' H ' ' A' ' 57' ' ' GLY . 79.6 mt -131.35 40.46 3.43 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.648 -0.705 . . . . 1.0 110.377 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.7 m -60.01 14.24 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.901 -0.59 . . . . 1.0 111.982 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.593 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . -148.3 159.17 27.94 Favored Glycine 0 N--CA 1.466 0.689 0 N-CA-C 110.444 -1.062 . . . . 1.0 110.444 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.5 t -148.24 130.5 15.57 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.577 0.703 . . . . 1.0 110.976 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.638 ' O ' ' N ' ' A' ' 61' ' ' GLY . 2.1 mt-10 179.91 123.1 0.22 Allowed Pre-proline 0 CA--C 1.55 0.943 0 CA-C-N 115.677 -0.692 . . . . 1.0 110.657 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -45.57 71.42 0.01 OUTLIER 'Trans proline' 0 N--CA 1.511 2.531 0 C-N-CA 122.524 2.149 . . . . 1.0 113.939 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.638 ' N ' ' O ' ' A' ' 59' ' ' GLU . . . -145.27 155.68 26.6 Favored Glycine 0 N--CA 1.47 0.951 0 N-CA-C 110.349 -1.1 . . . . 1.0 110.349 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -86.09 87.1 7.36 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 122.302 -0.529 . . . . 1.0 109.768 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.505 ' ND1' ' CE1' ' A' ' 65' ' ' TYR . 61.1 t-80 -92.38 137.51 32.31 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.548 0.69 . . . . 1.0 112.342 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -90.42 115.93 27.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.623 -0.717 . . . . 1.0 109.212 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.505 ' CE1' ' ND1' ' A' ' 63' ' ' HIS . 71.1 m-85 -104.75 135.22 46.54 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.878 0.847 . . . . 1.0 111.455 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -81.06 142.09 33.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.899 -1.046 . . . . 1.0 111.252 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.9 t -74.94 117.5 19.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.373 0.606 . . . . 1.0 110.417 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -106.73 114.8 29.12 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 122.334 1.064 . . . . 1.0 109.886 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.581 HG12 ' N ' ' A' ' 70' ' ' GLU . 27.3 t -85.52 169.27 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 115.57 -0.741 . . . . 1.0 110.871 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.581 ' N ' HG12 ' A' ' 69' ' ' VAL . 10.7 tm-20 -94.4 111.8 55.11 Favored Pre-proline 0 CA--C 1.553 1.09 0 CA-C-N 115.668 -0.696 . . . . 1.0 109.833 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -48.09 131.3 21.53 Favored 'Trans proline' 0 N--CA 1.506 2.217 0 C-N-CA 121.782 1.654 . . . . 1.0 112.859 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.8 mt -99.54 109.51 55.42 Favored Pre-proline 0 CA--C 1.554 1.099 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.792 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.97 55.63 3.43 Favored 'Trans proline' 0 N--CA 1.506 2.246 0 C-N-CA 122.069 1.846 . . . . 1.0 113.095 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -175.09 -44.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.242 0.544 . . . . 1.0 110.882 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.664 HG22 ' N ' ' A' ' 76' ' ' LYS . 63.7 mt -112.63 174.22 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-O 121.559 0.695 . . . . 1.0 110.114 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.664 ' N ' HG22 ' A' ' 75' ' ' ILE . 60.5 tttp -117.83 156.44 28.37 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 122.583 1.182 . . . . 1.0 111.238 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.9 tt -99.39 153.17 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 115.367 -0.833 . . . . 1.0 109.966 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.9 t -108.14 -49.68 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 122.142 -0.349 . . . . 1.0 110.665 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -179.69 -175.99 0.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 122.316 1.055 . . . . 1.0 110.52 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.4 mt -129.86 167.42 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 122.15 0.976 . . . . 1.0 109.307 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.7 t -167.04 106.09 0.63 Allowed Pre-proline 0 CA--C 1.554 1.131 0 CA-C-O 118.438 -0.791 . . . . 1.0 111.452 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -62.39 -173.78 2.74 Favored 'Cis proline' 0 N--CA 1.507 2.283 0 CA-C-N 120.191 1.104 . . . . 1.0 111.528 -0.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -118.54 -23.51 7.11 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.516 0.674 . . . . 1.0 109.191 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 t -144.36 149.85 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.1 m -136.39 157.11 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-O 121.75 0.786 . . . . 1.0 111.567 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 71.7 m -109.1 119.13 38.6 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.174 -0.921 . . . . 1.0 110.613 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.8 mt -122.7 126.22 47.14 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.701 -0.682 . . . . 1.0 110.222 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -83.64 130.52 34.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.587 0.708 . . . . 1.0 110.255 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -104.02 136.15 44.19 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.652 0.739 . . . . 1.0 110.297 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -138.1 140.45 39.97 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.331 1.063 . . . . 1.0 111.053 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -67.18 167.33 12.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.842 -1.072 . . . . 1.0 110.644 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 . . . . . 0 N--CA 1.473 0.686 0 CA-C-O 121.653 0.739 . . . . 1.0 110.972 -179.667 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 112.793 0.664 . . . . 1.0 112.793 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.32 118.14 50.36 Favored Pre-proline 0 CA--C 1.549 0.908 0 O-C-N 121.85 -0.531 . . . . 1.0 112.159 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.47 141.79 35.57 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 CA-C-N 120.404 1.18 . . . . 1.0 113.392 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.427 HG22 ' N ' ' A' ' 11' ' ' LEU . 91.1 m -107.36 157.4 17.98 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.575 0.702 . . . . 1.0 110.024 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.571 HD13 ' H ' ' A' ' 12' ' ' THR . 0.1 OUTLIER -144.09 139.41 28.89 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.445 0.64 . . . . 1.0 110.428 179.818 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.571 ' H ' HD13 ' A' ' 11' ' ' LEU . 56.3 m -123.5 120.19 32.16 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.509 0.671 . . . . 1.0 110.571 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 35.7 mt -130.52 134.08 46.77 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.454 -0.794 . . . . 1.0 110.027 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.5 m -58.67 179.58 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.6 tp -120.33 112.99 19.71 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-O 121.602 0.715 . . . . 1.0 111.043 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.5 pt -116.78 154.26 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-O 121.809 0.814 . . . . 1.0 110.763 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.82 125.56 41.35 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.806 -0.559 . . . . 1.0 110.536 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.483 ' O ' ' O ' ' A' ' 19' ' ' ASN . 63.9 tttm -119.7 137.68 53.76 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.615 0.721 . . . . 1.0 109.707 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 18' ' ' LYS . 16.1 m120 43.53 100.84 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.993 -0.549 . . . . 1.0 110.876 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.3 m -136.55 132.43 18.7 Favored Pre-proline 0 N--CA 1.479 0.979 0 CA-C-O 119.45 -0.31 . . . . 1.0 111.577 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -36.84 95.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 121.641 1.561 . . . . 1.0 112.541 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -39.33 161.79 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.53 0.681 . . . . 1.0 111.869 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.4 t30 72.61 12.19 5.47 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 122.006 -0.433 . . . . 1.0 110.746 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.7 p -133.51 153.75 51.38 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.745 0.783 . . . . 1.0 110.661 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 47.8 ttp -143.74 138.6 28.93 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.46 0.647 . . . . 1.0 110.184 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 69.9 mt -75.02 154.12 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.611 0.72 . . . . 1.0 111.047 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.6 ttt -107.13 -28.01 10.24 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 121.391 0.615 . . . . 1.0 109.859 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 30' ' ' LEU . 9.0 m -64.75 138.2 58.24 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.575 -0.528 . . . . 1.0 109.575 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -66.99 -6.74 18.14 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.287 -0.883 . . . . 1.0 111.261 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.447 ' H ' HG22 ' A' ' 28' ' ' THR . 12.2 mt 59.38 95.24 0.05 OUTLIER Pre-proline 0 CA--C 1.548 0.868 0 CA-C-O 118.736 -0.649 . . . . 1.0 111.864 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -85.99 154.91 9.87 Favored 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 122.649 2.233 . . . . 1.0 112.744 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.6 m -57.89 175.59 0.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.614 -0.679 . . . . 1.0 111.26 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.6 m -132.59 133.46 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-O 121.317 0.58 . . . . 1.0 111.091 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -104.98 126.84 52.48 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -130.07 155.63 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 122.163 0.982 . . . . 1.0 111.2 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -119.52 138.8 52.94 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.426 -0.807 . . . . 1.0 110.165 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.5 p -129.97 141.93 50.7 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 115.855 -0.611 . . . . 1.0 110.723 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -82.77 164.23 20.75 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.719 -0.474 . . . . 1.0 109.719 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.51 -157.88 18.13 Favored Glycine 0 N--CA 1.472 1.07 0 N-CA-C 110.827 -0.909 . . . . 1.0 110.827 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -152.77 98.79 2.38 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.471 0.653 . . . . 1.0 110.829 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.463 HD22 HG13 ' A' ' 75' ' ' ILE . 27.4 p30 -174.42 75.08 0.34 Allowed Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.497 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.4 38.88 0.35 Allowed 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 121.691 1.594 . . . . 1.0 111.86 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.42 ' H ' ' C ' ' A' ' 41' ' ' ASN . 38.7 m -170.11 97.14 0.28 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.413 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.1 mt -127.96 53.56 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 109.805 -0.442 . . . . 1.0 109.805 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.517 ' C ' ' H ' ' A' ' 47' ' ' ASN . 4.7 p-10 39.43 56.98 2.17 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.499 -0.319 . . . . 1.0 111.235 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.3 m -70.14 35.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.052 0.453 . . . . 1.0 111.098 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.517 ' H ' ' C ' ' A' ' 45' ' ' ASN . 70.9 m-20 -59.97 -24.18 64.2 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.295 -0.412 . . . . 1.0 110.577 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.513 ' O ' ' C ' ' A' ' 49' ' ' LEU . 96.4 mt-10 -124.38 -54.85 1.67 Allowed 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.934 -0.576 . . . . 1.0 110.009 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.64 ' H ' HD12 ' A' ' 49' ' ' LEU . 9.1 mp -25.42 113.7 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.074 0.464 . . . . 1.0 110.845 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -141.76 -171.86 3.43 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.898 0.856 . . . . 1.0 111.551 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.455 ' O ' ' CG ' ' A' ' 52' ' ' TYR . . . -93.19 158.02 15.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.928 -1.033 . . . . 1.0 108.321 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.455 ' CG ' ' O ' ' A' ' 51' ' ' ALA . 91.8 m-85 -153.6 157.84 40.29 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 122.273 1.035 . . . . 1.0 111.889 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.3 147.22 22.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 114.64 -1.164 . . . . 1.0 109.357 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -115.88 106.23 13.58 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.452 0.644 . . . . 1.0 110.606 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.505 ' C ' ' H ' ' A' ' 57' ' ' GLY . 24.4 mt -104.77 32.77 3.93 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.802 -0.635 . . . . 1.0 110.179 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 88.9 p -62.4 8.71 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.849 -0.614 . . . . 1.0 111.859 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . -88.88 -168.73 44.18 Favored Glycine 0 N--CA 1.47 0.959 0 N-CA-C 110.84 -0.904 . . . . 1.0 110.84 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 82.0 p -162.41 76.71 0.47 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.413 0.625 . . . . 1.0 111.446 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -138.13 88.03 15.68 Favored Pre-proline 0 N--CA 1.472 0.666 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.589 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -48.09 108.76 0.19 Allowed 'Trans proline' 0 N--CA 1.504 2.11 0 C-N-CA 122.364 2.043 . . . . 1.0 112.775 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.74 -165.04 25.41 Favored Glycine 0 N--CA 1.47 0.909 0 N-CA-C 110.343 -1.103 . . . . 1.0 110.343 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.544 ' CD ' ' H ' ' A' ' 62' ' ' GLU . 0.9 OUTLIER -71.77 142.89 49.7 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.261 -0.552 . . . . 1.0 109.641 179.477 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.45 ' O ' ' CD1' ' A' ' 65' ' ' TYR . 62.7 t-80 -161.12 126.02 3.6 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.149 -0.62 . . . . 1.0 112.45 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -77.24 117.32 18.65 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.806 -0.813 . . . . 1.0 108.806 178.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.45 ' CD1' ' O ' ' A' ' 63' ' ' HIS . 91.4 m-85 -94.38 -122.77 0.1 Allowed 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.985 -0.447 . . . . 1.0 111.821 -178.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -160.3 130.68 5.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.127 0.489 . . . . 1.0 110.732 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.7 t -92.94 115.94 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.122 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -142.27 151.83 42.42 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.742 0.782 . . . . 1.0 110.487 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 70' ' ' GLU . 41.6 t -134.63 157.39 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-O 121.405 0.622 . . . . 1.0 111.201 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.417 ' N ' HG12 ' A' ' 69' ' ' VAL . 9.3 pt-20 -58.26 147.28 67.6 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 115.575 -0.738 . . . . 1.0 110.681 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -73.64 162.08 40.56 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 121.892 1.728 . . . . 1.0 112.417 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.84 101.41 12.82 Favored Pre-proline 0 N--CA 1.48 1.048 0 CA-C-N 115.3 -0.864 . . . . 1.0 110.526 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -50.04 140.33 32.33 Favored 'Trans proline' 0 N--CA 1.502 2.026 0 C-N-CA 121.31 1.34 . . . . 1.0 113.064 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 78.88 -11.9 1.15 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.555 0.742 . . . . 1.0 111.318 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.463 HG13 HD22 ' A' ' 41' ' ' ASN . 42.9 mm -125.96 153.17 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 122.276 1.036 . . . . 1.0 110.006 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -121.65 158.5 28.53 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 122.751 1.262 . . . . 1.0 110.735 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.613 HG23 ' O ' ' A' ' 77' ' ' ILE . 17.6 tt -99.3 95.88 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 115.125 -0.943 . . . . 1.0 109.813 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.7 t -44.91 -53.48 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 O-C-N 121.975 -0.453 . . . . 1.0 110.893 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -167.8 -146.2 0.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.685 0.755 . . . . 1.0 110.559 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.434 HG22 ' O ' ' A' ' 82' ' ' PRO . 1.9 mt -148.63 157.18 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 109.238 -0.653 . . . . 1.0 109.238 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 82' ' ' PRO . 43.3 t -163.17 101.05 1.0 Allowed Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 118.434 -0.793 . . . . 1.0 111.672 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.474 ' O ' ' N ' ' A' ' 81' ' ' SER . 24.0 Cg_exo -63.97 -166.31 1.35 Allowed 'Cis proline' 0 N--CA 1.511 2.541 0 CA-C-N 120.134 1.083 . . . . 1.0 111.393 -0.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -129.81 -18.7 3.4 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.446 0.641 . . . . 1.0 109.512 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.2 t -142.86 135.7 25.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.889 -0.782 . . . . 1.0 108.889 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.9 m -130.65 146.34 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-O 121.841 0.829 . . . . 1.0 111.376 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.0 t -106.29 131.99 52.86 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.071 -0.968 . . . . 1.0 110.49 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 35.1 mt -134.26 126.2 29.32 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.056 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -91.7 122.11 33.96 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.484 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.7 mt -93.43 140.69 29.3 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.415 0.626 . . . . 1.0 109.972 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -133.06 144.68 50.17 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.954 0.883 . . . . 1.0 111.2 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -69.67 144.56 52.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.195 -0.911 . . . . 1.0 110.809 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 121.634 0.73 . . . . 1.0 110.81 -179.706 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 . . . . . 0 CA--C 1.535 0.396 0 CA-C-O 120.819 0.342 . . . . 1.0 111.641 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 40.03 84.36 0.18 Allowed Pre-proline 0 CA--C 1.538 0.499 0 O-C-N 121.833 -0.542 . . . . 1.0 112.119 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.35 135.17 64.53 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.3 2.0 . . . . 1.0 112.954 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 68.2 m -127.96 122.56 32.65 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.679 0.752 . . . . 1.0 109.827 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.4 mt -137.02 164.66 27.84 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.647 0.737 . . . . 1.0 110.509 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.2 m -101.54 128.35 47.83 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.348 0.594 . . . . 1.0 110.282 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 tp -123.4 153.56 40.22 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.61 -0.723 . . . . 1.0 110.227 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.1 t -106.18 152.24 23.72 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.03 0.443 . . . . 1.0 109.906 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 pp -119.71 117.48 28.36 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.353 0.596 . . . . 1.0 111.035 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.3 pt -110.99 163.08 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-O 121.724 0.773 . . . . 1.0 110.713 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.76 116.46 24.04 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.89 -0.506 . . . . 1.0 110.944 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.5 mmtt -61.15 -32.67 72.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.91 0.386 . . . . 1.0 110.68 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -144.54 76.06 1.48 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.133 0.492 . . . . 1.0 110.252 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.1 m -60.47 116.07 16.33 Favored Pre-proline 0 CA--C 1.554 1.119 0 CA-C-O 118.873 -0.584 . . . . 1.0 111.385 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.96 138.17 52.35 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 120.926 1.084 . . . . 1.0 111.846 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.47 152.5 43.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.922 0.868 . . . . 1.0 111.592 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.4 m-20 69.08 6.28 5.56 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.097 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.0 p -100.73 145.64 28.22 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.61 0.719 . . . . 1.0 110.785 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -136.61 116.4 13.09 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.506 0.67 . . . . 1.0 110.332 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 65.7 mt -69.32 148.43 11.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.828 0.823 . . . . 1.0 110.828 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 46.9 mtt -114.23 -35.67 4.93 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.677 -0.692 . . . . 1.0 109.935 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.6 m -79.78 147.92 31.64 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.498 -0.556 . . . . 1.0 109.498 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -78.68 150.9 32.47 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.289 -0.882 . . . . 1.0 110.069 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 tp -76.39 112.7 22.84 Favored Pre-proline 0 CA--C 1.557 1.214 0 CA-C-N 115.678 -0.692 . . . . 1.0 111.983 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -90.53 151.7 4.33 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 121.456 1.437 . . . . 1.0 112.567 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.3 p -84.03 170.16 14.2 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.618 -0.676 . . . . 1.0 110.834 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.2 p -135.88 136.54 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 121.558 0.694 . . . . 1.0 110.949 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 42.4 mtm105 -98.24 130.99 44.95 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.929 -0.578 . . . . 1.0 109.464 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 t -124.24 128.59 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 121.963 0.887 . . . . 1.0 111.428 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -97.43 153.33 18.18 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.534 -0.757 . . . . 1.0 110.341 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 16.1 p -131.9 133.08 44.19 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.166 0.507 . . . . 1.0 111.315 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -80.75 47.04 0.93 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.245 0.545 . . . . 1.0 109.648 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.54 -171.71 34.65 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 110.558 -1.017 . . . . 1.0 110.558 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.569 ' O ' HD11 ' A' ' 75' ' ' ILE . 62.4 t80 -107.6 164.36 12.29 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.473 0.654 . . . . 1.0 110.636 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.53 ' N ' ' CD2' ' A' ' 40' ' ' TYR . 3.0 p-10 -114.3 90.76 21.47 Favored Pre-proline 0 N--CA 1.477 0.923 0 CA-C-N 116.147 -0.478 . . . . 1.0 111.056 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -50.78 -41.5 54.49 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 121.746 1.631 . . . . 1.0 112.025 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.9 t -171.27 42.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.576 0.227 . . . . 1.0 110.732 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.407 ' O ' HG23 ' A' ' 44' ' ' ILE . 14.7 tt -58.64 126.77 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.978 0.418 . . . . 1.0 110.415 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.495 ' C ' ' H ' ' A' ' 47' ' ' ASN . 44.6 p-10 -99.96 86.13 3.2 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.947 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.9 m -72.25 33.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.99 0.424 . . . . 1.0 110.675 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.495 ' H ' ' C ' ' A' ' 45' ' ' ASN . 71.5 m-80 -100.99 -10.22 20.76 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.311 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -131.53 1.84 4.11 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.469 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.608 ' O ' ' CG ' ' A' ' 50' ' ' PHE . 51.1 mt -95.81 154.85 17.01 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.608 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 70.3 m-85 -165.72 174.21 9.96 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.795 0.807 . . . . 1.0 111.694 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.432 ' C ' ' CG ' ' A' ' 52' ' ' TYR . . . -111.64 169.94 8.47 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.052 -0.976 . . . . 1.0 108.431 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.432 ' CG ' ' C ' ' A' ' 51' ' ' ALA . 22.8 m-85 -151.23 169.58 21.58 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 122.181 0.991 . . . . 1.0 112.134 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.3 m -136.26 144.77 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 114.73 -1.123 . . . . 1.0 109.496 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -85.58 83.49 7.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.404 0.621 . . . . 1.0 110.374 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 57' ' ' GLY . 1.2 mp -94.15 -26.8 16.54 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.603 -0.726 . . . . 1.0 109.769 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 55' ' ' LEU . 47.5 t 29.61 -90.26 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.644 0.735 . . . . 1.0 112.336 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . -129.07 71.49 0.49 Allowed Glycine 0 N--CA 1.472 1.06 0 N-CA-C 111.039 -0.824 . . . . 1.0 111.039 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 27.8 t -83.26 163.41 20.74 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.728 0.775 . . . . 1.0 111.343 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.5 mp0 -130.93 148.75 71.5 Favored Pre-proline 0 N--CA 1.48 1.062 0 CA-C-N 115.593 -0.73 . . . . 1.0 111.255 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -39.79 144.06 0.37 Allowed 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 122.064 1.843 . . . . 1.0 113.387 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 142.27 -137.68 8.02 Favored Glycine 0 N--CA 1.468 0.809 0 N-CA-C 110.517 -1.033 . . . . 1.0 110.517 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -140.09 69.93 1.36 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.322 0.582 . . . . 1.0 109.553 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -93.03 130.84 38.48 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.09 -0.505 . . . . 1.0 112.124 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -82.41 142.01 32.3 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.117 -0.697 . . . . 1.0 109.117 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -133.2 136.45 45.66 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.753 0.787 . . . . 1.0 111.675 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -73.19 135.78 44.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.07 -0.968 . . . . 1.0 111.485 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.83 129.02 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.173 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -121.01 149.58 42.45 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.816 0.817 . . . . 1.0 110.513 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.1 t -124.54 137.54 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 115.978 -0.555 . . . . 1.0 111.316 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -63.05 115.24 16.08 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-O 118.483 -0.77 . . . . 1.0 110.26 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.8 136.17 42.82 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 CA-C-N 120.281 1.136 . . . . 1.0 113.032 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.5 mp -91.73 115.99 65.61 Favored Pre-proline 0 CA--C 1.553 1.07 0 CA-C-N 115.481 -0.781 . . . . 1.0 110.442 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -50.41 134.66 39.07 Favored 'Trans proline' 0 N--CA 1.506 2.226 0 C-N-CA 120.968 1.112 . . . . 1.0 113.496 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 67.59 4.87 4.05 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.417 0.687 . . . . 1.0 111.436 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.569 HD11 ' O ' ' A' ' 40' ' ' TYR . 7.4 mm -138.26 154.36 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 122.319 1.057 . . . . 1.0 109.721 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -127.34 165.47 19.67 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 122.425 1.107 . . . . 1.0 111.074 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.8 pt -118.49 121.5 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 115.471 -0.786 . . . . 1.0 109.887 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 80.2 t -56.1 -50.58 69.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 O-C-N 122.086 -0.384 . . . . 1.0 110.378 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 177.67 147.61 0.14 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 122.198 0.999 . . . . 1.0 110.418 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.413 HG12 ' H ' ' A' ' 80' ' ' ILE . 16.3 pt -84.52 172.1 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.347 -0.842 . . . . 1.0 109.789 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 t -178.26 119.13 0.25 Allowed Pre-proline 0 CA--C 1.552 1.027 0 CA-C-O 117.941 -1.028 . . . . 1.0 111.438 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -65.38 141.22 48.09 Favored 'Cis proline' 0 N--CA 1.509 2.411 0 CA-C-N 120.657 1.27 . . . . 1.0 111.444 -1.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -76.58 -18.02 58.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.769 0.795 . . . . 1.0 109.546 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.2 t -137.01 143.96 33.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.937 -0.764 . . . . 1.0 108.937 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.9 m -135.24 160.15 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.832 0.825 . . . . 1.0 111.469 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 58.1 m -116.08 130.2 56.69 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.021 -0.99 . . . . 1.0 110.365 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 83.0 mt -134.62 123.15 23.33 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.681 -0.691 . . . . 1.0 110.034 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -93.69 123.9 37.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.497 0.665 . . . . 1.0 110.145 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 64.9 mt -105.76 157.61 17.32 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.657 -0.701 . . . . 1.0 110.129 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -145.89 138.13 25.4 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.606 0.717 . . . . 1.0 111.023 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -69.49 143.46 53.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.564 -0.744 . . . . 1.0 110.324 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 86.0 t60 . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 121.53 0.681 . . . . 1.0 111.019 -179.823 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 54.8 mmm-85 . . . . . 0 N--CA 1.477 0.886 0 CA-C-O 121.661 0.743 . . . . 1.0 111.702 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 41.57 97.23 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 123.36 0.664 . . . . 1.0 112.0 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.6 140.98 54.32 Favored 'Trans proline' 0 N--CA 1.498 1.783 0 C-N-CA 122.403 2.069 . . . . 1.0 113.111 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 71.4 m -129.52 107.85 9.79 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.528 0.68 . . . . 1.0 110.228 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 60.5 mt -110.61 159.67 17.36 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.795 0.807 . . . . 1.0 110.439 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.9 m -119.58 120.67 37.4 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.538 0.685 . . . . 1.0 110.72 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.8 132.56 53.33 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.419 -0.81 . . . . 1.0 110.093 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.0 m -65.33 160.04 22.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.075 -0.511 . . . . 1.0 109.863 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.2 tp -113.44 126.91 55.86 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.5 0.667 . . . . 1.0 110.856 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.5 pt -117.53 179.75 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.707 0.765 . . . . 1.0 111.017 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.69 115.27 29.27 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.284 0.564 . . . . 1.0 111.197 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -113.44 166.23 11.7 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.321 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 48.8 26.83 1.38 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.875 0.369 . . . . 1.0 110.015 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.9 m -63.94 129.7 94.04 Favored Pre-proline 0 CA--C 1.547 0.843 0 CA-C-O 119.057 -0.497 . . . . 1.0 112.175 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.28 141.28 56.18 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 121.753 1.635 . . . . 1.0 111.427 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.41 149.08 49.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 122.125 0.964 . . . . 1.0 111.232 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 74.41 6.22 4.59 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.881 -0.6 . . . . 1.0 111.195 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.6 p -113.21 146.4 39.37 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.794 0.807 . . . . 1.0 110.745 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 24.6 ptm -142.6 139.9 31.49 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.518 0.675 . . . . 1.0 110.14 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 75.6 mt -88.33 145.81 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.697 0.761 . . . . 1.0 111.027 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 20.8 ttt -111.83 -23.5 10.54 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.781 -0.645 . . . . 1.0 109.511 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.1 p -87.7 121.95 30.76 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.501 0.667 . . . . 1.0 109.242 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -63.84 141.47 58.76 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.271 -0.893 . . . . 1.0 110.869 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.446 ' N ' HD12 ' A' ' 30' ' ' LEU . 10.7 mp -81.56 118.09 70.8 Favored Pre-proline 0 CA--C 1.554 1.123 0 N-CA-C 112.238 0.459 . . . . 1.0 112.238 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -86.2 162.79 9.98 Favored 'Trans proline' 0 N--CA 1.501 1.957 0 C-N-CA 122.383 2.056 . . . . 1.0 112.793 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 56.5 m -70.44 168.52 15.97 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.563 -0.711 . . . . 1.0 111.259 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.9 p -136.82 139.11 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-O 121.427 0.632 . . . . 1.0 111.116 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 80' ' ' ILE . 1.6 mpt_? -102.38 124.41 47.89 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.134 -0.691 . . . . 1.0 109.134 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.5 t -120.33 125.69 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 122.0 0.905 . . . . 1.0 111.132 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -98.59 147.04 25.21 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.288 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 70.4 p -129.39 131.28 46.78 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.492 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -53.78 -72.52 0.06 Allowed 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.723 0.773 . . . . 1.0 110.139 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.21 -171.93 0.09 OUTLIER Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.009 -0.837 . . . . 1.0 111.009 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -106.24 175.89 5.35 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.658 0.742 . . . . 1.0 110.944 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -136.42 74.28 54.4 Favored Pre-proline 0 N--CA 1.472 0.644 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.644 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -52.09 -37.72 69.17 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 C-N-CA 122.29 1.993 . . . . 1.0 111.892 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 44' ' ' ILE . 70.8 m -146.55 -97.69 0.09 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.383 -0.372 . . . . 1.0 110.832 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 43' ' ' SER . 68.7 mt 59.12 128.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.897 0.38 . . . . 1.0 110.086 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -56.34 90.64 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.194 0.521 . . . . 1.0 110.772 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.1 t -57.11 -17.05 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.017 0.437 . . . . 1.0 110.867 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -83.17 12.22 5.46 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.395 0.617 . . . . 1.0 110.182 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -132.93 54.86 1.93 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.205 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 85.4 mt -144.03 110.33 5.47 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.974 -0.557 . . . . 1.0 109.721 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -147.79 157.4 43.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 122.022 0.915 . . . . 1.0 111.791 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -119.25 139.39 51.96 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.871 -1.059 . . . . 1.0 108.433 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -117.56 168.39 10.45 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 122.536 1.16 . . . . 1.0 112.1 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.3 m -123.93 139.32 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 114.458 -1.246 . . . . 1.0 109.367 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.447 ' C ' ' H ' ' A' ' 56' ' ' SER . 40.0 p-10 -99.79 78.49 2.14 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.565 0.697 . . . . 1.0 110.484 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 56' ' ' SER . 23.9 mt -71.86 45.94 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.539 -0.755 . . . . 1.0 109.844 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.473 ' O ' ' C ' ' A' ' 57' ' ' GLY . 14.6 m -57.55 -142.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.329 0.585 . . . . 1.0 111.16 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.497 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . 30.75 -112.94 0.05 OUTLIER Glycine 0 N--CA 1.472 1.067 0 N-CA-C 111.121 -0.792 . . . . 1.0 111.121 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 1.9 p 154.55 -5.21 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 115.632 -0.284 . . . . 1.0 111.354 178.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.633 ' CD ' ' H ' ' A' ' 59' ' ' GLU . 8.6 mp0 -37.91 95.86 0.1 Allowed Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 111.762 0.282 . . . . 1.0 111.762 -178.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -62.64 138.47 70.02 Favored 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 122.483 2.122 . . . . 1.0 112.489 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 141.47 -117.54 1.22 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.608 -0.997 . . . . 1.0 110.608 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -137.53 73.77 1.46 Allowed 'General case' 0 N--CA 1.477 0.878 0 O-C-N 122.239 -0.565 . . . . 1.0 109.952 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -88.32 136.03 33.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.827 0.822 . . . . 1.0 112.247 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.406 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 32.7 p-10 -82.99 110.26 17.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.24 -0.891 . . . . 1.0 109.029 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -97.12 159.49 14.88 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.839 0.828 . . . . 1.0 111.626 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -104.58 141.39 36.49 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.934 -1.03 . . . . 1.0 111.296 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.7 t -80.01 124.47 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.43 0.634 . . . . 1.0 110.232 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -100.42 88.86 3.77 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.646 0.736 . . . . 1.0 110.297 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.5 t -86.71 134.75 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.044 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -74.35 146.54 84.23 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.51 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.58 154.72 64.31 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 122.371 2.047 . . . . 1.0 112.198 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.3 mt -112.43 123.25 34.52 Favored Pre-proline 0 N--CA 1.48 1.032 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.721 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.95 135.71 23.75 Favored 'Trans proline' 0 N--CA 1.504 2.098 0 C-N-CA 121.853 1.702 . . . . 1.0 112.392 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 79.48 -15.12 0.79 Allowed 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.39 0.676 . . . . 1.0 111.258 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.7 mm -120.8 146.17 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-O 122.077 0.941 . . . . 1.0 110.005 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -110.19 112.48 24.47 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 122.061 0.934 . . . . 1.0 111.167 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.8 tt -59.72 146.32 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-O 121.391 0.615 . . . . 1.0 110.094 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 68.6 t -103.66 -42.39 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 122.004 -0.435 . . . . 1.0 110.741 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -172.98 175.36 3.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.923 0.868 . . . . 1.0 110.776 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.422 ' O ' ' O ' ' A' ' 34' ' ' ARG . 61.9 mt -110.23 -77.61 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 115.648 -0.706 . . . . 1.0 109.767 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 80' ' ' ILE . 88.3 p 54.97 108.35 0.02 OUTLIER Pre-proline 0 CA--C 1.549 0.939 0 CA-C-O 118.228 -0.891 . . . . 1.0 112.213 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -68.93 122.02 5.38 Favored 'Cis proline' 0 N--CA 1.503 2.044 0 CA-C-N 120.373 1.169 . . . . 1.0 111.794 0.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 91.8 mtm180 -68.71 -34.21 75.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.929 0.871 . . . . 1.0 109.428 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.5 t -130.32 142.51 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.469 0.707 . . . . 1.0 109.117 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.4 m -135.51 153.61 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-O 121.766 0.793 . . . . 1.0 111.746 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 38.4 m -107.29 120.77 43.06 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.17 -0.923 . . . . 1.0 110.602 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 60.0 mt -126.75 134.64 50.58 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.349 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -93.25 131.15 38.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.352 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.1 mt -112.98 140.27 47.94 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.362 0.601 . . . . 1.0 110.085 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -139.1 152.21 47.31 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.894 0.854 . . . . 1.0 111.067 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -69.12 139.74 54.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.153 -0.93 . . . . 1.0 110.826 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 121.666 0.746 . . . . 1.0 111.078 -179.751 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 . . . . . 0 CA--C 1.531 0.227 0 CA-C-O 121.187 0.518 . . . . 1.0 111.765 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 53.03 83.16 0.23 Allowed Pre-proline 0 CA--C 1.54 0.586 0 O-C-N 121.814 -0.554 . . . . 1.0 112.288 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.69 147.72 78.31 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 122.678 2.252 . . . . 1.0 112.834 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 81.9 m -119.27 107.15 13.06 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.578 0.704 . . . . 1.0 110.133 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.4 mt -117.91 152.79 34.73 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.18 0.991 . . . . 1.0 110.427 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.2 m -117.17 123.92 47.87 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.604 -0.725 . . . . 1.0 110.607 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.501 HD13 ' H ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -112.51 145.64 39.89 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.606 -0.724 . . . . 1.0 110.468 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.501 ' H ' HD13 ' A' ' 13' ' ' LEU . 95.9 p -86.38 155.59 20.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.263 0.554 . . . . 1.0 109.908 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.7 tp -95.03 129.61 42.04 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.197 0.523 . . . . 1.0 110.755 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.0 pt -127.03 148.76 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-O 121.451 0.643 . . . . 1.0 110.958 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.9 104.64 16.86 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 121.841 -0.537 . . . . 1.0 110.971 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -82.68 59.68 4.86 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.33 0.586 . . . . 1.0 110.928 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.694 ' ND2' ' H ' ' A' ' 55' ' ' LEU . 1.8 p30 171.71 -79.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.356 0.598 . . . . 1.0 110.062 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.9 m 48.66 70.38 2.12 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 115.918 -0.583 . . . . 1.0 111.625 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 22' ' ' ALA . 40.0 Cg_endo -66.64 143.47 68.38 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 121.849 1.699 . . . . 1.0 111.557 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.469 ' C ' ' H ' ' A' ' 24' ' ' SER . . . -48.36 -175.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.54 0.686 . . . . 1.0 111.727 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.6 m120 73.55 -25.68 0.19 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.089 0.471 . . . . 1.0 111.048 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 22' ' ' ALA . 2.9 t -134.27 149.77 50.95 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 122.013 0.911 . . . . 1.0 110.614 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 17.0 ptm -143.62 142.79 31.2 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.613 -0.721 . . . . 1.0 110.414 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 80.5 mt -86.23 119.04 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 121.546 0.688 . . . . 1.0 110.833 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 12.3 ptm -98.69 -6.6 29.33 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.453 0.644 . . . . 1.0 109.571 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 91.5 m -84.47 136.25 33.91 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -67.95 123.31 20.24 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.316 -0.865 . . . . 1.0 110.334 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.454 HD22 ' N ' ' A' ' 30' ' ' LEU . 4.4 mm? -53.08 103.11 0.35 Allowed Pre-proline 0 CA--C 1.547 0.841 0 CA-C-O 118.68 -0.676 . . . . 1.0 112.096 -178.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -65.32 155.73 67.02 Favored 'Trans proline' 0 N--CA 1.506 2.256 0 C-N-CA 122.517 2.145 . . . . 1.0 113.144 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.6 p -93.17 165.58 12.75 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.646 -0.659 . . . . 1.0 110.994 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.6 m -137.8 135.43 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-O 121.141 0.496 . . . . 1.0 110.985 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.404 HH22 ' CE ' ' A' ' 36' ' ' LYS . 8.4 ptm180 -97.96 128.37 44.49 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.538 -0.542 . . . . 1.0 109.538 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 t -122.84 134.69 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 122.172 0.987 . . . . 1.0 111.473 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.404 ' CE ' HH22 ' A' ' 34' ' ' ARG . 68.7 mttm -109.4 155.85 20.76 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.357 -0.838 . . . . 1.0 110.412 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 76.0 p -138.02 124.9 21.2 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.247 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 39' ' ' GLY . 10.6 tm-20 -46.54 -67.17 0.31 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.859 0.838 . . . . 1.0 110.524 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 38' ' ' GLU . . . -58.74 -147.99 0.01 OUTLIER Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.017 -0.833 . . . . 1.0 111.017 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -141.97 122.9 14.48 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.651 0.739 . . . . 1.0 110.762 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.618 ' CB ' HD12 ' A' ' 44' ' ' ILE . 6.7 p-10 -127.37 45.88 1.8 Allowed Pre-proline 0 N--CA 1.476 0.861 0 CA-C-N 116.024 -0.535 . . . . 1.0 111.164 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 41' ' ' ASN . 56.8 Cg_endo -67.72 -8.59 22.85 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.528 2.152 . . . . 1.0 111.667 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.6 t -143.58 77.02 1.54 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.169 0.509 . . . . 1.0 111.045 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.618 HD12 ' CB ' ' A' ' 41' ' ' ASN . 24.5 mt -144.06 156.17 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 121.932 0.873 . . . . 1.0 109.535 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.526 ' C ' ' H ' ' A' ' 47' ' ' ASN . 18.0 t-20 -68.16 55.51 0.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.447 -0.797 . . . . 1.0 110.67 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.4 m -70.56 24.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 121.023 0.44 . . . . 1.0 110.96 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.526 ' H ' ' C ' ' A' ' 45' ' ' ASN . 53.3 t30 -87.79 6.58 34.52 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.149 0.5 . . . . 1.0 110.413 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -126.29 8.34 7.19 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.208 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.488 HD21 HG12 ' A' ' 72' ' ' ILE . 16.2 mt -95.61 121.71 37.59 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.236 0.541 . . . . 1.0 109.707 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -148.51 163.54 36.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 122.466 1.127 . . . . 1.0 111.619 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -109.91 133.01 53.63 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.398 -1.274 . . . . 1.0 108.351 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.525 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 7.7 p90 -145.32 152.72 40.35 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 122.76 1.267 . . . . 1.0 112.164 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.8 m -111.75 138.61 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 114.214 -1.357 . . . . 1.0 109.068 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -88.35 87.05 7.17 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.625 -0.716 . . . . 1.0 110.519 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.694 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 4.1 mp -69.66 -10.59 58.88 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.079 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 55' ' ' LEU . 56.9 m 29.13 -108.93 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.655 0.613 . . . . 1.0 112.655 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.504 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -68.97 -76.33 0.47 Allowed Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.04 -0.824 . . . . 1.0 111.04 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 3.0 p 149.31 134.27 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.37 0.605 . . . . 1.0 111.663 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -132.98 77.03 69.18 Favored Pre-proline 0 N--CA 1.483 1.176 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.883 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.68 153.9 64.09 Favored 'Trans proline' 0 N--CA 1.507 2.308 0 C-N-CA 123.153 2.568 . . . . 1.0 112.953 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.558 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . 98.6 50.82 1.48 Allowed Glycine 0 N--CA 1.472 1.057 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.558 ' O ' ' O ' ' A' ' 61' ' ' GLY . 97.3 mt-10 54.79 137.3 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 O-C-N 122.245 -0.562 . . . . 1.0 110.217 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.672 ' CG ' ' H ' ' A' ' 64' ' ' ASP . 8.8 t-80 -149.92 -166.0 2.43 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 122.595 1.188 . . . . 1.0 112.377 -178.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.672 ' H ' ' CG ' ' A' ' 63' ' ' HIS . 79.4 m-20 -143.35 97.89 3.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.58 -1.191 . . . . 1.0 109.155 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -99.76 135.83 40.58 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.791 0.805 . . . . 1.0 111.405 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.476 ' CD ' ' N ' ' A' ' 67' ' ' VAL . 10.2 tm-20 -72.08 152.87 42.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.992 -1.003 . . . . 1.0 111.326 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.476 ' N ' ' CD ' ' A' ' 66' ' ' GLU . 41.1 t -91.02 116.06 31.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.668 0.747 . . . . 1.0 110.119 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.432 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 28.1 ttmt -109.61 106.39 16.06 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 122.163 0.983 . . . . 1.0 110.443 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.1 t -99.05 139.61 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 115.689 -0.687 . . . . 1.0 111.242 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -68.37 117.65 51.83 Favored Pre-proline 0 CA--C 1.55 0.972 0 CA-C-O 118.719 -0.657 . . . . 1.0 110.56 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.58 141.29 19.66 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 C-N-CA 121.718 1.612 . . . . 1.0 112.701 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.488 HG12 HD21 ' A' ' 49' ' ' LEU . 44.7 mm -113.14 119.27 42.75 Favored Pre-proline 0 N--CA 1.484 1.229 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.07 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.23 89.09 0.93 Allowed 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 122.019 1.813 . . . . 1.0 112.585 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 166.25 -19.99 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 122.685 0.394 . . . . 1.0 110.573 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.8 mm -134.8 156.14 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 121.851 0.834 . . . . 1.0 110.244 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -101.03 144.51 29.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 122.755 1.264 . . . . 1.0 111.2 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.564 HG23 ' O ' ' A' ' 77' ' ' ILE . 18.4 tt -108.59 114.86 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 115.208 -0.905 . . . . 1.0 110.148 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.9 t -66.05 -41.05 88.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 O-C-N 122.133 -0.355 . . . . 1.0 110.408 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.409 ' CD ' ' NH2' ' A' ' 83' ' ' ARG . 1.9 mt-10 -179.54 -175.53 0.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 122.177 0.989 . . . . 1.0 110.595 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.0 mt -107.56 -75.35 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 115.346 -0.843 . . . . 1.0 109.839 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.0 m 53.57 101.43 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.714 0 CA-C-O 118.219 -0.896 . . . . 1.0 111.848 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.52 172.35 35.49 Favored 'Cis proline' 0 N--CA 1.505 2.18 0 CA-C-N 120.287 1.138 . . . . 1.0 111.805 0.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.409 ' NH2' ' CD ' ' A' ' 79' ' ' GLU . 97.3 mtt180 -119.85 -12.97 9.12 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.679 0.752 . . . . 1.0 109.097 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.6 t -145.82 141.96 21.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.065 -0.717 . . . . 1.0 109.065 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.7 m -135.37 139.93 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-O 121.542 0.686 . . . . 1.0 111.662 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.525 ' O ' HG23 ' A' ' 86' ' ' THR . 12.9 t -103.04 119.86 39.62 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.387 -0.824 . . . . 1.0 110.753 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 62.1 mt -108.7 -178.22 3.53 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.658 0.742 . . . . 1.0 110.157 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -139.56 110.76 6.95 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.469 -0.787 . . . . 1.0 110.512 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.5 mt -105.01 139.43 39.71 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.493 -0.776 . . . . 1.0 110.086 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -145.43 144.21 30.5 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.741 0.781 . . . . 1.0 111.168 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -67.06 137.82 56.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.434 -0.803 . . . . 1.0 110.737 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.445 ' CG ' ' O ' ' A' ' 92' ' ' HIS . 7.9 p80 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 121.252 0.549 . . . . 1.0 111.358 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 74.4 mtp85 . . . . . 0 N--CA 1.469 0.524 0 CA-C-O 121.325 0.583 . . . . 1.0 112.194 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -165.3 107.59 0.78 Allowed Pre-proline 0 CA--C 1.545 0.757 0 O-C-N 121.927 -0.483 . . . . 1.0 111.273 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -77.04 161.72 32.48 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.484 1.456 . . . . 1.0 112.738 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.4 m -110.06 99.67 8.73 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.662 0.744 . . . . 1.0 110.122 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 57.8 mt -107.3 146.53 31.41 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.445 0.641 . . . . 1.0 110.287 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.9 t -124.03 127.72 48.3 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.274 0.559 . . . . 1.0 110.756 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 44.7 mt -110.46 137.42 48.18 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.602 -0.726 . . . . 1.0 110.221 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.1 t -63.36 171.17 2.58 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.865 -0.42 . . . . 1.0 109.865 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.9 tp -125.67 116.04 21.05 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.796 0.808 . . . . 1.0 110.805 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 38.2 pt -117.61 149.66 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-O 121.749 0.785 . . . . 1.0 110.67 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.56 124.73 39.72 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.87 -0.519 . . . . 1.0 110.689 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -120.64 -178.49 3.73 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.364 0.602 . . . . 1.0 110.0 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 45.03 37.02 2.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.373 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.05 109.39 6.16 Favored Pre-proline 0 CA--C 1.561 1.402 0 CA-C-O 118.479 -0.772 . . . . 1.0 111.005 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -59.05 -146.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.508 2.332 0 C-N-CA 121.141 1.228 . . . . 1.0 111.922 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.547 ' O ' ' C ' ' A' ' 23' ' ' ASN . . . -49.17 143.95 5.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 122.07 0.938 . . . . 1.0 111.544 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.547 ' C ' ' O ' ' A' ' 22' ' ' ALA . 77.7 m-20 -13.91 84.84 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.483 0.659 . . . . 1.0 112.067 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 22' ' ' ALA . 40.5 t -96.06 149.12 21.95 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.644 0.735 . . . . 1.0 110.886 -178.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 26.2 ttt -144.44 103.64 3.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.558 0.694 . . . . 1.0 110.089 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.907 ' H ' HD12 ' A' ' 26' ' ' ILE . 2.7 mp -70.57 119.63 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.953 -0.567 . . . . 1.0 111.051 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -60.9 -45.26 95.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.261 0.553 . . . . 1.0 109.555 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.8 p -79.14 171.16 15.58 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -102.59 166.9 10.26 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.331 -0.856 . . . . 1.0 110.273 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 22.3 mt -102.56 94.21 4.84 Favored Pre-proline 0 CA--C 1.553 1.083 0 CA-C-N 115.553 -0.749 . . . . 1.0 112.104 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -80.79 157.6 21.23 Favored 'Trans proline' 0 N--CA 1.504 2.106 0 C-N-CA 121.819 1.679 . . . . 1.0 112.964 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 96.0 p -67.73 161.81 25.2 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 121.728 -0.608 . . . . 1.0 110.953 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.3 m -120.19 138.45 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.174 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 67.5 mtp85 -89.47 118.81 29.39 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.829 -0.434 . . . . 1.0 109.829 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.91 132.26 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 121.816 0.817 . . . . 1.0 111.534 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -102.52 150.99 22.84 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.66 -0.7 . . . . 1.0 110.211 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 72.6 p -134.96 136.86 42.56 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.057 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -53.34 -69.65 0.11 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.805 0.812 . . . . 1.0 110.428 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.46 ' H ' HG23 ' A' ' 75' ' ' ILE . . . -49.04 172.45 0.06 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.252 -0.739 . . . . 1.0 111.252 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.442 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 68.2 t80 -96.92 -8.08 31.64 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.838 0.352 . . . . 1.0 111.308 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.7 m120 59.69 77.9 0.36 Allowed Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.749 -0.205 . . . . 1.0 111.294 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -45.69 -45.19 16.87 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 121.603 1.535 . . . . 1.0 112.371 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.4 p -169.86 21.77 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.785 0.326 . . . . 1.0 111.119 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.513 HD12 ' N ' ' A' ' 44' ' ' ILE . 1.6 mp -53.39 133.59 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 121.657 0.742 . . . . 1.0 110.032 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -55.56 91.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.677 -0.692 . . . . 1.0 110.802 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 55.9 t -55.37 -16.68 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.44 -0.346 . . . . 1.0 110.621 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.5 ' O ' ' N ' ' A' ' 49' ' ' LEU . 10.2 p30 -80.58 -48.28 12.94 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.837 0.351 . . . . 1.0 110.308 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.462 ' N ' ' OD1' ' A' ' 47' ' ' ASN . 80.0 tt0 -43.99 -14.81 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 116.002 -0.545 . . . . 1.0 111.448 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.5 ' N ' ' O ' ' A' ' 47' ' ' ASN . 40.3 mt -95.02 139.53 31.26 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.455 ' CE2' ' O ' ' A' ' 47' ' ' ASN . 92.5 m-85 -150.86 159.43 44.56 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.768 0.794 . . . . 1.0 111.486 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -120.23 134.65 55.21 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.027 -0.988 . . . . 1.0 108.704 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 22.2 p90 -150.32 149.09 29.64 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.323 1.059 . . . . 1.0 112.104 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.0 m -105.62 147.44 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 114.648 -1.16 . . . . 1.0 109.083 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.462 ' C ' ' H ' ' A' ' 56' ' ' SER . 50.1 p-10 -101.23 81.03 2.17 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.305 0.574 . . . . 1.0 110.757 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.0 mt -56.29 -6.07 0.24 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.247 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.462 ' H ' ' C ' ' A' ' 54' ' ' ASP . 42.9 t 34.82 -95.49 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.25 0.62 . . . . 1.0 112.612 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.948 ' O ' ' O ' ' A' ' 58' ' ' SER . . . -114.55 62.39 0.33 Allowed Glycine 0 N--CA 1.472 1.094 0 N-CA-C 110.77 -0.932 . . . . 1.0 110.77 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.948 ' O ' ' O ' ' A' ' 57' ' ' GLY . 8.6 m 8.51 144.07 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.125 0 N-CA-C 113.707 1.003 . . . . 1.0 113.707 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.528 ' H ' HD12 ' A' ' 89' ' ' LEU . 73.5 mm-40 -133.64 82.02 52.13 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 110.07 -0.345 . . . . 1.0 110.07 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -49.36 139.97 27.71 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.133 1.889 . . . . 1.0 112.305 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.04 -97.37 0.81 Allowed Glycine 0 N--CA 1.47 0.959 0 N-CA-C 110.602 -0.999 . . . . 1.0 110.602 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -165.18 139.88 5.05 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 122.242 -0.563 . . . . 1.0 109.62 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.665 ' CG ' ' H ' ' A' ' 64' ' ' ASP . 32.5 t60 -154.94 -164.24 1.75 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 122.365 1.079 . . . . 1.0 112.167 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.665 ' H ' ' CG ' ' A' ' 63' ' ' HIS . 12.7 p-10 -122.79 145.04 48.78 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 114.607 -1.178 . . . . 1.0 109.134 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -142.56 138.12 30.6 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.309 0.576 . . . . 1.0 111.627 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -94.31 142.56 27.27 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.528 -0.76 . . . . 1.0 111.045 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.9 t -95.95 135.38 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.333 0.587 . . . . 1.0 110.175 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.72 151.24 52.03 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.881 0.848 . . . . 1.0 110.472 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.7 t -131.19 144.66 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 121.571 0.7 . . . . 1.0 111.131 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -68.08 128.49 93.27 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-N 115.422 -0.808 . . . . 1.0 110.445 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -39.51 153.9 0.05 OUTLIER 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.069 1.846 . . . . 1.0 113.433 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.565 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -101.07 154.85 36.92 Favored Pre-proline 0 N--CA 1.483 1.202 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.582 -179.29 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 72' ' ' ILE . 61.1 Cg_exo -37.46 -106.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.509 2.415 0 C-N-CA 122.775 2.317 . . . . 1.0 113.698 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -105.99 18.25 22.37 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.036 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.586 HG22 ' N ' ' A' ' 76' ' ' LYS . 81.5 mt -103.53 166.1 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 121.351 0.596 . . . . 1.0 110.136 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.586 ' N ' HG22 ' A' ' 75' ' ' ILE . 66.1 tttm -118.98 119.98 35.92 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.894 0.854 . . . . 1.0 111.533 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.439 ' HB ' HD11 ' A' ' 72' ' ' ILE . 19.3 tt -59.81 143.01 14.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.128 0.49 . . . . 1.0 110.323 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 85.1 t -96.14 -49.4 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 122.104 -0.373 . . . . 1.0 110.689 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -173.17 133.62 0.52 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.415 0.626 . . . . 1.0 111.031 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.8 tp -100.85 134.15 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-O 121.492 0.663 . . . . 1.0 109.381 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 61.8 p -145.45 143.06 19.03 Favored Pre-proline 0 N--CA 1.478 0.948 0 CA-C-O 118.939 -0.553 . . . . 1.0 111.795 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.6 138.66 56.2 Favored 'Cis proline' 0 N--CA 1.505 2.196 0 CA-C-N 119.602 0.894 . . . . 1.0 111.896 -1.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -67.87 -35.27 78.24 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.98 0.895 . . . . 1.0 109.947 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 t -134.89 145.6 32.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.178 -0.675 . . . . 1.0 109.178 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.65 161.44 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-O 122.431 1.11 . . . . 1.0 110.833 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 75.8 m -105.98 124.21 49.21 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.434 -1.257 . . . . 1.0 110.525 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 87.5 mt -130.62 116.98 18.84 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.192 0.52 . . . . 1.0 110.093 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -96.82 110.62 23.06 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.389 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.528 HD12 ' H ' ' A' ' 59' ' ' GLU . 51.5 mt -78.83 150.59 32.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.056 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -129.4 141.28 51.09 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 122.092 0.949 . . . . 1.0 111.045 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -65.63 126.59 28.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.009 -0.996 . . . . 1.0 110.584 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.447 ' CG ' ' O ' ' A' ' 92' ' ' HIS . 78.4 t60 . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.039 0.447 . . . . 1.0 111.095 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 . . . . . 0 N--CA 1.464 0.245 0 CA-C-O 121.432 0.634 . . . . 1.0 111.455 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 41.64 75.99 0.56 Allowed Pre-proline 0 C--N 1.327 -0.372 0 C-N-CA 122.975 0.51 . . . . 1.0 112.293 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.68 153.37 54.13 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.426 2.084 . . . . 1.0 113.019 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 75.3 m -106.15 99.24 8.84 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.408 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -94.02 146.73 23.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 122.13 0.967 . . . . 1.0 110.497 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.2 m -119.52 109.6 15.91 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.625 -0.716 . . . . 1.0 110.475 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.5 mt -110.36 134.14 52.58 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.318 -0.855 . . . . 1.0 109.696 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.0 m -79.74 164.95 23.29 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.91 -0.404 . . . . 1.0 109.91 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.2 tp -113.08 118.21 34.14 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.73 0.776 . . . . 1.0 110.648 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.8 pp -128.19 162.17 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 CA-C-O 121.751 0.786 . . . . 1.0 110.925 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.403 ' CB ' ' OG1' ' A' ' 20' ' ' THR . . . -79.69 157.99 27.08 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 121.769 -0.582 . . . . 1.0 111.001 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -66.94 -36.68 82.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.221 0.534 . . . . 1.0 111.282 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -166.45 -34.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.098 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.403 ' OG1' ' CB ' ' A' ' 17' ' ' ALA . 22.3 m 59.34 76.56 0.44 Allowed Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 116.343 -0.39 . . . . 1.0 111.463 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 22' ' ' ALA . 31.7 Cg_exo -57.88 148.96 72.82 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.249 1.966 . . . . 1.0 111.586 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.449 ' C ' ' H ' ' A' ' 24' ' ' SER . . . -51.37 -169.96 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.891 0.853 . . . . 1.0 111.74 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 71.23 -38.68 0.43 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.141 -0.481 . . . . 1.0 111.001 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.449 ' H ' ' C ' ' A' ' 22' ' ' ALA . 13.3 p -109.02 149.58 29.05 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.699 0.761 . . . . 1.0 110.587 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 11.7 tmm? -141.88 120.26 12.35 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.553 0.692 . . . . 1.0 110.33 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 74.0 mt -72.74 116.13 14.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.592 0.71 . . . . 1.0 110.881 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 78.0 mtp -94.83 -16.41 22.96 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.925 -0.579 . . . . 1.0 109.669 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.9 m -78.71 134.5 37.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.262 0.553 . . . . 1.0 109.69 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.407 ' H ' ' HD2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -78.57 123.99 27.68 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 121.288 -0.883 . . . . 1.0 110.316 -179.548 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.7 mt -70.43 114.71 28.18 Favored Pre-proline 0 CA--C 1.555 1.139 0 CA-C-N 115.748 -0.66 . . . . 1.0 112.05 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -84.68 152.59 11.62 Favored 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 121.77 1.647 . . . . 1.0 113.07 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.7 m -72.98 173.28 9.52 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.614 -0.679 . . . . 1.0 111.213 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.517 HG21 HD11 ' A' ' 80' ' ' ILE . 2.8 p -142.84 136.96 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-O 121.376 0.608 . . . . 1.0 111.046 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -97.54 129.33 44.7 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.4 0.619 . . . . 1.0 109.346 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -124.71 134.18 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-O 122.101 0.953 . . . . 1.0 111.576 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -107.81 149.02 28.73 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.465 -0.789 . . . . 1.0 110.289 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 72.1 p -127.78 132.04 49.55 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 116.045 -0.525 . . . . 1.0 111.294 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -58.04 -75.29 0.05 OUTLIER 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.827 0.823 . . . . 1.0 110.09 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.61 166.64 15.94 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.959 -0.856 . . . . 1.0 110.959 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -79.77 175.08 10.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.841 0.829 . . . . 1.0 110.683 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -124.0 92.77 47.98 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 115.71 -0.677 . . . . 1.0 110.65 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -52.36 -40.9 69.66 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 121.893 1.729 . . . . 1.0 112.13 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 44' ' ' ILE . 73.8 m -165.51 -96.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.63 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 43' ' ' SER . 65.7 mt 57.76 141.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.128 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -85.44 96.95 9.75 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.165 0.507 . . . . 1.0 110.806 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.4 m -86.13 5.92 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 120.942 0.401 . . . . 1.0 110.782 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -97.13 -1.13 45.78 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.107 0.48 . . . . 1.0 110.262 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.482 ' OE1' ' N ' ' A' ' 48' ' ' GLU . 18.8 mp0 -120.25 6.27 10.72 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.662 -0.699 . . . . 1.0 110.145 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.0 mt -122.26 128.44 51.12 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.635 0.731 . . . . 1.0 109.557 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -133.67 -168.45 2.11 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.248 1.023 . . . . 1.0 111.544 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -115.41 139.74 49.75 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.626 -1.17 . . . . 1.0 108.989 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.475 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 16.8 p90 -141.37 153.42 45.08 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 122.34 1.067 . . . . 1.0 112.36 -178.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.3 m -110.56 140.09 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 114.647 -1.16 . . . . 1.0 109.27 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -77.44 88.57 3.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.502 0.668 . . . . 1.0 110.328 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 57' ' ' GLY . 0.8 OUTLIER -90.39 -26.52 19.86 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.623 -0.717 . . . . 1.0 109.848 -179.735 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 55' ' ' LEU . 35.4 t 28.18 -89.86 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.004 0.521 . . . . 1.0 112.353 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . -62.55 -75.01 0.35 Allowed Glycine 0 CA--C 1.531 1.093 0 N-CA-C 111.029 -0.828 . . . . 1.0 111.029 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.0 t 75.56 95.82 0.07 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 122.879 0.471 . . . . 1.0 111.469 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -123.61 147.95 54.57 Favored Pre-proline 0 N--CA 1.482 1.16 0 CA-C-O 119.514 -0.279 . . . . 1.0 111.67 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -47.82 139.0 19.92 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 121.724 1.616 . . . . 1.0 113.304 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 139.66 -135.59 7.3 Favored Glycine 0 N--CA 1.472 1.086 0 N-CA-C 110.532 -1.027 . . . . 1.0 110.532 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -170.65 144.02 2.27 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -154.62 -164.66 1.87 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.708 1.242 . . . . 1.0 112.451 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 32.8 p-10 -111.74 91.84 3.81 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 114.33 -1.305 . . . . 1.0 108.942 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -82.56 132.16 35.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.679 0.752 . . . . 1.0 111.36 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.51 153.63 37.38 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.057 -0.974 . . . . 1.0 111.171 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 65.4 t -94.09 110.29 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 121.59 0.71 . . . . 1.0 110.152 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' A' ' 52' ' ' TYR . 1.6 tmtp? -112.01 118.6 35.87 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 122.039 0.923 . . . . 1.0 110.137 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.3 m -126.43 149.89 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 115.783 -0.644 . . . . 1.0 111.203 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -74.84 125.77 89.09 Favored Pre-proline 0 CA--C 1.549 0.92 0 CA-C-O 118.387 -0.816 . . . . 1.0 110.311 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.01 137.76 19.91 Favored 'Trans proline' 0 N--CA 1.5 1.892 0 C-N-CA 121.619 1.546 . . . . 1.0 112.357 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.5 mm -79.8 128.74 73.29 Favored Pre-proline 0 CA--C 1.554 1.131 0 CA-C-N 116.456 -0.338 . . . . 1.0 111.314 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.3 152.82 66.74 Favored 'Trans proline' 0 N--CA 1.502 2.024 0 C-N-CA 121.506 1.471 . . . . 1.0 112.818 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.9 t30 65.63 -1.27 1.06 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.295 0.638 . . . . 1.0 111.29 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.415 HG22 ' N ' ' A' ' 76' ' ' LYS . 66.5 mt -133.58 155.48 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 121.64 0.733 . . . . 1.0 110.191 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.415 ' N ' HG22 ' A' ' 75' ' ' ILE . 68.7 mttm -107.93 149.82 27.86 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 122.267 1.032 . . . . 1.0 111.236 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.625 HG23 ' O ' ' A' ' 77' ' ' ILE . 18.1 tt -100.41 101.54 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 115.732 -0.667 . . . . 1.0 109.995 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.2 t -46.02 -58.18 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 O-C-N 122.121 -0.362 . . . . 1.0 110.636 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -175.62 141.68 0.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.685 0.755 . . . . 1.0 110.686 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.517 HD11 HG21 ' A' ' 33' ' ' VAL . 8.6 tp -104.18 138.85 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.399 0.619 . . . . 1.0 109.579 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.2 m -147.32 134.93 10.48 Favored Pre-proline 0 N--CA 1.481 1.079 0 CA-C-O 118.481 -0.771 . . . . 1.0 112.293 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.84 -174.49 10.77 Favored 'Cis proline' 0 N--CA 1.503 2.037 0 CA-C-N 120.133 1.083 . . . . 1.0 111.701 -0.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -121.2 -18.31 7.45 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.927 0.87 . . . . 1.0 109.312 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.6 t -138.61 136.94 43.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.029 -0.73 . . . . 1.0 109.029 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.2 m -137.19 174.74 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 CA-C-O 121.771 0.796 . . . . 1.0 111.476 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.0 t -133.07 128.31 35.95 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.137 -0.938 . . . . 1.0 110.465 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 50.2 mt -130.74 120.95 24.58 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 120.954 0.407 . . . . 1.0 110.207 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -86.16 112.12 21.02 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.582 0.706 . . . . 1.0 110.281 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.6 mt -80.68 165.87 21.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.673 -0.694 . . . . 1.0 110.085 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -140.27 130.32 24.86 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.9 0.857 . . . . 1.0 110.971 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 -76.19 129.57 36.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.194 -0.912 . . . . 1.0 110.522 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 . . . . . 0 CA--C 1.534 0.328 0 CA-C-O 121.202 0.525 . . . . 1.0 111.145 -179.658 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.534 ' NH2' ' CZ ' ' A' ' 40' ' ' TYR . 88.6 mtm180 . . . . . 0 N--CA 1.468 0.432 0 CA-C-O 122.263 1.03 . . . . 1.0 111.381 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -152.28 86.27 4.44 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 115.9 -0.591 . . . . 1.0 111.509 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.95 119.83 6.93 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 122.166 1.911 . . . . 1.0 113.227 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 42.0 m -117.25 87.15 2.65 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 121.312 0.577 . . . . 1.0 110.739 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.771 HD22 ' N ' ' A' ' 11' ' ' LEU . 0.9 OUTLIER -98.6 147.15 25.1 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 122.122 0.963 . . . . 1.0 110.615 -179.462 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.5 m -106.79 124.28 49.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.717 0.77 . . . . 1.0 110.338 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.8 mt -112.99 130.53 56.1 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.107 -0.951 . . . . 1.0 110.131 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.9 m -69.19 161.07 29.94 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.0 tp -113.47 116.89 30.31 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.449 0.643 . . . . 1.0 111.055 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.7 pt -119.04 140.5 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-O 121.877 0.846 . . . . 1.0 110.694 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.27 117.91 17.61 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.22 0.533 . . . . 1.0 110.918 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.2 tptt -112.86 159.3 19.17 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.357 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 53.37 31.15 11.44 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.96 -0.385 . . . . 1.0 109.96 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.0 m -68.93 129.7 92.1 Favored Pre-proline 0 CA--C 1.546 0.823 0 CA-C-O 119.051 -0.499 . . . . 1.0 111.704 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -71.92 117.31 5.08 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 121.245 1.297 . . . . 1.0 111.431 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -42.83 158.15 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.87 0.843 . . . . 1.0 111.617 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.4 m120 73.2 9.71 5.22 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.958 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 90.3 p -112.44 145.13 40.73 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.738 0.78 . . . . 1.0 110.701 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.408 ' SD ' ' O ' ' A' ' 26' ' ' ILE . 12.5 tmm? -139.31 121.07 15.38 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.722 -0.672 . . . . 1.0 110.258 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.408 ' O ' ' SD ' ' A' ' 25' ' ' MET . 54.6 mt -73.8 144.98 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.888 0.851 . . . . 1.0 110.979 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 10.7 tpp -107.34 -26.78 10.85 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.571 -0.741 . . . . 1.0 109.596 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.9 m -81.09 156.49 25.78 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.203 -0.666 . . . . 1.0 109.203 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.438 ' C ' HD22 ' A' ' 30' ' ' LEU . 61.9 pttt -84.18 157.89 21.5 Favored 'General case' 0 CA--C 1.516 -0.362 0 O-C-N 121.273 -0.892 . . . . 1.0 110.19 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.466 HD22 ' N ' ' A' ' 30' ' ' LEU . 4.3 mm? -100.26 97.84 6.89 Favored Pre-proline 0 N--CA 1.484 1.262 0 CA-C-N 115.958 -0.565 . . . . 1.0 112.42 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 29' ' ' LYS . 37.2 Cg_endo -86.1 157.38 9.88 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.486 2.124 . . . . 1.0 112.714 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.4 m -77.35 -178.21 5.04 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.594 -0.691 . . . . 1.0 110.991 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.7 p -140.78 149.82 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 121.31 0.576 . . . . 1.0 111.146 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -102.87 123.83 47.24 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.49 0.662 . . . . 1.0 109.423 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 t -120.29 133.14 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-O 122.265 1.031 . . . . 1.0 111.52 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.437 ' H ' ' HB3' ' A' ' 79' ' ' GLU . 63.6 tttm -103.45 146.29 28.73 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.293 -0.867 . . . . 1.0 110.076 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 43.8 p -131.24 130.63 43.13 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.099 -0.501 . . . . 1.0 111.469 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.431 ' O ' ' O ' ' A' ' 39' ' ' GLY . 83.9 tt0 -57.36 -74.72 0.05 Allowed 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.648 0.737 . . . . 1.0 110.159 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 38' ' ' GLU . . . -50.17 -173.72 0.01 OUTLIER Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.347 -0.701 . . . . 1.0 111.347 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.715 ' O ' HD11 ' A' ' 75' ' ' ILE . 3.0 m-85 -104.92 167.9 9.41 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.494 0.664 . . . . 1.0 110.411 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -120.67 83.88 36.17 Favored Pre-proline 0 N--CA 1.476 0.831 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.412 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.56 -41.26 69.42 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.132 1.888 . . . . 1.0 112.162 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.515 ' O ' ' O ' ' A' ' 44' ' ' ILE . 73.7 m -161.17 -88.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.246 0.546 . . . . 1.0 110.401 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.515 ' O ' ' O ' ' A' ' 43' ' ' SER . 2.8 tt 31.56 100.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.352 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.604 ' C ' ' H ' ' A' ' 47' ' ' ASN . 87.9 m-20 -63.65 96.85 0.13 Allowed 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 120.969 0.414 . . . . 1.0 110.815 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.8 m -66.63 20.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.331 0.586 . . . . 1.0 110.718 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.604 ' H ' ' C ' ' A' ' 45' ' ' ASN . 94.1 m-20 -92.26 12.2 23.22 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.14 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -125.32 -1.23 7.61 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.694 -0.685 . . . . 1.0 110.288 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.8 mt -123.01 133.38 54.35 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -141.09 -166.57 2.2 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.009 0.909 . . . . 1.0 111.592 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -118.7 140.51 49.81 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.798 -1.092 . . . . 1.0 108.389 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -120.36 166.73 13.14 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 122.413 1.101 . . . . 1.0 112.084 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.3 m -133.73 145.49 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 114.475 -1.239 . . . . 1.0 109.305 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -94.92 81.83 3.78 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.709 0.766 . . . . 1.0 110.663 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.2 mp -75.11 -4.09 36.56 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.445 -0.798 . . . . 1.0 110.176 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.8 t -79.06 5.33 12.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.371 -0.377 . . . . 1.0 111.329 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -132.59 52.04 0.84 Allowed Glycine 0 N--CA 1.474 1.213 0 N-CA-C 111.344 -0.702 . . . . 1.0 111.344 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.7 t -153.45 -63.92 0.15 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.536 0.208 . . . . 1.0 111.316 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 66.36 151.92 0.12 Allowed Pre-proline 0 N--CA 1.472 0.625 0 C-N-CA 122.562 0.345 . . . . 1.0 111.443 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -35.06 143.29 0.08 OUTLIER 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 122.866 2.377 . . . . 1.0 113.369 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.513 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . 120.24 16.16 4.86 Favored Glycine 0 N--CA 1.472 1.057 0 N-CA-C 110.935 -0.866 . . . . 1.0 110.935 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.513 ' O ' ' O ' ' A' ' 61' ' ' GLY . 81.6 tt0 57.17 141.07 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 O-C-N 122.12 -0.635 . . . . 1.0 109.9 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.73 ' CG ' ' H ' ' A' ' 64' ' ' ASP . 7.6 t-80 -155.55 -163.65 1.57 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 122.883 1.325 . . . . 1.0 112.289 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.73 ' H ' ' CG ' ' A' ' 63' ' ' HIS . 95.6 m-20 -114.58 144.27 43.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.285 -1.325 . . . . 1.0 108.652 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' A' ' 65' ' ' TYR . 48.7 m-85 -134.76 139.15 44.93 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.426 0.631 . . . . 1.0 111.388 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -104.44 149.29 25.56 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.345 -0.843 . . . . 1.0 111.15 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 48.4 t -103.28 116.45 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 121.726 0.774 . . . . 1.0 110.203 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -123.51 139.74 53.71 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.293 1.044 . . . . 1.0 110.344 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.7 t -109.0 136.89 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 115.553 -0.748 . . . . 1.0 110.874 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -72.13 117.26 56.73 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-O 118.557 -0.735 . . . . 1.0 110.091 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -44.96 119.22 2.29 Favored 'Trans proline' 0 N--CA 1.505 2.167 0 C-N-CA 121.754 1.636 . . . . 1.0 113.157 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 33.9 mm -105.93 123.0 40.57 Favored Pre-proline 0 N--CA 1.487 1.39 0 CA-C-O 119.103 -0.475 . . . . 1.0 111.235 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.64 157.86 54.81 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.32 2.014 . . . . 1.0 112.092 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 33.6 t30 80.67 -26.27 0.16 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.481 0.712 . . . . 1.0 110.826 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.715 HD11 ' O ' ' A' ' 40' ' ' TYR . 12.7 mm -132.81 148.46 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 122.206 1.003 . . . . 1.0 110.489 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -113.77 149.6 34.65 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 122.762 1.268 . . . . 1.0 110.961 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.6 tt -91.97 142.99 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.209 -0.905 . . . . 1.0 110.112 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.8 t -120.72 -45.48 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 122.089 -0.382 . . . . 1.0 110.901 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.437 ' HB3' ' H ' ' A' ' 36' ' ' LYS . 81.4 tt0 -96.17 139.4 32.39 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 122.127 0.965 . . . . 1.0 110.667 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.5 mp -135.25 80.82 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 115.435 -0.802 . . . . 1.0 109.723 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.7 m -148.61 148.84 29.47 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 120.281 -0.568 . . . . 1.0 112.018 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.82 141.73 72.64 Favored 'Cis proline' 0 N--CA 1.509 2.423 0 C-N-CA 124.685 -0.964 . . . . 1.0 112.3 -1.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 90.8 mtm180 -61.76 -56.48 19.11 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.567 0.698 . . . . 1.0 109.368 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.1 t -135.21 149.25 28.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.231 -0.655 . . . . 1.0 109.231 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.2 m -144.75 163.73 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 121.647 0.737 . . . . 1.0 111.764 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 74.3 m -111.6 122.82 48.83 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.299 -0.864 . . . . 1.0 110.658 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.4 mt -107.99 -170.13 1.63 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.426 0.632 . . . . 1.0 110.204 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -146.56 112.6 5.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.47 0.652 . . . . 1.0 110.55 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.8 mt -107.33 143.16 36.01 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.555 0.693 . . . . 1.0 110.033 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -132.44 143.71 49.98 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.971 0.891 . . . . 1.0 111.036 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -68.65 131.16 44.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.165 -0.925 . . . . 1.0 110.547 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.474 0.736 0 CA-C-O 121.701 0.762 . . . . 1.0 111.071 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 . . . . . 0 CA--C 1.538 0.516 0 N-CA-C 112.558 0.577 . . . . 1.0 112.558 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -139.21 81.82 20.34 Favored Pre-proline 0 N--CA 1.476 0.867 0 O-C-N 121.942 -0.474 . . . . 1.0 111.329 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.94 134.5 55.53 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.794 2.329 . . . . 1.0 112.739 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.7 m -104.51 85.92 2.42 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.409 0.623 . . . . 1.0 110.143 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.8 mt -86.01 145.52 27.06 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.814 0.816 . . . . 1.0 110.544 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.3 m -109.57 119.56 39.79 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.531 0.682 . . . . 1.0 110.599 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.8 mp -102.54 135.36 44.31 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.39 -0.823 . . . . 1.0 109.879 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 59.3 m -79.33 105.8 10.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.895 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.5 tp -68.52 95.94 0.66 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.591 0.71 . . . . 1.0 110.938 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.3 pt -118.69 165.05 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 121.571 0.701 . . . . 1.0 111.038 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.99 164.34 23.54 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.792 -0.568 . . . . 1.0 111.12 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.1 mmtp -104.11 -56.85 2.13 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.221 0.534 . . . . 1.0 111.402 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -92.89 -54.54 3.7 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.547 0.689 . . . . 1.0 110.144 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.662 ' CG2' HD11 ' A' ' 26' ' ' ILE . 0.3 OUTLIER 45.66 80.91 0.27 Allowed Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 115.831 -0.622 . . . . 1.0 111.592 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.38 134.72 65.52 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.302 2.001 . . . . 1.0 111.238 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.45 -14.4 3.01 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 122.001 -0.437 . . . . 1.0 111.859 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -91.53 -15.34 28.87 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.957 -0.464 . . . . 1.0 111.161 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.4 t -108.3 153.48 23.18 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.524 0.678 . . . . 1.0 110.779 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 45.0 ttp -144.66 115.51 7.8 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.706 0.765 . . . . 1.0 110.086 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.946 ' H ' HD12 ' A' ' 26' ' ' ILE . 2.2 mp -68.11 115.39 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.862 0.839 . . . . 1.0 111.095 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 44.3 ttm -67.67 -28.07 67.38 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.685 -0.689 . . . . 1.0 109.44 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 30' ' ' LEU . 5.9 m -68.88 135.74 51.56 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -68.85 -13.99 62.76 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 121.279 -0.888 . . . . 1.0 111.097 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.474 ' H ' HG22 ' A' ' 28' ' ' THR . 24.1 mt 61.95 91.81 0.07 OUTLIER Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 115.828 -0.624 . . . . 1.0 112.31 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -86.57 158.47 9.27 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.854 2.369 . . . . 1.0 112.755 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 95.4 p -69.13 178.07 2.45 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.666 -0.646 . . . . 1.0 111.268 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.0 p -139.7 151.04 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-O 121.408 0.623 . . . . 1.0 111.053 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 100.0 mtt180 -98.96 129.19 45.26 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.6 t -127.03 154.66 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 122.384 1.087 . . . . 1.0 111.396 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -124.7 142.67 51.23 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.108 -0.951 . . . . 1.0 110.591 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 60.3 p -130.08 136.57 49.49 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.33 0.586 . . . . 1.0 111.264 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -109.84 41.62 1.67 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.526 0.679 . . . . 1.0 109.798 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -125.3 -9.45 5.03 Favored Glycine 0 N--CA 1.472 1.093 0 N-CA-C 111.039 -0.824 . . . . 1.0 111.039 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 59.73 153.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.234 0.54 . . . . 1.0 111.13 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -175.4 148.11 1.02 Allowed Pre-proline 0 CA--C 1.547 0.835 0 O-C-N 122.212 -0.305 . . . . 1.0 110.451 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.29 -58.97 0.11 Allowed 'Trans proline' 0 N--CA 1.509 2.429 0 C-N-CA 121.507 1.471 . . . . 1.0 112.599 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.484 ' O ' ' HB ' ' A' ' 44' ' ' ILE . 40.2 t -159.42 -56.8 0.06 Allowed 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.71 0.767 . . . . 1.0 110.71 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 43' ' ' SER . 42.3 mt 91.92 -113.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-N 115.39 -0.823 . . . . 1.0 109.73 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.513 ' OD1' ' ND2' ' A' ' 47' ' ' ASN . 11.2 t-20 -175.87 -19.47 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.653 0.74 . . . . 1.0 110.383 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.444 ' C ' ' O ' ' A' ' 45' ' ' ASN . 17.7 m 28.18 43.58 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-O 121.827 0.822 . . . . 1.0 112.036 -178.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.513 ' ND2' ' OD1' ' A' ' 45' ' ' ASN . 8.7 m120 -69.93 -40.92 75.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.577 -0.738 . . . . 1.0 110.754 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -127.95 13.08 6.78 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.617 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 28.5 mt -96.42 110.84 23.12 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.974 0.893 . . . . 1.0 109.597 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -148.24 -160.87 1.23 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 122.191 0.996 . . . . 1.0 111.533 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -117.2 142.49 46.97 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.703 -1.135 . . . . 1.0 108.263 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -134.57 175.12 9.82 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 122.03 0.919 . . . . 1.0 112.345 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.4 m -138.87 146.0 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 114.834 -1.075 . . . . 1.0 109.393 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -86.9 83.02 7.61 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.588 0.709 . . . . 1.0 110.318 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 56' ' ' SER . 0.7 OUTLIER -81.89 -13.79 57.09 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.0 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.454 ' C ' ' O ' ' A' ' 55' ' ' LEU . 77.3 p 20.18 -97.93 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 112.829 0.678 . . . . 1.0 112.829 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.493 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -60.57 -74.53 0.36 Allowed Glycine 0 CA--C 1.531 1.073 0 N-CA-C 110.583 -1.007 . . . . 1.0 110.583 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 3.9 m 101.94 45.24 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 123.94 0.896 . . . . 1.0 111.444 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 60' ' ' PRO . 12.3 mp0 -76.0 130.65 77.68 Favored Pre-proline 0 CA--C 1.548 0.902 0 CA-C-O 119.23 -0.414 . . . . 1.0 111.586 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 59' ' ' GLU . 88.7 Cg_exo -44.11 -179.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.506 2.251 0 C-N-CA 122.076 1.851 . . . . 1.0 113.044 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.54 -141.15 15.16 Favored Glycine 0 N--CA 1.472 1.093 0 N-CA-C 110.713 -0.955 . . . . 1.0 110.713 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.3 mp0 -138.19 75.1 1.5 Allowed 'General case' 0 N--CA 1.471 0.58 0 O-C-N 122.135 -0.626 . . . . 1.0 109.724 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -93.54 137.67 32.59 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.712 0.768 . . . . 1.0 112.013 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -85.37 139.19 31.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.282 -0.872 . . . . 1.0 109.072 178.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -132.11 127.94 37.09 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.718 0.77 . . . . 1.0 111.664 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 32.6 mp0 -67.87 132.81 48.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.091 -0.959 . . . . 1.0 111.318 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.6 t -76.27 124.96 35.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.507 0.67 . . . . 1.0 110.207 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -109.39 121.16 44.57 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.973 0.892 . . . . 1.0 110.196 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.3 m -109.75 129.61 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 115.833 -0.622 . . . . 1.0 111.008 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -50.35 127.76 23.49 Favored Pre-proline 0 CA--C 1.554 1.133 0 CA-C-O 118.87 -0.586 . . . . 1.0 110.554 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.3 112.01 3.42 Favored 'Trans proline' 0 N--CA 1.505 2.178 0 C-N-CA 121.684 1.59 . . . . 1.0 112.218 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.8 mp -82.02 129.71 63.27 Favored Pre-proline 0 CA--C 1.556 1.198 0 CA-C-O 119.411 -0.328 . . . . 1.0 110.795 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -67.15 140.98 55.63 Favored 'Trans proline' 0 N--CA 1.506 2.218 0 C-N-CA 121.755 1.637 . . . . 1.0 112.662 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.9 t30 66.93 10.32 7.55 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.271 0.629 . . . . 1.0 111.476 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mm -124.04 137.13 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-O 122.367 1.079 . . . . 1.0 109.746 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.33 121.14 38.89 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 122.145 0.974 . . . . 1.0 111.013 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.64 HG23 ' O ' ' A' ' 77' ' ' ILE . 7.4 tp -84.12 93.34 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.879 -0.601 . . . . 1.0 110.053 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.8 t -46.9 -53.65 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 O-C-N 121.97 -0.456 . . . . 1.0 110.835 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -170.42 -127.19 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.819 0.819 . . . . 1.0 110.408 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.8 mt -154.23 -77.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.131 -0.692 . . . . 1.0 109.131 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.6 t 58.71 101.94 0.04 OUTLIER Pre-proline 0 CA--C 1.549 0.907 0 CA-C-O 117.544 -1.217 . . . . 1.0 111.778 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -67.74 134.11 24.28 Favored 'Cis proline' 0 N--CA 1.512 2.598 0 CA-C-N 121.028 1.403 . . . . 1.0 111.831 0.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -66.26 -43.53 86.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.761 0.791 . . . . 1.0 109.661 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -130.08 153.21 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 109.377 -0.601 . . . . 1.0 109.377 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.5 p -145.38 136.06 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.604 0.716 . . . . 1.0 111.5 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 37.2 m -81.39 130.36 35.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.282 -0.872 . . . . 1.0 110.441 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 33.5 mt -133.45 124.47 27.12 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.104 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.409 ' N ' ' CD ' ' A' ' 88' ' ' GLN . 18.3 mp0 -93.28 121.43 34.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.687 0.756 . . . . 1.0 110.525 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.0 mt -96.98 162.06 13.56 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.445 -0.798 . . . . 1.0 109.802 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -152.81 151.62 30.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.642 0.734 . . . . 1.0 110.992 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -66.2 139.44 58.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.427 -0.806 . . . . 1.0 110.687 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 . . . . . 0 C--N 1.328 -0.342 0 CA-C-O 121.325 0.583 . . . . 1.0 111.165 -179.504 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 56.5 mmt-85 . . . . . 0 CA--C 1.529 0.139 0 CA-C-O 120.918 0.39 . . . . 1.0 111.51 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.478 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 4.9 p-10 44.3 54.35 11.92 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 112.935 0.717 . . . . 1.0 112.935 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.478 ' HD3' ' N ' ' A' ' 8' ' ' ASP . 57.6 Cg_endo -89.8 -178.03 1.54 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.806 2.337 . . . . 1.0 112.801 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 53.9 m -85.51 113.61 21.9 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.647 0.737 . . . . 1.0 110.423 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 74.9 mt -105.85 139.32 40.59 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.673 0.749 . . . . 1.0 110.572 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.472 ' C ' HD12 ' A' ' 13' ' ' LEU . 68.0 m -101.14 124.57 47.04 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.379 0.609 . . . . 1.0 110.428 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.472 HD12 ' C ' ' A' ' 12' ' ' THR . 10.3 mp -108.19 131.15 54.96 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.651 -0.704 . . . . 1.0 109.944 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.6 t -75.83 114.85 14.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.196 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 41.4 tp -69.37 105.99 2.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.246 0.546 . . . . 1.0 110.88 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.7 pt -118.08 142.6 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 121.692 0.758 . . . . 1.0 111.117 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.49 121.5 24.64 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.351 0.596 . . . . 1.0 110.76 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -114.03 50.4 0.93 Allowed 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.404 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 172.81 34.35 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.326 -0.62 . . . . 1.0 109.326 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.0 m -70.17 112.5 12.85 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-O 119.022 -0.513 . . . . 1.0 111.466 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -57.66 145.64 88.62 Favored 'Trans proline' 0 N--CA 1.501 1.948 0 C-N-CA 121.876 1.718 . . . . 1.0 111.832 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.93 150.38 49.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 122.155 0.979 . . . . 1.0 111.388 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 68.06 7.93 6.17 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.129 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.3 p -114.1 152.09 31.61 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.791 0.805 . . . . 1.0 110.521 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 49.0 ttp -141.47 120.27 12.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.704 -0.68 . . . . 1.0 110.082 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 72.2 mt -72.04 117.95 16.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.456 0.645 . . . . 1.0 110.665 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.417 ' SD ' ' OE1' ' A' ' 90' ' ' GLU . 76.4 mtp -83.79 58.64 4.75 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.806 0.812 . . . . 1.0 109.83 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.7 m -165.18 128.29 2.25 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.358 -0.608 . . . . 1.0 109.358 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.515 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 38.2 ttpt -68.2 158.44 33.24 Favored 'General case' 0 CA--C 1.515 -0.393 0 O-C-N 121.229 -0.92 . . . . 1.0 110.682 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.486 HD22 ' N ' ' A' ' 30' ' ' LEU . 4.3 mm? -98.55 96.86 4.12 Favored Pre-proline 0 CA--C 1.557 1.213 0 N-CA-C 112.374 0.509 . . . . 1.0 112.374 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' A' ' 29' ' ' LYS . 39.7 Cg_endo -86.51 152.05 9.02 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.485 2.123 . . . . 1.0 112.635 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.5 p -68.17 177.55 2.22 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.698 -0.626 . . . . 1.0 111.098 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -145.14 154.27 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.557 0.694 . . . . 1.0 111.079 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -104.42 127.0 52.02 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.5 m -131.6 161.75 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 122.169 0.985 . . . . 1.0 111.28 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -125.25 134.03 52.46 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.423 -0.808 . . . . 1.0 110.939 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 30.1 p -141.1 -175.27 4.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.647 0.736 . . . . 1.0 111.211 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -124.37 -138.17 0.29 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.727 -0.67 . . . . 1.0 110.089 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.66 -150.61 38.33 Favored Glycine 0 N--CA 1.458 0.161 0 N-CA-C 110.911 -0.876 . . . . 1.0 110.911 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -144.32 -25.96 0.52 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.252 0.549 . . . . 1.0 111.321 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 61.97 67.43 1.27 Allowed Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.451 -0.341 . . . . 1.0 111.128 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -58.64 -41.12 67.16 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 122.171 1.914 . . . . 1.0 111.92 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 55.4 p -172.07 55.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.614 -0.266 . . . . 1.0 110.533 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.8 mm -90.06 125.52 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.39 0.614 . . . . 1.0 110.062 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.514 ' C ' ' H ' ' A' ' 47' ' ' ASN . 82.5 m-20 -75.59 100.89 4.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.459 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.1 m -46.72 -9.54 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.234 0.54 . . . . 1.0 111.817 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.514 ' H ' ' C ' ' A' ' 45' ' ' ASN . 33.6 m120 -63.02 -36.14 82.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.228 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -102.98 55.79 0.76 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.001 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.524 ' O ' ' CG ' ' A' ' 50' ' ' PHE . 20.1 mt -152.28 118.97 5.7 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.225 0.536 . . . . 1.0 110.071 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.524 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 59.1 m-85 -161.64 173.91 14.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 122.513 1.149 . . . . 1.0 111.675 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.463 ' C ' ' CG ' ' A' ' 52' ' ' TYR . . . -100.47 170.14 8.6 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 114.219 -1.355 . . . . 1.0 108.728 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.463 ' CG ' ' C ' ' A' ' 51' ' ' ALA . 25.3 m-85 -151.57 163.77 38.33 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 122.221 1.01 . . . . 1.0 111.913 -178.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.1 m -137.19 145.74 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 114.735 -1.12 . . . . 1.0 109.443 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -98.76 81.91 2.72 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.504 0.668 . . . . 1.0 110.643 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.491 ' O ' ' C ' ' A' ' 56' ' ' SER . 70.1 mt -74.71 4.75 5.78 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.577 -0.738 . . . . 1.0 110.197 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.491 ' C ' ' O ' ' A' ' 55' ' ' LEU . 84.2 p 15.02 -113.75 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 115.593 -0.731 . . . . 1.0 112.88 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.41 -143.22 0.01 OUTLIER Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.791 -0.924 . . . . 1.0 110.791 178.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.4 m -151.08 32.25 0.6 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 121.324 -0.15 . . . . 1.0 111.047 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -41.96 101.7 0.25 Allowed Pre-proline 0 CA--C 1.543 0.698 0 CA-C-O 119.625 -0.226 . . . . 1.0 111.394 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -56.02 118.61 5.42 Favored 'Trans proline' 0 N--CA 1.502 2.01 0 C-N-CA 122.607 2.205 . . . . 1.0 112.736 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 149.71 -168.07 29.87 Favored Glycine 0 N--CA 1.465 0.575 0 N-CA-C 110.22 -1.152 . . . . 1.0 110.22 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.514 ' CD ' ' H ' ' A' ' 62' ' ' GLU . 1.2 pm0 -102.62 80.2 1.89 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.375 0.607 . . . . 1.0 109.735 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.409 ' CG ' ' N ' ' A' ' 64' ' ' ASP . 41.2 t-80 -90.69 161.37 15.39 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.911 0.862 . . . . 1.0 111.895 -178.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.409 ' N ' ' CG ' ' A' ' 63' ' ' HIS . 69.2 m-20 -88.34 128.1 35.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.126 -0.943 . . . . 1.0 109.432 178.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -122.37 97.7 5.59 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.8 0.81 . . . . 1.0 111.546 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.543 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 39.1 mp0 -59.25 131.72 51.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.969 -1.014 . . . . 1.0 111.463 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.8 t -77.81 128.18 38.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.702 0.763 . . . . 1.0 110.269 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -117.73 137.91 52.38 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.993 0.901 . . . . 1.0 110.346 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.1 t -110.71 129.92 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.038 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -51.14 123.28 19.74 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.45 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.38 88.68 1.13 Allowed 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 122.09 1.86 . . . . 1.0 112.656 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.472 ' H ' HD12 ' A' ' 72' ' ' ILE . 3.3 mp -79.72 128.21 75.26 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 120.935 -0.306 . . . . 1.0 110.735 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.404 ' O ' ' ND2' ' A' ' 74' ' ' ASN . 56.3 Cg_endo -71.33 80.99 1.27 Allowed 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 122.151 1.901 . . . . 1.0 112.782 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.404 ' ND2' ' O ' ' A' ' 73' ' ' PRO . 6.2 m-20 167.78 -52.19 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.844 0.354 . . . . 1.0 110.498 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.3 mm -91.23 136.87 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-O 121.879 0.847 . . . . 1.0 110.201 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -96.41 140.38 31.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 122.288 1.042 . . . . 1.0 111.343 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.8 tt -94.93 135.91 27.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.641 -0.709 . . . . 1.0 110.327 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.7 t -105.47 -52.38 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 O-C-N 122.074 -0.391 . . . . 1.0 110.354 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -148.05 -152.41 0.44 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.998 0.904 . . . . 1.0 110.63 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.417 ' O ' ' O ' ' A' ' 81' ' ' SER . 34.2 mt -144.1 -48.24 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.582 -0.735 . . . . 1.0 109.617 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 80' ' ' ILE . 79.3 p 31.04 96.38 0.04 OUTLIER Pre-proline 0 CA--C 1.557 1.219 0 CA-C-O 118.39 -0.814 . . . . 1.0 112.354 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -68.29 -172.15 6.19 Favored 'Cis proline' 0 N--CA 1.501 1.94 0 CA-C-N 120.2 1.107 . . . . 1.0 111.757 1.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -112.09 -30.93 7.05 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.591 -0.731 . . . . 1.0 109.788 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.3 t -149.04 152.57 11.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.162 -0.681 . . . . 1.0 109.162 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.1 p -143.43 140.56 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.604 0.716 . . . . 1.0 111.664 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 60.4 m -95.76 128.96 43.08 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.281 -0.872 . . . . 1.0 110.789 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.6 mt -116.93 167.17 11.36 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.617 -0.719 . . . . 1.0 110.235 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -118.07 116.7 27.4 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.854 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -105.25 130.26 53.43 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.889 0.852 . . . . 1.0 110.253 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.417 ' OE1' ' SD ' ' A' ' 27' ' ' MET . 39.0 tt0 -134.2 136.64 43.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 122.346 1.07 . . . . 1.0 111.149 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 29.0 p-80 -68.76 116.96 9.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.735 -1.12 . . . . 1.0 110.685 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 85.3 t60 . . . . . 0 N--CA 1.469 0.511 0 CA-C-O 121.027 0.441 . . . . 1.0 110.822 -179.6 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 75.0 p . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 109.674 -0.491 . . . . 1.0 109.674 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.5 m -149.37 149.35 30.72 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.698 -0.482 . . . . 1.0 109.698 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.412 ' N ' ' CD ' ' A' ' 3' ' ' GLN . 27.2 mp0 -75.8 -87.14 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 O-C-N 121.912 -0.493 . . . . 1.0 110.236 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 35.1 p -81.08 -151.12 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.589 0.709 . . . . 1.0 109.27 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 73.07 78.52 0.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 O-C-N 121.92 -0.487 . . . . 1.0 111.315 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.405 ' OD1' ' CD1' ' A' ' 40' ' ' TYR . 52.1 p-10 -137.08 149.12 47.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.44 0.638 . . . . 1.0 109.789 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -39.18 147.15 0.07 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.923 -0.581 . . . . 1.0 111.822 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -55.73 137.32 71.32 Favored Pre-proline 0 CA--C 1.549 0.926 0 O-C-N 121.848 -0.532 . . . . 1.0 112.007 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -72.82 142.0 34.61 Favored 'Trans proline' 0 N--CA 1.503 2.039 0 C-N-CA 122.347 2.031 . . . . 1.0 112.953 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.5 m -113.92 94.78 4.98 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 121.514 0.673 . . . . 1.0 110.013 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 66.4 mt -109.73 143.43 39.52 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.791 0.805 . . . . 1.0 110.394 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.9 t -102.08 133.26 47.19 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.949 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.763 HD22 ' N ' ' A' ' 13' ' ' LEU . 0.9 OUTLIER -108.87 139.9 43.08 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.618 0.723 . . . . 1.0 110.457 -179.695 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.1 m -74.55 109.8 8.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.899 -0.591 . . . . 1.0 109.869 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.7 tp -69.41 106.56 2.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.406 0.622 . . . . 1.0 110.878 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.4 pt -111.04 142.29 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-O 121.811 0.815 . . . . 1.0 110.857 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.67 127.13 33.93 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.85 -0.531 . . . . 1.0 111.058 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -115.73 162.13 17.72 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 120.952 0.406 . . . . 1.0 110.201 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 22.4 m120 57.47 34.77 25.07 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.94 -0.393 . . . . 1.0 109.94 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 49.4 m -60.21 114.68 10.54 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-O 119.089 -0.482 . . . . 1.0 111.528 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.8 149.83 18.79 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 121.533 1.489 . . . . 1.0 112.01 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.91 145.1 42.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 122.041 0.924 . . . . 1.0 111.374 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.2 m-20 64.14 18.48 11.28 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.945 -0.571 . . . . 1.0 111.093 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.5 t -110.66 147.17 34.86 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.948 0.88 . . . . 1.0 110.658 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 61.4 ttp -139.12 116.15 10.96 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.624 -0.716 . . . . 1.0 109.982 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 59.0 mt -69.71 149.4 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.978 0.894 . . . . 1.0 110.532 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.515 ' O ' ' OG1' ' A' ' 28' ' ' THR . 1.1 tpt -118.74 63.78 0.77 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.766 0.793 . . . . 1.0 109.58 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.515 ' OG1' ' O ' ' A' ' 27' ' ' MET . 33.7 m -178.02 146.59 0.42 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.104 -0.702 . . . . 1.0 109.104 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -85.04 151.41 24.18 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.295 -0.878 . . . . 1.0 110.444 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 mp -103.79 105.41 47.82 Favored Pre-proline 0 N--CA 1.482 1.166 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.894 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -87.78 152.09 7.36 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.374 2.05 . . . . 1.0 112.688 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 63.0 p -59.19 -179.02 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.653 -0.655 . . . . 1.0 111.19 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.6 p -139.65 144.93 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-O 121.264 0.554 . . . . 1.0 111.077 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 82.3 mtt85 -99.99 125.18 45.98 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.385 -0.598 . . . . 1.0 109.385 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 t -124.23 153.47 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-O 122.557 1.17 . . . . 1.0 111.189 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -124.7 138.16 54.31 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 114.968 -1.015 . . . . 1.0 110.6 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 51.5 p -125.51 131.85 52.73 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.754 -0.657 . . . . 1.0 111.3 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -77.99 47.53 0.65 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.473 0.654 . . . . 1.0 109.886 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.401 ' O ' ' CD1' ' A' ' 40' ' ' TYR . . . -149.53 -169.24 15.72 Favored Glycine 0 N--CA 1.466 0.645 0 N-CA-C 110.572 -1.011 . . . . 1.0 110.572 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.405 ' CD1' ' OD1' ' A' ' 6' ' ' ASP . 0.8 OUTLIER -142.36 108.73 5.29 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.264 0.554 . . . . 1.0 110.232 -179.499 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -119.69 84.35 30.64 Favored Pre-proline 0 N--CA 1.474 0.733 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.475 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -56.3 -19.3 27.49 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.305 2.003 . . . . 1.0 111.862 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.2 t -145.31 -101.71 0.1 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.997 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.429 HG22 ' O ' ' A' ' 44' ' ' ILE . 27.1 mm 58.8 37.97 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.856 -0.424 . . . . 1.0 109.856 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 39.45 70.9 0.19 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.89 0.376 . . . . 1.0 111.266 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.1 m -56.23 -14.52 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.048 0.452 . . . . 1.0 110.784 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 48' ' ' GLU . 22.2 p30 -58.94 -33.81 71.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.312 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.494 ' N ' ' OD1' ' A' ' 47' ' ' ASN . 74.6 tt0 -91.0 63.64 5.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.996 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 69.1 mt -148.37 110.68 4.65 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.441 0.638 . . . . 1.0 109.995 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -143.31 156.55 44.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 122.054 0.93 . . . . 1.0 111.865 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -115.78 140.87 48.8 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.82 -1.082 . . . . 1.0 108.416 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 16.7 p90 -141.24 144.62 34.81 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 122.082 0.944 . . . . 1.0 112.24 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.4 m -105.53 156.09 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 114.857 -1.065 . . . . 1.0 108.947 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -97.19 142.8 28.67 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.454 0.645 . . . . 1.0 110.523 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.593 ' C ' ' H ' ' A' ' 57' ' ' GLY . 79.6 mt -131.35 40.46 3.43 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.648 -0.705 . . . . 1.0 110.377 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.7 m -60.01 14.24 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.901 -0.59 . . . . 1.0 111.982 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.593 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . -148.3 159.17 27.94 Favored Glycine 0 N--CA 1.466 0.689 0 N-CA-C 110.444 -1.062 . . . . 1.0 110.444 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.5 t -148.24 130.5 15.57 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.577 0.703 . . . . 1.0 110.976 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.638 ' O ' ' N ' ' A' ' 61' ' ' GLY . 2.1 mt-10 179.91 123.1 0.22 Allowed Pre-proline 0 CA--C 1.55 0.943 0 CA-C-N 115.677 -0.692 . . . . 1.0 110.657 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -45.57 71.42 0.01 OUTLIER 'Trans proline' 0 N--CA 1.511 2.531 0 C-N-CA 122.524 2.149 . . . . 1.0 113.939 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.638 ' N ' ' O ' ' A' ' 59' ' ' GLU . . . -145.27 155.68 26.6 Favored Glycine 0 N--CA 1.47 0.951 0 N-CA-C 110.349 -1.1 . . . . 1.0 110.349 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -86.09 87.1 7.36 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 122.302 -0.529 . . . . 1.0 109.768 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.505 ' ND1' ' CE1' ' A' ' 65' ' ' TYR . 61.1 t-80 -92.38 137.51 32.31 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.548 0.69 . . . . 1.0 112.342 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -90.42 115.93 27.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.623 -0.717 . . . . 1.0 109.212 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.505 ' CE1' ' ND1' ' A' ' 63' ' ' HIS . 71.1 m-85 -104.75 135.22 46.54 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.878 0.847 . . . . 1.0 111.455 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -81.06 142.09 33.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.899 -1.046 . . . . 1.0 111.252 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.9 t -74.94 117.5 19.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.373 0.606 . . . . 1.0 110.417 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -106.73 114.8 29.12 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 122.334 1.064 . . . . 1.0 109.886 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.581 HG12 ' N ' ' A' ' 70' ' ' GLU . 27.3 t -85.52 169.27 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 115.57 -0.741 . . . . 1.0 110.871 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.581 ' N ' HG12 ' A' ' 69' ' ' VAL . 10.7 tm-20 -94.4 111.8 55.11 Favored Pre-proline 0 CA--C 1.553 1.09 0 CA-C-N 115.668 -0.696 . . . . 1.0 109.833 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -48.09 131.3 21.53 Favored 'Trans proline' 0 N--CA 1.506 2.217 0 C-N-CA 121.782 1.654 . . . . 1.0 112.859 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.8 mt -99.54 109.51 55.42 Favored Pre-proline 0 CA--C 1.554 1.099 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.792 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.97 55.63 3.43 Favored 'Trans proline' 0 N--CA 1.506 2.246 0 C-N-CA 122.069 1.846 . . . . 1.0 113.095 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -175.09 -44.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.242 0.544 . . . . 1.0 110.882 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.664 HG22 ' N ' ' A' ' 76' ' ' LYS . 63.7 mt -112.63 174.22 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-O 121.559 0.695 . . . . 1.0 110.114 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.664 ' N ' HG22 ' A' ' 75' ' ' ILE . 60.5 tttp -117.83 156.44 28.37 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 122.583 1.182 . . . . 1.0 111.238 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.9 tt -99.39 153.17 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 115.367 -0.833 . . . . 1.0 109.966 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.9 t -108.14 -49.68 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 122.142 -0.349 . . . . 1.0 110.665 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -179.69 -175.99 0.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 122.316 1.055 . . . . 1.0 110.52 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.4 mt -129.86 167.42 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 122.15 0.976 . . . . 1.0 109.307 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.7 t -167.04 106.09 0.63 Allowed Pre-proline 0 CA--C 1.554 1.131 0 CA-C-O 118.438 -0.791 . . . . 1.0 111.452 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -62.39 -173.78 2.74 Favored 'Cis proline' 0 N--CA 1.507 2.283 0 CA-C-N 120.191 1.104 . . . . 1.0 111.528 -0.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -118.54 -23.51 7.11 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.516 0.674 . . . . 1.0 109.191 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 t -144.36 149.85 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.1 m -136.39 157.11 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-O 121.75 0.786 . . . . 1.0 111.567 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 71.7 m -109.1 119.13 38.6 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.174 -0.921 . . . . 1.0 110.613 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.8 mt -122.7 126.22 47.14 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.701 -0.682 . . . . 1.0 110.222 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -83.64 130.52 34.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.587 0.708 . . . . 1.0 110.255 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -104.02 136.15 44.19 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.652 0.739 . . . . 1.0 110.297 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -138.1 140.45 39.97 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.331 1.063 . . . . 1.0 111.053 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -67.18 167.33 12.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.842 -1.072 . . . . 1.0 110.644 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.452 ' CG ' ' N ' ' A' ' 93' ' ' HIS . 57.8 t-80 -142.57 164.47 30.03 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.653 0.739 . . . . 1.0 110.972 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.452 ' N ' ' CG ' ' A' ' 92' ' ' HIS . 84.8 t60 55.07 93.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.286 0.565 . . . . 1.0 110.392 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -63.4 75.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.485 . . . . 1.0 111.214 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.433 ' N ' ' O ' ' A' ' 93' ' ' HIS . 60.8 m80 52.62 -174.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.631 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.988 -1.006 . . . . 1.0 110.48 179.839 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 43.2 t . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.504 -0.554 . . . . 1.0 109.504 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.7 m -68.27 138.58 55.63 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.846 -0.427 . . . . 1.0 109.846 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.15 -68.88 0.68 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.08 0.467 . . . . 1.0 109.827 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.5 p -75.62 168.86 19.22 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.857 -0.423 . . . . 1.0 109.857 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 51.4 mt -62.65 -45.86 90.88 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 121.938 -0.476 . . . . 1.0 111.065 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 53.4 p-10 -169.12 171.41 8.13 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.818 -0.438 . . . . 1.0 109.818 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -36.24 -64.96 0.29 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.793 0.664 . . . . 1.0 112.793 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.32 118.14 50.36 Favored Pre-proline 0 CA--C 1.549 0.908 0 O-C-N 121.85 -0.531 . . . . 1.0 112.159 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.47 141.79 35.57 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 CA-C-N 120.404 1.18 . . . . 1.0 113.392 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.427 HG22 ' N ' ' A' ' 11' ' ' LEU . 91.1 m -107.36 157.4 17.98 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.575 0.702 . . . . 1.0 110.024 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.571 HD13 ' H ' ' A' ' 12' ' ' THR . 0.1 OUTLIER -144.09 139.41 28.89 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.445 0.64 . . . . 1.0 110.428 179.818 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.571 ' H ' HD13 ' A' ' 11' ' ' LEU . 56.3 m -123.5 120.19 32.16 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.509 0.671 . . . . 1.0 110.571 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 35.7 mt -130.52 134.08 46.77 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.454 -0.794 . . . . 1.0 110.027 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.5 m -58.67 179.58 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.6 tp -120.33 112.99 19.71 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-O 121.602 0.715 . . . . 1.0 111.043 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.5 pt -116.78 154.26 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-O 121.809 0.814 . . . . 1.0 110.763 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.82 125.56 41.35 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.806 -0.559 . . . . 1.0 110.536 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.483 ' O ' ' O ' ' A' ' 19' ' ' ASN . 63.9 tttm -119.7 137.68 53.76 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.615 0.721 . . . . 1.0 109.707 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 18' ' ' LYS . 16.1 m120 43.53 100.84 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.993 -0.549 . . . . 1.0 110.876 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.3 m -136.55 132.43 18.7 Favored Pre-proline 0 N--CA 1.479 0.979 0 CA-C-O 119.45 -0.31 . . . . 1.0 111.577 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -36.84 95.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 121.641 1.561 . . . . 1.0 112.541 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -39.33 161.79 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.53 0.681 . . . . 1.0 111.869 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.4 t30 72.61 12.19 5.47 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 122.006 -0.433 . . . . 1.0 110.746 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.7 p -133.51 153.75 51.38 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.745 0.783 . . . . 1.0 110.661 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 47.8 ttp -143.74 138.6 28.93 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.46 0.647 . . . . 1.0 110.184 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 69.9 mt -75.02 154.12 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.611 0.72 . . . . 1.0 111.047 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.6 ttt -107.13 -28.01 10.24 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 121.391 0.615 . . . . 1.0 109.859 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 30' ' ' LEU . 9.0 m -64.75 138.2 58.24 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.575 -0.528 . . . . 1.0 109.575 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -66.99 -6.74 18.14 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.287 -0.883 . . . . 1.0 111.261 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.447 ' H ' HG22 ' A' ' 28' ' ' THR . 12.2 mt 59.38 95.24 0.05 OUTLIER Pre-proline 0 CA--C 1.548 0.868 0 CA-C-O 118.736 -0.649 . . . . 1.0 111.864 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -85.99 154.91 9.87 Favored 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 122.649 2.233 . . . . 1.0 112.744 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.6 m -57.89 175.59 0.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.614 -0.679 . . . . 1.0 111.26 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.6 m -132.59 133.46 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-O 121.317 0.58 . . . . 1.0 111.091 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -104.98 126.84 52.48 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -130.07 155.63 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 122.163 0.982 . . . . 1.0 111.2 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -119.52 138.8 52.94 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.426 -0.807 . . . . 1.0 110.165 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.5 p -129.97 141.93 50.7 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 115.855 -0.611 . . . . 1.0 110.723 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -82.77 164.23 20.75 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.719 -0.474 . . . . 1.0 109.719 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.51 -157.88 18.13 Favored Glycine 0 N--CA 1.472 1.07 0 N-CA-C 110.827 -0.909 . . . . 1.0 110.827 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -152.77 98.79 2.38 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.471 0.653 . . . . 1.0 110.829 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.463 HD22 HG13 ' A' ' 75' ' ' ILE . 27.4 p30 -174.42 75.08 0.34 Allowed Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.497 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.4 38.88 0.35 Allowed 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 121.691 1.594 . . . . 1.0 111.86 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.42 ' H ' ' C ' ' A' ' 41' ' ' ASN . 38.7 m -170.11 97.14 0.28 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.413 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.1 mt -127.96 53.56 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 109.805 -0.442 . . . . 1.0 109.805 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.517 ' C ' ' H ' ' A' ' 47' ' ' ASN . 4.7 p-10 39.43 56.98 2.17 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.499 -0.319 . . . . 1.0 111.235 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.3 m -70.14 35.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.052 0.453 . . . . 1.0 111.098 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.517 ' H ' ' C ' ' A' ' 45' ' ' ASN . 70.9 m-20 -59.97 -24.18 64.2 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.295 -0.412 . . . . 1.0 110.577 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.513 ' O ' ' C ' ' A' ' 49' ' ' LEU . 96.4 mt-10 -124.38 -54.85 1.67 Allowed 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.934 -0.576 . . . . 1.0 110.009 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.64 ' H ' HD12 ' A' ' 49' ' ' LEU . 9.1 mp -25.42 113.7 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.074 0.464 . . . . 1.0 110.845 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -141.76 -171.86 3.43 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.898 0.856 . . . . 1.0 111.551 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.455 ' O ' ' CG ' ' A' ' 52' ' ' TYR . . . -93.19 158.02 15.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.928 -1.033 . . . . 1.0 108.321 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.455 ' CG ' ' O ' ' A' ' 51' ' ' ALA . 91.8 m-85 -153.6 157.84 40.29 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 122.273 1.035 . . . . 1.0 111.889 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.3 147.22 22.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 114.64 -1.164 . . . . 1.0 109.357 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -115.88 106.23 13.58 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.452 0.644 . . . . 1.0 110.606 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.505 ' C ' ' H ' ' A' ' 57' ' ' GLY . 24.4 mt -104.77 32.77 3.93 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.802 -0.635 . . . . 1.0 110.179 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 88.9 p -62.4 8.71 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.849 -0.614 . . . . 1.0 111.859 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . -88.88 -168.73 44.18 Favored Glycine 0 N--CA 1.47 0.959 0 N-CA-C 110.84 -0.904 . . . . 1.0 110.84 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 82.0 p -162.41 76.71 0.47 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.413 0.625 . . . . 1.0 111.446 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -138.13 88.03 15.68 Favored Pre-proline 0 N--CA 1.472 0.666 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.589 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -48.09 108.76 0.19 Allowed 'Trans proline' 0 N--CA 1.504 2.11 0 C-N-CA 122.364 2.043 . . . . 1.0 112.775 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.74 -165.04 25.41 Favored Glycine 0 N--CA 1.47 0.909 0 N-CA-C 110.343 -1.103 . . . . 1.0 110.343 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.544 ' CD ' ' H ' ' A' ' 62' ' ' GLU . 0.9 OUTLIER -71.77 142.89 49.7 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.261 -0.552 . . . . 1.0 109.641 179.477 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.45 ' O ' ' CD1' ' A' ' 65' ' ' TYR . 62.7 t-80 -161.12 126.02 3.6 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.149 -0.62 . . . . 1.0 112.45 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -77.24 117.32 18.65 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.806 -0.813 . . . . 1.0 108.806 178.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.45 ' CD1' ' O ' ' A' ' 63' ' ' HIS . 91.4 m-85 -94.38 -122.77 0.1 Allowed 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.985 -0.447 . . . . 1.0 111.821 -178.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -160.3 130.68 5.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.127 0.489 . . . . 1.0 110.732 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.7 t -92.94 115.94 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.122 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -142.27 151.83 42.42 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.742 0.782 . . . . 1.0 110.487 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 70' ' ' GLU . 41.6 t -134.63 157.39 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-O 121.405 0.622 . . . . 1.0 111.201 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.417 ' N ' HG12 ' A' ' 69' ' ' VAL . 9.3 pt-20 -58.26 147.28 67.6 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 115.575 -0.738 . . . . 1.0 110.681 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -73.64 162.08 40.56 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 121.892 1.728 . . . . 1.0 112.417 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.84 101.41 12.82 Favored Pre-proline 0 N--CA 1.48 1.048 0 CA-C-N 115.3 -0.864 . . . . 1.0 110.526 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -50.04 140.33 32.33 Favored 'Trans proline' 0 N--CA 1.502 2.026 0 C-N-CA 121.31 1.34 . . . . 1.0 113.064 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 78.88 -11.9 1.15 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.555 0.742 . . . . 1.0 111.318 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.463 HG13 HD22 ' A' ' 41' ' ' ASN . 42.9 mm -125.96 153.17 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 122.276 1.036 . . . . 1.0 110.006 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -121.65 158.5 28.53 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 122.751 1.262 . . . . 1.0 110.735 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.613 HG23 ' O ' ' A' ' 77' ' ' ILE . 17.6 tt -99.3 95.88 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 115.125 -0.943 . . . . 1.0 109.813 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.7 t -44.91 -53.48 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 O-C-N 121.975 -0.453 . . . . 1.0 110.893 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -167.8 -146.2 0.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.685 0.755 . . . . 1.0 110.559 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.434 HG22 ' O ' ' A' ' 82' ' ' PRO . 1.9 mt -148.63 157.18 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 109.238 -0.653 . . . . 1.0 109.238 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 82' ' ' PRO . 43.3 t -163.17 101.05 1.0 Allowed Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 118.434 -0.793 . . . . 1.0 111.672 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.474 ' O ' ' N ' ' A' ' 81' ' ' SER . 24.0 Cg_exo -63.97 -166.31 1.35 Allowed 'Cis proline' 0 N--CA 1.511 2.541 0 CA-C-N 120.134 1.083 . . . . 1.0 111.393 -0.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -129.81 -18.7 3.4 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.446 0.641 . . . . 1.0 109.512 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.2 t -142.86 135.7 25.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.889 -0.782 . . . . 1.0 108.889 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.9 m -130.65 146.34 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-O 121.841 0.829 . . . . 1.0 111.376 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.0 t -106.29 131.99 52.86 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.071 -0.968 . . . . 1.0 110.49 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 35.1 mt -134.26 126.2 29.32 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.056 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -91.7 122.11 33.96 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.484 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.7 mt -93.43 140.69 29.3 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.415 0.626 . . . . 1.0 109.972 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -133.06 144.68 50.17 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.954 0.883 . . . . 1.0 111.2 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -69.67 144.56 52.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.195 -0.911 . . . . 1.0 110.809 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -73.64 96.6 2.5 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.634 0.73 . . . . 1.0 110.81 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -85.59 -9.0 57.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 1.0 109.948 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -66.64 -30.28 70.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.795 0.331 . . . . 1.0 110.887 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.45 ' O ' ' ND1' ' A' ' 96' ' ' HIS . 10.6 t-160 -59.02 -40.67 85.7 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.83 -0.433 . . . . 1.0 109.83 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.45 ' ND1' ' O ' ' A' ' 95' ' ' HIS . 73.1 m-70 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 117.927 -1.035 . . . . 1.0 109.82 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 93.4 p . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.51 -0.552 . . . . 1.0 109.51 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.3 m -61.03 -74.42 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.089 0.471 . . . . 1.0 110.828 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.6 mm100 -135.5 -174.13 3.55 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.252 0.549 . . . . 1.0 110.17 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.9 p 49.97 38.39 16.26 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.848 0.832 . . . . 1.0 110.124 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 55.9 tp -59.31 -59.21 5.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 1.0 111.116 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 53.3 p-10 -75.74 50.53 0.57 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.313 0.578 . . . . 1.0 110.442 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 42.69 -125.1 0.73 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.064 -0.516 . . . . 1.0 111.641 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 40.03 84.36 0.18 Allowed Pre-proline 0 CA--C 1.538 0.499 0 O-C-N 121.833 -0.542 . . . . 1.0 112.119 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.35 135.17 64.53 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.3 2.0 . . . . 1.0 112.954 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 68.2 m -127.96 122.56 32.65 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.679 0.752 . . . . 1.0 109.827 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.4 mt -137.02 164.66 27.84 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.647 0.737 . . . . 1.0 110.509 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.2 m -101.54 128.35 47.83 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.348 0.594 . . . . 1.0 110.282 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 tp -123.4 153.56 40.22 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.61 -0.723 . . . . 1.0 110.227 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.1 t -106.18 152.24 23.72 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.03 0.443 . . . . 1.0 109.906 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 pp -119.71 117.48 28.36 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.353 0.596 . . . . 1.0 111.035 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.3 pt -110.99 163.08 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-O 121.724 0.773 . . . . 1.0 110.713 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.76 116.46 24.04 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.89 -0.506 . . . . 1.0 110.944 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.5 mmtt -61.15 -32.67 72.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.91 0.386 . . . . 1.0 110.68 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -144.54 76.06 1.48 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.133 0.492 . . . . 1.0 110.252 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.1 m -60.47 116.07 16.33 Favored Pre-proline 0 CA--C 1.554 1.119 0 CA-C-O 118.873 -0.584 . . . . 1.0 111.385 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.96 138.17 52.35 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 120.926 1.084 . . . . 1.0 111.846 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.47 152.5 43.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.922 0.868 . . . . 1.0 111.592 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.4 m-20 69.08 6.28 5.56 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.097 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.0 p -100.73 145.64 28.22 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.61 0.719 . . . . 1.0 110.785 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -136.61 116.4 13.09 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.506 0.67 . . . . 1.0 110.332 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 65.7 mt -69.32 148.43 11.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.828 0.823 . . . . 1.0 110.828 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 46.9 mtt -114.23 -35.67 4.93 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.677 -0.692 . . . . 1.0 109.935 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.6 m -79.78 147.92 31.64 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.498 -0.556 . . . . 1.0 109.498 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -78.68 150.9 32.47 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.289 -0.882 . . . . 1.0 110.069 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 tp -76.39 112.7 22.84 Favored Pre-proline 0 CA--C 1.557 1.214 0 CA-C-N 115.678 -0.692 . . . . 1.0 111.983 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -90.53 151.7 4.33 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 121.456 1.437 . . . . 1.0 112.567 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.3 p -84.03 170.16 14.2 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.618 -0.676 . . . . 1.0 110.834 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.2 p -135.88 136.54 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 121.558 0.694 . . . . 1.0 110.949 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 42.4 mtm105 -98.24 130.99 44.95 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.929 -0.578 . . . . 1.0 109.464 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 t -124.24 128.59 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 121.963 0.887 . . . . 1.0 111.428 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -97.43 153.33 18.18 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.534 -0.757 . . . . 1.0 110.341 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 16.1 p -131.9 133.08 44.19 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.166 0.507 . . . . 1.0 111.315 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -80.75 47.04 0.93 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.245 0.545 . . . . 1.0 109.648 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.54 -171.71 34.65 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 110.558 -1.017 . . . . 1.0 110.558 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.569 ' O ' HD11 ' A' ' 75' ' ' ILE . 62.4 t80 -107.6 164.36 12.29 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.473 0.654 . . . . 1.0 110.636 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.53 ' N ' ' CD2' ' A' ' 40' ' ' TYR . 3.0 p-10 -114.3 90.76 21.47 Favored Pre-proline 0 N--CA 1.477 0.923 0 CA-C-N 116.147 -0.478 . . . . 1.0 111.056 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -50.78 -41.5 54.49 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 121.746 1.631 . . . . 1.0 112.025 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.9 t -171.27 42.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.576 0.227 . . . . 1.0 110.732 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.407 ' O ' HG23 ' A' ' 44' ' ' ILE . 14.7 tt -58.64 126.77 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.978 0.418 . . . . 1.0 110.415 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.495 ' C ' ' H ' ' A' ' 47' ' ' ASN . 44.6 p-10 -99.96 86.13 3.2 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.947 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.9 m -72.25 33.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.99 0.424 . . . . 1.0 110.675 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.495 ' H ' ' C ' ' A' ' 45' ' ' ASN . 71.5 m-80 -100.99 -10.22 20.76 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.311 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -131.53 1.84 4.11 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.469 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.608 ' O ' ' CG ' ' A' ' 50' ' ' PHE . 51.1 mt -95.81 154.85 17.01 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.608 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 70.3 m-85 -165.72 174.21 9.96 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.795 0.807 . . . . 1.0 111.694 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.432 ' C ' ' CG ' ' A' ' 52' ' ' TYR . . . -111.64 169.94 8.47 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.052 -0.976 . . . . 1.0 108.431 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.432 ' CG ' ' C ' ' A' ' 51' ' ' ALA . 22.8 m-85 -151.23 169.58 21.58 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 122.181 0.991 . . . . 1.0 112.134 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.3 m -136.26 144.77 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 114.73 -1.123 . . . . 1.0 109.496 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -85.58 83.49 7.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.404 0.621 . . . . 1.0 110.374 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 57' ' ' GLY . 1.2 mp -94.15 -26.8 16.54 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.603 -0.726 . . . . 1.0 109.769 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 55' ' ' LEU . 47.5 t 29.61 -90.26 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.644 0.735 . . . . 1.0 112.336 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . -129.07 71.49 0.49 Allowed Glycine 0 N--CA 1.472 1.06 0 N-CA-C 111.039 -0.824 . . . . 1.0 111.039 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 27.8 t -83.26 163.41 20.74 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.728 0.775 . . . . 1.0 111.343 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.5 mp0 -130.93 148.75 71.5 Favored Pre-proline 0 N--CA 1.48 1.062 0 CA-C-N 115.593 -0.73 . . . . 1.0 111.255 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -39.79 144.06 0.37 Allowed 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 122.064 1.843 . . . . 1.0 113.387 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 142.27 -137.68 8.02 Favored Glycine 0 N--CA 1.468 0.809 0 N-CA-C 110.517 -1.033 . . . . 1.0 110.517 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -140.09 69.93 1.36 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.322 0.582 . . . . 1.0 109.553 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -93.03 130.84 38.48 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.09 -0.505 . . . . 1.0 112.124 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -82.41 142.01 32.3 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.117 -0.697 . . . . 1.0 109.117 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -133.2 136.45 45.66 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.753 0.787 . . . . 1.0 111.675 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -73.19 135.78 44.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.07 -0.968 . . . . 1.0 111.485 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.83 129.02 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.173 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -121.01 149.58 42.45 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.816 0.817 . . . . 1.0 110.513 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.1 t -124.54 137.54 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 115.978 -0.555 . . . . 1.0 111.316 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -63.05 115.24 16.08 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-O 118.483 -0.77 . . . . 1.0 110.26 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.8 136.17 42.82 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 CA-C-N 120.281 1.136 . . . . 1.0 113.032 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.5 mp -91.73 115.99 65.61 Favored Pre-proline 0 CA--C 1.553 1.07 0 CA-C-N 115.481 -0.781 . . . . 1.0 110.442 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -50.41 134.66 39.07 Favored 'Trans proline' 0 N--CA 1.506 2.226 0 C-N-CA 120.968 1.112 . . . . 1.0 113.496 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 67.59 4.87 4.05 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.417 0.687 . . . . 1.0 111.436 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.569 HD11 ' O ' ' A' ' 40' ' ' TYR . 7.4 mm -138.26 154.36 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 122.319 1.057 . . . . 1.0 109.721 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -127.34 165.47 19.67 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 122.425 1.107 . . . . 1.0 111.074 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.8 pt -118.49 121.5 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 115.471 -0.786 . . . . 1.0 109.887 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 80.2 t -56.1 -50.58 69.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 O-C-N 122.086 -0.384 . . . . 1.0 110.378 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 177.67 147.61 0.14 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 122.198 0.999 . . . . 1.0 110.418 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.413 HG12 ' H ' ' A' ' 80' ' ' ILE . 16.3 pt -84.52 172.1 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.347 -0.842 . . . . 1.0 109.789 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 t -178.26 119.13 0.25 Allowed Pre-proline 0 CA--C 1.552 1.027 0 CA-C-O 117.941 -1.028 . . . . 1.0 111.438 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -65.38 141.22 48.09 Favored 'Cis proline' 0 N--CA 1.509 2.411 0 CA-C-N 120.657 1.27 . . . . 1.0 111.444 -1.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -76.58 -18.02 58.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.769 0.795 . . . . 1.0 109.546 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.2 t -137.01 143.96 33.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.937 -0.764 . . . . 1.0 108.937 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.9 m -135.24 160.15 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.832 0.825 . . . . 1.0 111.469 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 58.1 m -116.08 130.2 56.69 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.021 -0.99 . . . . 1.0 110.365 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 83.0 mt -134.62 123.15 23.33 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.681 -0.691 . . . . 1.0 110.034 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -93.69 123.9 37.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.497 0.665 . . . . 1.0 110.145 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 64.9 mt -105.76 157.61 17.32 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.657 -0.701 . . . . 1.0 110.129 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -145.89 138.13 25.4 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.606 0.717 . . . . 1.0 111.023 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -69.49 143.46 53.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.564 -0.744 . . . . 1.0 110.324 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -56.2 136.63 52.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.53 0.681 . . . . 1.0 111.019 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -70.13 127.28 32.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.264 0.554 . . . . 1.0 110.374 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -87.83 133.41 33.9 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.285 0.565 . . . . 1.0 111.066 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -170.84 33.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 1.0 109.824 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.445 ' ND1' ' N ' ' A' ' 96' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 117.951 -1.023 . . . . 1.0 110.262 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.7 p . . . . . 0 N--CA 1.487 1.411 0 N-CA-C 109.452 -0.573 . . . . 1.0 109.452 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.8 t -165.61 -57.14 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.727 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 54.31 75.74 0.27 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.303 0.573 . . . . 1.0 110.222 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.8 m 56.41 105.09 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.668 -0.493 . . . . 1.0 109.668 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 53.6 tp -145.53 -60.45 0.34 Allowed 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.973 -0.455 . . . . 1.0 110.839 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' A' ' 7' ' ' ARG . 26.2 t0 57.41 175.31 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.987 0.422 . . . . 1.0 110.369 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.41 ' H ' ' CG ' ' A' ' 6' ' ' ASP . 54.8 mmm-85 -136.05 139.04 42.76 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.661 0.743 . . . . 1.0 111.702 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 41.57 97.23 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 123.36 0.664 . . . . 1.0 112.0 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.6 140.98 54.32 Favored 'Trans proline' 0 N--CA 1.498 1.783 0 C-N-CA 122.403 2.069 . . . . 1.0 113.111 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 71.4 m -129.52 107.85 9.79 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.528 0.68 . . . . 1.0 110.228 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 60.5 mt -110.61 159.67 17.36 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.795 0.807 . . . . 1.0 110.439 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.9 m -119.58 120.67 37.4 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.538 0.685 . . . . 1.0 110.72 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.8 132.56 53.33 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.419 -0.81 . . . . 1.0 110.093 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.0 m -65.33 160.04 22.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.075 -0.511 . . . . 1.0 109.863 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.2 tp -113.44 126.91 55.86 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.5 0.667 . . . . 1.0 110.856 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.5 pt -117.53 179.75 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.707 0.765 . . . . 1.0 111.017 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.69 115.27 29.27 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.284 0.564 . . . . 1.0 111.197 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -113.44 166.23 11.7 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.321 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 48.8 26.83 1.38 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.875 0.369 . . . . 1.0 110.015 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.9 m -63.94 129.7 94.04 Favored Pre-proline 0 CA--C 1.547 0.843 0 CA-C-O 119.057 -0.497 . . . . 1.0 112.175 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.28 141.28 56.18 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 121.753 1.635 . . . . 1.0 111.427 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.41 149.08 49.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 122.125 0.964 . . . . 1.0 111.232 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 74.41 6.22 4.59 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.881 -0.6 . . . . 1.0 111.195 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.6 p -113.21 146.4 39.37 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.794 0.807 . . . . 1.0 110.745 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 24.6 ptm -142.6 139.9 31.49 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.518 0.675 . . . . 1.0 110.14 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 75.6 mt -88.33 145.81 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.697 0.761 . . . . 1.0 111.027 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 20.8 ttt -111.83 -23.5 10.54 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.781 -0.645 . . . . 1.0 109.511 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.1 p -87.7 121.95 30.76 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.501 0.667 . . . . 1.0 109.242 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -63.84 141.47 58.76 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.271 -0.893 . . . . 1.0 110.869 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.446 ' N ' HD12 ' A' ' 30' ' ' LEU . 10.7 mp -81.56 118.09 70.8 Favored Pre-proline 0 CA--C 1.554 1.123 0 N-CA-C 112.238 0.459 . . . . 1.0 112.238 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -86.2 162.79 9.98 Favored 'Trans proline' 0 N--CA 1.501 1.957 0 C-N-CA 122.383 2.056 . . . . 1.0 112.793 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 56.5 m -70.44 168.52 15.97 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.563 -0.711 . . . . 1.0 111.259 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.9 p -136.82 139.11 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-O 121.427 0.632 . . . . 1.0 111.116 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 80' ' ' ILE . 1.6 mpt_? -102.38 124.41 47.89 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.134 -0.691 . . . . 1.0 109.134 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.5 t -120.33 125.69 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 122.0 0.905 . . . . 1.0 111.132 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -98.59 147.04 25.21 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.288 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 70.4 p -129.39 131.28 46.78 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.492 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -53.78 -72.52 0.06 Allowed 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.723 0.773 . . . . 1.0 110.139 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.21 -171.93 0.09 OUTLIER Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.009 -0.837 . . . . 1.0 111.009 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -106.24 175.89 5.35 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.658 0.742 . . . . 1.0 110.944 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -136.42 74.28 54.4 Favored Pre-proline 0 N--CA 1.472 0.644 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.644 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -52.09 -37.72 69.17 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 C-N-CA 122.29 1.993 . . . . 1.0 111.892 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 44' ' ' ILE . 70.8 m -146.55 -97.69 0.09 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.383 -0.372 . . . . 1.0 110.832 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 43' ' ' SER . 68.7 mt 59.12 128.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.897 0.38 . . . . 1.0 110.086 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -56.34 90.64 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.194 0.521 . . . . 1.0 110.772 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.1 t -57.11 -17.05 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.017 0.437 . . . . 1.0 110.867 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -83.17 12.22 5.46 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.395 0.617 . . . . 1.0 110.182 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -132.93 54.86 1.93 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.205 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 85.4 mt -144.03 110.33 5.47 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.974 -0.557 . . . . 1.0 109.721 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -147.79 157.4 43.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 122.022 0.915 . . . . 1.0 111.791 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -119.25 139.39 51.96 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.871 -1.059 . . . . 1.0 108.433 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -117.56 168.39 10.45 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 122.536 1.16 . . . . 1.0 112.1 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.3 m -123.93 139.32 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 114.458 -1.246 . . . . 1.0 109.367 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.447 ' C ' ' H ' ' A' ' 56' ' ' SER . 40.0 p-10 -99.79 78.49 2.14 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.565 0.697 . . . . 1.0 110.484 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 56' ' ' SER . 23.9 mt -71.86 45.94 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.539 -0.755 . . . . 1.0 109.844 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.473 ' O ' ' C ' ' A' ' 57' ' ' GLY . 14.6 m -57.55 -142.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.329 0.585 . . . . 1.0 111.16 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.497 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . 30.75 -112.94 0.05 OUTLIER Glycine 0 N--CA 1.472 1.067 0 N-CA-C 111.121 -0.792 . . . . 1.0 111.121 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 1.9 p 154.55 -5.21 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 115.632 -0.284 . . . . 1.0 111.354 178.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.633 ' CD ' ' H ' ' A' ' 59' ' ' GLU . 8.6 mp0 -37.91 95.86 0.1 Allowed Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 111.762 0.282 . . . . 1.0 111.762 -178.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -62.64 138.47 70.02 Favored 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 122.483 2.122 . . . . 1.0 112.489 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 141.47 -117.54 1.22 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.608 -0.997 . . . . 1.0 110.608 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -137.53 73.77 1.46 Allowed 'General case' 0 N--CA 1.477 0.878 0 O-C-N 122.239 -0.565 . . . . 1.0 109.952 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -88.32 136.03 33.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.827 0.822 . . . . 1.0 112.247 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.406 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 32.7 p-10 -82.99 110.26 17.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.24 -0.891 . . . . 1.0 109.029 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -97.12 159.49 14.88 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.839 0.828 . . . . 1.0 111.626 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -104.58 141.39 36.49 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.934 -1.03 . . . . 1.0 111.296 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.7 t -80.01 124.47 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.43 0.634 . . . . 1.0 110.232 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -100.42 88.86 3.77 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.646 0.736 . . . . 1.0 110.297 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.5 t -86.71 134.75 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.044 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -74.35 146.54 84.23 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.51 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.58 154.72 64.31 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 122.371 2.047 . . . . 1.0 112.198 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.3 mt -112.43 123.25 34.52 Favored Pre-proline 0 N--CA 1.48 1.032 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.721 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.95 135.71 23.75 Favored 'Trans proline' 0 N--CA 1.504 2.098 0 C-N-CA 121.853 1.702 . . . . 1.0 112.392 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 79.48 -15.12 0.79 Allowed 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.39 0.676 . . . . 1.0 111.258 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.7 mm -120.8 146.17 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-O 122.077 0.941 . . . . 1.0 110.005 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -110.19 112.48 24.47 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 122.061 0.934 . . . . 1.0 111.167 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.8 tt -59.72 146.32 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-O 121.391 0.615 . . . . 1.0 110.094 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 68.6 t -103.66 -42.39 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 122.004 -0.435 . . . . 1.0 110.741 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -172.98 175.36 3.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.923 0.868 . . . . 1.0 110.776 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.422 ' O ' ' O ' ' A' ' 34' ' ' ARG . 61.9 mt -110.23 -77.61 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 115.648 -0.706 . . . . 1.0 109.767 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 80' ' ' ILE . 88.3 p 54.97 108.35 0.02 OUTLIER Pre-proline 0 CA--C 1.549 0.939 0 CA-C-O 118.228 -0.891 . . . . 1.0 112.213 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -68.93 122.02 5.38 Favored 'Cis proline' 0 N--CA 1.503 2.044 0 CA-C-N 120.373 1.169 . . . . 1.0 111.794 0.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 91.8 mtm180 -68.71 -34.21 75.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.929 0.871 . . . . 1.0 109.428 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.5 t -130.32 142.51 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.469 0.707 . . . . 1.0 109.117 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.4 m -135.51 153.61 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-O 121.766 0.793 . . . . 1.0 111.746 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 38.4 m -107.29 120.77 43.06 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.17 -0.923 . . . . 1.0 110.602 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 60.0 mt -126.75 134.64 50.58 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.349 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -93.25 131.15 38.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.352 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.1 mt -112.98 140.27 47.94 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.362 0.601 . . . . 1.0 110.085 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -139.1 152.21 47.31 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.894 0.854 . . . . 1.0 111.067 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -69.12 139.74 54.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.153 -0.93 . . . . 1.0 110.826 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -69.18 98.32 1.01 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.666 0.746 . . . . 1.0 111.078 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -76.24 101.99 5.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.225 0.536 . . . . 1.0 110.382 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -165.21 128.98 2.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.815 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.464 ' CG ' ' N ' ' A' ' 96' ' ' HIS . 39.3 p-80 -58.83 -49.08 79.04 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.033 -0.358 . . . . 1.0 110.033 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.464 ' N ' ' CG ' ' A' ' 95' ' ' HIS . 81.3 t60 . . . . . 0 C--O 1.219 -0.526 0 CA-C-O 117.915 -1.041 . . . . 1.0 109.807 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.4 t . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 109.47 -0.567 . . . . 1.0 109.47 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.9 t 55.37 -174.49 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.954 -0.387 . . . . 1.0 109.954 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -71.41 123.22 21.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.554 0.692 . . . . 1.0 110.116 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.9 m -155.91 74.64 0.87 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.584 0.707 . . . . 1.0 109.626 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.532 ' C ' ' H ' ' A' ' 7' ' ' ARG . 0.6 OUTLIER -156.16 -163.71 1.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.125 0.488 . . . . 1.0 110.669 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.8 t0 71.27 -34.15 0.29 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.064 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.532 ' H ' ' C ' ' A' ' 5' ' ' LEU . 88.5 mtm180 46.22 103.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.187 0.518 . . . . 1.0 111.765 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 53.03 83.16 0.23 Allowed Pre-proline 0 CA--C 1.54 0.586 0 O-C-N 121.814 -0.554 . . . . 1.0 112.288 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.69 147.72 78.31 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 122.678 2.252 . . . . 1.0 112.834 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 81.9 m -119.27 107.15 13.06 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.578 0.704 . . . . 1.0 110.133 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.4 mt -117.91 152.79 34.73 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.18 0.991 . . . . 1.0 110.427 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.2 m -117.17 123.92 47.87 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.604 -0.725 . . . . 1.0 110.607 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.501 HD13 ' H ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -112.51 145.64 39.89 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.606 -0.724 . . . . 1.0 110.468 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.501 ' H ' HD13 ' A' ' 13' ' ' LEU . 95.9 p -86.38 155.59 20.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.263 0.554 . . . . 1.0 109.908 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.7 tp -95.03 129.61 42.04 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.197 0.523 . . . . 1.0 110.755 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.0 pt -127.03 148.76 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-O 121.451 0.643 . . . . 1.0 110.958 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.9 104.64 16.86 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 121.841 -0.537 . . . . 1.0 110.971 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -82.68 59.68 4.86 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.33 0.586 . . . . 1.0 110.928 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.694 ' ND2' ' H ' ' A' ' 55' ' ' LEU . 1.8 p30 171.71 -79.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.356 0.598 . . . . 1.0 110.062 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.9 m 48.66 70.38 2.12 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 115.918 -0.583 . . . . 1.0 111.625 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 22' ' ' ALA . 40.0 Cg_endo -66.64 143.47 68.38 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 121.849 1.699 . . . . 1.0 111.557 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.469 ' C ' ' H ' ' A' ' 24' ' ' SER . . . -48.36 -175.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.54 0.686 . . . . 1.0 111.727 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.6 m120 73.55 -25.68 0.19 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.089 0.471 . . . . 1.0 111.048 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 22' ' ' ALA . 2.9 t -134.27 149.77 50.95 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 122.013 0.911 . . . . 1.0 110.614 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 17.0 ptm -143.62 142.79 31.2 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.613 -0.721 . . . . 1.0 110.414 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 80.5 mt -86.23 119.04 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 121.546 0.688 . . . . 1.0 110.833 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 12.3 ptm -98.69 -6.6 29.33 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.453 0.644 . . . . 1.0 109.571 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 91.5 m -84.47 136.25 33.91 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -67.95 123.31 20.24 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.316 -0.865 . . . . 1.0 110.334 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.454 HD22 ' N ' ' A' ' 30' ' ' LEU . 4.4 mm? -53.08 103.11 0.35 Allowed Pre-proline 0 CA--C 1.547 0.841 0 CA-C-O 118.68 -0.676 . . . . 1.0 112.096 -178.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -65.32 155.73 67.02 Favored 'Trans proline' 0 N--CA 1.506 2.256 0 C-N-CA 122.517 2.145 . . . . 1.0 113.144 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.6 p -93.17 165.58 12.75 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.646 -0.659 . . . . 1.0 110.994 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.6 m -137.8 135.43 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-O 121.141 0.496 . . . . 1.0 110.985 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.404 HH22 ' CE ' ' A' ' 36' ' ' LYS . 8.4 ptm180 -97.96 128.37 44.49 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.538 -0.542 . . . . 1.0 109.538 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 t -122.84 134.69 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 122.172 0.987 . . . . 1.0 111.473 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.404 ' CE ' HH22 ' A' ' 34' ' ' ARG . 68.7 mttm -109.4 155.85 20.76 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.357 -0.838 . . . . 1.0 110.412 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 76.0 p -138.02 124.9 21.2 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.247 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 39' ' ' GLY . 10.6 tm-20 -46.54 -67.17 0.31 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.859 0.838 . . . . 1.0 110.524 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 38' ' ' GLU . . . -58.74 -147.99 0.01 OUTLIER Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.017 -0.833 . . . . 1.0 111.017 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -141.97 122.9 14.48 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.651 0.739 . . . . 1.0 110.762 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.618 ' CB ' HD12 ' A' ' 44' ' ' ILE . 6.7 p-10 -127.37 45.88 1.8 Allowed Pre-proline 0 N--CA 1.476 0.861 0 CA-C-N 116.024 -0.535 . . . . 1.0 111.164 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 41' ' ' ASN . 56.8 Cg_endo -67.72 -8.59 22.85 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.528 2.152 . . . . 1.0 111.667 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.6 t -143.58 77.02 1.54 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.169 0.509 . . . . 1.0 111.045 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.618 HD12 ' CB ' ' A' ' 41' ' ' ASN . 24.5 mt -144.06 156.17 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 121.932 0.873 . . . . 1.0 109.535 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.526 ' C ' ' H ' ' A' ' 47' ' ' ASN . 18.0 t-20 -68.16 55.51 0.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.447 -0.797 . . . . 1.0 110.67 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.4 m -70.56 24.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 121.023 0.44 . . . . 1.0 110.96 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.526 ' H ' ' C ' ' A' ' 45' ' ' ASN . 53.3 t30 -87.79 6.58 34.52 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.149 0.5 . . . . 1.0 110.413 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -126.29 8.34 7.19 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.208 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.488 HD21 HG12 ' A' ' 72' ' ' ILE . 16.2 mt -95.61 121.71 37.59 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.236 0.541 . . . . 1.0 109.707 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -148.51 163.54 36.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 122.466 1.127 . . . . 1.0 111.619 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -109.91 133.01 53.63 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.398 -1.274 . . . . 1.0 108.351 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.525 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 7.7 p90 -145.32 152.72 40.35 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 122.76 1.267 . . . . 1.0 112.164 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.8 m -111.75 138.61 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 114.214 -1.357 . . . . 1.0 109.068 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -88.35 87.05 7.17 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.625 -0.716 . . . . 1.0 110.519 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.694 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 4.1 mp -69.66 -10.59 58.88 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.079 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 55' ' ' LEU . 56.9 m 29.13 -108.93 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.655 0.613 . . . . 1.0 112.655 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.504 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -68.97 -76.33 0.47 Allowed Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.04 -0.824 . . . . 1.0 111.04 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 3.0 p 149.31 134.27 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.37 0.605 . . . . 1.0 111.663 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -132.98 77.03 69.18 Favored Pre-proline 0 N--CA 1.483 1.176 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.883 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.68 153.9 64.09 Favored 'Trans proline' 0 N--CA 1.507 2.308 0 C-N-CA 123.153 2.568 . . . . 1.0 112.953 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.558 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . 98.6 50.82 1.48 Allowed Glycine 0 N--CA 1.472 1.057 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.558 ' O ' ' O ' ' A' ' 61' ' ' GLY . 97.3 mt-10 54.79 137.3 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 O-C-N 122.245 -0.562 . . . . 1.0 110.217 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.672 ' CG ' ' H ' ' A' ' 64' ' ' ASP . 8.8 t-80 -149.92 -166.0 2.43 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 122.595 1.188 . . . . 1.0 112.377 -178.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.672 ' H ' ' CG ' ' A' ' 63' ' ' HIS . 79.4 m-20 -143.35 97.89 3.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.58 -1.191 . . . . 1.0 109.155 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -99.76 135.83 40.58 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.791 0.805 . . . . 1.0 111.405 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.476 ' CD ' ' N ' ' A' ' 67' ' ' VAL . 10.2 tm-20 -72.08 152.87 42.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.992 -1.003 . . . . 1.0 111.326 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.476 ' N ' ' CD ' ' A' ' 66' ' ' GLU . 41.1 t -91.02 116.06 31.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.668 0.747 . . . . 1.0 110.119 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.432 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 28.1 ttmt -109.61 106.39 16.06 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 122.163 0.983 . . . . 1.0 110.443 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.1 t -99.05 139.61 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 115.689 -0.687 . . . . 1.0 111.242 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -68.37 117.65 51.83 Favored Pre-proline 0 CA--C 1.55 0.972 0 CA-C-O 118.719 -0.657 . . . . 1.0 110.56 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.58 141.29 19.66 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 C-N-CA 121.718 1.612 . . . . 1.0 112.701 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.488 HG12 HD21 ' A' ' 49' ' ' LEU . 44.7 mm -113.14 119.27 42.75 Favored Pre-proline 0 N--CA 1.484 1.229 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.07 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.23 89.09 0.93 Allowed 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 122.019 1.813 . . . . 1.0 112.585 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 166.25 -19.99 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 122.685 0.394 . . . . 1.0 110.573 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.8 mm -134.8 156.14 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 121.851 0.834 . . . . 1.0 110.244 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -101.03 144.51 29.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 122.755 1.264 . . . . 1.0 111.2 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.564 HG23 ' O ' ' A' ' 77' ' ' ILE . 18.4 tt -108.59 114.86 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 115.208 -0.905 . . . . 1.0 110.148 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.9 t -66.05 -41.05 88.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 O-C-N 122.133 -0.355 . . . . 1.0 110.408 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.409 ' CD ' ' NH2' ' A' ' 83' ' ' ARG . 1.9 mt-10 -179.54 -175.53 0.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 122.177 0.989 . . . . 1.0 110.595 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.0 mt -107.56 -75.35 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 115.346 -0.843 . . . . 1.0 109.839 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.0 m 53.57 101.43 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.714 0 CA-C-O 118.219 -0.896 . . . . 1.0 111.848 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.52 172.35 35.49 Favored 'Cis proline' 0 N--CA 1.505 2.18 0 CA-C-N 120.287 1.138 . . . . 1.0 111.805 0.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.409 ' NH2' ' CD ' ' A' ' 79' ' ' GLU . 97.3 mtt180 -119.85 -12.97 9.12 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.679 0.752 . . . . 1.0 109.097 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.6 t -145.82 141.96 21.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.065 -0.717 . . . . 1.0 109.065 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.7 m -135.37 139.93 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-O 121.542 0.686 . . . . 1.0 111.662 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.525 ' O ' HG23 ' A' ' 86' ' ' THR . 12.9 t -103.04 119.86 39.62 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.387 -0.824 . . . . 1.0 110.753 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 62.1 mt -108.7 -178.22 3.53 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.658 0.742 . . . . 1.0 110.157 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -139.56 110.76 6.95 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.469 -0.787 . . . . 1.0 110.512 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.5 mt -105.01 139.43 39.71 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.493 -0.776 . . . . 1.0 110.086 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -145.43 144.21 30.5 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.741 0.781 . . . . 1.0 111.168 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.467 ' O ' ' N ' ' A' ' 93' ' ' HIS . 21.4 p-80 -67.06 137.82 56.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.434 -0.803 . . . . 1.0 110.737 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.445 ' CG ' ' O ' ' A' ' 92' ' ' HIS . 7.9 p80 -61.99 72.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.252 0.549 . . . . 1.0 111.358 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.467 ' N ' ' O ' ' A' ' 91' ' ' HIS . 86.5 t60 -61.89 -45.06 95.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.951 0.405 . . . . 1.0 110.36 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -71.46 123.81 23.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.205 0.526 . . . . 1.0 110.922 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 37.7 p-80 -71.24 134.35 46.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.327 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 . . . . . 0 C--O 1.219 -0.528 0 CA-C-O 118.082 -0.961 . . . . 1.0 110.545 -179.853 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.9 p . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.552 -0.536 . . . . 1.0 109.552 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.0 m -70.22 144.19 51.96 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.797 -0.446 . . . . 1.0 109.797 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -84.66 177.41 8.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.389 0.614 . . . . 1.0 110.171 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.0 p 49.81 80.82 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.562 0.696 . . . . 1.0 110.074 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.539 HD12 ' N ' ' A' ' 5' ' ' LEU . 9.1 mp -84.63 87.31 7.27 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.075 0.464 . . . . 1.0 110.699 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -138.03 -112.85 0.17 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.832 -0.433 . . . . 1.0 109.832 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 74.4 mtp85 39.73 66.2 0.61 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.325 0.583 . . . . 1.0 112.194 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -165.3 107.59 0.78 Allowed Pre-proline 0 CA--C 1.545 0.757 0 O-C-N 121.927 -0.483 . . . . 1.0 111.273 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -77.04 161.72 32.48 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.484 1.456 . . . . 1.0 112.738 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.4 m -110.06 99.67 8.73 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.662 0.744 . . . . 1.0 110.122 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 57.8 mt -107.3 146.53 31.41 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.445 0.641 . . . . 1.0 110.287 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.9 t -124.03 127.72 48.3 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.274 0.559 . . . . 1.0 110.756 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 44.7 mt -110.46 137.42 48.18 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.602 -0.726 . . . . 1.0 110.221 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.1 t -63.36 171.17 2.58 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.865 -0.42 . . . . 1.0 109.865 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.9 tp -125.67 116.04 21.05 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.796 0.808 . . . . 1.0 110.805 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 38.2 pt -117.61 149.66 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-O 121.749 0.785 . . . . 1.0 110.67 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.56 124.73 39.72 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.87 -0.519 . . . . 1.0 110.689 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -120.64 -178.49 3.73 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.364 0.602 . . . . 1.0 110.0 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 45.03 37.02 2.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.373 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.05 109.39 6.16 Favored Pre-proline 0 CA--C 1.561 1.402 0 CA-C-O 118.479 -0.772 . . . . 1.0 111.005 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -59.05 -146.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.508 2.332 0 C-N-CA 121.141 1.228 . . . . 1.0 111.922 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.547 ' O ' ' C ' ' A' ' 23' ' ' ASN . . . -49.17 143.95 5.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 122.07 0.938 . . . . 1.0 111.544 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.547 ' C ' ' O ' ' A' ' 22' ' ' ALA . 77.7 m-20 -13.91 84.84 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.483 0.659 . . . . 1.0 112.067 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 22' ' ' ALA . 40.5 t -96.06 149.12 21.95 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.644 0.735 . . . . 1.0 110.886 -178.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 26.2 ttt -144.44 103.64 3.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.558 0.694 . . . . 1.0 110.089 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.907 ' H ' HD12 ' A' ' 26' ' ' ILE . 2.7 mp -70.57 119.63 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.953 -0.567 . . . . 1.0 111.051 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -60.9 -45.26 95.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.261 0.553 . . . . 1.0 109.555 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.8 p -79.14 171.16 15.58 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -102.59 166.9 10.26 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.331 -0.856 . . . . 1.0 110.273 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 22.3 mt -102.56 94.21 4.84 Favored Pre-proline 0 CA--C 1.553 1.083 0 CA-C-N 115.553 -0.749 . . . . 1.0 112.104 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -80.79 157.6 21.23 Favored 'Trans proline' 0 N--CA 1.504 2.106 0 C-N-CA 121.819 1.679 . . . . 1.0 112.964 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 96.0 p -67.73 161.81 25.2 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 121.728 -0.608 . . . . 1.0 110.953 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.3 m -120.19 138.45 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.174 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 67.5 mtp85 -89.47 118.81 29.39 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.829 -0.434 . . . . 1.0 109.829 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.91 132.26 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 121.816 0.817 . . . . 1.0 111.534 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -102.52 150.99 22.84 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.66 -0.7 . . . . 1.0 110.211 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 72.6 p -134.96 136.86 42.56 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.057 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -53.34 -69.65 0.11 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.805 0.812 . . . . 1.0 110.428 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.46 ' H ' HG23 ' A' ' 75' ' ' ILE . . . -49.04 172.45 0.06 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.252 -0.739 . . . . 1.0 111.252 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.442 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 68.2 t80 -96.92 -8.08 31.64 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.838 0.352 . . . . 1.0 111.308 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.7 m120 59.69 77.9 0.36 Allowed Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.749 -0.205 . . . . 1.0 111.294 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -45.69 -45.19 16.87 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 121.603 1.535 . . . . 1.0 112.371 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.4 p -169.86 21.77 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.785 0.326 . . . . 1.0 111.119 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.513 HD12 ' N ' ' A' ' 44' ' ' ILE . 1.6 mp -53.39 133.59 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 121.657 0.742 . . . . 1.0 110.032 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -55.56 91.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.677 -0.692 . . . . 1.0 110.802 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 55.9 t -55.37 -16.68 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.44 -0.346 . . . . 1.0 110.621 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.5 ' O ' ' N ' ' A' ' 49' ' ' LEU . 10.2 p30 -80.58 -48.28 12.94 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.837 0.351 . . . . 1.0 110.308 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.462 ' N ' ' OD1' ' A' ' 47' ' ' ASN . 80.0 tt0 -43.99 -14.81 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 116.002 -0.545 . . . . 1.0 111.448 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.5 ' N ' ' O ' ' A' ' 47' ' ' ASN . 40.3 mt -95.02 139.53 31.26 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.455 ' CE2' ' O ' ' A' ' 47' ' ' ASN . 92.5 m-85 -150.86 159.43 44.56 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.768 0.794 . . . . 1.0 111.486 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -120.23 134.65 55.21 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.027 -0.988 . . . . 1.0 108.704 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 22.2 p90 -150.32 149.09 29.64 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.323 1.059 . . . . 1.0 112.104 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.0 m -105.62 147.44 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 114.648 -1.16 . . . . 1.0 109.083 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.462 ' C ' ' H ' ' A' ' 56' ' ' SER . 50.1 p-10 -101.23 81.03 2.17 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.305 0.574 . . . . 1.0 110.757 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.0 mt -56.29 -6.07 0.24 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.247 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.462 ' H ' ' C ' ' A' ' 54' ' ' ASP . 42.9 t 34.82 -95.49 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.25 0.62 . . . . 1.0 112.612 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.948 ' O ' ' O ' ' A' ' 58' ' ' SER . . . -114.55 62.39 0.33 Allowed Glycine 0 N--CA 1.472 1.094 0 N-CA-C 110.77 -0.932 . . . . 1.0 110.77 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.948 ' O ' ' O ' ' A' ' 57' ' ' GLY . 8.6 m 8.51 144.07 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.125 0 N-CA-C 113.707 1.003 . . . . 1.0 113.707 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.528 ' H ' HD12 ' A' ' 89' ' ' LEU . 73.5 mm-40 -133.64 82.02 52.13 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 110.07 -0.345 . . . . 1.0 110.07 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -49.36 139.97 27.71 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.133 1.889 . . . . 1.0 112.305 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.04 -97.37 0.81 Allowed Glycine 0 N--CA 1.47 0.959 0 N-CA-C 110.602 -0.999 . . . . 1.0 110.602 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -165.18 139.88 5.05 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 122.242 -0.563 . . . . 1.0 109.62 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.665 ' CG ' ' H ' ' A' ' 64' ' ' ASP . 32.5 t60 -154.94 -164.24 1.75 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 122.365 1.079 . . . . 1.0 112.167 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.665 ' H ' ' CG ' ' A' ' 63' ' ' HIS . 12.7 p-10 -122.79 145.04 48.78 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 114.607 -1.178 . . . . 1.0 109.134 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -142.56 138.12 30.6 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.309 0.576 . . . . 1.0 111.627 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -94.31 142.56 27.27 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.528 -0.76 . . . . 1.0 111.045 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.9 t -95.95 135.38 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.333 0.587 . . . . 1.0 110.175 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.72 151.24 52.03 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.881 0.848 . . . . 1.0 110.472 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.7 t -131.19 144.66 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 121.571 0.7 . . . . 1.0 111.131 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -68.08 128.49 93.27 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-N 115.422 -0.808 . . . . 1.0 110.445 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -39.51 153.9 0.05 OUTLIER 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.069 1.846 . . . . 1.0 113.433 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.565 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -101.07 154.85 36.92 Favored Pre-proline 0 N--CA 1.483 1.202 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.582 -179.29 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 72' ' ' ILE . 61.1 Cg_exo -37.46 -106.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.509 2.415 0 C-N-CA 122.775 2.317 . . . . 1.0 113.698 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -105.99 18.25 22.37 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.036 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.586 HG22 ' N ' ' A' ' 76' ' ' LYS . 81.5 mt -103.53 166.1 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 121.351 0.596 . . . . 1.0 110.136 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.586 ' N ' HG22 ' A' ' 75' ' ' ILE . 66.1 tttm -118.98 119.98 35.92 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.894 0.854 . . . . 1.0 111.533 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.439 ' HB ' HD11 ' A' ' 72' ' ' ILE . 19.3 tt -59.81 143.01 14.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.128 0.49 . . . . 1.0 110.323 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 85.1 t -96.14 -49.4 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 122.104 -0.373 . . . . 1.0 110.689 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -173.17 133.62 0.52 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.415 0.626 . . . . 1.0 111.031 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.8 tp -100.85 134.15 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-O 121.492 0.663 . . . . 1.0 109.381 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 61.8 p -145.45 143.06 19.03 Favored Pre-proline 0 N--CA 1.478 0.948 0 CA-C-O 118.939 -0.553 . . . . 1.0 111.795 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.6 138.66 56.2 Favored 'Cis proline' 0 N--CA 1.505 2.196 0 CA-C-N 119.602 0.894 . . . . 1.0 111.896 -1.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -67.87 -35.27 78.24 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.98 0.895 . . . . 1.0 109.947 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 t -134.89 145.6 32.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.178 -0.675 . . . . 1.0 109.178 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.65 161.44 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-O 122.431 1.11 . . . . 1.0 110.833 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 75.8 m -105.98 124.21 49.21 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.434 -1.257 . . . . 1.0 110.525 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 87.5 mt -130.62 116.98 18.84 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.192 0.52 . . . . 1.0 110.093 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -96.82 110.62 23.06 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.389 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.528 HD12 ' H ' ' A' ' 59' ' ' GLU . 51.5 mt -78.83 150.59 32.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.056 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -129.4 141.28 51.09 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 122.092 0.949 . . . . 1.0 111.045 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -65.63 126.59 28.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.009 -0.996 . . . . 1.0 110.584 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.447 ' CG ' ' O ' ' A' ' 92' ' ' HIS . 78.4 t60 -72.18 43.62 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.039 0.447 . . . . 1.0 111.095 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.439 ' ND1' ' N ' ' A' ' 93' ' ' HIS . 0.2 OUTLIER -73.01 1.44 8.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.232 0.539 . . . . 1.0 110.291 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -61.26 -49.28 77.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 1.0 111.156 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.424 ' O ' ' NE2' ' A' ' 92' ' ' HIS . 86.3 t60 -170.3 132.07 1.0 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.034 -0.358 . . . . 1.0 110.034 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 . . . . . 0 C--O 1.219 -0.524 0 CA-C-O 118.171 -0.919 . . . . 1.0 110.606 179.826 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.436 -0.579 . . . . 1.0 109.436 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.2 t 54.48 173.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.917 -0.401 . . . . 1.0 109.917 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -156.72 158.29 36.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.387 0.613 . . . . 1.0 110.121 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 51.2 p -71.08 137.85 49.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.121 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 5' ' ' LEU . 9.8 mp 53.29 -177.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.198 0.523 . . . . 1.0 110.755 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -166.12 162.61 17.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.238 0.542 . . . . 1.0 109.852 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -73.45 151.25 41.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.432 0.634 . . . . 1.0 111.455 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 41.64 75.99 0.56 Allowed Pre-proline 0 C--N 1.327 -0.372 0 C-N-CA 122.975 0.51 . . . . 1.0 112.293 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.68 153.37 54.13 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.426 2.084 . . . . 1.0 113.019 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 75.3 m -106.15 99.24 8.84 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.408 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -94.02 146.73 23.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 122.13 0.967 . . . . 1.0 110.497 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.2 m -119.52 109.6 15.91 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.625 -0.716 . . . . 1.0 110.475 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.5 mt -110.36 134.14 52.58 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.318 -0.855 . . . . 1.0 109.696 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.0 m -79.74 164.95 23.29 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.91 -0.404 . . . . 1.0 109.91 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.2 tp -113.08 118.21 34.14 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.73 0.776 . . . . 1.0 110.648 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.8 pp -128.19 162.17 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 CA-C-O 121.751 0.786 . . . . 1.0 110.925 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.403 ' CB ' ' OG1' ' A' ' 20' ' ' THR . . . -79.69 157.99 27.08 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 121.769 -0.582 . . . . 1.0 111.001 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -66.94 -36.68 82.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.221 0.534 . . . . 1.0 111.282 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -166.45 -34.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.098 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.403 ' OG1' ' CB ' ' A' ' 17' ' ' ALA . 22.3 m 59.34 76.56 0.44 Allowed Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 116.343 -0.39 . . . . 1.0 111.463 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 22' ' ' ALA . 31.7 Cg_exo -57.88 148.96 72.82 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.249 1.966 . . . . 1.0 111.586 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.449 ' C ' ' H ' ' A' ' 24' ' ' SER . . . -51.37 -169.96 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.891 0.853 . . . . 1.0 111.74 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 71.23 -38.68 0.43 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.141 -0.481 . . . . 1.0 111.001 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.449 ' H ' ' C ' ' A' ' 22' ' ' ALA . 13.3 p -109.02 149.58 29.05 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.699 0.761 . . . . 1.0 110.587 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 11.7 tmm? -141.88 120.26 12.35 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.553 0.692 . . . . 1.0 110.33 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 74.0 mt -72.74 116.13 14.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.592 0.71 . . . . 1.0 110.881 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 78.0 mtp -94.83 -16.41 22.96 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.925 -0.579 . . . . 1.0 109.669 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.9 m -78.71 134.5 37.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.262 0.553 . . . . 1.0 109.69 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.407 ' H ' ' HD2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -78.57 123.99 27.68 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 121.288 -0.883 . . . . 1.0 110.316 -179.548 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.7 mt -70.43 114.71 28.18 Favored Pre-proline 0 CA--C 1.555 1.139 0 CA-C-N 115.748 -0.66 . . . . 1.0 112.05 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -84.68 152.59 11.62 Favored 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 121.77 1.647 . . . . 1.0 113.07 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.7 m -72.98 173.28 9.52 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.614 -0.679 . . . . 1.0 111.213 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.517 HG21 HD11 ' A' ' 80' ' ' ILE . 2.8 p -142.84 136.96 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-O 121.376 0.608 . . . . 1.0 111.046 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -97.54 129.33 44.7 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.4 0.619 . . . . 1.0 109.346 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -124.71 134.18 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-O 122.101 0.953 . . . . 1.0 111.576 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -107.81 149.02 28.73 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.465 -0.789 . . . . 1.0 110.289 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 72.1 p -127.78 132.04 49.55 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 116.045 -0.525 . . . . 1.0 111.294 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -58.04 -75.29 0.05 OUTLIER 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.827 0.823 . . . . 1.0 110.09 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.61 166.64 15.94 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.959 -0.856 . . . . 1.0 110.959 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -79.77 175.08 10.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.841 0.829 . . . . 1.0 110.683 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -124.0 92.77 47.98 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 115.71 -0.677 . . . . 1.0 110.65 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -52.36 -40.9 69.66 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 121.893 1.729 . . . . 1.0 112.13 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 44' ' ' ILE . 73.8 m -165.51 -96.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.63 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 43' ' ' SER . 65.7 mt 57.76 141.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.128 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -85.44 96.95 9.75 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.165 0.507 . . . . 1.0 110.806 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.4 m -86.13 5.92 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 120.942 0.401 . . . . 1.0 110.782 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -97.13 -1.13 45.78 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.107 0.48 . . . . 1.0 110.262 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.482 ' OE1' ' N ' ' A' ' 48' ' ' GLU . 18.8 mp0 -120.25 6.27 10.72 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.662 -0.699 . . . . 1.0 110.145 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.0 mt -122.26 128.44 51.12 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.635 0.731 . . . . 1.0 109.557 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -133.67 -168.45 2.11 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.248 1.023 . . . . 1.0 111.544 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -115.41 139.74 49.75 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.626 -1.17 . . . . 1.0 108.989 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.475 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 16.8 p90 -141.37 153.42 45.08 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 122.34 1.067 . . . . 1.0 112.36 -178.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.3 m -110.56 140.09 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 114.647 -1.16 . . . . 1.0 109.27 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -77.44 88.57 3.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.502 0.668 . . . . 1.0 110.328 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 57' ' ' GLY . 0.8 OUTLIER -90.39 -26.52 19.86 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.623 -0.717 . . . . 1.0 109.848 -179.735 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 55' ' ' LEU . 35.4 t 28.18 -89.86 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.004 0.521 . . . . 1.0 112.353 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . -62.55 -75.01 0.35 Allowed Glycine 0 CA--C 1.531 1.093 0 N-CA-C 111.029 -0.828 . . . . 1.0 111.029 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.0 t 75.56 95.82 0.07 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 122.879 0.471 . . . . 1.0 111.469 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -123.61 147.95 54.57 Favored Pre-proline 0 N--CA 1.482 1.16 0 CA-C-O 119.514 -0.279 . . . . 1.0 111.67 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -47.82 139.0 19.92 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 121.724 1.616 . . . . 1.0 113.304 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 139.66 -135.59 7.3 Favored Glycine 0 N--CA 1.472 1.086 0 N-CA-C 110.532 -1.027 . . . . 1.0 110.532 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -170.65 144.02 2.27 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -154.62 -164.66 1.87 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.708 1.242 . . . . 1.0 112.451 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 32.8 p-10 -111.74 91.84 3.81 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 114.33 -1.305 . . . . 1.0 108.942 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -82.56 132.16 35.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.679 0.752 . . . . 1.0 111.36 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.51 153.63 37.38 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.057 -0.974 . . . . 1.0 111.171 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 65.4 t -94.09 110.29 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 121.59 0.71 . . . . 1.0 110.152 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' A' ' 52' ' ' TYR . 1.6 tmtp? -112.01 118.6 35.87 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 122.039 0.923 . . . . 1.0 110.137 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.3 m -126.43 149.89 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 115.783 -0.644 . . . . 1.0 111.203 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -74.84 125.77 89.09 Favored Pre-proline 0 CA--C 1.549 0.92 0 CA-C-O 118.387 -0.816 . . . . 1.0 110.311 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.01 137.76 19.91 Favored 'Trans proline' 0 N--CA 1.5 1.892 0 C-N-CA 121.619 1.546 . . . . 1.0 112.357 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.5 mm -79.8 128.74 73.29 Favored Pre-proline 0 CA--C 1.554 1.131 0 CA-C-N 116.456 -0.338 . . . . 1.0 111.314 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.3 152.82 66.74 Favored 'Trans proline' 0 N--CA 1.502 2.024 0 C-N-CA 121.506 1.471 . . . . 1.0 112.818 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.9 t30 65.63 -1.27 1.06 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.295 0.638 . . . . 1.0 111.29 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.415 HG22 ' N ' ' A' ' 76' ' ' LYS . 66.5 mt -133.58 155.48 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 121.64 0.733 . . . . 1.0 110.191 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.415 ' N ' HG22 ' A' ' 75' ' ' ILE . 68.7 mttm -107.93 149.82 27.86 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 122.267 1.032 . . . . 1.0 111.236 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.625 HG23 ' O ' ' A' ' 77' ' ' ILE . 18.1 tt -100.41 101.54 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 115.732 -0.667 . . . . 1.0 109.995 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.2 t -46.02 -58.18 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 O-C-N 122.121 -0.362 . . . . 1.0 110.636 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -175.62 141.68 0.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.685 0.755 . . . . 1.0 110.686 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.517 HD11 HG21 ' A' ' 33' ' ' VAL . 8.6 tp -104.18 138.85 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.399 0.619 . . . . 1.0 109.579 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.2 m -147.32 134.93 10.48 Favored Pre-proline 0 N--CA 1.481 1.079 0 CA-C-O 118.481 -0.771 . . . . 1.0 112.293 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.84 -174.49 10.77 Favored 'Cis proline' 0 N--CA 1.503 2.037 0 CA-C-N 120.133 1.083 . . . . 1.0 111.701 -0.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -121.2 -18.31 7.45 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.927 0.87 . . . . 1.0 109.312 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.6 t -138.61 136.94 43.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.029 -0.73 . . . . 1.0 109.029 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.2 m -137.19 174.74 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 CA-C-O 121.771 0.796 . . . . 1.0 111.476 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.0 t -133.07 128.31 35.95 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.137 -0.938 . . . . 1.0 110.465 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 50.2 mt -130.74 120.95 24.58 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 120.954 0.407 . . . . 1.0 110.207 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -86.16 112.12 21.02 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.582 0.706 . . . . 1.0 110.281 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.6 mt -80.68 165.87 21.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.673 -0.694 . . . . 1.0 110.085 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -140.27 130.32 24.86 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.9 0.857 . . . . 1.0 110.971 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 -76.19 129.57 36.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.194 -0.912 . . . . 1.0 110.522 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.559 ' CG ' ' H ' ' A' ' 93' ' ' HIS . 12.0 t-80 -73.16 -122.76 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.202 0.525 . . . . 1.0 111.145 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.559 ' H ' ' CG ' ' A' ' 92' ' ' HIS . 79.2 m80 -154.59 155.45 34.76 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.216 0.531 . . . . 1.0 110.494 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.428 ' O ' ' CG ' ' A' ' 95' ' ' HIS . 92.1 m-70 -80.09 121.19 25.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.276 0.56 . . . . 1.0 111.046 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.428 ' CG ' ' O ' ' A' ' 94' ' ' HIS . 89.4 m-70 -156.9 4.44 0.15 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.183 -0.462 . . . . 1.0 109.839 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 79.4 m80 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.988 -1.006 . . . . 1.0 110.354 179.788 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 40.6 t . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.548 -0.538 . . . . 1.0 109.548 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.1 t -161.26 162.27 31.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.107 -0.497 . . . . 1.0 109.724 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -67.4 -18.74 65.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.287 0.565 . . . . 1.0 110.124 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.4 p -65.11 130.87 44.93 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.463 -0.569 . . . . 1.0 109.463 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 51.3 tp -64.72 -54.61 28.87 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 122.057 -0.402 . . . . 1.0 111.304 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 7' ' ' ARG . 14.4 p30 177.12 -41.2 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.095 0.474 . . . . 1.0 109.874 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.534 ' NH2' ' CZ ' ' A' ' 40' ' ' TYR . 88.6 mtm180 -72.44 146.65 46.78 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 122.263 1.03 . . . . 1.0 111.381 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -152.28 86.27 4.44 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 115.9 -0.591 . . . . 1.0 111.509 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.95 119.83 6.93 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 122.166 1.911 . . . . 1.0 113.227 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 42.0 m -117.25 87.15 2.65 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 121.312 0.577 . . . . 1.0 110.739 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.771 HD22 ' N ' ' A' ' 11' ' ' LEU . 0.9 OUTLIER -98.6 147.15 25.1 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 122.122 0.963 . . . . 1.0 110.615 -179.462 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.5 m -106.79 124.28 49.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.717 0.77 . . . . 1.0 110.338 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.8 mt -112.99 130.53 56.1 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.107 -0.951 . . . . 1.0 110.131 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.9 m -69.19 161.07 29.94 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.0 tp -113.47 116.89 30.31 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.449 0.643 . . . . 1.0 111.055 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.7 pt -119.04 140.5 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-O 121.877 0.846 . . . . 1.0 110.694 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.27 117.91 17.61 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.22 0.533 . . . . 1.0 110.918 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.2 tptt -112.86 159.3 19.17 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.357 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 53.37 31.15 11.44 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.96 -0.385 . . . . 1.0 109.96 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.0 m -68.93 129.7 92.1 Favored Pre-proline 0 CA--C 1.546 0.823 0 CA-C-O 119.051 -0.499 . . . . 1.0 111.704 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -71.92 117.31 5.08 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 121.245 1.297 . . . . 1.0 111.431 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -42.83 158.15 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.87 0.843 . . . . 1.0 111.617 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.4 m120 73.2 9.71 5.22 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.958 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 90.3 p -112.44 145.13 40.73 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.738 0.78 . . . . 1.0 110.701 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.408 ' SD ' ' O ' ' A' ' 26' ' ' ILE . 12.5 tmm? -139.31 121.07 15.38 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.722 -0.672 . . . . 1.0 110.258 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.408 ' O ' ' SD ' ' A' ' 25' ' ' MET . 54.6 mt -73.8 144.98 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.888 0.851 . . . . 1.0 110.979 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 10.7 tpp -107.34 -26.78 10.85 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.571 -0.741 . . . . 1.0 109.596 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.9 m -81.09 156.49 25.78 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.203 -0.666 . . . . 1.0 109.203 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.438 ' C ' HD22 ' A' ' 30' ' ' LEU . 61.9 pttt -84.18 157.89 21.5 Favored 'General case' 0 CA--C 1.516 -0.362 0 O-C-N 121.273 -0.892 . . . . 1.0 110.19 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.466 HD22 ' N ' ' A' ' 30' ' ' LEU . 4.3 mm? -100.26 97.84 6.89 Favored Pre-proline 0 N--CA 1.484 1.262 0 CA-C-N 115.958 -0.565 . . . . 1.0 112.42 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 29' ' ' LYS . 37.2 Cg_endo -86.1 157.38 9.88 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.486 2.124 . . . . 1.0 112.714 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.4 m -77.35 -178.21 5.04 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.594 -0.691 . . . . 1.0 110.991 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.7 p -140.78 149.82 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 121.31 0.576 . . . . 1.0 111.146 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -102.87 123.83 47.24 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.49 0.662 . . . . 1.0 109.423 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 t -120.29 133.14 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-O 122.265 1.031 . . . . 1.0 111.52 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.437 ' H ' ' HB3' ' A' ' 79' ' ' GLU . 63.6 tttm -103.45 146.29 28.73 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.293 -0.867 . . . . 1.0 110.076 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 43.8 p -131.24 130.63 43.13 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.099 -0.501 . . . . 1.0 111.469 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.431 ' O ' ' O ' ' A' ' 39' ' ' GLY . 83.9 tt0 -57.36 -74.72 0.05 Allowed 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.648 0.737 . . . . 1.0 110.159 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 38' ' ' GLU . . . -50.17 -173.72 0.01 OUTLIER Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.347 -0.701 . . . . 1.0 111.347 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.715 ' O ' HD11 ' A' ' 75' ' ' ILE . 3.0 m-85 -104.92 167.9 9.41 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.494 0.664 . . . . 1.0 110.411 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -120.67 83.88 36.17 Favored Pre-proline 0 N--CA 1.476 0.831 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.412 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.56 -41.26 69.42 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.132 1.888 . . . . 1.0 112.162 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.515 ' O ' ' O ' ' A' ' 44' ' ' ILE . 73.7 m -161.17 -88.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.246 0.546 . . . . 1.0 110.401 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.515 ' O ' ' O ' ' A' ' 43' ' ' SER . 2.8 tt 31.56 100.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.352 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.604 ' C ' ' H ' ' A' ' 47' ' ' ASN . 87.9 m-20 -63.65 96.85 0.13 Allowed 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 120.969 0.414 . . . . 1.0 110.815 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.8 m -66.63 20.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.331 0.586 . . . . 1.0 110.718 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.604 ' H ' ' C ' ' A' ' 45' ' ' ASN . 94.1 m-20 -92.26 12.2 23.22 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.14 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -125.32 -1.23 7.61 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.694 -0.685 . . . . 1.0 110.288 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.8 mt -123.01 133.38 54.35 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -141.09 -166.57 2.2 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.009 0.909 . . . . 1.0 111.592 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -118.7 140.51 49.81 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.798 -1.092 . . . . 1.0 108.389 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -120.36 166.73 13.14 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 122.413 1.101 . . . . 1.0 112.084 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.3 m -133.73 145.49 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 114.475 -1.239 . . . . 1.0 109.305 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -94.92 81.83 3.78 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.709 0.766 . . . . 1.0 110.663 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.2 mp -75.11 -4.09 36.56 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.445 -0.798 . . . . 1.0 110.176 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.8 t -79.06 5.33 12.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.371 -0.377 . . . . 1.0 111.329 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -132.59 52.04 0.84 Allowed Glycine 0 N--CA 1.474 1.213 0 N-CA-C 111.344 -0.702 . . . . 1.0 111.344 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.7 t -153.45 -63.92 0.15 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.536 0.208 . . . . 1.0 111.316 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 66.36 151.92 0.12 Allowed Pre-proline 0 N--CA 1.472 0.625 0 C-N-CA 122.562 0.345 . . . . 1.0 111.443 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -35.06 143.29 0.08 OUTLIER 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 122.866 2.377 . . . . 1.0 113.369 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.513 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . 120.24 16.16 4.86 Favored Glycine 0 N--CA 1.472 1.057 0 N-CA-C 110.935 -0.866 . . . . 1.0 110.935 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.513 ' O ' ' O ' ' A' ' 61' ' ' GLY . 81.6 tt0 57.17 141.07 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 O-C-N 122.12 -0.635 . . . . 1.0 109.9 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.73 ' CG ' ' H ' ' A' ' 64' ' ' ASP . 7.6 t-80 -155.55 -163.65 1.57 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 122.883 1.325 . . . . 1.0 112.289 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.73 ' H ' ' CG ' ' A' ' 63' ' ' HIS . 95.6 m-20 -114.58 144.27 43.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.285 -1.325 . . . . 1.0 108.652 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' A' ' 65' ' ' TYR . 48.7 m-85 -134.76 139.15 44.93 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.426 0.631 . . . . 1.0 111.388 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -104.44 149.29 25.56 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.345 -0.843 . . . . 1.0 111.15 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 48.4 t -103.28 116.45 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 121.726 0.774 . . . . 1.0 110.203 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -123.51 139.74 53.71 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.293 1.044 . . . . 1.0 110.344 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.7 t -109.0 136.89 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 115.553 -0.748 . . . . 1.0 110.874 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -72.13 117.26 56.73 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-O 118.557 -0.735 . . . . 1.0 110.091 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -44.96 119.22 2.29 Favored 'Trans proline' 0 N--CA 1.505 2.167 0 C-N-CA 121.754 1.636 . . . . 1.0 113.157 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 33.9 mm -105.93 123.0 40.57 Favored Pre-proline 0 N--CA 1.487 1.39 0 CA-C-O 119.103 -0.475 . . . . 1.0 111.235 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.64 157.86 54.81 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.32 2.014 . . . . 1.0 112.092 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 33.6 t30 80.67 -26.27 0.16 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.481 0.712 . . . . 1.0 110.826 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.715 HD11 ' O ' ' A' ' 40' ' ' TYR . 12.7 mm -132.81 148.46 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 122.206 1.003 . . . . 1.0 110.489 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -113.77 149.6 34.65 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 122.762 1.268 . . . . 1.0 110.961 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.6 tt -91.97 142.99 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.209 -0.905 . . . . 1.0 110.112 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.8 t -120.72 -45.48 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 122.089 -0.382 . . . . 1.0 110.901 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.437 ' HB3' ' H ' ' A' ' 36' ' ' LYS . 81.4 tt0 -96.17 139.4 32.39 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 122.127 0.965 . . . . 1.0 110.667 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.5 mp -135.25 80.82 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 115.435 -0.802 . . . . 1.0 109.723 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.7 m -148.61 148.84 29.47 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 120.281 -0.568 . . . . 1.0 112.018 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.82 141.73 72.64 Favored 'Cis proline' 0 N--CA 1.509 2.423 0 C-N-CA 124.685 -0.964 . . . . 1.0 112.3 -1.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 90.8 mtm180 -61.76 -56.48 19.11 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.567 0.698 . . . . 1.0 109.368 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.1 t -135.21 149.25 28.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.231 -0.655 . . . . 1.0 109.231 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.2 m -144.75 163.73 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 121.647 0.737 . . . . 1.0 111.764 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 74.3 m -111.6 122.82 48.83 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.299 -0.864 . . . . 1.0 110.658 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.4 mt -107.99 -170.13 1.63 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.426 0.632 . . . . 1.0 110.204 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -146.56 112.6 5.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.47 0.652 . . . . 1.0 110.55 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.8 mt -107.33 143.16 36.01 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.555 0.693 . . . . 1.0 110.033 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -132.44 143.71 49.98 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.971 0.891 . . . . 1.0 111.036 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -68.65 131.16 44.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.165 -0.925 . . . . 1.0 110.547 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.425 ' NE2' ' O ' ' A' ' 95' ' ' HIS . 0.7 OUTLIER -133.19 128.22 35.49 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.701 0.762 . . . . 1.0 111.071 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -78.46 89.43 4.43 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.328 0.585 . . . . 1.0 110.317 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.563 ' CG ' ' H ' ' A' ' 95' ' ' HIS . 49.3 t-80 52.76 173.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.211 0.529 . . . . 1.0 111.225 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.563 ' H ' ' CG ' ' A' ' 94' ' ' HIS . 83.3 t60 55.68 97.15 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.207 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 . . . . . 0 C--O 1.221 -0.414 0 CA-C-O 117.954 -1.022 . . . . 1.0 110.753 -179.723 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.481 ' H2 ' HG22 ' A' ' 4' ' ' THR . 45.9 t . . . . . 0 N--CA 1.484 1.255 0 N-CA-C 109.418 -0.586 . . . . 1.0 109.418 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.3 t -66.25 -51.72 54.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.874 0.369 . . . . 1.0 111.178 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -173.45 17.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.635 0.731 . . . . 1.0 110.062 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.481 HG22 ' H2 ' ' A' ' 1' ' ' SER . 0.1 OUTLIER -62.21 -43.66 98.34 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.741 0.782 . . . . 1.0 109.658 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 11.1 mp -65.79 167.16 9.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.7 0.762 . . . . 1.0 110.296 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 8' ' ' ASP . 51.6 p-10 -151.17 146.46 26.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.591 -0.732 . . . . 1.0 109.662 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -48.98 -8.82 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.808 -0.633 . . . . 1.0 112.558 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 6' ' ' ASP . 12.2 p-10 -139.21 81.82 20.34 Favored Pre-proline 0 N--CA 1.476 0.867 0 O-C-N 121.942 -0.474 . . . . 1.0 111.329 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.94 134.5 55.53 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.794 2.329 . . . . 1.0 112.739 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.7 m -104.51 85.92 2.42 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.409 0.623 . . . . 1.0 110.143 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.8 mt -86.01 145.52 27.06 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.814 0.816 . . . . 1.0 110.544 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.3 m -109.57 119.56 39.79 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.531 0.682 . . . . 1.0 110.599 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.8 mp -102.54 135.36 44.31 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.39 -0.823 . . . . 1.0 109.879 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 59.3 m -79.33 105.8 10.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.895 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.5 tp -68.52 95.94 0.66 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.591 0.71 . . . . 1.0 110.938 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.3 pt -118.69 165.05 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 121.571 0.701 . . . . 1.0 111.038 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.99 164.34 23.54 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.792 -0.568 . . . . 1.0 111.12 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.1 mmtp -104.11 -56.85 2.13 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.221 0.534 . . . . 1.0 111.402 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -92.89 -54.54 3.7 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.547 0.689 . . . . 1.0 110.144 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.662 ' CG2' HD11 ' A' ' 26' ' ' ILE . 0.3 OUTLIER 45.66 80.91 0.27 Allowed Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 115.831 -0.622 . . . . 1.0 111.592 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.38 134.72 65.52 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.302 2.001 . . . . 1.0 111.238 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.45 -14.4 3.01 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 122.001 -0.437 . . . . 1.0 111.859 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -91.53 -15.34 28.87 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.957 -0.464 . . . . 1.0 111.161 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.4 t -108.3 153.48 23.18 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.524 0.678 . . . . 1.0 110.779 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 45.0 ttp -144.66 115.51 7.8 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.706 0.765 . . . . 1.0 110.086 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.946 ' H ' HD12 ' A' ' 26' ' ' ILE . 2.2 mp -68.11 115.39 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.862 0.839 . . . . 1.0 111.095 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 44.3 ttm -67.67 -28.07 67.38 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.685 -0.689 . . . . 1.0 109.44 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 30' ' ' LEU . 5.9 m -68.88 135.74 51.56 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -68.85 -13.99 62.76 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 121.279 -0.888 . . . . 1.0 111.097 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.474 ' H ' HG22 ' A' ' 28' ' ' THR . 24.1 mt 61.95 91.81 0.07 OUTLIER Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 115.828 -0.624 . . . . 1.0 112.31 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -86.57 158.47 9.27 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.854 2.369 . . . . 1.0 112.755 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 95.4 p -69.13 178.07 2.45 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.666 -0.646 . . . . 1.0 111.268 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.0 p -139.7 151.04 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-O 121.408 0.623 . . . . 1.0 111.053 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 100.0 mtt180 -98.96 129.19 45.26 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.6 t -127.03 154.66 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 122.384 1.087 . . . . 1.0 111.396 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -124.7 142.67 51.23 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.108 -0.951 . . . . 1.0 110.591 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 60.3 p -130.08 136.57 49.49 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.33 0.586 . . . . 1.0 111.264 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -109.84 41.62 1.67 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.526 0.679 . . . . 1.0 109.798 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -125.3 -9.45 5.03 Favored Glycine 0 N--CA 1.472 1.093 0 N-CA-C 111.039 -0.824 . . . . 1.0 111.039 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 59.73 153.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.234 0.54 . . . . 1.0 111.13 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -175.4 148.11 1.02 Allowed Pre-proline 0 CA--C 1.547 0.835 0 O-C-N 122.212 -0.305 . . . . 1.0 110.451 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.29 -58.97 0.11 Allowed 'Trans proline' 0 N--CA 1.509 2.429 0 C-N-CA 121.507 1.471 . . . . 1.0 112.599 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.484 ' O ' ' HB ' ' A' ' 44' ' ' ILE . 40.2 t -159.42 -56.8 0.06 Allowed 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.71 0.767 . . . . 1.0 110.71 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 43' ' ' SER . 42.3 mt 91.92 -113.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-N 115.39 -0.823 . . . . 1.0 109.73 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.513 ' OD1' ' ND2' ' A' ' 47' ' ' ASN . 11.2 t-20 -175.87 -19.47 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.653 0.74 . . . . 1.0 110.383 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.444 ' C ' ' O ' ' A' ' 45' ' ' ASN . 17.7 m 28.18 43.58 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-O 121.827 0.822 . . . . 1.0 112.036 -178.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.513 ' ND2' ' OD1' ' A' ' 45' ' ' ASN . 8.7 m120 -69.93 -40.92 75.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.577 -0.738 . . . . 1.0 110.754 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -127.95 13.08 6.78 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.617 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 28.5 mt -96.42 110.84 23.12 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.974 0.893 . . . . 1.0 109.597 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -148.24 -160.87 1.23 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 122.191 0.996 . . . . 1.0 111.533 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -117.2 142.49 46.97 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.703 -1.135 . . . . 1.0 108.263 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -134.57 175.12 9.82 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 122.03 0.919 . . . . 1.0 112.345 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.4 m -138.87 146.0 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 114.834 -1.075 . . . . 1.0 109.393 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -86.9 83.02 7.61 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.588 0.709 . . . . 1.0 110.318 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 56' ' ' SER . 0.7 OUTLIER -81.89 -13.79 57.09 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.0 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.454 ' C ' ' O ' ' A' ' 55' ' ' LEU . 77.3 p 20.18 -97.93 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 112.829 0.678 . . . . 1.0 112.829 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.493 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -60.57 -74.53 0.36 Allowed Glycine 0 CA--C 1.531 1.073 0 N-CA-C 110.583 -1.007 . . . . 1.0 110.583 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 3.9 m 101.94 45.24 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 123.94 0.896 . . . . 1.0 111.444 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 60' ' ' PRO . 12.3 mp0 -76.0 130.65 77.68 Favored Pre-proline 0 CA--C 1.548 0.902 0 CA-C-O 119.23 -0.414 . . . . 1.0 111.586 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 59' ' ' GLU . 88.7 Cg_exo -44.11 -179.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.506 2.251 0 C-N-CA 122.076 1.851 . . . . 1.0 113.044 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.54 -141.15 15.16 Favored Glycine 0 N--CA 1.472 1.093 0 N-CA-C 110.713 -0.955 . . . . 1.0 110.713 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.3 mp0 -138.19 75.1 1.5 Allowed 'General case' 0 N--CA 1.471 0.58 0 O-C-N 122.135 -0.626 . . . . 1.0 109.724 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -93.54 137.67 32.59 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.712 0.768 . . . . 1.0 112.013 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -85.37 139.19 31.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.282 -0.872 . . . . 1.0 109.072 178.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -132.11 127.94 37.09 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.718 0.77 . . . . 1.0 111.664 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 32.6 mp0 -67.87 132.81 48.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.091 -0.959 . . . . 1.0 111.318 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.6 t -76.27 124.96 35.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.507 0.67 . . . . 1.0 110.207 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -109.39 121.16 44.57 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.973 0.892 . . . . 1.0 110.196 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.3 m -109.75 129.61 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 115.833 -0.622 . . . . 1.0 111.008 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -50.35 127.76 23.49 Favored Pre-proline 0 CA--C 1.554 1.133 0 CA-C-O 118.87 -0.586 . . . . 1.0 110.554 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.3 112.01 3.42 Favored 'Trans proline' 0 N--CA 1.505 2.178 0 C-N-CA 121.684 1.59 . . . . 1.0 112.218 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.8 mp -82.02 129.71 63.27 Favored Pre-proline 0 CA--C 1.556 1.198 0 CA-C-O 119.411 -0.328 . . . . 1.0 110.795 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -67.15 140.98 55.63 Favored 'Trans proline' 0 N--CA 1.506 2.218 0 C-N-CA 121.755 1.637 . . . . 1.0 112.662 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.9 t30 66.93 10.32 7.55 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.271 0.629 . . . . 1.0 111.476 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mm -124.04 137.13 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-O 122.367 1.079 . . . . 1.0 109.746 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.33 121.14 38.89 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 122.145 0.974 . . . . 1.0 111.013 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.64 HG23 ' O ' ' A' ' 77' ' ' ILE . 7.4 tp -84.12 93.34 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.879 -0.601 . . . . 1.0 110.053 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.8 t -46.9 -53.65 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 O-C-N 121.97 -0.456 . . . . 1.0 110.835 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -170.42 -127.19 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.819 0.819 . . . . 1.0 110.408 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.8 mt -154.23 -77.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.131 -0.692 . . . . 1.0 109.131 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.6 t 58.71 101.94 0.04 OUTLIER Pre-proline 0 CA--C 1.549 0.907 0 CA-C-O 117.544 -1.217 . . . . 1.0 111.778 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -67.74 134.11 24.28 Favored 'Cis proline' 0 N--CA 1.512 2.598 0 CA-C-N 121.028 1.403 . . . . 1.0 111.831 0.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -66.26 -43.53 86.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.761 0.791 . . . . 1.0 109.661 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -130.08 153.21 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 109.377 -0.601 . . . . 1.0 109.377 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.5 p -145.38 136.06 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.604 0.716 . . . . 1.0 111.5 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 37.2 m -81.39 130.36 35.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.282 -0.872 . . . . 1.0 110.441 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 33.5 mt -133.45 124.47 27.12 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.104 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.409 ' CD ' ' N ' ' A' ' 88' ' ' GLN . 18.3 mp0 -93.28 121.43 34.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.687 0.756 . . . . 1.0 110.525 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.0 mt -96.98 162.06 13.56 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.445 -0.798 . . . . 1.0 109.802 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -152.81 151.62 30.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.642 0.734 . . . . 1.0 110.992 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.441 ' O ' ' N ' ' A' ' 93' ' ' HIS . 19.3 p-80 -66.2 139.44 58.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.427 -0.806 . . . . 1.0 110.687 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -65.12 69.52 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.325 0.583 . . . . 1.0 111.165 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.441 ' N ' ' O ' ' A' ' 91' ' ' HIS . 84.7 t60 -67.31 -44.73 78.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.099 0.476 . . . . 1.0 110.402 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -61.97 85.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.123 0.487 . . . . 1.0 110.976 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -76.63 55.84 1.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.055 0.455 . . . . 1.0 109.776 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.936 -1.031 . . . . 1.0 110.838 -179.816 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.7 t . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.675 -0.491 . . . . 1.0 109.675 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.9 p -73.65 157.43 36.61 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.487 -0.56 . . . . 1.0 109.487 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 53.72 88.21 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.397 0.618 . . . . 1.0 110.249 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.4 t -91.35 156.03 18.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.636 0.732 . . . . 1.0 109.572 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.12 136.17 53.4 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.705 0.764 . . . . 1.0 110.54 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.446 ' CG ' ' H ' ' A' ' 7' ' ' ARG . 51.9 t0 178.8 -118.69 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.609 -0.723 . . . . 1.0 109.717 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.446 ' H ' ' CG ' ' A' ' 6' ' ' ASP . 56.5 mmt-85 60.43 -122.56 0.98 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.51 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.478 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 4.9 p-10 44.3 54.35 11.92 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 112.935 0.717 . . . . 1.0 112.935 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.478 ' HD3' ' N ' ' A' ' 8' ' ' ASP . 57.6 Cg_endo -89.8 -178.03 1.54 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.806 2.337 . . . . 1.0 112.801 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 53.9 m -85.51 113.61 21.9 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.647 0.737 . . . . 1.0 110.423 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 74.9 mt -105.85 139.32 40.59 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.673 0.749 . . . . 1.0 110.572 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.472 ' C ' HD12 ' A' ' 13' ' ' LEU . 68.0 m -101.14 124.57 47.04 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.379 0.609 . . . . 1.0 110.428 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.472 HD12 ' C ' ' A' ' 12' ' ' THR . 10.3 mp -108.19 131.15 54.96 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.651 -0.704 . . . . 1.0 109.944 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.6 t -75.83 114.85 14.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.196 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 41.4 tp -69.37 105.99 2.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.246 0.546 . . . . 1.0 110.88 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.7 pt -118.08 142.6 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 121.692 0.758 . . . . 1.0 111.117 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.49 121.5 24.64 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.351 0.596 . . . . 1.0 110.76 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -114.03 50.4 0.93 Allowed 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.404 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 172.81 34.35 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.326 -0.62 . . . . 1.0 109.326 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.0 m -70.17 112.5 12.85 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-O 119.022 -0.513 . . . . 1.0 111.466 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -57.66 145.64 88.62 Favored 'Trans proline' 0 N--CA 1.501 1.948 0 C-N-CA 121.876 1.718 . . . . 1.0 111.832 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.93 150.38 49.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 122.155 0.979 . . . . 1.0 111.388 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 68.06 7.93 6.17 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.129 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.3 p -114.1 152.09 31.61 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.791 0.805 . . . . 1.0 110.521 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 49.0 ttp -141.47 120.27 12.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.704 -0.68 . . . . 1.0 110.082 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 72.2 mt -72.04 117.95 16.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.456 0.645 . . . . 1.0 110.665 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.417 ' SD ' ' OE1' ' A' ' 90' ' ' GLU . 76.4 mtp -83.79 58.64 4.75 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.806 0.812 . . . . 1.0 109.83 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.7 m -165.18 128.29 2.25 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.358 -0.608 . . . . 1.0 109.358 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.515 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 38.2 ttpt -68.2 158.44 33.24 Favored 'General case' 0 CA--C 1.515 -0.393 0 O-C-N 121.229 -0.92 . . . . 1.0 110.682 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.486 HD22 ' N ' ' A' ' 30' ' ' LEU . 4.3 mm? -98.55 96.86 4.12 Favored Pre-proline 0 CA--C 1.557 1.213 0 N-CA-C 112.374 0.509 . . . . 1.0 112.374 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' A' ' 29' ' ' LYS . 39.7 Cg_endo -86.51 152.05 9.02 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.485 2.123 . . . . 1.0 112.635 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.5 p -68.17 177.55 2.22 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.698 -0.626 . . . . 1.0 111.098 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -145.14 154.27 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.557 0.694 . . . . 1.0 111.079 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -104.42 127.0 52.02 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.5 m -131.6 161.75 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 122.169 0.985 . . . . 1.0 111.28 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -125.25 134.03 52.46 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.423 -0.808 . . . . 1.0 110.939 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 30.1 p -141.1 -175.27 4.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.647 0.736 . . . . 1.0 111.211 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -124.37 -138.17 0.29 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.727 -0.67 . . . . 1.0 110.089 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.66 -150.61 38.33 Favored Glycine 0 N--CA 1.458 0.161 0 N-CA-C 110.911 -0.876 . . . . 1.0 110.911 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -144.32 -25.96 0.52 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.252 0.549 . . . . 1.0 111.321 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 61.97 67.43 1.27 Allowed Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.451 -0.341 . . . . 1.0 111.128 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -58.64 -41.12 67.16 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 122.171 1.914 . . . . 1.0 111.92 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 55.4 p -172.07 55.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.614 -0.266 . . . . 1.0 110.533 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.8 mm -90.06 125.52 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.39 0.614 . . . . 1.0 110.062 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.514 ' O ' ' N ' ' A' ' 47' ' ' ASN . 82.5 m-20 -75.59 100.89 4.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.459 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.1 m -46.72 -9.54 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.234 0.54 . . . . 1.0 111.817 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 45' ' ' ASN . 33.6 m120 -63.02 -36.14 82.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.228 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -102.98 55.79 0.76 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.001 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.524 ' O ' ' CG ' ' A' ' 50' ' ' PHE . 20.1 mt -152.28 118.97 5.7 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.225 0.536 . . . . 1.0 110.071 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.524 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 59.1 m-85 -161.64 173.91 14.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 122.513 1.149 . . . . 1.0 111.675 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.463 ' C ' ' CG ' ' A' ' 52' ' ' TYR . . . -100.47 170.14 8.6 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 114.219 -1.355 . . . . 1.0 108.728 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.463 ' CG ' ' C ' ' A' ' 51' ' ' ALA . 25.3 m-85 -151.57 163.77 38.33 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 122.221 1.01 . . . . 1.0 111.913 -178.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.1 m -137.19 145.74 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 114.735 -1.12 . . . . 1.0 109.443 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -98.76 81.91 2.72 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.504 0.668 . . . . 1.0 110.643 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.491 ' O ' ' C ' ' A' ' 56' ' ' SER . 70.1 mt -74.71 4.75 5.78 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.577 -0.738 . . . . 1.0 110.197 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.491 ' C ' ' O ' ' A' ' 55' ' ' LEU . 84.2 p 15.02 -113.75 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 115.593 -0.731 . . . . 1.0 112.88 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.41 -143.22 0.01 OUTLIER Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.791 -0.924 . . . . 1.0 110.791 178.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.4 m -151.08 32.25 0.6 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 121.324 -0.15 . . . . 1.0 111.047 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -41.96 101.7 0.25 Allowed Pre-proline 0 CA--C 1.543 0.698 0 CA-C-O 119.625 -0.226 . . . . 1.0 111.394 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -56.02 118.61 5.42 Favored 'Trans proline' 0 N--CA 1.502 2.01 0 C-N-CA 122.607 2.205 . . . . 1.0 112.736 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 149.71 -168.07 29.87 Favored Glycine 0 N--CA 1.465 0.575 0 N-CA-C 110.22 -1.152 . . . . 1.0 110.22 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.514 ' CD ' ' H ' ' A' ' 62' ' ' GLU . 1.2 pm0 -102.62 80.2 1.89 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.375 0.607 . . . . 1.0 109.735 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.409 ' CG ' ' N ' ' A' ' 64' ' ' ASP . 41.2 t-80 -90.69 161.37 15.39 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.911 0.862 . . . . 1.0 111.895 -178.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.409 ' N ' ' CG ' ' A' ' 63' ' ' HIS . 69.2 m-20 -88.34 128.1 35.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.126 -0.943 . . . . 1.0 109.432 178.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -122.37 97.7 5.59 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.8 0.81 . . . . 1.0 111.546 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.543 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 39.1 mp0 -59.25 131.72 51.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.969 -1.014 . . . . 1.0 111.463 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.8 t -77.81 128.18 38.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.702 0.763 . . . . 1.0 110.269 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -117.73 137.91 52.38 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.993 0.901 . . . . 1.0 110.346 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.1 t -110.71 129.92 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.038 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -51.14 123.28 19.74 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.45 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.38 88.68 1.13 Allowed 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 122.09 1.86 . . . . 1.0 112.656 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.472 ' H ' HD12 ' A' ' 72' ' ' ILE . 3.3 mp -79.72 128.21 75.26 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 120.935 -0.306 . . . . 1.0 110.735 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.404 ' O ' ' ND2' ' A' ' 74' ' ' ASN . 56.3 Cg_endo -71.33 80.99 1.27 Allowed 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 122.151 1.901 . . . . 1.0 112.782 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.404 ' ND2' ' O ' ' A' ' 73' ' ' PRO . 6.2 m-20 167.78 -52.19 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.844 0.354 . . . . 1.0 110.498 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.3 mm -91.23 136.87 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-O 121.879 0.847 . . . . 1.0 110.201 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -96.41 140.38 31.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 122.288 1.042 . . . . 1.0 111.343 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.8 tt -94.93 135.91 27.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.641 -0.709 . . . . 1.0 110.327 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.7 t -105.47 -52.38 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 O-C-N 122.074 -0.391 . . . . 1.0 110.354 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -148.05 -152.41 0.44 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.998 0.904 . . . . 1.0 110.63 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.417 ' O ' ' O ' ' A' ' 81' ' ' SER . 34.2 mt -144.1 -48.24 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.582 -0.735 . . . . 1.0 109.617 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 80' ' ' ILE . 79.3 p 31.04 96.38 0.04 OUTLIER Pre-proline 0 CA--C 1.557 1.219 0 CA-C-O 118.39 -0.814 . . . . 1.0 112.354 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -68.29 -172.15 6.19 Favored 'Cis proline' 0 N--CA 1.501 1.94 0 CA-C-N 120.2 1.107 . . . . 1.0 111.757 1.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -112.09 -30.93 7.05 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.591 -0.731 . . . . 1.0 109.788 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.3 t -149.04 152.57 11.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.162 -0.681 . . . . 1.0 109.162 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.1 p -143.43 140.56 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.604 0.716 . . . . 1.0 111.664 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 60.4 m -95.76 128.96 43.08 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.281 -0.872 . . . . 1.0 110.789 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.6 mt -116.93 167.17 11.36 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.617 -0.719 . . . . 1.0 110.235 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -118.07 116.7 27.4 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.854 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -105.25 130.26 53.43 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.889 0.852 . . . . 1.0 110.253 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.417 ' OE1' ' SD ' ' A' ' 27' ' ' MET . 39.0 tt0 -134.2 136.64 43.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 122.346 1.07 . . . . 1.0 111.149 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 29.0 p-80 -68.76 116.96 9.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.735 -1.12 . . . . 1.0 110.685 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -91.62 68.43 5.61 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.027 0.441 . . . . 1.0 110.822 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.406 ' CG ' ' O ' ' A' ' 93' ' ' HIS . 14.4 p80 -62.07 99.46 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.426 0.631 . . . . 1.0 110.416 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.516 ' CG ' ' N ' ' A' ' 95' ' ' HIS . 56.9 t-80 -164.25 168.07 19.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.607 0.717 . . . . 1.0 110.531 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.516 ' N ' ' CG ' ' A' ' 94' ' ' HIS . 58.6 t-80 -138.38 97.34 3.35 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.835 -0.621 . . . . 1.0 110.066 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 79.1 t60 . . . . . 0 C--O 1.219 -0.549 0 CA-C-O 117.936 -1.031 . . . . 1.0 110.362 -179.888 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 . . . . . 0 N--CA 1.471 0.621 0 CA-C-O 121.213 0.53 . . . . 1.0 111.822 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -55.73 137.32 71.32 Favored Pre-proline 0 CA--C 1.549 0.926 0 O-C-N 121.848 -0.532 . . . . 1.0 112.007 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -72.82 142.0 34.61 Favored 'Trans proline' 0 N--CA 1.503 2.039 0 C-N-CA 122.347 2.031 . . . . 1.0 112.953 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.5 m -113.92 94.78 4.98 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 121.514 0.673 . . . . 1.0 110.013 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 66.4 mt -109.73 143.43 39.52 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.791 0.805 . . . . 1.0 110.394 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.9 t -102.08 133.26 47.19 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.949 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.763 HD22 ' N ' ' A' ' 13' ' ' LEU . 0.9 OUTLIER -108.87 139.9 43.08 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.618 0.723 . . . . 1.0 110.457 -179.695 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.1 m -74.55 109.8 8.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.899 -0.591 . . . . 1.0 109.869 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.7 tp -69.41 106.56 2.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.406 0.622 . . . . 1.0 110.878 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.4 pt -111.04 142.29 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-O 121.811 0.815 . . . . 1.0 110.857 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.67 127.13 33.93 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.85 -0.531 . . . . 1.0 111.058 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -115.73 162.13 17.72 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 120.952 0.406 . . . . 1.0 110.201 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 22.4 m120 57.47 34.77 25.07 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.94 -0.393 . . . . 1.0 109.94 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 49.4 m -60.21 114.68 10.54 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-O 119.089 -0.482 . . . . 1.0 111.528 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.8 149.83 18.79 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 121.533 1.489 . . . . 1.0 112.01 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.91 145.1 42.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 122.041 0.924 . . . . 1.0 111.374 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.2 m-20 64.14 18.48 11.28 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.945 -0.571 . . . . 1.0 111.093 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.5 t -110.66 147.17 34.86 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.948 0.88 . . . . 1.0 110.658 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 61.4 ttp -139.12 116.15 10.96 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.624 -0.716 . . . . 1.0 109.982 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 59.0 mt -69.71 149.4 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.978 0.894 . . . . 1.0 110.532 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.515 ' O ' ' OG1' ' A' ' 28' ' ' THR . 1.1 tpt -118.74 63.78 0.77 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.766 0.793 . . . . 1.0 109.58 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.515 ' OG1' ' O ' ' A' ' 27' ' ' MET . 33.7 m -178.02 146.59 0.42 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.104 -0.702 . . . . 1.0 109.104 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -85.04 151.41 24.18 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.295 -0.878 . . . . 1.0 110.444 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 mp -103.79 105.41 47.82 Favored Pre-proline 0 N--CA 1.482 1.166 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.894 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -87.78 152.09 7.36 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.374 2.05 . . . . 1.0 112.688 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 63.0 p -59.19 -179.02 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.653 -0.655 . . . . 1.0 111.19 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.6 p -139.65 144.93 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-O 121.264 0.554 . . . . 1.0 111.077 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 82.3 mtt85 -99.99 125.18 45.98 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.385 -0.598 . . . . 1.0 109.385 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 t -124.23 153.47 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-O 122.557 1.17 . . . . 1.0 111.189 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -124.7 138.16 54.31 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 114.968 -1.015 . . . . 1.0 110.6 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 51.5 p -125.51 131.85 52.73 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.754 -0.657 . . . . 1.0 111.3 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -77.99 47.53 0.65 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.473 0.654 . . . . 1.0 109.886 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.401 ' O ' ' CD1' ' A' ' 40' ' ' TYR . . . -149.53 -169.24 15.72 Favored Glycine 0 N--CA 1.466 0.645 0 N-CA-C 110.572 -1.011 . . . . 1.0 110.572 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.401 ' CD1' ' O ' ' A' ' 39' ' ' GLY . 0.8 OUTLIER -142.36 108.73 5.29 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.264 0.554 . . . . 1.0 110.232 -179.499 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -119.69 84.35 30.64 Favored Pre-proline 0 N--CA 1.474 0.733 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.475 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -56.3 -19.3 27.49 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.305 2.003 . . . . 1.0 111.862 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.2 t -145.31 -101.71 0.1 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.997 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.429 HG22 ' O ' ' A' ' 44' ' ' ILE . 27.1 mm 58.8 37.97 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.856 -0.424 . . . . 1.0 109.856 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 39.45 70.9 0.19 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.89 0.376 . . . . 1.0 111.266 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.1 m -56.23 -14.52 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.048 0.452 . . . . 1.0 110.784 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 48' ' ' GLU . 22.2 p30 -58.94 -33.81 71.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.312 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.494 ' N ' ' OD1' ' A' ' 47' ' ' ASN . 74.6 tt0 -91.0 63.64 5.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.996 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 69.1 mt -148.37 110.68 4.65 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.441 0.638 . . . . 1.0 109.995 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -143.31 156.55 44.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 122.054 0.93 . . . . 1.0 111.865 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -115.78 140.87 48.8 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.82 -1.082 . . . . 1.0 108.416 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 16.7 p90 -141.24 144.62 34.81 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 122.082 0.944 . . . . 1.0 112.24 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.4 m -105.53 156.09 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 114.857 -1.065 . . . . 1.0 108.947 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -97.19 142.8 28.67 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.454 0.645 . . . . 1.0 110.523 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.593 ' C ' ' H ' ' A' ' 57' ' ' GLY . 79.6 mt -131.35 40.46 3.43 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.648 -0.705 . . . . 1.0 110.377 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.7 m -60.01 14.24 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.901 -0.59 . . . . 1.0 111.982 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.593 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . -148.3 159.17 27.94 Favored Glycine 0 N--CA 1.466 0.689 0 N-CA-C 110.444 -1.062 . . . . 1.0 110.444 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.5 t -148.24 130.5 15.57 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.577 0.703 . . . . 1.0 110.976 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.638 ' O ' ' N ' ' A' ' 61' ' ' GLY . 2.1 mt-10 179.91 123.1 0.22 Allowed Pre-proline 0 CA--C 1.55 0.943 0 CA-C-N 115.677 -0.692 . . . . 1.0 110.657 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -45.57 71.42 0.01 OUTLIER 'Trans proline' 0 N--CA 1.511 2.531 0 C-N-CA 122.524 2.149 . . . . 1.0 113.939 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.638 ' N ' ' O ' ' A' ' 59' ' ' GLU . . . -145.27 155.68 26.6 Favored Glycine 0 N--CA 1.47 0.951 0 N-CA-C 110.349 -1.1 . . . . 1.0 110.349 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -86.09 87.1 7.36 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 122.302 -0.529 . . . . 1.0 109.768 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.505 ' ND1' ' CE1' ' A' ' 65' ' ' TYR . 61.1 t-80 -92.38 137.51 32.31 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.548 0.69 . . . . 1.0 112.342 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -90.42 115.93 27.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.623 -0.717 . . . . 1.0 109.212 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.505 ' CE1' ' ND1' ' A' ' 63' ' ' HIS . 71.1 m-85 -104.75 135.22 46.54 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.878 0.847 . . . . 1.0 111.455 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -81.06 142.09 33.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.899 -1.046 . . . . 1.0 111.252 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.9 t -74.94 117.5 19.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.373 0.606 . . . . 1.0 110.417 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -106.73 114.8 29.12 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 122.334 1.064 . . . . 1.0 109.886 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.581 HG12 ' N ' ' A' ' 70' ' ' GLU . 27.3 t -85.52 169.27 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 115.57 -0.741 . . . . 1.0 110.871 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.581 ' N ' HG12 ' A' ' 69' ' ' VAL . 10.7 tm-20 -94.4 111.8 55.11 Favored Pre-proline 0 CA--C 1.553 1.09 0 CA-C-N 115.668 -0.696 . . . . 1.0 109.833 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -48.09 131.3 21.53 Favored 'Trans proline' 0 N--CA 1.506 2.217 0 C-N-CA 121.782 1.654 . . . . 1.0 112.859 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.8 mt -99.54 109.51 55.42 Favored Pre-proline 0 CA--C 1.554 1.099 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.792 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.97 55.63 3.43 Favored 'Trans proline' 0 N--CA 1.506 2.246 0 C-N-CA 122.069 1.846 . . . . 1.0 113.095 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -175.09 -44.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.242 0.544 . . . . 1.0 110.882 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.664 HG22 ' N ' ' A' ' 76' ' ' LYS . 63.7 mt -112.63 174.22 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-O 121.559 0.695 . . . . 1.0 110.114 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.664 ' N ' HG22 ' A' ' 75' ' ' ILE . 60.5 tttp -117.83 156.44 28.37 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 122.583 1.182 . . . . 1.0 111.238 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.9 tt -99.39 153.17 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 115.367 -0.833 . . . . 1.0 109.966 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.9 t -108.14 -49.68 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 122.142 -0.349 . . . . 1.0 110.665 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -179.69 -175.99 0.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 122.316 1.055 . . . . 1.0 110.52 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.4 mt -129.86 167.42 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 122.15 0.976 . . . . 1.0 109.307 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.7 t -167.04 106.09 0.63 Allowed Pre-proline 0 CA--C 1.554 1.131 0 CA-C-O 118.438 -0.791 . . . . 1.0 111.452 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -62.39 -173.78 2.74 Favored 'Cis proline' 0 N--CA 1.507 2.283 0 CA-C-N 120.191 1.104 . . . . 1.0 111.528 -0.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -118.54 -23.51 7.11 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.516 0.674 . . . . 1.0 109.191 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 t -144.36 149.85 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.1 m -136.39 157.11 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-O 121.75 0.786 . . . . 1.0 111.567 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 71.7 m -109.1 119.13 38.6 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.174 -0.921 . . . . 1.0 110.613 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.8 mt -122.7 126.22 47.14 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.701 -0.682 . . . . 1.0 110.222 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -83.64 130.52 34.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.587 0.708 . . . . 1.0 110.255 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -104.02 136.15 44.19 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.652 0.739 . . . . 1.0 110.297 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -138.1 140.45 39.97 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.331 1.063 . . . . 1.0 111.053 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -67.18 167.33 12.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.842 -1.072 . . . . 1.0 110.644 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 . . . . . 0 N--CA 1.473 0.686 0 CA-C-O 121.653 0.739 . . . . 1.0 110.972 -179.667 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 112.793 0.664 . . . . 1.0 112.793 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.32 118.14 50.36 Favored Pre-proline 0 CA--C 1.549 0.908 0 O-C-N 121.85 -0.531 . . . . 1.0 112.159 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.47 141.79 35.57 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 CA-C-N 120.404 1.18 . . . . 1.0 113.392 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.427 HG22 ' N ' ' A' ' 11' ' ' LEU . 91.1 m -107.36 157.4 17.98 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.575 0.702 . . . . 1.0 110.024 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.571 HD13 ' H ' ' A' ' 12' ' ' THR . 0.1 OUTLIER -144.09 139.41 28.89 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.445 0.64 . . . . 1.0 110.428 179.818 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.571 ' H ' HD13 ' A' ' 11' ' ' LEU . 56.3 m -123.5 120.19 32.16 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.509 0.671 . . . . 1.0 110.571 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 35.7 mt -130.52 134.08 46.77 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.454 -0.794 . . . . 1.0 110.027 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.5 m -58.67 179.58 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.6 tp -120.33 112.99 19.71 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-O 121.602 0.715 . . . . 1.0 111.043 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.5 pt -116.78 154.26 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-O 121.809 0.814 . . . . 1.0 110.763 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.82 125.56 41.35 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.806 -0.559 . . . . 1.0 110.536 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.483 ' O ' ' O ' ' A' ' 19' ' ' ASN . 63.9 tttm -119.7 137.68 53.76 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.615 0.721 . . . . 1.0 109.707 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 18' ' ' LYS . 82.3 m-20 43.53 100.84 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.993 -0.549 . . . . 1.0 110.876 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.3 m -136.55 132.43 18.7 Favored Pre-proline 0 N--CA 1.479 0.979 0 CA-C-O 119.45 -0.31 . . . . 1.0 111.577 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -36.84 95.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 121.641 1.561 . . . . 1.0 112.541 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -39.33 161.79 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.53 0.681 . . . . 1.0 111.869 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 72.61 12.19 5.47 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 122.006 -0.433 . . . . 1.0 110.746 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.7 p -133.51 153.75 51.38 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.745 0.783 . . . . 1.0 110.661 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 47.8 ttp -143.74 138.6 28.93 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.46 0.647 . . . . 1.0 110.184 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 69.9 mt -75.02 154.12 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.611 0.72 . . . . 1.0 111.047 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.6 ttt -107.13 -28.01 10.24 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 121.391 0.615 . . . . 1.0 109.859 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 30' ' ' LEU . 9.0 m -64.75 138.2 58.24 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.575 -0.528 . . . . 1.0 109.575 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -66.99 -6.74 18.14 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.287 -0.883 . . . . 1.0 111.261 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.447 ' H ' HG22 ' A' ' 28' ' ' THR . 12.2 mt 59.38 95.24 0.05 OUTLIER Pre-proline 0 CA--C 1.548 0.868 0 CA-C-O 118.736 -0.649 . . . . 1.0 111.864 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -85.99 154.91 9.87 Favored 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 122.649 2.233 . . . . 1.0 112.744 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.6 m -57.89 175.59 0.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.614 -0.679 . . . . 1.0 111.26 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.6 m -132.59 133.46 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-O 121.317 0.58 . . . . 1.0 111.091 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -104.98 126.84 52.48 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -130.07 155.63 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 122.163 0.982 . . . . 1.0 111.2 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -119.52 138.8 52.94 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.426 -0.807 . . . . 1.0 110.165 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.5 p -129.97 141.93 50.7 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 115.855 -0.611 . . . . 1.0 110.723 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -82.77 164.23 20.75 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.719 -0.474 . . . . 1.0 109.719 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.51 -157.88 18.13 Favored Glycine 0 N--CA 1.472 1.07 0 N-CA-C 110.827 -0.909 . . . . 1.0 110.827 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -152.77 98.79 2.38 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.471 0.653 . . . . 1.0 110.829 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.458 ' N ' HD22 ' A' ' 41' ' ' ASN . 0.1 OUTLIER -174.42 75.08 0.34 Allowed Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.497 179.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.4 38.88 0.35 Allowed 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 121.691 1.594 . . . . 1.0 111.86 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.42 ' H ' ' C ' ' A' ' 41' ' ' ASN . 38.7 m -170.11 97.14 0.28 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.413 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.1 mt -127.96 53.56 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 109.805 -0.442 . . . . 1.0 109.805 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.517 ' C ' ' H ' ' A' ' 47' ' ' ASN . 4.7 p-10 39.43 56.98 2.17 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.499 -0.319 . . . . 1.0 111.235 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.3 m -70.14 35.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.052 0.453 . . . . 1.0 111.098 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.517 ' H ' ' C ' ' A' ' 45' ' ' ASN . 70.9 m-20 -59.97 -24.18 64.2 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.295 -0.412 . . . . 1.0 110.577 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.513 ' O ' ' C ' ' A' ' 49' ' ' LEU . 96.4 mt-10 -124.38 -54.85 1.67 Allowed 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.934 -0.576 . . . . 1.0 110.009 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.64 ' H ' HD12 ' A' ' 49' ' ' LEU . 9.1 mp -25.42 113.7 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.074 0.464 . . . . 1.0 110.845 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -141.76 -171.86 3.43 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.898 0.856 . . . . 1.0 111.551 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.455 ' O ' ' CG ' ' A' ' 52' ' ' TYR . . . -93.19 158.02 15.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.928 -1.033 . . . . 1.0 108.321 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.455 ' CG ' ' O ' ' A' ' 51' ' ' ALA . 91.8 m-85 -153.6 157.84 40.29 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 122.273 1.035 . . . . 1.0 111.889 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.3 147.22 22.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 114.64 -1.164 . . . . 1.0 109.357 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -115.88 106.23 13.58 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.452 0.644 . . . . 1.0 110.606 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.505 ' C ' ' H ' ' A' ' 57' ' ' GLY . 24.4 mt -104.77 32.77 3.93 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.802 -0.635 . . . . 1.0 110.179 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 88.9 p -62.4 8.71 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.849 -0.614 . . . . 1.0 111.859 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . -88.88 -168.73 44.18 Favored Glycine 0 N--CA 1.47 0.959 0 N-CA-C 110.84 -0.904 . . . . 1.0 110.84 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 82.0 p -162.41 76.71 0.47 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.413 0.625 . . . . 1.0 111.446 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -138.13 88.03 15.68 Favored Pre-proline 0 N--CA 1.472 0.666 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.589 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -48.09 108.76 0.19 Allowed 'Trans proline' 0 N--CA 1.504 2.11 0 C-N-CA 122.364 2.043 . . . . 1.0 112.775 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.74 -165.04 25.41 Favored Glycine 0 N--CA 1.47 0.909 0 N-CA-C 110.343 -1.103 . . . . 1.0 110.343 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.544 ' CD ' ' H ' ' A' ' 62' ' ' GLU . 0.9 OUTLIER -71.77 142.89 49.7 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.261 -0.552 . . . . 1.0 109.641 179.477 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.45 ' O ' ' CD1' ' A' ' 65' ' ' TYR . 62.7 t-80 -161.12 126.02 3.6 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.149 -0.62 . . . . 1.0 112.45 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -77.24 117.32 18.65 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.806 -0.813 . . . . 1.0 108.806 178.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.45 ' CD1' ' O ' ' A' ' 63' ' ' HIS . 91.4 m-85 -94.38 -122.77 0.1 Allowed 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.985 -0.447 . . . . 1.0 111.821 -178.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -160.3 130.68 5.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.127 0.489 . . . . 1.0 110.732 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.7 t -92.94 115.94 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.122 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -142.27 151.83 42.42 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.742 0.782 . . . . 1.0 110.487 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 70' ' ' GLU . 41.6 t -134.63 157.39 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-O 121.405 0.622 . . . . 1.0 111.201 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.417 ' N ' HG12 ' A' ' 69' ' ' VAL . 9.3 pt-20 -58.26 147.28 67.6 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 115.575 -0.738 . . . . 1.0 110.681 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -73.64 162.08 40.56 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 121.892 1.728 . . . . 1.0 112.417 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.84 101.41 12.82 Favored Pre-proline 0 N--CA 1.48 1.048 0 CA-C-N 115.3 -0.864 . . . . 1.0 110.526 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -50.04 140.33 32.33 Favored 'Trans proline' 0 N--CA 1.502 2.026 0 C-N-CA 121.31 1.34 . . . . 1.0 113.064 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.432 ' N ' ' ND2' ' A' ' 74' ' ' ASN . 1.1 m120 78.88 -11.9 1.15 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.555 0.742 . . . . 1.0 111.318 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 42.9 mm -125.96 153.17 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 122.276 1.036 . . . . 1.0 110.006 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -121.65 158.5 28.53 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 122.751 1.262 . . . . 1.0 110.735 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.613 HG23 ' O ' ' A' ' 77' ' ' ILE . 17.6 tt -99.3 95.88 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 115.125 -0.943 . . . . 1.0 109.813 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.7 t -44.91 -53.48 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 O-C-N 121.975 -0.453 . . . . 1.0 110.893 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -167.8 -146.2 0.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.685 0.755 . . . . 1.0 110.559 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.434 HG22 ' O ' ' A' ' 82' ' ' PRO . 1.9 mt -148.63 157.18 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 109.238 -0.653 . . . . 1.0 109.238 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 82' ' ' PRO . 43.3 t -163.17 101.05 1.0 Allowed Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 118.434 -0.793 . . . . 1.0 111.672 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.474 ' O ' ' N ' ' A' ' 81' ' ' SER . 24.0 Cg_exo -63.97 -166.31 1.35 Allowed 'Cis proline' 0 N--CA 1.511 2.541 0 CA-C-N 120.134 1.083 . . . . 1.0 111.393 -0.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -129.81 -18.7 3.4 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.446 0.641 . . . . 1.0 109.512 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.2 t -142.86 135.7 25.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.889 -0.782 . . . . 1.0 108.889 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.9 m -130.65 146.34 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-O 121.841 0.829 . . . . 1.0 111.376 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.0 t -106.29 131.99 52.86 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.071 -0.968 . . . . 1.0 110.49 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 35.1 mt -134.26 126.2 29.32 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.056 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -91.7 122.11 33.96 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.484 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.7 mt -93.43 140.69 29.3 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.415 0.626 . . . . 1.0 109.972 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -133.06 144.68 50.17 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.954 0.883 . . . . 1.0 111.2 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -69.67 144.56 52.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.195 -0.911 . . . . 1.0 110.809 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 121.634 0.73 . . . . 1.0 110.81 -179.706 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 . . . . . 0 CA--C 1.535 0.396 0 CA-C-O 120.819 0.342 . . . . 1.0 111.641 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 40.03 84.36 0.18 Allowed Pre-proline 0 CA--C 1.538 0.499 0 O-C-N 121.833 -0.542 . . . . 1.0 112.119 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.35 135.17 64.53 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.3 2.0 . . . . 1.0 112.954 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 68.2 m -127.96 122.56 32.65 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.679 0.752 . . . . 1.0 109.827 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.4 mt -137.02 164.66 27.84 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.647 0.737 . . . . 1.0 110.509 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.2 m -101.54 128.35 47.83 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.348 0.594 . . . . 1.0 110.282 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 tp -123.4 153.56 40.22 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.61 -0.723 . . . . 1.0 110.227 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.1 t -106.18 152.24 23.72 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.03 0.443 . . . . 1.0 109.906 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 pp -119.71 117.48 28.36 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.353 0.596 . . . . 1.0 111.035 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.3 pt -110.99 163.08 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-O 121.724 0.773 . . . . 1.0 110.713 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.76 116.46 24.04 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.89 -0.506 . . . . 1.0 110.944 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.5 mmtt -61.15 -32.67 72.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.91 0.386 . . . . 1.0 110.68 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -144.54 76.06 1.48 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.133 0.492 . . . . 1.0 110.252 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.1 m -60.47 116.07 16.33 Favored Pre-proline 0 CA--C 1.554 1.119 0 CA-C-O 118.873 -0.584 . . . . 1.0 111.385 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.96 138.17 52.35 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 120.926 1.084 . . . . 1.0 111.846 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.47 152.5 43.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.922 0.868 . . . . 1.0 111.592 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.4 m-20 69.08 6.28 5.56 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.097 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.0 p -100.73 145.64 28.22 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.61 0.719 . . . . 1.0 110.785 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -136.61 116.4 13.09 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.506 0.67 . . . . 1.0 110.332 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 65.7 mt -69.32 148.43 11.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.828 0.823 . . . . 1.0 110.828 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 46.9 mtt -114.23 -35.67 4.93 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.677 -0.692 . . . . 1.0 109.935 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.6 m -79.78 147.92 31.64 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.498 -0.556 . . . . 1.0 109.498 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -78.68 150.9 32.47 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.289 -0.882 . . . . 1.0 110.069 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 tp -76.39 112.7 22.84 Favored Pre-proline 0 CA--C 1.557 1.214 0 CA-C-N 115.678 -0.692 . . . . 1.0 111.983 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -90.53 151.7 4.33 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 121.456 1.437 . . . . 1.0 112.567 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.3 p -84.03 170.16 14.2 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.618 -0.676 . . . . 1.0 110.834 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.2 p -135.88 136.54 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 121.558 0.694 . . . . 1.0 110.949 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 42.4 mtm105 -98.24 130.99 44.95 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.929 -0.578 . . . . 1.0 109.464 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 t -124.24 128.59 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 121.963 0.887 . . . . 1.0 111.428 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -97.43 153.33 18.18 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.534 -0.757 . . . . 1.0 110.341 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 16.1 p -131.9 133.08 44.19 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.166 0.507 . . . . 1.0 111.315 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -80.75 47.04 0.93 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.245 0.545 . . . . 1.0 109.648 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.54 -171.71 34.65 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 110.558 -1.017 . . . . 1.0 110.558 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.569 ' O ' HD11 ' A' ' 75' ' ' ILE . 62.4 t80 -107.6 164.36 12.29 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.473 0.654 . . . . 1.0 110.636 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.53 ' N ' ' CD2' ' A' ' 40' ' ' TYR . 4.8 p30 -114.3 90.76 21.47 Favored Pre-proline 0 N--CA 1.477 0.923 0 CA-C-N 116.147 -0.478 . . . . 1.0 111.056 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -50.78 -41.5 54.49 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 121.746 1.631 . . . . 1.0 112.025 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.9 t -171.27 42.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.576 0.227 . . . . 1.0 110.732 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.407 ' O ' HG23 ' A' ' 44' ' ' ILE . 14.7 tt -58.64 126.77 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.978 0.418 . . . . 1.0 110.415 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.495 ' C ' ' H ' ' A' ' 47' ' ' ASN . 44.6 p-10 -99.96 86.13 3.2 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.947 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.9 m -72.25 33.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.99 0.424 . . . . 1.0 110.675 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.495 ' H ' ' C ' ' A' ' 45' ' ' ASN . 71.5 m-80 -100.99 -10.22 20.76 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.311 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -131.53 1.84 4.11 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.469 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.608 ' O ' ' CG ' ' A' ' 50' ' ' PHE . 51.1 mt -95.81 154.85 17.01 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.608 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 70.3 m-85 -165.72 174.21 9.96 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.795 0.807 . . . . 1.0 111.694 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.432 ' C ' ' CG ' ' A' ' 52' ' ' TYR . . . -111.64 169.94 8.47 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.052 -0.976 . . . . 1.0 108.431 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.432 ' CG ' ' C ' ' A' ' 51' ' ' ALA . 22.8 m-85 -151.23 169.58 21.58 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 122.181 0.991 . . . . 1.0 112.134 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.3 m -136.26 144.77 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 114.73 -1.123 . . . . 1.0 109.496 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -85.58 83.49 7.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.404 0.621 . . . . 1.0 110.374 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 57' ' ' GLY . 1.2 mp -94.15 -26.8 16.54 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.603 -0.726 . . . . 1.0 109.769 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 55' ' ' LEU . 47.5 t 29.61 -90.26 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.644 0.735 . . . . 1.0 112.336 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . -129.07 71.49 0.49 Allowed Glycine 0 N--CA 1.472 1.06 0 N-CA-C 111.039 -0.824 . . . . 1.0 111.039 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 27.8 t -83.26 163.41 20.74 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.728 0.775 . . . . 1.0 111.343 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.5 mp0 -130.93 148.75 71.5 Favored Pre-proline 0 N--CA 1.48 1.062 0 CA-C-N 115.593 -0.73 . . . . 1.0 111.255 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -39.79 144.06 0.37 Allowed 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 122.064 1.843 . . . . 1.0 113.387 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 142.27 -137.68 8.02 Favored Glycine 0 N--CA 1.468 0.809 0 N-CA-C 110.517 -1.033 . . . . 1.0 110.517 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -140.09 69.93 1.36 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.322 0.582 . . . . 1.0 109.553 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -93.03 130.84 38.48 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.09 -0.505 . . . . 1.0 112.124 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -82.41 142.01 32.3 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.117 -0.697 . . . . 1.0 109.117 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -133.2 136.45 45.66 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.753 0.787 . . . . 1.0 111.675 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -73.19 135.78 44.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.07 -0.968 . . . . 1.0 111.485 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.83 129.02 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.173 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -121.01 149.58 42.45 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.816 0.817 . . . . 1.0 110.513 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.1 t -124.54 137.54 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 115.978 -0.555 . . . . 1.0 111.316 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -63.05 115.24 16.08 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-O 118.483 -0.77 . . . . 1.0 110.26 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.8 136.17 42.82 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 CA-C-N 120.281 1.136 . . . . 1.0 113.032 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.5 mp -91.73 115.99 65.61 Favored Pre-proline 0 CA--C 1.553 1.07 0 CA-C-N 115.481 -0.781 . . . . 1.0 110.442 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -50.41 134.66 39.07 Favored 'Trans proline' 0 N--CA 1.506 2.226 0 C-N-CA 120.968 1.112 . . . . 1.0 113.496 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 67.59 4.87 4.05 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.417 0.687 . . . . 1.0 111.436 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.569 HD11 ' O ' ' A' ' 40' ' ' TYR . 7.4 mm -138.26 154.36 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 122.319 1.057 . . . . 1.0 109.721 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -127.34 165.47 19.67 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 122.425 1.107 . . . . 1.0 111.074 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.8 pt -118.49 121.5 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 115.471 -0.786 . . . . 1.0 109.887 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 80.2 t -56.1 -50.58 69.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 O-C-N 122.086 -0.384 . . . . 1.0 110.378 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 177.67 147.61 0.14 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 122.198 0.999 . . . . 1.0 110.418 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.413 HG12 ' H ' ' A' ' 80' ' ' ILE . 16.3 pt -84.52 172.1 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.347 -0.842 . . . . 1.0 109.789 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 t -178.26 119.13 0.25 Allowed Pre-proline 0 CA--C 1.552 1.027 0 CA-C-O 117.941 -1.028 . . . . 1.0 111.438 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -65.38 141.22 48.09 Favored 'Cis proline' 0 N--CA 1.509 2.411 0 CA-C-N 120.657 1.27 . . . . 1.0 111.444 -1.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -76.58 -18.02 58.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.769 0.795 . . . . 1.0 109.546 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.2 t -137.01 143.96 33.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.937 -0.764 . . . . 1.0 108.937 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.9 m -135.24 160.15 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.832 0.825 . . . . 1.0 111.469 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 58.1 m -116.08 130.2 56.69 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.021 -0.99 . . . . 1.0 110.365 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 83.0 mt -134.62 123.15 23.33 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.681 -0.691 . . . . 1.0 110.034 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -93.69 123.9 37.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.497 0.665 . . . . 1.0 110.145 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 64.9 mt -105.76 157.61 17.32 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.657 -0.701 . . . . 1.0 110.129 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -145.89 138.13 25.4 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.606 0.717 . . . . 1.0 111.023 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -69.49 143.46 53.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.564 -0.744 . . . . 1.0 110.324 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 86.0 t60 . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 121.53 0.681 . . . . 1.0 111.019 -179.823 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 54.8 mmm-85 . . . . . 0 N--CA 1.477 0.886 0 CA-C-O 121.661 0.743 . . . . 1.0 111.702 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 41.57 97.23 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 123.36 0.664 . . . . 1.0 112.0 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.6 140.98 54.32 Favored 'Trans proline' 0 N--CA 1.498 1.783 0 C-N-CA 122.403 2.069 . . . . 1.0 113.111 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 71.4 m -129.52 107.85 9.79 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.528 0.68 . . . . 1.0 110.228 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 60.5 mt -110.61 159.67 17.36 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.795 0.807 . . . . 1.0 110.439 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.9 m -119.58 120.67 37.4 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.538 0.685 . . . . 1.0 110.72 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.8 132.56 53.33 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.419 -0.81 . . . . 1.0 110.093 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.0 m -65.33 160.04 22.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.075 -0.511 . . . . 1.0 109.863 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.2 tp -113.44 126.91 55.86 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.5 0.667 . . . . 1.0 110.856 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.5 pt -117.53 179.75 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.707 0.765 . . . . 1.0 111.017 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.69 115.27 29.27 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.284 0.564 . . . . 1.0 111.197 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -113.44 166.23 11.7 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.321 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 48.8 26.83 1.38 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.875 0.369 . . . . 1.0 110.015 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.9 m -63.94 129.7 94.04 Favored Pre-proline 0 CA--C 1.547 0.843 0 CA-C-O 119.057 -0.497 . . . . 1.0 112.175 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.28 141.28 56.18 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 121.753 1.635 . . . . 1.0 111.427 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.41 149.08 49.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 122.125 0.964 . . . . 1.0 111.232 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 74.41 6.22 4.59 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.881 -0.6 . . . . 1.0 111.195 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.6 p -113.21 146.4 39.37 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.794 0.807 . . . . 1.0 110.745 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 24.6 ptm -142.6 139.9 31.49 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.518 0.675 . . . . 1.0 110.14 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 75.6 mt -88.33 145.81 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.697 0.761 . . . . 1.0 111.027 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 20.8 ttt -111.83 -23.5 10.54 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.781 -0.645 . . . . 1.0 109.511 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.1 p -87.7 121.95 30.76 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.501 0.667 . . . . 1.0 109.242 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -63.84 141.47 58.76 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.271 -0.893 . . . . 1.0 110.869 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.446 ' N ' HD12 ' A' ' 30' ' ' LEU . 10.7 mp -81.56 118.09 70.8 Favored Pre-proline 0 CA--C 1.554 1.123 0 N-CA-C 112.238 0.459 . . . . 1.0 112.238 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -86.2 162.79 9.98 Favored 'Trans proline' 0 N--CA 1.501 1.957 0 C-N-CA 122.383 2.056 . . . . 1.0 112.793 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 56.5 m -70.44 168.52 15.97 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.563 -0.711 . . . . 1.0 111.259 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.9 p -136.82 139.11 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-O 121.427 0.632 . . . . 1.0 111.116 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 80' ' ' ILE . 1.6 mpt_? -102.38 124.41 47.89 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.134 -0.691 . . . . 1.0 109.134 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.5 t -120.33 125.69 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 122.0 0.905 . . . . 1.0 111.132 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -98.59 147.04 25.21 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.288 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 70.4 p -129.39 131.28 46.78 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.492 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -53.78 -72.52 0.06 Allowed 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.723 0.773 . . . . 1.0 110.139 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.21 -171.93 0.09 OUTLIER Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.009 -0.837 . . . . 1.0 111.009 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -106.24 175.89 5.35 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.658 0.742 . . . . 1.0 110.944 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -136.42 74.28 54.4 Favored Pre-proline 0 N--CA 1.472 0.644 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.644 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -52.09 -37.72 69.17 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 C-N-CA 122.29 1.993 . . . . 1.0 111.892 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 44' ' ' ILE . 70.8 m -146.55 -97.69 0.09 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.383 -0.372 . . . . 1.0 110.832 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 43' ' ' SER . 68.7 mt 59.12 128.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.897 0.38 . . . . 1.0 110.086 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.524 ' ND2' ' N ' ' A' ' 45' ' ' ASN . 0.1 OUTLIER -56.34 90.64 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.194 0.521 . . . . 1.0 110.772 -179.847 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.1 t -57.11 -17.05 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.017 0.437 . . . . 1.0 110.867 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -83.17 12.22 5.46 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.395 0.617 . . . . 1.0 110.182 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -132.93 54.86 1.93 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.205 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 85.4 mt -144.03 110.33 5.47 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.974 -0.557 . . . . 1.0 109.721 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -147.79 157.4 43.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 122.022 0.915 . . . . 1.0 111.791 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -119.25 139.39 51.96 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.871 -1.059 . . . . 1.0 108.433 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -117.56 168.39 10.45 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 122.536 1.16 . . . . 1.0 112.1 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.3 m -123.93 139.32 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 114.458 -1.246 . . . . 1.0 109.367 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.447 ' C ' ' H ' ' A' ' 56' ' ' SER . 40.0 p-10 -99.79 78.49 2.14 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.565 0.697 . . . . 1.0 110.484 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 56' ' ' SER . 23.9 mt -71.86 45.94 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.539 -0.755 . . . . 1.0 109.844 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.473 ' O ' ' C ' ' A' ' 57' ' ' GLY . 14.6 m -57.55 -142.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.329 0.585 . . . . 1.0 111.16 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.497 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . 30.75 -112.94 0.05 OUTLIER Glycine 0 N--CA 1.472 1.067 0 N-CA-C 111.121 -0.792 . . . . 1.0 111.121 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 1.9 p 154.55 -5.21 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 115.632 -0.284 . . . . 1.0 111.354 178.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.633 ' CD ' ' H ' ' A' ' 59' ' ' GLU . 8.6 mp0 -37.91 95.86 0.1 Allowed Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 111.762 0.282 . . . . 1.0 111.762 -178.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -62.64 138.47 70.02 Favored 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 122.483 2.122 . . . . 1.0 112.489 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 141.47 -117.54 1.22 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.608 -0.997 . . . . 1.0 110.608 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -137.53 73.77 1.46 Allowed 'General case' 0 N--CA 1.477 0.878 0 O-C-N 122.239 -0.565 . . . . 1.0 109.952 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -88.32 136.03 33.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.827 0.822 . . . . 1.0 112.247 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.406 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 32.7 p-10 -82.99 110.26 17.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.24 -0.891 . . . . 1.0 109.029 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -97.12 159.49 14.88 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.839 0.828 . . . . 1.0 111.626 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -104.58 141.39 36.49 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.934 -1.03 . . . . 1.0 111.296 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.7 t -80.01 124.47 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.43 0.634 . . . . 1.0 110.232 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -100.42 88.86 3.77 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.646 0.736 . . . . 1.0 110.297 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.5 t -86.71 134.75 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.044 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -74.35 146.54 84.23 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.51 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.58 154.72 64.31 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 122.371 2.047 . . . . 1.0 112.198 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.3 mt -112.43 123.25 34.52 Favored Pre-proline 0 N--CA 1.48 1.032 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.721 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.95 135.71 23.75 Favored 'Trans proline' 0 N--CA 1.504 2.098 0 C-N-CA 121.853 1.702 . . . . 1.0 112.392 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 79.48 -15.12 0.79 Allowed 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.39 0.676 . . . . 1.0 111.258 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.7 mm -120.8 146.17 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-O 122.077 0.941 . . . . 1.0 110.005 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -110.19 112.48 24.47 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 122.061 0.934 . . . . 1.0 111.167 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.8 tt -59.72 146.32 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-O 121.391 0.615 . . . . 1.0 110.094 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 68.6 t -103.66 -42.39 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 122.004 -0.435 . . . . 1.0 110.741 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -172.98 175.36 3.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.923 0.868 . . . . 1.0 110.776 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.422 ' O ' ' O ' ' A' ' 34' ' ' ARG . 61.9 mt -110.23 -77.61 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 115.648 -0.706 . . . . 1.0 109.767 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 80' ' ' ILE . 88.3 p 54.97 108.35 0.02 OUTLIER Pre-proline 0 CA--C 1.549 0.939 0 CA-C-O 118.228 -0.891 . . . . 1.0 112.213 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -68.93 122.02 5.38 Favored 'Cis proline' 0 N--CA 1.503 2.044 0 CA-C-N 120.373 1.169 . . . . 1.0 111.794 0.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 91.8 mtm180 -68.71 -34.21 75.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.929 0.871 . . . . 1.0 109.428 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.5 t -130.32 142.51 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.469 0.707 . . . . 1.0 109.117 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.4 m -135.51 153.61 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-O 121.766 0.793 . . . . 1.0 111.746 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 38.4 m -107.29 120.77 43.06 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.17 -0.923 . . . . 1.0 110.602 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 60.0 mt -126.75 134.64 50.58 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.349 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -93.25 131.15 38.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.352 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.1 mt -112.98 140.27 47.94 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.362 0.601 . . . . 1.0 110.085 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -139.1 152.21 47.31 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.894 0.854 . . . . 1.0 111.067 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -69.12 139.74 54.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.153 -0.93 . . . . 1.0 110.826 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 121.666 0.746 . . . . 1.0 111.078 -179.751 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 . . . . . 0 CA--C 1.531 0.227 0 CA-C-O 121.187 0.518 . . . . 1.0 111.765 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 53.03 83.16 0.23 Allowed Pre-proline 0 CA--C 1.54 0.586 0 O-C-N 121.814 -0.554 . . . . 1.0 112.288 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.69 147.72 78.31 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 122.678 2.252 . . . . 1.0 112.834 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 81.9 m -119.27 107.15 13.06 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.578 0.704 . . . . 1.0 110.133 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.4 mt -117.91 152.79 34.73 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.18 0.991 . . . . 1.0 110.427 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.2 m -117.17 123.92 47.87 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.604 -0.725 . . . . 1.0 110.607 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.501 HD13 ' H ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -112.51 145.64 39.89 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.606 -0.724 . . . . 1.0 110.468 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.501 ' H ' HD13 ' A' ' 13' ' ' LEU . 95.9 p -86.38 155.59 20.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.263 0.554 . . . . 1.0 109.908 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.7 tp -95.03 129.61 42.04 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.197 0.523 . . . . 1.0 110.755 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.0 pt -127.03 148.76 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-O 121.451 0.643 . . . . 1.0 110.958 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.9 104.64 16.86 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 121.841 -0.537 . . . . 1.0 110.971 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -82.68 59.68 4.86 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.33 0.586 . . . . 1.0 110.928 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.694 ' ND2' ' H ' ' A' ' 55' ' ' LEU . 1.8 p30 171.71 -79.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.356 0.598 . . . . 1.0 110.062 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.9 m 48.66 70.38 2.12 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 115.918 -0.583 . . . . 1.0 111.625 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 22' ' ' ALA . 40.0 Cg_endo -66.64 143.47 68.38 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 121.849 1.699 . . . . 1.0 111.557 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.469 ' C ' ' H ' ' A' ' 24' ' ' SER . . . -48.36 -175.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.54 0.686 . . . . 1.0 111.727 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.6 m120 73.55 -25.68 0.19 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.089 0.471 . . . . 1.0 111.048 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 22' ' ' ALA . 2.9 t -134.27 149.77 50.95 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 122.013 0.911 . . . . 1.0 110.614 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 17.0 ptm -143.62 142.79 31.2 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.613 -0.721 . . . . 1.0 110.414 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 80.5 mt -86.23 119.04 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 121.546 0.688 . . . . 1.0 110.833 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 12.3 ptm -98.69 -6.6 29.33 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.453 0.644 . . . . 1.0 109.571 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 91.5 m -84.47 136.25 33.91 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -67.95 123.31 20.24 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.316 -0.865 . . . . 1.0 110.334 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.454 HD22 ' N ' ' A' ' 30' ' ' LEU . 4.4 mm? -53.08 103.11 0.35 Allowed Pre-proline 0 CA--C 1.547 0.841 0 CA-C-O 118.68 -0.676 . . . . 1.0 112.096 -178.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -65.32 155.73 67.02 Favored 'Trans proline' 0 N--CA 1.506 2.256 0 C-N-CA 122.517 2.145 . . . . 1.0 113.144 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.6 p -93.17 165.58 12.75 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.646 -0.659 . . . . 1.0 110.994 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.6 m -137.8 135.43 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-O 121.141 0.496 . . . . 1.0 110.985 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.404 HH22 ' CE ' ' A' ' 36' ' ' LYS . 8.4 ptm180 -97.96 128.37 44.49 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.538 -0.542 . . . . 1.0 109.538 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 t -122.84 134.69 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 122.172 0.987 . . . . 1.0 111.473 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.404 ' CE ' HH22 ' A' ' 34' ' ' ARG . 68.7 mttm -109.4 155.85 20.76 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.357 -0.838 . . . . 1.0 110.412 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 76.0 p -138.02 124.9 21.2 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.247 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 39' ' ' GLY . 10.6 tm-20 -46.54 -67.17 0.31 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.859 0.838 . . . . 1.0 110.524 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 38' ' ' GLU . . . -58.74 -147.99 0.01 OUTLIER Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.017 -0.833 . . . . 1.0 111.017 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -141.97 122.9 14.48 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.651 0.739 . . . . 1.0 110.762 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.618 ' CB ' HD12 ' A' ' 44' ' ' ILE . 6.7 p-10 -127.37 45.88 1.8 Allowed Pre-proline 0 N--CA 1.476 0.861 0 CA-C-N 116.024 -0.535 . . . . 1.0 111.164 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 41' ' ' ASN . 56.8 Cg_endo -67.72 -8.59 22.85 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.528 2.152 . . . . 1.0 111.667 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.6 t -143.58 77.02 1.54 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.169 0.509 . . . . 1.0 111.045 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.618 HD12 ' CB ' ' A' ' 41' ' ' ASN . 24.5 mt -144.06 156.17 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 121.932 0.873 . . . . 1.0 109.535 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.526 ' C ' ' H ' ' A' ' 47' ' ' ASN . 18.0 t-20 -68.16 55.51 0.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.447 -0.797 . . . . 1.0 110.67 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.4 m -70.56 24.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 121.023 0.44 . . . . 1.0 110.96 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.526 ' H ' ' C ' ' A' ' 45' ' ' ASN . 53.3 t30 -87.79 6.58 34.52 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.149 0.5 . . . . 1.0 110.413 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -126.29 8.34 7.19 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.208 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.488 HD21 HG12 ' A' ' 72' ' ' ILE . 16.2 mt -95.61 121.71 37.59 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.236 0.541 . . . . 1.0 109.707 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -148.51 163.54 36.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 122.466 1.127 . . . . 1.0 111.619 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -109.91 133.01 53.63 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.398 -1.274 . . . . 1.0 108.351 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.525 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 7.7 p90 -145.32 152.72 40.35 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 122.76 1.267 . . . . 1.0 112.164 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.8 m -111.75 138.61 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 114.214 -1.357 . . . . 1.0 109.068 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -88.35 87.05 7.17 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.625 -0.716 . . . . 1.0 110.519 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.694 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 4.1 mp -69.66 -10.59 58.88 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.079 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 55' ' ' LEU . 56.9 m 29.13 -108.93 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.655 0.613 . . . . 1.0 112.655 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.504 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -68.97 -76.33 0.47 Allowed Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.04 -0.824 . . . . 1.0 111.04 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 3.0 p 149.31 134.27 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.37 0.605 . . . . 1.0 111.663 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -132.98 77.03 69.18 Favored Pre-proline 0 N--CA 1.483 1.176 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.883 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.68 153.9 64.09 Favored 'Trans proline' 0 N--CA 1.507 2.308 0 C-N-CA 123.153 2.568 . . . . 1.0 112.953 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.558 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . 98.6 50.82 1.48 Allowed Glycine 0 N--CA 1.472 1.057 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.558 ' O ' ' O ' ' A' ' 61' ' ' GLY . 97.3 mt-10 54.79 137.3 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 O-C-N 122.245 -0.562 . . . . 1.0 110.217 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.672 ' CG ' ' H ' ' A' ' 64' ' ' ASP . 36.1 t60 -149.92 -166.0 2.43 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 122.595 1.188 . . . . 1.0 112.377 -178.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.672 ' H ' ' CG ' ' A' ' 63' ' ' HIS . 79.4 m-20 -143.35 97.89 3.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.58 -1.191 . . . . 1.0 109.155 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -99.76 135.83 40.58 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.791 0.805 . . . . 1.0 111.405 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.476 ' CD ' ' N ' ' A' ' 67' ' ' VAL . 10.2 tm-20 -72.08 152.87 42.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.992 -1.003 . . . . 1.0 111.326 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.476 ' N ' ' CD ' ' A' ' 66' ' ' GLU . 41.1 t -91.02 116.06 31.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.668 0.747 . . . . 1.0 110.119 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.432 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 28.1 ttmt -109.61 106.39 16.06 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 122.163 0.983 . . . . 1.0 110.443 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.1 t -99.05 139.61 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 115.689 -0.687 . . . . 1.0 111.242 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -68.37 117.65 51.83 Favored Pre-proline 0 CA--C 1.55 0.972 0 CA-C-O 118.719 -0.657 . . . . 1.0 110.56 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.58 141.29 19.66 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 C-N-CA 121.718 1.612 . . . . 1.0 112.701 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.488 HG12 HD21 ' A' ' 49' ' ' LEU . 44.7 mm -113.14 119.27 42.75 Favored Pre-proline 0 N--CA 1.484 1.229 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.07 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.23 89.09 0.93 Allowed 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 122.019 1.813 . . . . 1.0 112.585 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 166.25 -19.99 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 122.685 0.394 . . . . 1.0 110.573 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.8 mm -134.8 156.14 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 121.851 0.834 . . . . 1.0 110.244 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -101.03 144.51 29.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 122.755 1.264 . . . . 1.0 111.2 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.564 HG23 ' O ' ' A' ' 77' ' ' ILE . 18.4 tt -108.59 114.86 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 115.208 -0.905 . . . . 1.0 110.148 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.9 t -66.05 -41.05 88.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 O-C-N 122.133 -0.355 . . . . 1.0 110.408 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.409 ' CD ' ' NH2' ' A' ' 83' ' ' ARG . 1.9 mt-10 -179.54 -175.53 0.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 122.177 0.989 . . . . 1.0 110.595 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.0 mt -107.56 -75.35 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 115.346 -0.843 . . . . 1.0 109.839 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.0 m 53.57 101.43 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.714 0 CA-C-O 118.219 -0.896 . . . . 1.0 111.848 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.52 172.35 35.49 Favored 'Cis proline' 0 N--CA 1.505 2.18 0 CA-C-N 120.287 1.138 . . . . 1.0 111.805 0.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.409 ' NH2' ' CD ' ' A' ' 79' ' ' GLU . 97.3 mtt180 -119.85 -12.97 9.12 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.679 0.752 . . . . 1.0 109.097 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.6 t -145.82 141.96 21.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.065 -0.717 . . . . 1.0 109.065 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.7 m -135.37 139.93 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-O 121.542 0.686 . . . . 1.0 111.662 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.525 ' O ' HG23 ' A' ' 86' ' ' THR . 12.9 t -103.04 119.86 39.62 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.387 -0.824 . . . . 1.0 110.753 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 62.1 mt -108.7 -178.22 3.53 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.658 0.742 . . . . 1.0 110.157 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -139.56 110.76 6.95 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.469 -0.787 . . . . 1.0 110.512 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.5 mt -105.01 139.43 39.71 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.493 -0.776 . . . . 1.0 110.086 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -145.43 144.21 30.5 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.741 0.781 . . . . 1.0 111.168 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.445 ' H ' ' CD2' ' A' ' 91' ' ' HIS . 13.8 p80 -67.06 137.82 56.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.434 -0.803 . . . . 1.0 110.737 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.445 ' CG ' ' O ' ' A' ' 92' ' ' HIS . 7.9 p80 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 121.252 0.549 . . . . 1.0 111.358 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 74.4 mtp85 . . . . . 0 N--CA 1.469 0.524 0 CA-C-O 121.325 0.583 . . . . 1.0 112.194 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -165.3 107.59 0.78 Allowed Pre-proline 0 CA--C 1.545 0.757 0 O-C-N 121.927 -0.483 . . . . 1.0 111.273 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -77.04 161.72 32.48 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.484 1.456 . . . . 1.0 112.738 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.4 m -110.06 99.67 8.73 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.662 0.744 . . . . 1.0 110.122 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 57.8 mt -107.3 146.53 31.41 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.445 0.641 . . . . 1.0 110.287 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.9 t -124.03 127.72 48.3 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.274 0.559 . . . . 1.0 110.756 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 44.7 mt -110.46 137.42 48.18 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.602 -0.726 . . . . 1.0 110.221 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.1 t -63.36 171.17 2.58 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.865 -0.42 . . . . 1.0 109.865 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.9 tp -125.67 116.04 21.05 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.796 0.808 . . . . 1.0 110.805 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 38.2 pt -117.61 149.66 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-O 121.749 0.785 . . . . 1.0 110.67 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.56 124.73 39.72 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.87 -0.519 . . . . 1.0 110.689 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -120.64 -178.49 3.73 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.364 0.602 . . . . 1.0 110.0 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 45.03 37.02 2.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.373 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.05 109.39 6.16 Favored Pre-proline 0 CA--C 1.561 1.402 0 CA-C-O 118.479 -0.772 . . . . 1.0 111.005 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -59.05 -146.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.508 2.332 0 C-N-CA 121.141 1.228 . . . . 1.0 111.922 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.547 ' O ' ' C ' ' A' ' 23' ' ' ASN . . . -49.17 143.95 5.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 122.07 0.938 . . . . 1.0 111.544 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.547 ' C ' ' O ' ' A' ' 22' ' ' ALA . 12.2 m120 -13.91 84.84 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.483 0.659 . . . . 1.0 112.067 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 22' ' ' ALA . 40.5 t -96.06 149.12 21.95 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.644 0.735 . . . . 1.0 110.886 -178.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 26.2 ttt -144.44 103.64 3.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.558 0.694 . . . . 1.0 110.089 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.907 ' H ' HD12 ' A' ' 26' ' ' ILE . 2.7 mp -70.57 119.63 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.953 -0.567 . . . . 1.0 111.051 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -60.9 -45.26 95.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.261 0.553 . . . . 1.0 109.555 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.8 p -79.14 171.16 15.58 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -102.59 166.9 10.26 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.331 -0.856 . . . . 1.0 110.273 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 22.3 mt -102.56 94.21 4.84 Favored Pre-proline 0 CA--C 1.553 1.083 0 CA-C-N 115.553 -0.749 . . . . 1.0 112.104 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -80.79 157.6 21.23 Favored 'Trans proline' 0 N--CA 1.504 2.106 0 C-N-CA 121.819 1.679 . . . . 1.0 112.964 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 96.0 p -67.73 161.81 25.2 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 121.728 -0.608 . . . . 1.0 110.953 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.3 m -120.19 138.45 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.174 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 67.5 mtp85 -89.47 118.81 29.39 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.829 -0.434 . . . . 1.0 109.829 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.91 132.26 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 121.816 0.817 . . . . 1.0 111.534 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -102.52 150.99 22.84 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.66 -0.7 . . . . 1.0 110.211 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 72.6 p -134.96 136.86 42.56 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.057 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -53.34 -69.65 0.11 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.805 0.812 . . . . 1.0 110.428 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.46 ' H ' HG23 ' A' ' 75' ' ' ILE . . . -49.04 172.45 0.06 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.252 -0.739 . . . . 1.0 111.252 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.442 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 68.2 t80 -96.92 -8.08 31.64 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.838 0.352 . . . . 1.0 111.308 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.7 m120 59.69 77.9 0.36 Allowed Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.749 -0.205 . . . . 1.0 111.294 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -45.69 -45.19 16.87 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 121.603 1.535 . . . . 1.0 112.371 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.4 p -169.86 21.77 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.785 0.326 . . . . 1.0 111.119 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.513 HD12 ' N ' ' A' ' 44' ' ' ILE . 1.6 mp -53.39 133.59 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 121.657 0.742 . . . . 1.0 110.032 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -55.56 91.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.677 -0.692 . . . . 1.0 110.802 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 55.9 t -55.37 -16.68 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.44 -0.346 . . . . 1.0 110.621 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.5 ' O ' ' N ' ' A' ' 49' ' ' LEU . 10.2 p30 -80.58 -48.28 12.94 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.837 0.351 . . . . 1.0 110.308 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.462 ' N ' ' OD1' ' A' ' 47' ' ' ASN . 80.0 tt0 -43.99 -14.81 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 116.002 -0.545 . . . . 1.0 111.448 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.5 ' N ' ' O ' ' A' ' 47' ' ' ASN . 40.3 mt -95.02 139.53 31.26 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.455 ' CE2' ' O ' ' A' ' 47' ' ' ASN . 92.5 m-85 -150.86 159.43 44.56 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.768 0.794 . . . . 1.0 111.486 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -120.23 134.65 55.21 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.027 -0.988 . . . . 1.0 108.704 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 22.2 p90 -150.32 149.09 29.64 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.323 1.059 . . . . 1.0 112.104 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.0 m -105.62 147.44 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 114.648 -1.16 . . . . 1.0 109.083 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.462 ' C ' ' H ' ' A' ' 56' ' ' SER . 50.1 p-10 -101.23 81.03 2.17 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.305 0.574 . . . . 1.0 110.757 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.0 mt -56.29 -6.07 0.24 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.247 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.462 ' H ' ' C ' ' A' ' 54' ' ' ASP . 42.9 t 34.82 -95.49 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.25 0.62 . . . . 1.0 112.612 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.948 ' O ' ' O ' ' A' ' 58' ' ' SER . . . -114.55 62.39 0.33 Allowed Glycine 0 N--CA 1.472 1.094 0 N-CA-C 110.77 -0.932 . . . . 1.0 110.77 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.948 ' O ' ' O ' ' A' ' 57' ' ' GLY . 8.6 m 8.51 144.07 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.125 0 N-CA-C 113.707 1.003 . . . . 1.0 113.707 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.528 ' H ' HD12 ' A' ' 89' ' ' LEU . 73.5 mm-40 -133.64 82.02 52.13 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 110.07 -0.345 . . . . 1.0 110.07 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -49.36 139.97 27.71 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.133 1.889 . . . . 1.0 112.305 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.04 -97.37 0.81 Allowed Glycine 0 N--CA 1.47 0.959 0 N-CA-C 110.602 -0.999 . . . . 1.0 110.602 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -165.18 139.88 5.05 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 122.242 -0.563 . . . . 1.0 109.62 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.665 ' CG ' ' H ' ' A' ' 64' ' ' ASP . 32.5 t60 -154.94 -164.24 1.75 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 122.365 1.079 . . . . 1.0 112.167 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.665 ' H ' ' CG ' ' A' ' 63' ' ' HIS . 12.7 p-10 -122.79 145.04 48.78 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 114.607 -1.178 . . . . 1.0 109.134 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -142.56 138.12 30.6 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.309 0.576 . . . . 1.0 111.627 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -94.31 142.56 27.27 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.528 -0.76 . . . . 1.0 111.045 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.9 t -95.95 135.38 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.333 0.587 . . . . 1.0 110.175 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.72 151.24 52.03 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.881 0.848 . . . . 1.0 110.472 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.7 t -131.19 144.66 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 121.571 0.7 . . . . 1.0 111.131 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -68.08 128.49 93.27 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-N 115.422 -0.808 . . . . 1.0 110.445 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -39.51 153.9 0.05 OUTLIER 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.069 1.846 . . . . 1.0 113.433 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.565 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -101.07 154.85 36.92 Favored Pre-proline 0 N--CA 1.483 1.202 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.582 -179.29 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 72' ' ' ILE . 61.1 Cg_exo -37.46 -106.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.509 2.415 0 C-N-CA 122.775 2.317 . . . . 1.0 113.698 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -105.99 18.25 22.37 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.036 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.586 HG22 ' N ' ' A' ' 76' ' ' LYS . 81.5 mt -103.53 166.1 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 121.351 0.596 . . . . 1.0 110.136 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.586 ' N ' HG22 ' A' ' 75' ' ' ILE . 66.1 tttm -118.98 119.98 35.92 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.894 0.854 . . . . 1.0 111.533 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.439 ' HB ' HD11 ' A' ' 72' ' ' ILE . 19.3 tt -59.81 143.01 14.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.128 0.49 . . . . 1.0 110.323 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 85.1 t -96.14 -49.4 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 122.104 -0.373 . . . . 1.0 110.689 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -173.17 133.62 0.52 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.415 0.626 . . . . 1.0 111.031 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.8 tp -100.85 134.15 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-O 121.492 0.663 . . . . 1.0 109.381 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 61.8 p -145.45 143.06 19.03 Favored Pre-proline 0 N--CA 1.478 0.948 0 CA-C-O 118.939 -0.553 . . . . 1.0 111.795 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.6 138.66 56.2 Favored 'Cis proline' 0 N--CA 1.505 2.196 0 CA-C-N 119.602 0.894 . . . . 1.0 111.896 -1.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -67.87 -35.27 78.24 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.98 0.895 . . . . 1.0 109.947 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 t -134.89 145.6 32.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.178 -0.675 . . . . 1.0 109.178 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.65 161.44 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-O 122.431 1.11 . . . . 1.0 110.833 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 75.8 m -105.98 124.21 49.21 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.434 -1.257 . . . . 1.0 110.525 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 87.5 mt -130.62 116.98 18.84 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.192 0.52 . . . . 1.0 110.093 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -96.82 110.62 23.06 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.389 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.528 HD12 ' H ' ' A' ' 59' ' ' GLU . 51.5 mt -78.83 150.59 32.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.056 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -129.4 141.28 51.09 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 122.092 0.949 . . . . 1.0 111.045 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -65.63 126.59 28.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.009 -0.996 . . . . 1.0 110.584 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.447 ' CG ' ' O ' ' A' ' 92' ' ' HIS . 78.4 t60 . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.039 0.447 . . . . 1.0 111.095 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 . . . . . 0 N--CA 1.464 0.245 0 CA-C-O 121.432 0.634 . . . . 1.0 111.455 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 41.64 75.99 0.56 Allowed Pre-proline 0 C--N 1.327 -0.372 0 C-N-CA 122.975 0.51 . . . . 1.0 112.293 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.68 153.37 54.13 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.426 2.084 . . . . 1.0 113.019 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 75.3 m -106.15 99.24 8.84 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.408 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -94.02 146.73 23.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 122.13 0.967 . . . . 1.0 110.497 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.2 m -119.52 109.6 15.91 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.625 -0.716 . . . . 1.0 110.475 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.5 mt -110.36 134.14 52.58 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.318 -0.855 . . . . 1.0 109.696 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.0 m -79.74 164.95 23.29 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.91 -0.404 . . . . 1.0 109.91 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.2 tp -113.08 118.21 34.14 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.73 0.776 . . . . 1.0 110.648 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.8 pp -128.19 162.17 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 CA-C-O 121.751 0.786 . . . . 1.0 110.925 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.403 ' CB ' ' OG1' ' A' ' 20' ' ' THR . . . -79.69 157.99 27.08 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 121.769 -0.582 . . . . 1.0 111.001 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -66.94 -36.68 82.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.221 0.534 . . . . 1.0 111.282 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -166.45 -34.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.098 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.403 ' OG1' ' CB ' ' A' ' 17' ' ' ALA . 22.3 m 59.34 76.56 0.44 Allowed Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 116.343 -0.39 . . . . 1.0 111.463 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 22' ' ' ALA . 31.7 Cg_exo -57.88 148.96 72.82 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.249 1.966 . . . . 1.0 111.586 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.449 ' C ' ' H ' ' A' ' 24' ' ' SER . . . -51.37 -169.96 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.891 0.853 . . . . 1.0 111.74 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.609 HD21 ' CD2' ' A' ' 91' ' ' HIS . 0.4 OUTLIER 71.23 -38.68 0.43 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.141 -0.481 . . . . 1.0 111.001 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.449 ' H ' ' C ' ' A' ' 22' ' ' ALA . 13.3 p -109.02 149.58 29.05 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.699 0.761 . . . . 1.0 110.587 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 11.7 tmm? -141.88 120.26 12.35 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.553 0.692 . . . . 1.0 110.33 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 74.0 mt -72.74 116.13 14.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.592 0.71 . . . . 1.0 110.881 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 78.0 mtp -94.83 -16.41 22.96 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.925 -0.579 . . . . 1.0 109.669 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.9 m -78.71 134.5 37.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.262 0.553 . . . . 1.0 109.69 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.407 ' H ' ' HD2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -78.57 123.99 27.68 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 121.288 -0.883 . . . . 1.0 110.316 -179.548 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.7 mt -70.43 114.71 28.18 Favored Pre-proline 0 CA--C 1.555 1.139 0 CA-C-N 115.748 -0.66 . . . . 1.0 112.05 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -84.68 152.59 11.62 Favored 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 121.77 1.647 . . . . 1.0 113.07 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.7 m -72.98 173.28 9.52 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.614 -0.679 . . . . 1.0 111.213 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.517 HG21 HD11 ' A' ' 80' ' ' ILE . 2.8 p -142.84 136.96 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-O 121.376 0.608 . . . . 1.0 111.046 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -97.54 129.33 44.7 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.4 0.619 . . . . 1.0 109.346 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -124.71 134.18 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-O 122.101 0.953 . . . . 1.0 111.576 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -107.81 149.02 28.73 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.465 -0.789 . . . . 1.0 110.289 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 72.1 p -127.78 132.04 49.55 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 116.045 -0.525 . . . . 1.0 111.294 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -58.04 -75.29 0.05 OUTLIER 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.827 0.823 . . . . 1.0 110.09 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.61 166.64 15.94 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.959 -0.856 . . . . 1.0 110.959 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -79.77 175.08 10.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.841 0.829 . . . . 1.0 110.683 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.511 HD22 ' N ' ' A' ' 41' ' ' ASN . 1.5 m-80 -124.0 92.77 47.98 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 115.71 -0.677 . . . . 1.0 110.65 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -52.36 -40.9 69.66 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 121.893 1.729 . . . . 1.0 112.13 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 44' ' ' ILE . 73.8 m -165.51 -96.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.63 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 43' ' ' SER . 65.7 mt 57.76 141.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.128 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -85.44 96.95 9.75 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.165 0.507 . . . . 1.0 110.806 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.4 m -86.13 5.92 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 120.942 0.401 . . . . 1.0 110.782 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -97.13 -1.13 45.78 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.107 0.48 . . . . 1.0 110.262 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.482 ' OE1' ' N ' ' A' ' 48' ' ' GLU . 18.8 mp0 -120.25 6.27 10.72 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.662 -0.699 . . . . 1.0 110.145 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.0 mt -122.26 128.44 51.12 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.635 0.731 . . . . 1.0 109.557 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -133.67 -168.45 2.11 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.248 1.023 . . . . 1.0 111.544 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -115.41 139.74 49.75 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.626 -1.17 . . . . 1.0 108.989 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.475 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 16.8 p90 -141.37 153.42 45.08 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 122.34 1.067 . . . . 1.0 112.36 -178.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.3 m -110.56 140.09 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 114.647 -1.16 . . . . 1.0 109.27 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -77.44 88.57 3.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.502 0.668 . . . . 1.0 110.328 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 57' ' ' GLY . 0.8 OUTLIER -90.39 -26.52 19.86 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.623 -0.717 . . . . 1.0 109.848 -179.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 55' ' ' LEU . 35.4 t 28.18 -89.86 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.004 0.521 . . . . 1.0 112.353 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . -62.55 -75.01 0.35 Allowed Glycine 0 CA--C 1.531 1.093 0 N-CA-C 111.029 -0.828 . . . . 1.0 111.029 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.0 t 75.56 95.82 0.07 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 122.879 0.471 . . . . 1.0 111.469 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -123.61 147.95 54.57 Favored Pre-proline 0 N--CA 1.482 1.16 0 CA-C-O 119.514 -0.279 . . . . 1.0 111.67 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -47.82 139.0 19.92 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 121.724 1.616 . . . . 1.0 113.304 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 139.66 -135.59 7.3 Favored Glycine 0 N--CA 1.472 1.086 0 N-CA-C 110.532 -1.027 . . . . 1.0 110.532 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -170.65 144.02 2.27 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -154.62 -164.66 1.87 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.708 1.242 . . . . 1.0 112.451 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 32.8 p-10 -111.74 91.84 3.81 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 114.33 -1.305 . . . . 1.0 108.942 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -82.56 132.16 35.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.679 0.752 . . . . 1.0 111.36 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.51 153.63 37.38 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.057 -0.974 . . . . 1.0 111.171 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 65.4 t -94.09 110.29 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 121.59 0.71 . . . . 1.0 110.152 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' A' ' 52' ' ' TYR . 1.6 tmtp? -112.01 118.6 35.87 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 122.039 0.923 . . . . 1.0 110.137 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.3 m -126.43 149.89 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 115.783 -0.644 . . . . 1.0 111.203 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -74.84 125.77 89.09 Favored Pre-proline 0 CA--C 1.549 0.92 0 CA-C-O 118.387 -0.816 . . . . 1.0 110.311 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.01 137.76 19.91 Favored 'Trans proline' 0 N--CA 1.5 1.892 0 C-N-CA 121.619 1.546 . . . . 1.0 112.357 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.5 mm -79.8 128.74 73.29 Favored Pre-proline 0 CA--C 1.554 1.131 0 CA-C-N 116.456 -0.338 . . . . 1.0 111.314 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.3 152.82 66.74 Favored 'Trans proline' 0 N--CA 1.502 2.024 0 C-N-CA 121.506 1.471 . . . . 1.0 112.818 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.9 t30 65.63 -1.27 1.06 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.295 0.638 . . . . 1.0 111.29 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.415 HG22 ' N ' ' A' ' 76' ' ' LYS . 66.5 mt -133.58 155.48 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 121.64 0.733 . . . . 1.0 110.191 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.415 ' N ' HG22 ' A' ' 75' ' ' ILE . 68.7 mttm -107.93 149.82 27.86 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 122.267 1.032 . . . . 1.0 111.236 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.625 HG23 ' O ' ' A' ' 77' ' ' ILE . 18.1 tt -100.41 101.54 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 115.732 -0.667 . . . . 1.0 109.995 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.2 t -46.02 -58.18 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 O-C-N 122.121 -0.362 . . . . 1.0 110.636 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -175.62 141.68 0.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.685 0.755 . . . . 1.0 110.686 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.517 HD11 HG21 ' A' ' 33' ' ' VAL . 8.6 tp -104.18 138.85 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.399 0.619 . . . . 1.0 109.579 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.2 m -147.32 134.93 10.48 Favored Pre-proline 0 N--CA 1.481 1.079 0 CA-C-O 118.481 -0.771 . . . . 1.0 112.293 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.84 -174.49 10.77 Favored 'Cis proline' 0 N--CA 1.503 2.037 0 CA-C-N 120.133 1.083 . . . . 1.0 111.701 -0.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -121.2 -18.31 7.45 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.927 0.87 . . . . 1.0 109.312 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.6 t -138.61 136.94 43.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.029 -0.73 . . . . 1.0 109.029 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.2 m -137.19 174.74 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 CA-C-O 121.771 0.796 . . . . 1.0 111.476 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.0 t -133.07 128.31 35.95 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.137 -0.938 . . . . 1.0 110.465 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 50.2 mt -130.74 120.95 24.58 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 120.954 0.407 . . . . 1.0 110.207 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -86.16 112.12 21.02 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.582 0.706 . . . . 1.0 110.281 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.6 mt -80.68 165.87 21.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.673 -0.694 . . . . 1.0 110.085 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -140.27 130.32 24.86 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.9 0.857 . . . . 1.0 110.971 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.609 ' CD2' HD21 ' A' ' 23' ' ' ASN . 60.5 t-80 -76.19 129.57 36.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.194 -0.912 . . . . 1.0 110.522 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 . . . . . 0 CA--C 1.534 0.328 0 CA-C-O 121.202 0.525 . . . . 1.0 111.145 -179.658 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.534 ' NH2' ' CZ ' ' A' ' 40' ' ' TYR . 88.6 mtm180 . . . . . 0 N--CA 1.468 0.432 0 CA-C-O 122.263 1.03 . . . . 1.0 111.381 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -152.28 86.27 4.44 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 115.9 -0.591 . . . . 1.0 111.509 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.95 119.83 6.93 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 122.166 1.911 . . . . 1.0 113.227 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 42.0 m -117.25 87.15 2.65 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 121.312 0.577 . . . . 1.0 110.739 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.771 HD22 ' N ' ' A' ' 11' ' ' LEU . 0.9 OUTLIER -98.6 147.15 25.1 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 122.122 0.963 . . . . 1.0 110.615 -179.462 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.5 m -106.79 124.28 49.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.717 0.77 . . . . 1.0 110.338 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.8 mt -112.99 130.53 56.1 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.107 -0.951 . . . . 1.0 110.131 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.9 m -69.19 161.07 29.94 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.0 tp -113.47 116.89 30.31 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.449 0.643 . . . . 1.0 111.055 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.7 pt -119.04 140.5 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-O 121.877 0.846 . . . . 1.0 110.694 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.27 117.91 17.61 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.22 0.533 . . . . 1.0 110.918 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.2 tptt -112.86 159.3 19.17 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.357 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 53.37 31.15 11.44 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.96 -0.385 . . . . 1.0 109.96 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.0 m -68.93 129.7 92.1 Favored Pre-proline 0 CA--C 1.546 0.823 0 CA-C-O 119.051 -0.499 . . . . 1.0 111.704 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -71.92 117.31 5.08 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 121.245 1.297 . . . . 1.0 111.431 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -42.83 158.15 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.87 0.843 . . . . 1.0 111.617 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.4 m120 73.2 9.71 5.22 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.958 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 90.3 p -112.44 145.13 40.73 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.738 0.78 . . . . 1.0 110.701 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.408 ' SD ' ' O ' ' A' ' 26' ' ' ILE . 12.5 tmm? -139.31 121.07 15.38 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.722 -0.672 . . . . 1.0 110.258 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.408 ' O ' ' SD ' ' A' ' 25' ' ' MET . 54.6 mt -73.8 144.98 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.888 0.851 . . . . 1.0 110.979 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 10.7 tpp -107.34 -26.78 10.85 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.571 -0.741 . . . . 1.0 109.596 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.9 m -81.09 156.49 25.78 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.203 -0.666 . . . . 1.0 109.203 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.438 ' C ' HD22 ' A' ' 30' ' ' LEU . 61.9 pttt -84.18 157.89 21.5 Favored 'General case' 0 CA--C 1.516 -0.362 0 O-C-N 121.273 -0.892 . . . . 1.0 110.19 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.466 HD22 ' N ' ' A' ' 30' ' ' LEU . 4.3 mm? -100.26 97.84 6.89 Favored Pre-proline 0 N--CA 1.484 1.262 0 CA-C-N 115.958 -0.565 . . . . 1.0 112.42 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 29' ' ' LYS . 37.2 Cg_endo -86.1 157.38 9.88 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.486 2.124 . . . . 1.0 112.714 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.4 m -77.35 -178.21 5.04 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.594 -0.691 . . . . 1.0 110.991 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.7 p -140.78 149.82 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 121.31 0.576 . . . . 1.0 111.146 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -102.87 123.83 47.24 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.49 0.662 . . . . 1.0 109.423 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 t -120.29 133.14 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-O 122.265 1.031 . . . . 1.0 111.52 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.437 ' H ' ' HB3' ' A' ' 79' ' ' GLU . 63.6 tttm -103.45 146.29 28.73 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.293 -0.867 . . . . 1.0 110.076 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 43.8 p -131.24 130.63 43.13 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.099 -0.501 . . . . 1.0 111.469 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.431 ' O ' ' O ' ' A' ' 39' ' ' GLY . 83.9 tt0 -57.36 -74.72 0.05 Allowed 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.648 0.737 . . . . 1.0 110.159 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 38' ' ' GLU . . . -50.17 -173.72 0.01 OUTLIER Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.347 -0.701 . . . . 1.0 111.347 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.715 ' O ' HD11 ' A' ' 75' ' ' ILE . 3.0 m-85 -104.92 167.9 9.41 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.494 0.664 . . . . 1.0 110.411 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -120.67 83.88 36.17 Favored Pre-proline 0 N--CA 1.476 0.831 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.412 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.56 -41.26 69.42 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.132 1.888 . . . . 1.0 112.162 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.515 ' O ' ' O ' ' A' ' 44' ' ' ILE . 73.7 m -161.17 -88.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.246 0.546 . . . . 1.0 110.401 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.515 ' O ' ' O ' ' A' ' 43' ' ' SER . 2.8 tt 31.56 100.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.352 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.604 ' C ' ' H ' ' A' ' 47' ' ' ASN . 87.9 m-20 -63.65 96.85 0.13 Allowed 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 120.969 0.414 . . . . 1.0 110.815 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.8 m -66.63 20.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.331 0.586 . . . . 1.0 110.718 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.604 ' H ' ' C ' ' A' ' 45' ' ' ASN . 94.1 m-20 -92.26 12.2 23.22 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.14 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -125.32 -1.23 7.61 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.694 -0.685 . . . . 1.0 110.288 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.8 mt -123.01 133.38 54.35 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -141.09 -166.57 2.2 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.009 0.909 . . . . 1.0 111.592 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -118.7 140.51 49.81 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.798 -1.092 . . . . 1.0 108.389 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -120.36 166.73 13.14 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 122.413 1.101 . . . . 1.0 112.084 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.3 m -133.73 145.49 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 114.475 -1.239 . . . . 1.0 109.305 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -94.92 81.83 3.78 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.709 0.766 . . . . 1.0 110.663 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.2 mp -75.11 -4.09 36.56 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.445 -0.798 . . . . 1.0 110.176 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.8 t -79.06 5.33 12.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.371 -0.377 . . . . 1.0 111.329 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -132.59 52.04 0.84 Allowed Glycine 0 N--CA 1.474 1.213 0 N-CA-C 111.344 -0.702 . . . . 1.0 111.344 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.7 t -153.45 -63.92 0.15 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.536 0.208 . . . . 1.0 111.316 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 66.36 151.92 0.12 Allowed Pre-proline 0 N--CA 1.472 0.625 0 C-N-CA 122.562 0.345 . . . . 1.0 111.443 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -35.06 143.29 0.08 OUTLIER 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 122.866 2.377 . . . . 1.0 113.369 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.513 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . 120.24 16.16 4.86 Favored Glycine 0 N--CA 1.472 1.057 0 N-CA-C 110.935 -0.866 . . . . 1.0 110.935 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.513 ' O ' ' O ' ' A' ' 61' ' ' GLY . 81.6 tt0 57.17 141.07 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 O-C-N 122.12 -0.635 . . . . 1.0 109.9 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.73 ' CG ' ' H ' ' A' ' 64' ' ' ASP . 39.5 t60 -155.55 -163.65 1.57 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 122.883 1.325 . . . . 1.0 112.289 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.73 ' H ' ' CG ' ' A' ' 63' ' ' HIS . 95.6 m-20 -114.58 144.27 43.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.285 -1.325 . . . . 1.0 108.652 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' A' ' 65' ' ' TYR . 48.7 m-85 -134.76 139.15 44.93 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.426 0.631 . . . . 1.0 111.388 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -104.44 149.29 25.56 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.345 -0.843 . . . . 1.0 111.15 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 48.4 t -103.28 116.45 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 121.726 0.774 . . . . 1.0 110.203 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -123.51 139.74 53.71 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.293 1.044 . . . . 1.0 110.344 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.7 t -109.0 136.89 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 115.553 -0.748 . . . . 1.0 110.874 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -72.13 117.26 56.73 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-O 118.557 -0.735 . . . . 1.0 110.091 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -44.96 119.22 2.29 Favored 'Trans proline' 0 N--CA 1.505 2.167 0 C-N-CA 121.754 1.636 . . . . 1.0 113.157 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 33.9 mm -105.93 123.0 40.57 Favored Pre-proline 0 N--CA 1.487 1.39 0 CA-C-O 119.103 -0.475 . . . . 1.0 111.235 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.64 157.86 54.81 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.32 2.014 . . . . 1.0 112.092 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 33.6 t30 80.67 -26.27 0.16 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.481 0.712 . . . . 1.0 110.826 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.715 HD11 ' O ' ' A' ' 40' ' ' TYR . 12.7 mm -132.81 148.46 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 122.206 1.003 . . . . 1.0 110.489 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -113.77 149.6 34.65 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 122.762 1.268 . . . . 1.0 110.961 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.6 tt -91.97 142.99 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.209 -0.905 . . . . 1.0 110.112 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.8 t -120.72 -45.48 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 122.089 -0.382 . . . . 1.0 110.901 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.437 ' HB3' ' H ' ' A' ' 36' ' ' LYS . 81.4 tt0 -96.17 139.4 32.39 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 122.127 0.965 . . . . 1.0 110.667 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.5 mp -135.25 80.82 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 115.435 -0.802 . . . . 1.0 109.723 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.7 m -148.61 148.84 29.47 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 120.281 -0.568 . . . . 1.0 112.018 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.82 141.73 72.64 Favored 'Cis proline' 0 N--CA 1.509 2.423 0 C-N-CA 124.685 -0.964 . . . . 1.0 112.3 -1.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 90.8 mtm180 -61.76 -56.48 19.11 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.567 0.698 . . . . 1.0 109.368 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.1 t -135.21 149.25 28.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.231 -0.655 . . . . 1.0 109.231 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.2 m -144.75 163.73 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 121.647 0.737 . . . . 1.0 111.764 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 74.3 m -111.6 122.82 48.83 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.299 -0.864 . . . . 1.0 110.658 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.4 mt -107.99 -170.13 1.63 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.426 0.632 . . . . 1.0 110.204 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -146.56 112.6 5.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.47 0.652 . . . . 1.0 110.55 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.8 mt -107.33 143.16 36.01 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.555 0.693 . . . . 1.0 110.033 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -132.44 143.71 49.98 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.971 0.891 . . . . 1.0 111.036 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -68.65 131.16 44.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.165 -0.925 . . . . 1.0 110.547 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.474 0.736 0 CA-C-O 121.701 0.762 . . . . 1.0 111.071 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 . . . . . 0 CA--C 1.538 0.516 0 N-CA-C 112.558 0.577 . . . . 1.0 112.558 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -139.21 81.82 20.34 Favored Pre-proline 0 N--CA 1.476 0.867 0 O-C-N 121.942 -0.474 . . . . 1.0 111.329 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.94 134.5 55.53 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.794 2.329 . . . . 1.0 112.739 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.7 m -104.51 85.92 2.42 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.409 0.623 . . . . 1.0 110.143 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.8 mt -86.01 145.52 27.06 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.814 0.816 . . . . 1.0 110.544 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.3 m -109.57 119.56 39.79 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.531 0.682 . . . . 1.0 110.599 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.8 mp -102.54 135.36 44.31 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.39 -0.823 . . . . 1.0 109.879 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 59.3 m -79.33 105.8 10.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.895 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.5 tp -68.52 95.94 0.66 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.591 0.71 . . . . 1.0 110.938 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.3 pt -118.69 165.05 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 121.571 0.701 . . . . 1.0 111.038 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.99 164.34 23.54 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.792 -0.568 . . . . 1.0 111.12 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.1 mmtp -104.11 -56.85 2.13 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.221 0.534 . . . . 1.0 111.402 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -92.89 -54.54 3.7 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.547 0.689 . . . . 1.0 110.144 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.662 ' CG2' HD11 ' A' ' 26' ' ' ILE . 0.3 OUTLIER 45.66 80.91 0.27 Allowed Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 115.831 -0.622 . . . . 1.0 111.592 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.38 134.72 65.52 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.302 2.001 . . . . 1.0 111.238 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.45 -14.4 3.01 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 122.001 -0.437 . . . . 1.0 111.859 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -91.53 -15.34 28.87 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.957 -0.464 . . . . 1.0 111.161 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.4 t -108.3 153.48 23.18 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.524 0.678 . . . . 1.0 110.779 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 45.0 ttp -144.66 115.51 7.8 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.706 0.765 . . . . 1.0 110.086 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.946 ' H ' HD12 ' A' ' 26' ' ' ILE . 2.2 mp -68.11 115.39 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.862 0.839 . . . . 1.0 111.095 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 44.3 ttm -67.67 -28.07 67.38 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.685 -0.689 . . . . 1.0 109.44 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 30' ' ' LEU . 5.9 m -68.88 135.74 51.56 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -68.85 -13.99 62.76 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 121.279 -0.888 . . . . 1.0 111.097 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.474 ' H ' HG22 ' A' ' 28' ' ' THR . 24.1 mt 61.95 91.81 0.07 OUTLIER Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 115.828 -0.624 . . . . 1.0 112.31 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -86.57 158.47 9.27 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.854 2.369 . . . . 1.0 112.755 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 95.4 p -69.13 178.07 2.45 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.666 -0.646 . . . . 1.0 111.268 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.0 p -139.7 151.04 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-O 121.408 0.623 . . . . 1.0 111.053 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 100.0 mtt180 -98.96 129.19 45.26 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.6 t -127.03 154.66 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 122.384 1.087 . . . . 1.0 111.396 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -124.7 142.67 51.23 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.108 -0.951 . . . . 1.0 110.591 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 60.3 p -130.08 136.57 49.49 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.33 0.586 . . . . 1.0 111.264 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -109.84 41.62 1.67 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.526 0.679 . . . . 1.0 109.798 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -125.3 -9.45 5.03 Favored Glycine 0 N--CA 1.472 1.093 0 N-CA-C 111.039 -0.824 . . . . 1.0 111.039 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 59.73 153.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.234 0.54 . . . . 1.0 111.13 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.468 ' ND2' ' N ' ' A' ' 41' ' ' ASN . 0.1 OUTLIER -175.4 148.11 1.02 Allowed Pre-proline 0 CA--C 1.547 0.835 0 O-C-N 122.212 -0.305 . . . . 1.0 110.451 179.854 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.29 -58.97 0.11 Allowed 'Trans proline' 0 N--CA 1.509 2.429 0 C-N-CA 121.507 1.471 . . . . 1.0 112.599 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.484 ' O ' ' HB ' ' A' ' 44' ' ' ILE . 40.2 t -159.42 -56.8 0.06 Allowed 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.71 0.767 . . . . 1.0 110.71 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 43' ' ' SER . 42.3 mt 91.92 -113.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-N 115.39 -0.823 . . . . 1.0 109.73 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.622 ' ND2' HD21 ' A' ' 47' ' ' ASN . 11.2 t-20 -175.87 -19.47 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.653 0.74 . . . . 1.0 110.383 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.444 ' C ' ' O ' ' A' ' 45' ' ' ASN . 17.7 m 28.18 43.58 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-O 121.827 0.822 . . . . 1.0 112.036 -178.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.622 HD21 ' ND2' ' A' ' 45' ' ' ASN . 99.3 m-20 -69.93 -40.92 75.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.577 -0.738 . . . . 1.0 110.754 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -127.95 13.08 6.78 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.617 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 28.5 mt -96.42 110.84 23.12 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.974 0.893 . . . . 1.0 109.597 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -148.24 -160.87 1.23 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 122.191 0.996 . . . . 1.0 111.533 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -117.2 142.49 46.97 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.703 -1.135 . . . . 1.0 108.263 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -134.57 175.12 9.82 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 122.03 0.919 . . . . 1.0 112.345 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.4 m -138.87 146.0 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 114.834 -1.075 . . . . 1.0 109.393 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -86.9 83.02 7.61 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.588 0.709 . . . . 1.0 110.318 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 56' ' ' SER . 0.7 OUTLIER -81.89 -13.79 57.09 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.0 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.454 ' C ' ' O ' ' A' ' 55' ' ' LEU . 77.3 p 20.18 -97.93 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 112.829 0.678 . . . . 1.0 112.829 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.493 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -60.57 -74.53 0.36 Allowed Glycine 0 CA--C 1.531 1.073 0 N-CA-C 110.583 -1.007 . . . . 1.0 110.583 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 3.9 m 101.94 45.24 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 123.94 0.896 . . . . 1.0 111.444 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 60' ' ' PRO . 12.3 mp0 -76.0 130.65 77.68 Favored Pre-proline 0 CA--C 1.548 0.902 0 CA-C-O 119.23 -0.414 . . . . 1.0 111.586 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 59' ' ' GLU . 88.7 Cg_exo -44.11 -179.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.506 2.251 0 C-N-CA 122.076 1.851 . . . . 1.0 113.044 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.54 -141.15 15.16 Favored Glycine 0 N--CA 1.472 1.093 0 N-CA-C 110.713 -0.955 . . . . 1.0 110.713 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.3 mp0 -138.19 75.1 1.5 Allowed 'General case' 0 N--CA 1.471 0.58 0 O-C-N 122.135 -0.626 . . . . 1.0 109.724 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -93.54 137.67 32.59 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.712 0.768 . . . . 1.0 112.013 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -85.37 139.19 31.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.282 -0.872 . . . . 1.0 109.072 178.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -132.11 127.94 37.09 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.718 0.77 . . . . 1.0 111.664 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 32.6 mp0 -67.87 132.81 48.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.091 -0.959 . . . . 1.0 111.318 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.6 t -76.27 124.96 35.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.507 0.67 . . . . 1.0 110.207 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -109.39 121.16 44.57 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.973 0.892 . . . . 1.0 110.196 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.3 m -109.75 129.61 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 115.833 -0.622 . . . . 1.0 111.008 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -50.35 127.76 23.49 Favored Pre-proline 0 CA--C 1.554 1.133 0 CA-C-O 118.87 -0.586 . . . . 1.0 110.554 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.3 112.01 3.42 Favored 'Trans proline' 0 N--CA 1.505 2.178 0 C-N-CA 121.684 1.59 . . . . 1.0 112.218 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.8 mp -82.02 129.71 63.27 Favored Pre-proline 0 CA--C 1.556 1.198 0 CA-C-O 119.411 -0.328 . . . . 1.0 110.795 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -67.15 140.98 55.63 Favored 'Trans proline' 0 N--CA 1.506 2.218 0 C-N-CA 121.755 1.637 . . . . 1.0 112.662 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.9 t30 66.93 10.32 7.55 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.271 0.629 . . . . 1.0 111.476 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mm -124.04 137.13 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-O 122.367 1.079 . . . . 1.0 109.746 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.33 121.14 38.89 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 122.145 0.974 . . . . 1.0 111.013 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.64 HG23 ' O ' ' A' ' 77' ' ' ILE . 7.4 tp -84.12 93.34 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.879 -0.601 . . . . 1.0 110.053 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.8 t -46.9 -53.65 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 O-C-N 121.97 -0.456 . . . . 1.0 110.835 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -170.42 -127.19 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.819 0.819 . . . . 1.0 110.408 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.8 mt -154.23 -77.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.131 -0.692 . . . . 1.0 109.131 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.6 t 58.71 101.94 0.04 OUTLIER Pre-proline 0 CA--C 1.549 0.907 0 CA-C-O 117.544 -1.217 . . . . 1.0 111.778 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -67.74 134.11 24.28 Favored 'Cis proline' 0 N--CA 1.512 2.598 0 CA-C-N 121.028 1.403 . . . . 1.0 111.831 0.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -66.26 -43.53 86.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.761 0.791 . . . . 1.0 109.661 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -130.08 153.21 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 109.377 -0.601 . . . . 1.0 109.377 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.5 p -145.38 136.06 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.604 0.716 . . . . 1.0 111.5 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 37.2 m -81.39 130.36 35.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.282 -0.872 . . . . 1.0 110.441 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 33.5 mt -133.45 124.47 27.12 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.104 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.409 ' CD ' ' N ' ' A' ' 88' ' ' GLN . 18.3 mp0 -93.28 121.43 34.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.687 0.756 . . . . 1.0 110.525 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.0 mt -96.98 162.06 13.56 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.445 -0.798 . . . . 1.0 109.802 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -152.81 151.62 30.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.642 0.734 . . . . 1.0 110.992 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -66.2 139.44 58.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.427 -0.806 . . . . 1.0 110.687 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 . . . . . 0 C--N 1.328 -0.342 0 CA-C-O 121.325 0.583 . . . . 1.0 111.165 -179.504 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 56.5 mmt-85 . . . . . 0 CA--C 1.529 0.139 0 CA-C-O 120.918 0.39 . . . . 1.0 111.51 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.478 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 4.9 p-10 44.3 54.35 11.92 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 112.935 0.717 . . . . 1.0 112.935 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.478 ' HD3' ' N ' ' A' ' 8' ' ' ASP . 57.6 Cg_endo -89.8 -178.03 1.54 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.806 2.337 . . . . 1.0 112.801 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 53.9 m -85.51 113.61 21.9 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.647 0.737 . . . . 1.0 110.423 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 74.9 mt -105.85 139.32 40.59 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.673 0.749 . . . . 1.0 110.572 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.472 ' C ' HD12 ' A' ' 13' ' ' LEU . 68.0 m -101.14 124.57 47.04 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.379 0.609 . . . . 1.0 110.428 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.472 HD12 ' C ' ' A' ' 12' ' ' THR . 10.3 mp -108.19 131.15 54.96 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.651 -0.704 . . . . 1.0 109.944 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.6 t -75.83 114.85 14.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.196 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 41.4 tp -69.37 105.99 2.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.246 0.546 . . . . 1.0 110.88 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.7 pt -118.08 142.6 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 121.692 0.758 . . . . 1.0 111.117 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.49 121.5 24.64 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.351 0.596 . . . . 1.0 110.76 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -114.03 50.4 0.93 Allowed 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.404 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 172.81 34.35 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.326 -0.62 . . . . 1.0 109.326 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.0 m -70.17 112.5 12.85 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-O 119.022 -0.513 . . . . 1.0 111.466 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -57.66 145.64 88.62 Favored 'Trans proline' 0 N--CA 1.501 1.948 0 C-N-CA 121.876 1.718 . . . . 1.0 111.832 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.93 150.38 49.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 122.155 0.979 . . . . 1.0 111.388 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 68.06 7.93 6.17 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.129 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.3 p -114.1 152.09 31.61 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.791 0.805 . . . . 1.0 110.521 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 49.0 ttp -141.47 120.27 12.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.704 -0.68 . . . . 1.0 110.082 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 72.2 mt -72.04 117.95 16.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.456 0.645 . . . . 1.0 110.665 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.417 ' SD ' ' OE1' ' A' ' 90' ' ' GLU . 76.4 mtp -83.79 58.64 4.75 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.806 0.812 . . . . 1.0 109.83 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.7 m -165.18 128.29 2.25 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.358 -0.608 . . . . 1.0 109.358 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.515 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 38.2 ttpt -68.2 158.44 33.24 Favored 'General case' 0 CA--C 1.515 -0.393 0 O-C-N 121.229 -0.92 . . . . 1.0 110.682 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.486 HD22 ' N ' ' A' ' 30' ' ' LEU . 4.3 mm? -98.55 96.86 4.12 Favored Pre-proline 0 CA--C 1.557 1.213 0 N-CA-C 112.374 0.509 . . . . 1.0 112.374 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' A' ' 29' ' ' LYS . 39.7 Cg_endo -86.51 152.05 9.02 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.485 2.123 . . . . 1.0 112.635 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.5 p -68.17 177.55 2.22 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.698 -0.626 . . . . 1.0 111.098 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -145.14 154.27 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.557 0.694 . . . . 1.0 111.079 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -104.42 127.0 52.02 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.5 m -131.6 161.75 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 122.169 0.985 . . . . 1.0 111.28 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -125.25 134.03 52.46 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.423 -0.808 . . . . 1.0 110.939 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 30.1 p -141.1 -175.27 4.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.647 0.736 . . . . 1.0 111.211 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -124.37 -138.17 0.29 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.727 -0.67 . . . . 1.0 110.089 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.66 -150.61 38.33 Favored Glycine 0 N--CA 1.458 0.161 0 N-CA-C 110.911 -0.876 . . . . 1.0 110.911 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -144.32 -25.96 0.52 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.252 0.549 . . . . 1.0 111.321 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 61.97 67.43 1.27 Allowed Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.451 -0.341 . . . . 1.0 111.128 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -58.64 -41.12 67.16 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 122.171 1.914 . . . . 1.0 111.92 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 55.4 p -172.07 55.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.614 -0.266 . . . . 1.0 110.533 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.8 mm -90.06 125.52 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.39 0.614 . . . . 1.0 110.062 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.514 ' C ' ' H ' ' A' ' 47' ' ' ASN . 12.0 m120 -75.59 100.89 4.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.459 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.1 m -46.72 -9.54 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.234 0.54 . . . . 1.0 111.817 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.514 ' H ' ' C ' ' A' ' 45' ' ' ASN . 33.6 m120 -63.02 -36.14 82.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.228 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -102.98 55.79 0.76 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.001 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.524 ' O ' ' CG ' ' A' ' 50' ' ' PHE . 20.1 mt -152.28 118.97 5.7 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.225 0.536 . . . . 1.0 110.071 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.524 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 59.1 m-85 -161.64 173.91 14.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 122.513 1.149 . . . . 1.0 111.675 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.463 ' C ' ' CG ' ' A' ' 52' ' ' TYR . . . -100.47 170.14 8.6 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 114.219 -1.355 . . . . 1.0 108.728 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.463 ' CG ' ' C ' ' A' ' 51' ' ' ALA . 25.3 m-85 -151.57 163.77 38.33 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 122.221 1.01 . . . . 1.0 111.913 -178.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.1 m -137.19 145.74 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 114.735 -1.12 . . . . 1.0 109.443 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -98.76 81.91 2.72 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.504 0.668 . . . . 1.0 110.643 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.491 ' O ' ' C ' ' A' ' 56' ' ' SER . 70.1 mt -74.71 4.75 5.78 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.577 -0.738 . . . . 1.0 110.197 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.491 ' C ' ' O ' ' A' ' 55' ' ' LEU . 84.2 p 15.02 -113.75 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 115.593 -0.731 . . . . 1.0 112.88 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.41 -143.22 0.01 OUTLIER Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.791 -0.924 . . . . 1.0 110.791 178.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.4 m -151.08 32.25 0.6 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 121.324 -0.15 . . . . 1.0 111.047 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -41.96 101.7 0.25 Allowed Pre-proline 0 CA--C 1.543 0.698 0 CA-C-O 119.625 -0.226 . . . . 1.0 111.394 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -56.02 118.61 5.42 Favored 'Trans proline' 0 N--CA 1.502 2.01 0 C-N-CA 122.607 2.205 . . . . 1.0 112.736 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 149.71 -168.07 29.87 Favored Glycine 0 N--CA 1.465 0.575 0 N-CA-C 110.22 -1.152 . . . . 1.0 110.22 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.514 ' CD ' ' H ' ' A' ' 62' ' ' GLU . 1.2 pm0 -102.62 80.2 1.89 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.375 0.607 . . . . 1.0 109.735 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.438 ' CD2' ' O ' ' A' ' 64' ' ' ASP . 83.7 t60 -90.69 161.37 15.39 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.911 0.862 . . . . 1.0 111.895 -178.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.438 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 69.2 m-20 -88.34 128.1 35.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.126 -0.943 . . . . 1.0 109.432 178.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -122.37 97.7 5.59 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.8 0.81 . . . . 1.0 111.546 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.543 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 39.1 mp0 -59.25 131.72 51.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.969 -1.014 . . . . 1.0 111.463 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.8 t -77.81 128.18 38.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.702 0.763 . . . . 1.0 110.269 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -117.73 137.91 52.38 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.993 0.901 . . . . 1.0 110.346 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.1 t -110.71 129.92 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.038 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -51.14 123.28 19.74 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.45 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.38 88.68 1.13 Allowed 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 122.09 1.86 . . . . 1.0 112.656 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.472 ' H ' HD12 ' A' ' 72' ' ' ILE . 3.3 mp -79.72 128.21 75.26 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 120.935 -0.306 . . . . 1.0 110.735 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.404 ' O ' ' ND2' ' A' ' 74' ' ' ASN . 56.3 Cg_endo -71.33 80.99 1.27 Allowed 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 122.151 1.901 . . . . 1.0 112.782 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.404 ' ND2' ' O ' ' A' ' 73' ' ' PRO . 6.2 m-20 167.78 -52.19 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.844 0.354 . . . . 1.0 110.498 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.3 mm -91.23 136.87 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-O 121.879 0.847 . . . . 1.0 110.201 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -96.41 140.38 31.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 122.288 1.042 . . . . 1.0 111.343 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.8 tt -94.93 135.91 27.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.641 -0.709 . . . . 1.0 110.327 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.7 t -105.47 -52.38 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 O-C-N 122.074 -0.391 . . . . 1.0 110.354 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -148.05 -152.41 0.44 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.998 0.904 . . . . 1.0 110.63 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.417 ' O ' ' O ' ' A' ' 81' ' ' SER . 34.2 mt -144.1 -48.24 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.582 -0.735 . . . . 1.0 109.617 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 80' ' ' ILE . 79.3 p 31.04 96.38 0.04 OUTLIER Pre-proline 0 CA--C 1.557 1.219 0 CA-C-O 118.39 -0.814 . . . . 1.0 112.354 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -68.29 -172.15 6.19 Favored 'Cis proline' 0 N--CA 1.501 1.94 0 CA-C-N 120.2 1.107 . . . . 1.0 111.757 1.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -112.09 -30.93 7.05 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.591 -0.731 . . . . 1.0 109.788 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.3 t -149.04 152.57 11.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.162 -0.681 . . . . 1.0 109.162 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.1 p -143.43 140.56 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.604 0.716 . . . . 1.0 111.664 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 60.4 m -95.76 128.96 43.08 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.281 -0.872 . . . . 1.0 110.789 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.6 mt -116.93 167.17 11.36 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.617 -0.719 . . . . 1.0 110.235 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -118.07 116.7 27.4 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.854 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -105.25 130.26 53.43 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.889 0.852 . . . . 1.0 110.253 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.417 ' OE1' ' SD ' ' A' ' 27' ' ' MET . 39.0 tt0 -134.2 136.64 43.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 122.346 1.07 . . . . 1.0 111.149 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 29.0 p-80 -68.76 116.96 9.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.735 -1.12 . . . . 1.0 110.685 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 85.3 t60 . . . . . 0 N--CA 1.469 0.511 0 CA-C-O 121.027 0.441 . . . . 1.0 110.822 -179.6 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 75.0 p . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 109.674 -0.491 . . . . 1.0 109.674 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.5 m -149.37 149.35 30.72 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.698 -0.482 . . . . 1.0 109.698 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.412 ' N ' ' CD ' ' A' ' 3' ' ' GLN . 27.2 mp0 -75.8 -87.14 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 O-C-N 121.912 -0.493 . . . . 1.0 110.236 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 35.1 p -81.08 -151.12 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.589 0.709 . . . . 1.0 109.27 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 73.07 78.52 0.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 O-C-N 121.92 -0.487 . . . . 1.0 111.315 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.405 ' OD1' ' CD1' ' A' ' 40' ' ' TYR . 52.1 p-10 -137.08 149.12 47.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.44 0.638 . . . . 1.0 109.789 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -39.18 147.15 0.07 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.923 -0.581 . . . . 1.0 111.822 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -55.73 137.32 71.32 Favored Pre-proline 0 CA--C 1.549 0.926 0 O-C-N 121.848 -0.532 . . . . 1.0 112.007 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -72.82 142.0 34.61 Favored 'Trans proline' 0 N--CA 1.503 2.039 0 C-N-CA 122.347 2.031 . . . . 1.0 112.953 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.5 m -113.92 94.78 4.98 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 121.514 0.673 . . . . 1.0 110.013 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 66.4 mt -109.73 143.43 39.52 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.791 0.805 . . . . 1.0 110.394 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.9 t -102.08 133.26 47.19 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.949 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.763 HD22 ' N ' ' A' ' 13' ' ' LEU . 0.9 OUTLIER -108.87 139.9 43.08 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.618 0.723 . . . . 1.0 110.457 -179.695 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.1 m -74.55 109.8 8.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.899 -0.591 . . . . 1.0 109.869 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.7 tp -69.41 106.56 2.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.406 0.622 . . . . 1.0 110.878 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.4 pt -111.04 142.29 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-O 121.811 0.815 . . . . 1.0 110.857 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.67 127.13 33.93 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.85 -0.531 . . . . 1.0 111.058 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -115.73 162.13 17.72 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 120.952 0.406 . . . . 1.0 110.201 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 22.4 m120 57.47 34.77 25.07 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.94 -0.393 . . . . 1.0 109.94 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 49.4 m -60.21 114.68 10.54 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-O 119.089 -0.482 . . . . 1.0 111.528 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.8 149.83 18.79 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 121.533 1.489 . . . . 1.0 112.01 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.91 145.1 42.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 122.041 0.924 . . . . 1.0 111.374 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.2 m-20 64.14 18.48 11.28 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.945 -0.571 . . . . 1.0 111.093 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.5 t -110.66 147.17 34.86 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.948 0.88 . . . . 1.0 110.658 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 61.4 ttp -139.12 116.15 10.96 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.624 -0.716 . . . . 1.0 109.982 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 59.0 mt -69.71 149.4 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.978 0.894 . . . . 1.0 110.532 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.515 ' O ' ' OG1' ' A' ' 28' ' ' THR . 1.1 tpt -118.74 63.78 0.77 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.766 0.793 . . . . 1.0 109.58 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.515 ' OG1' ' O ' ' A' ' 27' ' ' MET . 33.7 m -178.02 146.59 0.42 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.104 -0.702 . . . . 1.0 109.104 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -85.04 151.41 24.18 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.295 -0.878 . . . . 1.0 110.444 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 mp -103.79 105.41 47.82 Favored Pre-proline 0 N--CA 1.482 1.166 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.894 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -87.78 152.09 7.36 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.374 2.05 . . . . 1.0 112.688 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 63.0 p -59.19 -179.02 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.653 -0.655 . . . . 1.0 111.19 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.6 p -139.65 144.93 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-O 121.264 0.554 . . . . 1.0 111.077 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 82.3 mtt85 -99.99 125.18 45.98 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.385 -0.598 . . . . 1.0 109.385 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 t -124.23 153.47 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-O 122.557 1.17 . . . . 1.0 111.189 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -124.7 138.16 54.31 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 114.968 -1.015 . . . . 1.0 110.6 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 51.5 p -125.51 131.85 52.73 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.754 -0.657 . . . . 1.0 111.3 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -77.99 47.53 0.65 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.473 0.654 . . . . 1.0 109.886 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.401 ' O ' ' CD1' ' A' ' 40' ' ' TYR . . . -149.53 -169.24 15.72 Favored Glycine 0 N--CA 1.466 0.645 0 N-CA-C 110.572 -1.011 . . . . 1.0 110.572 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.405 ' CD1' ' OD1' ' A' ' 6' ' ' ASP . 0.8 OUTLIER -142.36 108.73 5.29 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.264 0.554 . . . . 1.0 110.232 -179.499 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -119.69 84.35 30.64 Favored Pre-proline 0 N--CA 1.474 0.733 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.475 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -56.3 -19.3 27.49 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.305 2.003 . . . . 1.0 111.862 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.2 t -145.31 -101.71 0.1 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.997 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.429 HG22 ' O ' ' A' ' 44' ' ' ILE . 27.1 mm 58.8 37.97 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.856 -0.424 . . . . 1.0 109.856 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 39.45 70.9 0.19 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.89 0.376 . . . . 1.0 111.266 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.1 m -56.23 -14.52 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.048 0.452 . . . . 1.0 110.784 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 48' ' ' GLU . 22.2 p30 -58.94 -33.81 71.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.312 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.494 ' N ' ' OD1' ' A' ' 47' ' ' ASN . 74.6 tt0 -91.0 63.64 5.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.996 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 69.1 mt -148.37 110.68 4.65 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.441 0.638 . . . . 1.0 109.995 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -143.31 156.55 44.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 122.054 0.93 . . . . 1.0 111.865 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -115.78 140.87 48.8 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.82 -1.082 . . . . 1.0 108.416 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 16.7 p90 -141.24 144.62 34.81 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 122.082 0.944 . . . . 1.0 112.24 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.4 m -105.53 156.09 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 114.857 -1.065 . . . . 1.0 108.947 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -97.19 142.8 28.67 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.454 0.645 . . . . 1.0 110.523 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.593 ' C ' ' H ' ' A' ' 57' ' ' GLY . 79.6 mt -131.35 40.46 3.43 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.648 -0.705 . . . . 1.0 110.377 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.7 m -60.01 14.24 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.901 -0.59 . . . . 1.0 111.982 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.593 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . -148.3 159.17 27.94 Favored Glycine 0 N--CA 1.466 0.689 0 N-CA-C 110.444 -1.062 . . . . 1.0 110.444 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.5 t -148.24 130.5 15.57 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.577 0.703 . . . . 1.0 110.976 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.638 ' O ' ' N ' ' A' ' 61' ' ' GLY . 2.1 mt-10 179.91 123.1 0.22 Allowed Pre-proline 0 CA--C 1.55 0.943 0 CA-C-N 115.677 -0.692 . . . . 1.0 110.657 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -45.57 71.42 0.01 OUTLIER 'Trans proline' 0 N--CA 1.511 2.531 0 C-N-CA 122.524 2.149 . . . . 1.0 113.939 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.638 ' N ' ' O ' ' A' ' 59' ' ' GLU . . . -145.27 155.68 26.6 Favored Glycine 0 N--CA 1.47 0.951 0 N-CA-C 110.349 -1.1 . . . . 1.0 110.349 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -86.09 87.1 7.36 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 122.302 -0.529 . . . . 1.0 109.768 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.505 ' ND1' ' CE1' ' A' ' 65' ' ' TYR . 61.1 t-80 -92.38 137.51 32.31 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.548 0.69 . . . . 1.0 112.342 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -90.42 115.93 27.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.623 -0.717 . . . . 1.0 109.212 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.505 ' CE1' ' ND1' ' A' ' 63' ' ' HIS . 71.1 m-85 -104.75 135.22 46.54 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.878 0.847 . . . . 1.0 111.455 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -81.06 142.09 33.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.899 -1.046 . . . . 1.0 111.252 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.9 t -74.94 117.5 19.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.373 0.606 . . . . 1.0 110.417 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -106.73 114.8 29.12 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 122.334 1.064 . . . . 1.0 109.886 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.581 HG12 ' N ' ' A' ' 70' ' ' GLU . 27.3 t -85.52 169.27 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 115.57 -0.741 . . . . 1.0 110.871 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.581 ' N ' HG12 ' A' ' 69' ' ' VAL . 10.7 tm-20 -94.4 111.8 55.11 Favored Pre-proline 0 CA--C 1.553 1.09 0 CA-C-N 115.668 -0.696 . . . . 1.0 109.833 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -48.09 131.3 21.53 Favored 'Trans proline' 0 N--CA 1.506 2.217 0 C-N-CA 121.782 1.654 . . . . 1.0 112.859 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.8 mt -99.54 109.51 55.42 Favored Pre-proline 0 CA--C 1.554 1.099 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.792 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.97 55.63 3.43 Favored 'Trans proline' 0 N--CA 1.506 2.246 0 C-N-CA 122.069 1.846 . . . . 1.0 113.095 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -175.09 -44.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.242 0.544 . . . . 1.0 110.882 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.664 HG22 ' N ' ' A' ' 76' ' ' LYS . 63.7 mt -112.63 174.22 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-O 121.559 0.695 . . . . 1.0 110.114 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.664 ' N ' HG22 ' A' ' 75' ' ' ILE . 60.5 tttp -117.83 156.44 28.37 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 122.583 1.182 . . . . 1.0 111.238 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.9 tt -99.39 153.17 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 115.367 -0.833 . . . . 1.0 109.966 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.9 t -108.14 -49.68 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 122.142 -0.349 . . . . 1.0 110.665 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -179.69 -175.99 0.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 122.316 1.055 . . . . 1.0 110.52 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.4 mt -129.86 167.42 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 122.15 0.976 . . . . 1.0 109.307 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.7 t -167.04 106.09 0.63 Allowed Pre-proline 0 CA--C 1.554 1.131 0 CA-C-O 118.438 -0.791 . . . . 1.0 111.452 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -62.39 -173.78 2.74 Favored 'Cis proline' 0 N--CA 1.507 2.283 0 CA-C-N 120.191 1.104 . . . . 1.0 111.528 -0.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -118.54 -23.51 7.11 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.516 0.674 . . . . 1.0 109.191 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 t -144.36 149.85 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.1 m -136.39 157.11 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-O 121.75 0.786 . . . . 1.0 111.567 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 71.7 m -109.1 119.13 38.6 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.174 -0.921 . . . . 1.0 110.613 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.8 mt -122.7 126.22 47.14 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.701 -0.682 . . . . 1.0 110.222 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -83.64 130.52 34.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.587 0.708 . . . . 1.0 110.255 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -104.02 136.15 44.19 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.652 0.739 . . . . 1.0 110.297 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -138.1 140.45 39.97 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.331 1.063 . . . . 1.0 111.053 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -67.18 167.33 12.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.842 -1.072 . . . . 1.0 110.644 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.452 ' CG ' ' N ' ' A' ' 93' ' ' HIS . 57.8 t-80 -142.57 164.47 30.03 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.653 0.739 . . . . 1.0 110.972 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.452 ' N ' ' CG ' ' A' ' 92' ' ' HIS . 84.8 t60 55.07 93.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.286 0.565 . . . . 1.0 110.392 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -63.4 75.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.485 . . . . 1.0 111.214 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.433 ' N ' ' O ' ' A' ' 93' ' ' HIS . 60.8 m80 52.62 -174.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.631 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.988 -1.006 . . . . 1.0 110.48 179.839 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 43.2 t . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.504 -0.554 . . . . 1.0 109.504 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.7 m -68.27 138.58 55.63 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.846 -0.427 . . . . 1.0 109.846 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.464 ' NE2' ' OH ' ' A' ' 40' ' ' TYR . 1.1 pt20 -84.15 -68.88 0.68 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.08 0.467 . . . . 1.0 109.827 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.5 p -75.62 168.86 19.22 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.857 -0.423 . . . . 1.0 109.857 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 51.4 mt -62.65 -45.86 90.88 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 121.938 -0.476 . . . . 1.0 111.065 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 53.4 p-10 -169.12 171.41 8.13 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.818 -0.438 . . . . 1.0 109.818 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -36.24 -64.96 0.29 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.793 0.664 . . . . 1.0 112.793 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.32 118.14 50.36 Favored Pre-proline 0 CA--C 1.549 0.908 0 O-C-N 121.85 -0.531 . . . . 1.0 112.159 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.47 141.79 35.57 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 CA-C-N 120.404 1.18 . . . . 1.0 113.392 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.427 HG22 ' N ' ' A' ' 11' ' ' LEU . 91.1 m -107.36 157.4 17.98 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.575 0.702 . . . . 1.0 110.024 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.571 HD13 ' H ' ' A' ' 12' ' ' THR . 0.1 OUTLIER -144.09 139.41 28.89 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.445 0.64 . . . . 1.0 110.428 179.818 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.571 ' H ' HD13 ' A' ' 11' ' ' LEU . 56.3 m -123.5 120.19 32.16 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.509 0.671 . . . . 1.0 110.571 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 35.7 mt -130.52 134.08 46.77 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.454 -0.794 . . . . 1.0 110.027 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.5 m -58.67 179.58 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.6 tp -120.33 112.99 19.71 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-O 121.602 0.715 . . . . 1.0 111.043 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.5 pt -116.78 154.26 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-O 121.809 0.814 . . . . 1.0 110.763 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.82 125.56 41.35 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.806 -0.559 . . . . 1.0 110.536 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.483 ' O ' ' O ' ' A' ' 19' ' ' ASN . 63.9 tttm -119.7 137.68 53.76 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.615 0.721 . . . . 1.0 109.707 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 18' ' ' LYS . 82.3 m-20 43.53 100.84 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.993 -0.549 . . . . 1.0 110.876 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.3 m -136.55 132.43 18.7 Favored Pre-proline 0 N--CA 1.479 0.979 0 CA-C-O 119.45 -0.31 . . . . 1.0 111.577 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -36.84 95.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 121.641 1.561 . . . . 1.0 112.541 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -39.33 161.79 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.53 0.681 . . . . 1.0 111.869 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 72.61 12.19 5.47 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 122.006 -0.433 . . . . 1.0 110.746 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.7 p -133.51 153.75 51.38 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.745 0.783 . . . . 1.0 110.661 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 47.8 ttp -143.74 138.6 28.93 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.46 0.647 . . . . 1.0 110.184 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 69.9 mt -75.02 154.12 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.611 0.72 . . . . 1.0 111.047 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.6 ttt -107.13 -28.01 10.24 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 121.391 0.615 . . . . 1.0 109.859 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 30' ' ' LEU . 9.0 m -64.75 138.2 58.24 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.575 -0.528 . . . . 1.0 109.575 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -66.99 -6.74 18.14 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.287 -0.883 . . . . 1.0 111.261 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.447 ' H ' HG22 ' A' ' 28' ' ' THR . 12.2 mt 59.38 95.24 0.05 OUTLIER Pre-proline 0 CA--C 1.548 0.868 0 CA-C-O 118.736 -0.649 . . . . 1.0 111.864 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -85.99 154.91 9.87 Favored 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 122.649 2.233 . . . . 1.0 112.744 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.6 m -57.89 175.59 0.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.614 -0.679 . . . . 1.0 111.26 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.6 m -132.59 133.46 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-O 121.317 0.58 . . . . 1.0 111.091 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -104.98 126.84 52.48 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -130.07 155.63 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 122.163 0.982 . . . . 1.0 111.2 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -119.52 138.8 52.94 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.426 -0.807 . . . . 1.0 110.165 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.5 p -129.97 141.93 50.7 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 115.855 -0.611 . . . . 1.0 110.723 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -82.77 164.23 20.75 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.719 -0.474 . . . . 1.0 109.719 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.51 -157.88 18.13 Favored Glycine 0 N--CA 1.472 1.07 0 N-CA-C 110.827 -0.909 . . . . 1.0 110.827 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.464 ' OH ' ' NE2' ' A' ' 3' ' ' GLN . 68.1 t80 -152.77 98.79 2.38 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.471 0.653 . . . . 1.0 110.829 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.458 ' N ' HD22 ' A' ' 41' ' ' ASN . 0.1 OUTLIER -174.42 75.08 0.34 Allowed Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.497 179.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.4 38.88 0.35 Allowed 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 121.691 1.594 . . . . 1.0 111.86 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.42 ' H ' ' C ' ' A' ' 41' ' ' ASN . 38.7 m -170.11 97.14 0.28 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.413 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.1 mt -127.96 53.56 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 109.805 -0.442 . . . . 1.0 109.805 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.517 ' C ' ' H ' ' A' ' 47' ' ' ASN . 4.7 p-10 39.43 56.98 2.17 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.499 -0.319 . . . . 1.0 111.235 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.3 m -70.14 35.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.052 0.453 . . . . 1.0 111.098 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.517 ' H ' ' C ' ' A' ' 45' ' ' ASN . 70.9 m-20 -59.97 -24.18 64.2 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.295 -0.412 . . . . 1.0 110.577 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.513 ' O ' ' C ' ' A' ' 49' ' ' LEU . 96.4 mt-10 -124.38 -54.85 1.67 Allowed 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.934 -0.576 . . . . 1.0 110.009 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.64 ' H ' HD12 ' A' ' 49' ' ' LEU . 9.1 mp -25.42 113.7 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.074 0.464 . . . . 1.0 110.845 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -141.76 -171.86 3.43 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.898 0.856 . . . . 1.0 111.551 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.455 ' O ' ' CG ' ' A' ' 52' ' ' TYR . . . -93.19 158.02 15.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.928 -1.033 . . . . 1.0 108.321 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.455 ' CG ' ' O ' ' A' ' 51' ' ' ALA . 91.8 m-85 -153.6 157.84 40.29 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 122.273 1.035 . . . . 1.0 111.889 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.3 147.22 22.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 114.64 -1.164 . . . . 1.0 109.357 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -115.88 106.23 13.58 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.452 0.644 . . . . 1.0 110.606 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.505 ' C ' ' H ' ' A' ' 57' ' ' GLY . 24.4 mt -104.77 32.77 3.93 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.802 -0.635 . . . . 1.0 110.179 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 88.9 p -62.4 8.71 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.849 -0.614 . . . . 1.0 111.859 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . -88.88 -168.73 44.18 Favored Glycine 0 N--CA 1.47 0.959 0 N-CA-C 110.84 -0.904 . . . . 1.0 110.84 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 82.0 p -162.41 76.71 0.47 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.413 0.625 . . . . 1.0 111.446 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -138.13 88.03 15.68 Favored Pre-proline 0 N--CA 1.472 0.666 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.589 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -48.09 108.76 0.19 Allowed 'Trans proline' 0 N--CA 1.504 2.11 0 C-N-CA 122.364 2.043 . . . . 1.0 112.775 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.74 -165.04 25.41 Favored Glycine 0 N--CA 1.47 0.909 0 N-CA-C 110.343 -1.103 . . . . 1.0 110.343 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.544 ' CD ' ' H ' ' A' ' 62' ' ' GLU . 0.9 OUTLIER -71.77 142.89 49.7 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.261 -0.552 . . . . 1.0 109.641 179.477 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.45 ' O ' ' CD1' ' A' ' 65' ' ' TYR . 62.7 t-80 -161.12 126.02 3.6 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.149 -0.62 . . . . 1.0 112.45 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -77.24 117.32 18.65 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.806 -0.813 . . . . 1.0 108.806 178.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.45 ' CD1' ' O ' ' A' ' 63' ' ' HIS . 91.4 m-85 -94.38 -122.77 0.1 Allowed 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.985 -0.447 . . . . 1.0 111.821 -178.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -160.3 130.68 5.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.127 0.489 . . . . 1.0 110.732 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.7 t -92.94 115.94 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.122 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -142.27 151.83 42.42 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.742 0.782 . . . . 1.0 110.487 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 70' ' ' GLU . 41.6 t -134.63 157.39 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-O 121.405 0.622 . . . . 1.0 111.201 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.417 ' N ' HG12 ' A' ' 69' ' ' VAL . 9.3 pt-20 -58.26 147.28 67.6 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 115.575 -0.738 . . . . 1.0 110.681 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -73.64 162.08 40.56 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 121.892 1.728 . . . . 1.0 112.417 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.84 101.41 12.82 Favored Pre-proline 0 N--CA 1.48 1.048 0 CA-C-N 115.3 -0.864 . . . . 1.0 110.526 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -50.04 140.33 32.33 Favored 'Trans proline' 0 N--CA 1.502 2.026 0 C-N-CA 121.31 1.34 . . . . 1.0 113.064 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.432 ' N ' ' ND2' ' A' ' 74' ' ' ASN . 1.1 m120 78.88 -11.9 1.15 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.555 0.742 . . . . 1.0 111.318 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 42.9 mm -125.96 153.17 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 122.276 1.036 . . . . 1.0 110.006 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -121.65 158.5 28.53 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 122.751 1.262 . . . . 1.0 110.735 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.613 HG23 ' O ' ' A' ' 77' ' ' ILE . 17.6 tt -99.3 95.88 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 115.125 -0.943 . . . . 1.0 109.813 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.7 t -44.91 -53.48 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 O-C-N 121.975 -0.453 . . . . 1.0 110.893 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -167.8 -146.2 0.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.685 0.755 . . . . 1.0 110.559 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.434 HG22 ' O ' ' A' ' 82' ' ' PRO . 1.9 mt -148.63 157.18 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 109.238 -0.653 . . . . 1.0 109.238 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 82' ' ' PRO . 43.3 t -163.17 101.05 1.0 Allowed Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 118.434 -0.793 . . . . 1.0 111.672 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.474 ' O ' ' N ' ' A' ' 81' ' ' SER . 24.0 Cg_exo -63.97 -166.31 1.35 Allowed 'Cis proline' 0 N--CA 1.511 2.541 0 CA-C-N 120.134 1.083 . . . . 1.0 111.393 -0.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -129.81 -18.7 3.4 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.446 0.641 . . . . 1.0 109.512 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.2 t -142.86 135.7 25.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.889 -0.782 . . . . 1.0 108.889 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.9 m -130.65 146.34 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-O 121.841 0.829 . . . . 1.0 111.376 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.0 t -106.29 131.99 52.86 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.071 -0.968 . . . . 1.0 110.49 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 35.1 mt -134.26 126.2 29.32 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.056 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -91.7 122.11 33.96 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.484 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.7 mt -93.43 140.69 29.3 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.415 0.626 . . . . 1.0 109.972 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -133.06 144.68 50.17 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.954 0.883 . . . . 1.0 111.2 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -69.67 144.56 52.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.195 -0.911 . . . . 1.0 110.809 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -73.64 96.6 2.5 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.634 0.73 . . . . 1.0 110.81 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -85.59 -9.0 57.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 1.0 109.948 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -66.64 -30.28 70.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.795 0.331 . . . . 1.0 110.887 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.45 ' O ' ' ND1' ' A' ' 96' ' ' HIS . 28.2 t60 -59.02 -40.67 85.7 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.83 -0.433 . . . . 1.0 109.83 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.45 ' ND1' ' O ' ' A' ' 95' ' ' HIS . 73.1 m-70 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 117.927 -1.035 . . . . 1.0 109.82 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 93.4 p . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.51 -0.552 . . . . 1.0 109.51 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.3 m -61.03 -74.42 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.089 0.471 . . . . 1.0 110.828 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -135.5 -174.13 3.55 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.252 0.549 . . . . 1.0 110.17 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.9 p 49.97 38.39 16.26 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.848 0.832 . . . . 1.0 110.124 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 55.9 tp -59.31 -59.21 5.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 1.0 111.116 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 53.3 p-10 -75.74 50.53 0.57 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.313 0.578 . . . . 1.0 110.442 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 42.69 -125.1 0.73 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.064 -0.516 . . . . 1.0 111.641 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 40.03 84.36 0.18 Allowed Pre-proline 0 CA--C 1.538 0.499 0 O-C-N 121.833 -0.542 . . . . 1.0 112.119 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.35 135.17 64.53 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.3 2.0 . . . . 1.0 112.954 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 68.2 m -127.96 122.56 32.65 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.679 0.752 . . . . 1.0 109.827 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.4 mt -137.02 164.66 27.84 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.647 0.737 . . . . 1.0 110.509 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.2 m -101.54 128.35 47.83 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.348 0.594 . . . . 1.0 110.282 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 tp -123.4 153.56 40.22 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.61 -0.723 . . . . 1.0 110.227 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.1 t -106.18 152.24 23.72 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.03 0.443 . . . . 1.0 109.906 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 pp -119.71 117.48 28.36 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.353 0.596 . . . . 1.0 111.035 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.3 pt -110.99 163.08 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-O 121.724 0.773 . . . . 1.0 110.713 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.76 116.46 24.04 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.89 -0.506 . . . . 1.0 110.944 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.5 mmtt -61.15 -32.67 72.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.91 0.386 . . . . 1.0 110.68 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -144.54 76.06 1.48 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.133 0.492 . . . . 1.0 110.252 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.1 m -60.47 116.07 16.33 Favored Pre-proline 0 CA--C 1.554 1.119 0 CA-C-O 118.873 -0.584 . . . . 1.0 111.385 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.96 138.17 52.35 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 120.926 1.084 . . . . 1.0 111.846 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.47 152.5 43.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.922 0.868 . . . . 1.0 111.592 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.4 m-20 69.08 6.28 5.56 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.097 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.0 p -100.73 145.64 28.22 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.61 0.719 . . . . 1.0 110.785 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -136.61 116.4 13.09 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.506 0.67 . . . . 1.0 110.332 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 65.7 mt -69.32 148.43 11.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.828 0.823 . . . . 1.0 110.828 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 46.9 mtt -114.23 -35.67 4.93 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.677 -0.692 . . . . 1.0 109.935 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.6 m -79.78 147.92 31.64 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.498 -0.556 . . . . 1.0 109.498 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -78.68 150.9 32.47 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.289 -0.882 . . . . 1.0 110.069 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 tp -76.39 112.7 22.84 Favored Pre-proline 0 CA--C 1.557 1.214 0 CA-C-N 115.678 -0.692 . . . . 1.0 111.983 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -90.53 151.7 4.33 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 121.456 1.437 . . . . 1.0 112.567 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.3 p -84.03 170.16 14.2 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.618 -0.676 . . . . 1.0 110.834 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.2 p -135.88 136.54 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 121.558 0.694 . . . . 1.0 110.949 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 42.4 mtm105 -98.24 130.99 44.95 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.929 -0.578 . . . . 1.0 109.464 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 t -124.24 128.59 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 121.963 0.887 . . . . 1.0 111.428 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -97.43 153.33 18.18 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.534 -0.757 . . . . 1.0 110.341 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 16.1 p -131.9 133.08 44.19 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.166 0.507 . . . . 1.0 111.315 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -80.75 47.04 0.93 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.245 0.545 . . . . 1.0 109.648 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.54 -171.71 34.65 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 110.558 -1.017 . . . . 1.0 110.558 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.569 ' O ' HD11 ' A' ' 75' ' ' ILE . 62.4 t80 -107.6 164.36 12.29 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.473 0.654 . . . . 1.0 110.636 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.53 ' N ' ' CD2' ' A' ' 40' ' ' TYR . 4.8 p30 -114.3 90.76 21.47 Favored Pre-proline 0 N--CA 1.477 0.923 0 CA-C-N 116.147 -0.478 . . . . 1.0 111.056 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -50.78 -41.5 54.49 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 121.746 1.631 . . . . 1.0 112.025 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.9 t -171.27 42.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.576 0.227 . . . . 1.0 110.732 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.407 ' O ' HG23 ' A' ' 44' ' ' ILE . 14.7 tt -58.64 126.77 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.978 0.418 . . . . 1.0 110.415 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.495 ' C ' ' H ' ' A' ' 47' ' ' ASN . 44.6 p-10 -99.96 86.13 3.2 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.947 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.9 m -72.25 33.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.99 0.424 . . . . 1.0 110.675 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.495 ' H ' ' C ' ' A' ' 45' ' ' ASN . 71.5 m-80 -100.99 -10.22 20.76 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.311 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -131.53 1.84 4.11 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.469 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.608 ' O ' ' CG ' ' A' ' 50' ' ' PHE . 51.1 mt -95.81 154.85 17.01 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.608 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 70.3 m-85 -165.72 174.21 9.96 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.795 0.807 . . . . 1.0 111.694 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.432 ' C ' ' CG ' ' A' ' 52' ' ' TYR . . . -111.64 169.94 8.47 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.052 -0.976 . . . . 1.0 108.431 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.432 ' CG ' ' C ' ' A' ' 51' ' ' ALA . 22.8 m-85 -151.23 169.58 21.58 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 122.181 0.991 . . . . 1.0 112.134 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.3 m -136.26 144.77 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 114.73 -1.123 . . . . 1.0 109.496 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -85.58 83.49 7.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.404 0.621 . . . . 1.0 110.374 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 57' ' ' GLY . 1.2 mp -94.15 -26.8 16.54 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.603 -0.726 . . . . 1.0 109.769 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 55' ' ' LEU . 47.5 t 29.61 -90.26 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.644 0.735 . . . . 1.0 112.336 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . -129.07 71.49 0.49 Allowed Glycine 0 N--CA 1.472 1.06 0 N-CA-C 111.039 -0.824 . . . . 1.0 111.039 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 27.8 t -83.26 163.41 20.74 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.728 0.775 . . . . 1.0 111.343 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.5 mp0 -130.93 148.75 71.5 Favored Pre-proline 0 N--CA 1.48 1.062 0 CA-C-N 115.593 -0.73 . . . . 1.0 111.255 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -39.79 144.06 0.37 Allowed 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 122.064 1.843 . . . . 1.0 113.387 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 142.27 -137.68 8.02 Favored Glycine 0 N--CA 1.468 0.809 0 N-CA-C 110.517 -1.033 . . . . 1.0 110.517 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -140.09 69.93 1.36 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.322 0.582 . . . . 1.0 109.553 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -93.03 130.84 38.48 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.09 -0.505 . . . . 1.0 112.124 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -82.41 142.01 32.3 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.117 -0.697 . . . . 1.0 109.117 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -133.2 136.45 45.66 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.753 0.787 . . . . 1.0 111.675 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -73.19 135.78 44.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.07 -0.968 . . . . 1.0 111.485 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.83 129.02 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.173 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -121.01 149.58 42.45 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.816 0.817 . . . . 1.0 110.513 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.1 t -124.54 137.54 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 115.978 -0.555 . . . . 1.0 111.316 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -63.05 115.24 16.08 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-O 118.483 -0.77 . . . . 1.0 110.26 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.8 136.17 42.82 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 CA-C-N 120.281 1.136 . . . . 1.0 113.032 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.5 mp -91.73 115.99 65.61 Favored Pre-proline 0 CA--C 1.553 1.07 0 CA-C-N 115.481 -0.781 . . . . 1.0 110.442 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -50.41 134.66 39.07 Favored 'Trans proline' 0 N--CA 1.506 2.226 0 C-N-CA 120.968 1.112 . . . . 1.0 113.496 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 67.59 4.87 4.05 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.417 0.687 . . . . 1.0 111.436 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.569 HD11 ' O ' ' A' ' 40' ' ' TYR . 7.4 mm -138.26 154.36 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 122.319 1.057 . . . . 1.0 109.721 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -127.34 165.47 19.67 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 122.425 1.107 . . . . 1.0 111.074 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.8 pt -118.49 121.5 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 115.471 -0.786 . . . . 1.0 109.887 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 80.2 t -56.1 -50.58 69.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 O-C-N 122.086 -0.384 . . . . 1.0 110.378 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 177.67 147.61 0.14 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 122.198 0.999 . . . . 1.0 110.418 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.413 HG12 ' H ' ' A' ' 80' ' ' ILE . 16.3 pt -84.52 172.1 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.347 -0.842 . . . . 1.0 109.789 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 t -178.26 119.13 0.25 Allowed Pre-proline 0 CA--C 1.552 1.027 0 CA-C-O 117.941 -1.028 . . . . 1.0 111.438 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -65.38 141.22 48.09 Favored 'Cis proline' 0 N--CA 1.509 2.411 0 CA-C-N 120.657 1.27 . . . . 1.0 111.444 -1.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -76.58 -18.02 58.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.769 0.795 . . . . 1.0 109.546 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.2 t -137.01 143.96 33.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.937 -0.764 . . . . 1.0 108.937 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.9 m -135.24 160.15 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.832 0.825 . . . . 1.0 111.469 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 58.1 m -116.08 130.2 56.69 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.021 -0.99 . . . . 1.0 110.365 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 83.0 mt -134.62 123.15 23.33 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.681 -0.691 . . . . 1.0 110.034 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -93.69 123.9 37.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.497 0.665 . . . . 1.0 110.145 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 64.9 mt -105.76 157.61 17.32 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.657 -0.701 . . . . 1.0 110.129 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -145.89 138.13 25.4 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.606 0.717 . . . . 1.0 111.023 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -69.49 143.46 53.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.564 -0.744 . . . . 1.0 110.324 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -56.2 136.63 52.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.53 0.681 . . . . 1.0 111.019 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -70.13 127.28 32.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.264 0.554 . . . . 1.0 110.374 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 46.8 m170 -87.83 133.41 33.9 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.285 0.565 . . . . 1.0 111.066 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.444 ' CD2' ' N ' ' A' ' 95' ' ' HIS . 0.4 OUTLIER -170.84 33.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 1.0 109.824 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.445 ' ND1' ' N ' ' A' ' 96' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 117.951 -1.023 . . . . 1.0 110.262 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.7 p . . . . . 0 N--CA 1.487 1.411 0 N-CA-C 109.452 -0.573 . . . . 1.0 109.452 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.8 t -165.61 -57.14 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.727 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 54.31 75.74 0.27 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.303 0.573 . . . . 1.0 110.222 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.8 m 56.41 105.09 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.668 -0.493 . . . . 1.0 109.668 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 53.6 tp -145.53 -60.45 0.34 Allowed 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.973 -0.455 . . . . 1.0 110.839 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' A' ' 7' ' ' ARG . 26.2 t0 57.41 175.31 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.987 0.422 . . . . 1.0 110.369 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.41 ' H ' ' CG ' ' A' ' 6' ' ' ASP . 54.8 mmm-85 -136.05 139.04 42.76 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.661 0.743 . . . . 1.0 111.702 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 41.57 97.23 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 123.36 0.664 . . . . 1.0 112.0 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.6 140.98 54.32 Favored 'Trans proline' 0 N--CA 1.498 1.783 0 C-N-CA 122.403 2.069 . . . . 1.0 113.111 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 71.4 m -129.52 107.85 9.79 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.528 0.68 . . . . 1.0 110.228 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 60.5 mt -110.61 159.67 17.36 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.795 0.807 . . . . 1.0 110.439 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.9 m -119.58 120.67 37.4 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.538 0.685 . . . . 1.0 110.72 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.8 132.56 53.33 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.419 -0.81 . . . . 1.0 110.093 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.0 m -65.33 160.04 22.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.075 -0.511 . . . . 1.0 109.863 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.2 tp -113.44 126.91 55.86 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.5 0.667 . . . . 1.0 110.856 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.5 pt -117.53 179.75 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.707 0.765 . . . . 1.0 111.017 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.69 115.27 29.27 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.284 0.564 . . . . 1.0 111.197 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -113.44 166.23 11.7 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.321 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 48.8 26.83 1.38 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.875 0.369 . . . . 1.0 110.015 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.9 m -63.94 129.7 94.04 Favored Pre-proline 0 CA--C 1.547 0.843 0 CA-C-O 119.057 -0.497 . . . . 1.0 112.175 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.28 141.28 56.18 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 121.753 1.635 . . . . 1.0 111.427 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.41 149.08 49.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 122.125 0.964 . . . . 1.0 111.232 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 74.41 6.22 4.59 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.881 -0.6 . . . . 1.0 111.195 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.6 p -113.21 146.4 39.37 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.794 0.807 . . . . 1.0 110.745 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 24.6 ptm -142.6 139.9 31.49 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.518 0.675 . . . . 1.0 110.14 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 75.6 mt -88.33 145.81 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.697 0.761 . . . . 1.0 111.027 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 20.8 ttt -111.83 -23.5 10.54 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.781 -0.645 . . . . 1.0 109.511 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.1 p -87.7 121.95 30.76 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.501 0.667 . . . . 1.0 109.242 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -63.84 141.47 58.76 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.271 -0.893 . . . . 1.0 110.869 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.446 ' N ' HD12 ' A' ' 30' ' ' LEU . 10.7 mp -81.56 118.09 70.8 Favored Pre-proline 0 CA--C 1.554 1.123 0 N-CA-C 112.238 0.459 . . . . 1.0 112.238 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -86.2 162.79 9.98 Favored 'Trans proline' 0 N--CA 1.501 1.957 0 C-N-CA 122.383 2.056 . . . . 1.0 112.793 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 56.5 m -70.44 168.52 15.97 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.563 -0.711 . . . . 1.0 111.259 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.9 p -136.82 139.11 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-O 121.427 0.632 . . . . 1.0 111.116 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 80' ' ' ILE . 1.6 mpt_? -102.38 124.41 47.89 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.134 -0.691 . . . . 1.0 109.134 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.5 t -120.33 125.69 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 122.0 0.905 . . . . 1.0 111.132 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -98.59 147.04 25.21 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.288 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 70.4 p -129.39 131.28 46.78 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.492 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -53.78 -72.52 0.06 Allowed 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.723 0.773 . . . . 1.0 110.139 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.21 -171.93 0.09 OUTLIER Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.009 -0.837 . . . . 1.0 111.009 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -106.24 175.89 5.35 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.658 0.742 . . . . 1.0 110.944 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -136.42 74.28 54.4 Favored Pre-proline 0 N--CA 1.472 0.644 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.644 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -52.09 -37.72 69.17 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 C-N-CA 122.29 1.993 . . . . 1.0 111.892 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 44' ' ' ILE . 70.8 m -146.55 -97.69 0.09 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.383 -0.372 . . . . 1.0 110.832 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 43' ' ' SER . 68.7 mt 59.12 128.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.897 0.38 . . . . 1.0 110.086 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.524 ' ND2' ' N ' ' A' ' 45' ' ' ASN . 0.1 OUTLIER -56.34 90.64 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.194 0.521 . . . . 1.0 110.772 -179.847 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.1 t -57.11 -17.05 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.017 0.437 . . . . 1.0 110.867 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -83.17 12.22 5.46 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.395 0.617 . . . . 1.0 110.182 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -132.93 54.86 1.93 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.205 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 85.4 mt -144.03 110.33 5.47 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.974 -0.557 . . . . 1.0 109.721 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -147.79 157.4 43.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 122.022 0.915 . . . . 1.0 111.791 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -119.25 139.39 51.96 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.871 -1.059 . . . . 1.0 108.433 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -117.56 168.39 10.45 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 122.536 1.16 . . . . 1.0 112.1 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.3 m -123.93 139.32 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 114.458 -1.246 . . . . 1.0 109.367 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.447 ' C ' ' H ' ' A' ' 56' ' ' SER . 40.0 p-10 -99.79 78.49 2.14 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.565 0.697 . . . . 1.0 110.484 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 56' ' ' SER . 23.9 mt -71.86 45.94 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.539 -0.755 . . . . 1.0 109.844 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.473 ' O ' ' C ' ' A' ' 57' ' ' GLY . 14.6 m -57.55 -142.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.329 0.585 . . . . 1.0 111.16 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.497 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . 30.75 -112.94 0.05 OUTLIER Glycine 0 N--CA 1.472 1.067 0 N-CA-C 111.121 -0.792 . . . . 1.0 111.121 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 1.9 p 154.55 -5.21 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 115.632 -0.284 . . . . 1.0 111.354 178.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.633 ' CD ' ' H ' ' A' ' 59' ' ' GLU . 8.6 mp0 -37.91 95.86 0.1 Allowed Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 111.762 0.282 . . . . 1.0 111.762 -178.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -62.64 138.47 70.02 Favored 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 122.483 2.122 . . . . 1.0 112.489 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 141.47 -117.54 1.22 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.608 -0.997 . . . . 1.0 110.608 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -137.53 73.77 1.46 Allowed 'General case' 0 N--CA 1.477 0.878 0 O-C-N 122.239 -0.565 . . . . 1.0 109.952 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -88.32 136.03 33.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.827 0.822 . . . . 1.0 112.247 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.406 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 32.7 p-10 -82.99 110.26 17.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.24 -0.891 . . . . 1.0 109.029 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -97.12 159.49 14.88 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.839 0.828 . . . . 1.0 111.626 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -104.58 141.39 36.49 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.934 -1.03 . . . . 1.0 111.296 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.7 t -80.01 124.47 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.43 0.634 . . . . 1.0 110.232 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -100.42 88.86 3.77 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.646 0.736 . . . . 1.0 110.297 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.5 t -86.71 134.75 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.044 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -74.35 146.54 84.23 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.51 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.58 154.72 64.31 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 122.371 2.047 . . . . 1.0 112.198 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.3 mt -112.43 123.25 34.52 Favored Pre-proline 0 N--CA 1.48 1.032 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.721 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.95 135.71 23.75 Favored 'Trans proline' 0 N--CA 1.504 2.098 0 C-N-CA 121.853 1.702 . . . . 1.0 112.392 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 79.48 -15.12 0.79 Allowed 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.39 0.676 . . . . 1.0 111.258 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.7 mm -120.8 146.17 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-O 122.077 0.941 . . . . 1.0 110.005 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -110.19 112.48 24.47 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 122.061 0.934 . . . . 1.0 111.167 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.8 tt -59.72 146.32 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-O 121.391 0.615 . . . . 1.0 110.094 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 68.6 t -103.66 -42.39 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 122.004 -0.435 . . . . 1.0 110.741 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -172.98 175.36 3.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.923 0.868 . . . . 1.0 110.776 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.422 ' O ' ' O ' ' A' ' 34' ' ' ARG . 61.9 mt -110.23 -77.61 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 115.648 -0.706 . . . . 1.0 109.767 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 80' ' ' ILE . 88.3 p 54.97 108.35 0.02 OUTLIER Pre-proline 0 CA--C 1.549 0.939 0 CA-C-O 118.228 -0.891 . . . . 1.0 112.213 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -68.93 122.02 5.38 Favored 'Cis proline' 0 N--CA 1.503 2.044 0 CA-C-N 120.373 1.169 . . . . 1.0 111.794 0.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 91.8 mtm180 -68.71 -34.21 75.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.929 0.871 . . . . 1.0 109.428 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.5 t -130.32 142.51 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.469 0.707 . . . . 1.0 109.117 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.4 m -135.51 153.61 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-O 121.766 0.793 . . . . 1.0 111.746 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 38.4 m -107.29 120.77 43.06 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.17 -0.923 . . . . 1.0 110.602 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 60.0 mt -126.75 134.64 50.58 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.349 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -93.25 131.15 38.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.352 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.1 mt -112.98 140.27 47.94 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.362 0.601 . . . . 1.0 110.085 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -139.1 152.21 47.31 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.894 0.854 . . . . 1.0 111.067 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -69.12 139.74 54.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.153 -0.93 . . . . 1.0 110.826 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -69.18 98.32 1.01 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.666 0.746 . . . . 1.0 111.078 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -76.24 101.99 5.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.225 0.536 . . . . 1.0 110.382 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -165.21 128.98 2.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.815 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.464 ' CG ' ' N ' ' A' ' 96' ' ' HIS . 39.3 p-80 -58.83 -49.08 79.04 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.033 -0.358 . . . . 1.0 110.033 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.464 ' N ' ' CG ' ' A' ' 95' ' ' HIS . 81.3 t60 . . . . . 0 C--O 1.219 -0.526 0 CA-C-O 117.915 -1.041 . . . . 1.0 109.807 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.4 t . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 109.47 -0.567 . . . . 1.0 109.47 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.9 t 55.37 -174.49 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.954 -0.387 . . . . 1.0 109.954 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -71.41 123.22 21.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.554 0.692 . . . . 1.0 110.116 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.9 m -155.91 74.64 0.87 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.584 0.707 . . . . 1.0 109.626 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.532 ' C ' ' H ' ' A' ' 7' ' ' ARG . 0.6 OUTLIER -156.16 -163.71 1.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.125 0.488 . . . . 1.0 110.669 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.8 t0 71.27 -34.15 0.29 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.064 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.532 ' H ' ' C ' ' A' ' 5' ' ' LEU . 88.5 mtm180 46.22 103.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.187 0.518 . . . . 1.0 111.765 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 53.03 83.16 0.23 Allowed Pre-proline 0 CA--C 1.54 0.586 0 O-C-N 121.814 -0.554 . . . . 1.0 112.288 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.69 147.72 78.31 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 122.678 2.252 . . . . 1.0 112.834 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 81.9 m -119.27 107.15 13.06 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.578 0.704 . . . . 1.0 110.133 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.4 mt -117.91 152.79 34.73 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.18 0.991 . . . . 1.0 110.427 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.2 m -117.17 123.92 47.87 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.604 -0.725 . . . . 1.0 110.607 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.501 HD13 ' H ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -112.51 145.64 39.89 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.606 -0.724 . . . . 1.0 110.468 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.501 ' H ' HD13 ' A' ' 13' ' ' LEU . 95.9 p -86.38 155.59 20.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.263 0.554 . . . . 1.0 109.908 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.7 tp -95.03 129.61 42.04 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.197 0.523 . . . . 1.0 110.755 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.0 pt -127.03 148.76 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-O 121.451 0.643 . . . . 1.0 110.958 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.9 104.64 16.86 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 121.841 -0.537 . . . . 1.0 110.971 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -82.68 59.68 4.86 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.33 0.586 . . . . 1.0 110.928 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.694 ' ND2' ' H ' ' A' ' 55' ' ' LEU . 1.8 p30 171.71 -79.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.356 0.598 . . . . 1.0 110.062 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.9 m 48.66 70.38 2.12 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 115.918 -0.583 . . . . 1.0 111.625 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 22' ' ' ALA . 40.0 Cg_endo -66.64 143.47 68.38 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 121.849 1.699 . . . . 1.0 111.557 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.469 ' C ' ' H ' ' A' ' 24' ' ' SER . . . -48.36 -175.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.54 0.686 . . . . 1.0 111.727 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.6 m120 73.55 -25.68 0.19 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.089 0.471 . . . . 1.0 111.048 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 22' ' ' ALA . 2.9 t -134.27 149.77 50.95 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 122.013 0.911 . . . . 1.0 110.614 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 17.0 ptm -143.62 142.79 31.2 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.613 -0.721 . . . . 1.0 110.414 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 80.5 mt -86.23 119.04 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 121.546 0.688 . . . . 1.0 110.833 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 12.3 ptm -98.69 -6.6 29.33 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.453 0.644 . . . . 1.0 109.571 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 91.5 m -84.47 136.25 33.91 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -67.95 123.31 20.24 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.316 -0.865 . . . . 1.0 110.334 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.454 HD22 ' N ' ' A' ' 30' ' ' LEU . 4.4 mm? -53.08 103.11 0.35 Allowed Pre-proline 0 CA--C 1.547 0.841 0 CA-C-O 118.68 -0.676 . . . . 1.0 112.096 -178.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -65.32 155.73 67.02 Favored 'Trans proline' 0 N--CA 1.506 2.256 0 C-N-CA 122.517 2.145 . . . . 1.0 113.144 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.6 p -93.17 165.58 12.75 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.646 -0.659 . . . . 1.0 110.994 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.6 m -137.8 135.43 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-O 121.141 0.496 . . . . 1.0 110.985 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.404 HH22 ' CE ' ' A' ' 36' ' ' LYS . 8.4 ptm180 -97.96 128.37 44.49 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.538 -0.542 . . . . 1.0 109.538 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 t -122.84 134.69 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 122.172 0.987 . . . . 1.0 111.473 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.404 ' CE ' HH22 ' A' ' 34' ' ' ARG . 68.7 mttm -109.4 155.85 20.76 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.357 -0.838 . . . . 1.0 110.412 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 76.0 p -138.02 124.9 21.2 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.247 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 39' ' ' GLY . 10.6 tm-20 -46.54 -67.17 0.31 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.859 0.838 . . . . 1.0 110.524 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 38' ' ' GLU . . . -58.74 -147.99 0.01 OUTLIER Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.017 -0.833 . . . . 1.0 111.017 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -141.97 122.9 14.48 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.651 0.739 . . . . 1.0 110.762 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.618 ' CB ' HD12 ' A' ' 44' ' ' ILE . 6.7 p-10 -127.37 45.88 1.8 Allowed Pre-proline 0 N--CA 1.476 0.861 0 CA-C-N 116.024 -0.535 . . . . 1.0 111.164 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 41' ' ' ASN . 56.8 Cg_endo -67.72 -8.59 22.85 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.528 2.152 . . . . 1.0 111.667 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.6 t -143.58 77.02 1.54 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.169 0.509 . . . . 1.0 111.045 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.618 HD12 ' CB ' ' A' ' 41' ' ' ASN . 24.5 mt -144.06 156.17 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 121.932 0.873 . . . . 1.0 109.535 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.526 ' C ' ' H ' ' A' ' 47' ' ' ASN . 18.0 t-20 -68.16 55.51 0.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.447 -0.797 . . . . 1.0 110.67 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.4 m -70.56 24.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 121.023 0.44 . . . . 1.0 110.96 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.526 ' H ' ' C ' ' A' ' 45' ' ' ASN . 53.3 t30 -87.79 6.58 34.52 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.149 0.5 . . . . 1.0 110.413 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -126.29 8.34 7.19 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.208 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.488 HD21 HG12 ' A' ' 72' ' ' ILE . 16.2 mt -95.61 121.71 37.59 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.236 0.541 . . . . 1.0 109.707 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -148.51 163.54 36.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 122.466 1.127 . . . . 1.0 111.619 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -109.91 133.01 53.63 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.398 -1.274 . . . . 1.0 108.351 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.525 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 7.7 p90 -145.32 152.72 40.35 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 122.76 1.267 . . . . 1.0 112.164 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.8 m -111.75 138.61 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 114.214 -1.357 . . . . 1.0 109.068 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -88.35 87.05 7.17 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.625 -0.716 . . . . 1.0 110.519 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.694 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 4.1 mp -69.66 -10.59 58.88 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.079 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 55' ' ' LEU . 56.9 m 29.13 -108.93 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.655 0.613 . . . . 1.0 112.655 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.504 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -68.97 -76.33 0.47 Allowed Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.04 -0.824 . . . . 1.0 111.04 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 3.0 p 149.31 134.27 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.37 0.605 . . . . 1.0 111.663 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -132.98 77.03 69.18 Favored Pre-proline 0 N--CA 1.483 1.176 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.883 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.68 153.9 64.09 Favored 'Trans proline' 0 N--CA 1.507 2.308 0 C-N-CA 123.153 2.568 . . . . 1.0 112.953 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.558 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . 98.6 50.82 1.48 Allowed Glycine 0 N--CA 1.472 1.057 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.558 ' O ' ' O ' ' A' ' 61' ' ' GLY . 97.3 mt-10 54.79 137.3 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 O-C-N 122.245 -0.562 . . . . 1.0 110.217 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.672 ' CG ' ' H ' ' A' ' 64' ' ' ASP . 36.1 t60 -149.92 -166.0 2.43 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 122.595 1.188 . . . . 1.0 112.377 -178.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.672 ' H ' ' CG ' ' A' ' 63' ' ' HIS . 79.4 m-20 -143.35 97.89 3.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.58 -1.191 . . . . 1.0 109.155 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -99.76 135.83 40.58 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.791 0.805 . . . . 1.0 111.405 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.476 ' CD ' ' N ' ' A' ' 67' ' ' VAL . 10.2 tm-20 -72.08 152.87 42.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.992 -1.003 . . . . 1.0 111.326 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.476 ' N ' ' CD ' ' A' ' 66' ' ' GLU . 41.1 t -91.02 116.06 31.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.668 0.747 . . . . 1.0 110.119 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.432 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 28.1 ttmt -109.61 106.39 16.06 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 122.163 0.983 . . . . 1.0 110.443 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.1 t -99.05 139.61 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 115.689 -0.687 . . . . 1.0 111.242 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -68.37 117.65 51.83 Favored Pre-proline 0 CA--C 1.55 0.972 0 CA-C-O 118.719 -0.657 . . . . 1.0 110.56 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.58 141.29 19.66 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 C-N-CA 121.718 1.612 . . . . 1.0 112.701 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.488 HG12 HD21 ' A' ' 49' ' ' LEU . 44.7 mm -113.14 119.27 42.75 Favored Pre-proline 0 N--CA 1.484 1.229 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.07 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.23 89.09 0.93 Allowed 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 122.019 1.813 . . . . 1.0 112.585 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 166.25 -19.99 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 122.685 0.394 . . . . 1.0 110.573 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.8 mm -134.8 156.14 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 121.851 0.834 . . . . 1.0 110.244 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -101.03 144.51 29.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 122.755 1.264 . . . . 1.0 111.2 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.564 HG23 ' O ' ' A' ' 77' ' ' ILE . 18.4 tt -108.59 114.86 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 115.208 -0.905 . . . . 1.0 110.148 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.9 t -66.05 -41.05 88.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 O-C-N 122.133 -0.355 . . . . 1.0 110.408 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.409 ' CD ' ' NH2' ' A' ' 83' ' ' ARG . 1.9 mt-10 -179.54 -175.53 0.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 122.177 0.989 . . . . 1.0 110.595 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.0 mt -107.56 -75.35 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 115.346 -0.843 . . . . 1.0 109.839 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.0 m 53.57 101.43 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.714 0 CA-C-O 118.219 -0.896 . . . . 1.0 111.848 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.52 172.35 35.49 Favored 'Cis proline' 0 N--CA 1.505 2.18 0 CA-C-N 120.287 1.138 . . . . 1.0 111.805 0.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.409 ' NH2' ' CD ' ' A' ' 79' ' ' GLU . 97.3 mtt180 -119.85 -12.97 9.12 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.679 0.752 . . . . 1.0 109.097 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.6 t -145.82 141.96 21.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.065 -0.717 . . . . 1.0 109.065 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.7 m -135.37 139.93 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-O 121.542 0.686 . . . . 1.0 111.662 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.525 ' O ' HG23 ' A' ' 86' ' ' THR . 12.9 t -103.04 119.86 39.62 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.387 -0.824 . . . . 1.0 110.753 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 62.1 mt -108.7 -178.22 3.53 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.658 0.742 . . . . 1.0 110.157 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -139.56 110.76 6.95 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.469 -0.787 . . . . 1.0 110.512 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.5 mt -105.01 139.43 39.71 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.493 -0.776 . . . . 1.0 110.086 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -145.43 144.21 30.5 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.741 0.781 . . . . 1.0 111.168 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.467 ' O ' ' N ' ' A' ' 93' ' ' HIS . 13.8 p80 -67.06 137.82 56.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.434 -0.803 . . . . 1.0 110.737 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.445 ' CG ' ' O ' ' A' ' 92' ' ' HIS . 7.9 p80 -61.99 72.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.252 0.549 . . . . 1.0 111.358 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.467 ' N ' ' O ' ' A' ' 91' ' ' HIS . 86.5 t60 -61.89 -45.06 95.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.951 0.405 . . . . 1.0 110.36 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -71.46 123.81 23.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.205 0.526 . . . . 1.0 110.922 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 37.7 p-80 -71.24 134.35 46.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.327 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 . . . . . 0 C--O 1.219 -0.528 0 CA-C-O 118.082 -0.961 . . . . 1.0 110.545 -179.853 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.9 p . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.552 -0.536 . . . . 1.0 109.552 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.0 m -70.22 144.19 51.96 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.797 -0.446 . . . . 1.0 109.797 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -84.66 177.41 8.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.389 0.614 . . . . 1.0 110.171 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.0 p 49.81 80.82 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.562 0.696 . . . . 1.0 110.074 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.539 HD12 ' N ' ' A' ' 5' ' ' LEU . 9.1 mp -84.63 87.31 7.27 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.075 0.464 . . . . 1.0 110.699 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -138.03 -112.85 0.17 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.832 -0.433 . . . . 1.0 109.832 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 74.4 mtp85 39.73 66.2 0.61 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.325 0.583 . . . . 1.0 112.194 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -165.3 107.59 0.78 Allowed Pre-proline 0 CA--C 1.545 0.757 0 O-C-N 121.927 -0.483 . . . . 1.0 111.273 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -77.04 161.72 32.48 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.484 1.456 . . . . 1.0 112.738 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.4 m -110.06 99.67 8.73 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.662 0.744 . . . . 1.0 110.122 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 57.8 mt -107.3 146.53 31.41 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.445 0.641 . . . . 1.0 110.287 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.9 t -124.03 127.72 48.3 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.274 0.559 . . . . 1.0 110.756 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 44.7 mt -110.46 137.42 48.18 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.602 -0.726 . . . . 1.0 110.221 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.1 t -63.36 171.17 2.58 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.865 -0.42 . . . . 1.0 109.865 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.9 tp -125.67 116.04 21.05 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.796 0.808 . . . . 1.0 110.805 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 38.2 pt -117.61 149.66 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-O 121.749 0.785 . . . . 1.0 110.67 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.56 124.73 39.72 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.87 -0.519 . . . . 1.0 110.689 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -120.64 -178.49 3.73 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.364 0.602 . . . . 1.0 110.0 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 45.03 37.02 2.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.373 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.05 109.39 6.16 Favored Pre-proline 0 CA--C 1.561 1.402 0 CA-C-O 118.479 -0.772 . . . . 1.0 111.005 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -59.05 -146.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.508 2.332 0 C-N-CA 121.141 1.228 . . . . 1.0 111.922 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.547 ' O ' ' C ' ' A' ' 23' ' ' ASN . . . -49.17 143.95 5.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 122.07 0.938 . . . . 1.0 111.544 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.547 ' C ' ' O ' ' A' ' 22' ' ' ALA . 12.2 m120 -13.91 84.84 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.483 0.659 . . . . 1.0 112.067 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 22' ' ' ALA . 40.5 t -96.06 149.12 21.95 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.644 0.735 . . . . 1.0 110.886 -178.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 26.2 ttt -144.44 103.64 3.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.558 0.694 . . . . 1.0 110.089 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.907 ' H ' HD12 ' A' ' 26' ' ' ILE . 2.7 mp -70.57 119.63 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.953 -0.567 . . . . 1.0 111.051 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -60.9 -45.26 95.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.261 0.553 . . . . 1.0 109.555 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.8 p -79.14 171.16 15.58 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -102.59 166.9 10.26 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.331 -0.856 . . . . 1.0 110.273 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 22.3 mt -102.56 94.21 4.84 Favored Pre-proline 0 CA--C 1.553 1.083 0 CA-C-N 115.553 -0.749 . . . . 1.0 112.104 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -80.79 157.6 21.23 Favored 'Trans proline' 0 N--CA 1.504 2.106 0 C-N-CA 121.819 1.679 . . . . 1.0 112.964 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 96.0 p -67.73 161.81 25.2 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 121.728 -0.608 . . . . 1.0 110.953 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.3 m -120.19 138.45 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.174 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 67.5 mtp85 -89.47 118.81 29.39 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.829 -0.434 . . . . 1.0 109.829 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.91 132.26 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 121.816 0.817 . . . . 1.0 111.534 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -102.52 150.99 22.84 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.66 -0.7 . . . . 1.0 110.211 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 72.6 p -134.96 136.86 42.56 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.057 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -53.34 -69.65 0.11 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.805 0.812 . . . . 1.0 110.428 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.46 ' H ' HG23 ' A' ' 75' ' ' ILE . . . -49.04 172.45 0.06 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.252 -0.739 . . . . 1.0 111.252 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.442 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 68.2 t80 -96.92 -8.08 31.64 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.838 0.352 . . . . 1.0 111.308 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.7 m120 59.69 77.9 0.36 Allowed Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.749 -0.205 . . . . 1.0 111.294 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -45.69 -45.19 16.87 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 121.603 1.535 . . . . 1.0 112.371 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.4 p -169.86 21.77 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.785 0.326 . . . . 1.0 111.119 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.513 HD12 ' N ' ' A' ' 44' ' ' ILE . 1.6 mp -53.39 133.59 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 121.657 0.742 . . . . 1.0 110.032 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -55.56 91.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.677 -0.692 . . . . 1.0 110.802 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 55.9 t -55.37 -16.68 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.44 -0.346 . . . . 1.0 110.621 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.5 ' O ' ' N ' ' A' ' 49' ' ' LEU . 10.2 p30 -80.58 -48.28 12.94 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.837 0.351 . . . . 1.0 110.308 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.462 ' N ' ' OD1' ' A' ' 47' ' ' ASN . 80.0 tt0 -43.99 -14.81 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 116.002 -0.545 . . . . 1.0 111.448 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.5 ' N ' ' O ' ' A' ' 47' ' ' ASN . 40.3 mt -95.02 139.53 31.26 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.455 ' CE2' ' O ' ' A' ' 47' ' ' ASN . 92.5 m-85 -150.86 159.43 44.56 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.768 0.794 . . . . 1.0 111.486 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -120.23 134.65 55.21 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.027 -0.988 . . . . 1.0 108.704 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 22.2 p90 -150.32 149.09 29.64 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.323 1.059 . . . . 1.0 112.104 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.0 m -105.62 147.44 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 114.648 -1.16 . . . . 1.0 109.083 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.462 ' C ' ' H ' ' A' ' 56' ' ' SER . 50.1 p-10 -101.23 81.03 2.17 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.305 0.574 . . . . 1.0 110.757 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.0 mt -56.29 -6.07 0.24 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.247 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.462 ' H ' ' C ' ' A' ' 54' ' ' ASP . 42.9 t 34.82 -95.49 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.25 0.62 . . . . 1.0 112.612 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.948 ' O ' ' O ' ' A' ' 58' ' ' SER . . . -114.55 62.39 0.33 Allowed Glycine 0 N--CA 1.472 1.094 0 N-CA-C 110.77 -0.932 . . . . 1.0 110.77 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.948 ' O ' ' O ' ' A' ' 57' ' ' GLY . 8.6 m 8.51 144.07 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.125 0 N-CA-C 113.707 1.003 . . . . 1.0 113.707 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.528 ' H ' HD12 ' A' ' 89' ' ' LEU . 73.5 mm-40 -133.64 82.02 52.13 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 110.07 -0.345 . . . . 1.0 110.07 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -49.36 139.97 27.71 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.133 1.889 . . . . 1.0 112.305 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.04 -97.37 0.81 Allowed Glycine 0 N--CA 1.47 0.959 0 N-CA-C 110.602 -0.999 . . . . 1.0 110.602 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -165.18 139.88 5.05 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 122.242 -0.563 . . . . 1.0 109.62 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.665 ' CG ' ' H ' ' A' ' 64' ' ' ASP . 32.5 t60 -154.94 -164.24 1.75 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 122.365 1.079 . . . . 1.0 112.167 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.665 ' H ' ' CG ' ' A' ' 63' ' ' HIS . 12.7 p-10 -122.79 145.04 48.78 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 114.607 -1.178 . . . . 1.0 109.134 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -142.56 138.12 30.6 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.309 0.576 . . . . 1.0 111.627 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -94.31 142.56 27.27 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.528 -0.76 . . . . 1.0 111.045 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.9 t -95.95 135.38 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.333 0.587 . . . . 1.0 110.175 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.72 151.24 52.03 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.881 0.848 . . . . 1.0 110.472 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.7 t -131.19 144.66 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 121.571 0.7 . . . . 1.0 111.131 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -68.08 128.49 93.27 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-N 115.422 -0.808 . . . . 1.0 110.445 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -39.51 153.9 0.05 OUTLIER 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.069 1.846 . . . . 1.0 113.433 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.565 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -101.07 154.85 36.92 Favored Pre-proline 0 N--CA 1.483 1.202 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.582 -179.29 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 72' ' ' ILE . 61.1 Cg_exo -37.46 -106.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.509 2.415 0 C-N-CA 122.775 2.317 . . . . 1.0 113.698 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -105.99 18.25 22.37 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.036 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.586 HG22 ' N ' ' A' ' 76' ' ' LYS . 81.5 mt -103.53 166.1 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 121.351 0.596 . . . . 1.0 110.136 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.586 ' N ' HG22 ' A' ' 75' ' ' ILE . 66.1 tttm -118.98 119.98 35.92 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.894 0.854 . . . . 1.0 111.533 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.439 ' HB ' HD11 ' A' ' 72' ' ' ILE . 19.3 tt -59.81 143.01 14.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.128 0.49 . . . . 1.0 110.323 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 85.1 t -96.14 -49.4 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 122.104 -0.373 . . . . 1.0 110.689 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -173.17 133.62 0.52 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.415 0.626 . . . . 1.0 111.031 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.8 tp -100.85 134.15 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-O 121.492 0.663 . . . . 1.0 109.381 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 61.8 p -145.45 143.06 19.03 Favored Pre-proline 0 N--CA 1.478 0.948 0 CA-C-O 118.939 -0.553 . . . . 1.0 111.795 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.6 138.66 56.2 Favored 'Cis proline' 0 N--CA 1.505 2.196 0 CA-C-N 119.602 0.894 . . . . 1.0 111.896 -1.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -67.87 -35.27 78.24 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.98 0.895 . . . . 1.0 109.947 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 t -134.89 145.6 32.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.178 -0.675 . . . . 1.0 109.178 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.65 161.44 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-O 122.431 1.11 . . . . 1.0 110.833 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 75.8 m -105.98 124.21 49.21 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.434 -1.257 . . . . 1.0 110.525 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 87.5 mt -130.62 116.98 18.84 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.192 0.52 . . . . 1.0 110.093 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -96.82 110.62 23.06 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.389 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.528 HD12 ' H ' ' A' ' 59' ' ' GLU . 51.5 mt -78.83 150.59 32.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.056 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -129.4 141.28 51.09 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 122.092 0.949 . . . . 1.0 111.045 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -65.63 126.59 28.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.009 -0.996 . . . . 1.0 110.584 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.447 ' CG ' ' O ' ' A' ' 92' ' ' HIS . 78.4 t60 -72.18 43.62 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.039 0.447 . . . . 1.0 111.095 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.439 ' ND1' ' N ' ' A' ' 93' ' ' HIS . 0.2 OUTLIER -73.01 1.44 8.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.232 0.539 . . . . 1.0 110.291 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -61.26 -49.28 77.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 1.0 111.156 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.424 ' O ' ' NE2' ' A' ' 92' ' ' HIS . 86.3 t60 -170.3 132.07 1.0 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.034 -0.358 . . . . 1.0 110.034 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 . . . . . 0 C--O 1.219 -0.524 0 CA-C-O 118.171 -0.919 . . . . 1.0 110.606 179.826 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.436 -0.579 . . . . 1.0 109.436 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.2 t 54.48 173.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.917 -0.401 . . . . 1.0 109.917 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -156.72 158.29 36.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.387 0.613 . . . . 1.0 110.121 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 51.2 p -71.08 137.85 49.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.121 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.485 HD12 ' N ' ' A' ' 5' ' ' LEU . 9.8 mp 53.29 -177.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.198 0.523 . . . . 1.0 110.755 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -166.12 162.61 17.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.238 0.542 . . . . 1.0 109.852 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -73.45 151.25 41.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.432 0.634 . . . . 1.0 111.455 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 41.64 75.99 0.56 Allowed Pre-proline 0 C--N 1.327 -0.372 0 C-N-CA 122.975 0.51 . . . . 1.0 112.293 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.68 153.37 54.13 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.426 2.084 . . . . 1.0 113.019 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 75.3 m -106.15 99.24 8.84 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.408 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -94.02 146.73 23.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 122.13 0.967 . . . . 1.0 110.497 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.2 m -119.52 109.6 15.91 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.625 -0.716 . . . . 1.0 110.475 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.5 mt -110.36 134.14 52.58 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.318 -0.855 . . . . 1.0 109.696 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.0 m -79.74 164.95 23.29 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.91 -0.404 . . . . 1.0 109.91 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.2 tp -113.08 118.21 34.14 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.73 0.776 . . . . 1.0 110.648 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.8 pp -128.19 162.17 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 CA-C-O 121.751 0.786 . . . . 1.0 110.925 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.403 ' CB ' ' OG1' ' A' ' 20' ' ' THR . . . -79.69 157.99 27.08 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 121.769 -0.582 . . . . 1.0 111.001 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -66.94 -36.68 82.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.221 0.534 . . . . 1.0 111.282 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -166.45 -34.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.098 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.403 ' OG1' ' CB ' ' A' ' 17' ' ' ALA . 22.3 m 59.34 76.56 0.44 Allowed Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 116.343 -0.39 . . . . 1.0 111.463 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 22' ' ' ALA . 31.7 Cg_exo -57.88 148.96 72.82 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.249 1.966 . . . . 1.0 111.586 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.449 ' C ' ' H ' ' A' ' 24' ' ' SER . . . -51.37 -169.96 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.891 0.853 . . . . 1.0 111.74 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.609 HD21 ' CD2' ' A' ' 91' ' ' HIS . 0.4 OUTLIER 71.23 -38.68 0.43 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.141 -0.481 . . . . 1.0 111.001 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.449 ' H ' ' C ' ' A' ' 22' ' ' ALA . 13.3 p -109.02 149.58 29.05 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.699 0.761 . . . . 1.0 110.587 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 11.7 tmm? -141.88 120.26 12.35 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.553 0.692 . . . . 1.0 110.33 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 74.0 mt -72.74 116.13 14.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.592 0.71 . . . . 1.0 110.881 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 78.0 mtp -94.83 -16.41 22.96 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.925 -0.579 . . . . 1.0 109.669 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.9 m -78.71 134.5 37.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.262 0.553 . . . . 1.0 109.69 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.407 ' H ' ' HD2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -78.57 123.99 27.68 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 121.288 -0.883 . . . . 1.0 110.316 -179.548 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.7 mt -70.43 114.71 28.18 Favored Pre-proline 0 CA--C 1.555 1.139 0 CA-C-N 115.748 -0.66 . . . . 1.0 112.05 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -84.68 152.59 11.62 Favored 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 121.77 1.647 . . . . 1.0 113.07 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.7 m -72.98 173.28 9.52 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.614 -0.679 . . . . 1.0 111.213 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.517 HG21 HD11 ' A' ' 80' ' ' ILE . 2.8 p -142.84 136.96 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-O 121.376 0.608 . . . . 1.0 111.046 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -97.54 129.33 44.7 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.4 0.619 . . . . 1.0 109.346 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -124.71 134.18 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-O 122.101 0.953 . . . . 1.0 111.576 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -107.81 149.02 28.73 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.465 -0.789 . . . . 1.0 110.289 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 72.1 p -127.78 132.04 49.55 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 116.045 -0.525 . . . . 1.0 111.294 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -58.04 -75.29 0.05 OUTLIER 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.827 0.823 . . . . 1.0 110.09 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.61 166.64 15.94 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.959 -0.856 . . . . 1.0 110.959 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -79.77 175.08 10.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.841 0.829 . . . . 1.0 110.683 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.511 ' N ' HD22 ' A' ' 41' ' ' ASN . 1.5 m-80 -124.0 92.77 47.98 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 115.71 -0.677 . . . . 1.0 110.65 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -52.36 -40.9 69.66 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 121.893 1.729 . . . . 1.0 112.13 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 44' ' ' ILE . 73.8 m -165.51 -96.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.63 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 43' ' ' SER . 65.7 mt 57.76 141.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.128 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -85.44 96.95 9.75 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.165 0.507 . . . . 1.0 110.806 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.4 m -86.13 5.92 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 120.942 0.401 . . . . 1.0 110.782 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -97.13 -1.13 45.78 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.107 0.48 . . . . 1.0 110.262 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.482 ' OE1' ' N ' ' A' ' 48' ' ' GLU . 18.8 mp0 -120.25 6.27 10.72 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.662 -0.699 . . . . 1.0 110.145 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.0 mt -122.26 128.44 51.12 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.635 0.731 . . . . 1.0 109.557 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -133.67 -168.45 2.11 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.248 1.023 . . . . 1.0 111.544 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -115.41 139.74 49.75 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.626 -1.17 . . . . 1.0 108.989 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.475 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 16.8 p90 -141.37 153.42 45.08 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 122.34 1.067 . . . . 1.0 112.36 -178.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.3 m -110.56 140.09 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 114.647 -1.16 . . . . 1.0 109.27 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -77.44 88.57 3.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.502 0.668 . . . . 1.0 110.328 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 57' ' ' GLY . 0.8 OUTLIER -90.39 -26.52 19.86 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.623 -0.717 . . . . 1.0 109.848 -179.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 55' ' ' LEU . 35.4 t 28.18 -89.86 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.004 0.521 . . . . 1.0 112.353 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . -62.55 -75.01 0.35 Allowed Glycine 0 CA--C 1.531 1.093 0 N-CA-C 111.029 -0.828 . . . . 1.0 111.029 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.0 t 75.56 95.82 0.07 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 122.879 0.471 . . . . 1.0 111.469 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -123.61 147.95 54.57 Favored Pre-proline 0 N--CA 1.482 1.16 0 CA-C-O 119.514 -0.279 . . . . 1.0 111.67 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -47.82 139.0 19.92 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 121.724 1.616 . . . . 1.0 113.304 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 139.66 -135.59 7.3 Favored Glycine 0 N--CA 1.472 1.086 0 N-CA-C 110.532 -1.027 . . . . 1.0 110.532 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -170.65 144.02 2.27 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -154.62 -164.66 1.87 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.708 1.242 . . . . 1.0 112.451 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 32.8 p-10 -111.74 91.84 3.81 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 114.33 -1.305 . . . . 1.0 108.942 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -82.56 132.16 35.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.679 0.752 . . . . 1.0 111.36 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.51 153.63 37.38 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.057 -0.974 . . . . 1.0 111.171 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 65.4 t -94.09 110.29 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 121.59 0.71 . . . . 1.0 110.152 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' A' ' 52' ' ' TYR . 1.6 tmtp? -112.01 118.6 35.87 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 122.039 0.923 . . . . 1.0 110.137 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.3 m -126.43 149.89 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 115.783 -0.644 . . . . 1.0 111.203 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -74.84 125.77 89.09 Favored Pre-proline 0 CA--C 1.549 0.92 0 CA-C-O 118.387 -0.816 . . . . 1.0 110.311 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.01 137.76 19.91 Favored 'Trans proline' 0 N--CA 1.5 1.892 0 C-N-CA 121.619 1.546 . . . . 1.0 112.357 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.5 mm -79.8 128.74 73.29 Favored Pre-proline 0 CA--C 1.554 1.131 0 CA-C-N 116.456 -0.338 . . . . 1.0 111.314 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.3 152.82 66.74 Favored 'Trans proline' 0 N--CA 1.502 2.024 0 C-N-CA 121.506 1.471 . . . . 1.0 112.818 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.9 t30 65.63 -1.27 1.06 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.295 0.638 . . . . 1.0 111.29 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.415 HG22 ' N ' ' A' ' 76' ' ' LYS . 66.5 mt -133.58 155.48 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 121.64 0.733 . . . . 1.0 110.191 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.415 ' N ' HG22 ' A' ' 75' ' ' ILE . 68.7 mttm -107.93 149.82 27.86 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 122.267 1.032 . . . . 1.0 111.236 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.625 HG23 ' O ' ' A' ' 77' ' ' ILE . 18.1 tt -100.41 101.54 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 115.732 -0.667 . . . . 1.0 109.995 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.2 t -46.02 -58.18 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 O-C-N 122.121 -0.362 . . . . 1.0 110.636 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -175.62 141.68 0.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.685 0.755 . . . . 1.0 110.686 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.517 HD11 HG21 ' A' ' 33' ' ' VAL . 8.6 tp -104.18 138.85 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.399 0.619 . . . . 1.0 109.579 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.2 m -147.32 134.93 10.48 Favored Pre-proline 0 N--CA 1.481 1.079 0 CA-C-O 118.481 -0.771 . . . . 1.0 112.293 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.84 -174.49 10.77 Favored 'Cis proline' 0 N--CA 1.503 2.037 0 CA-C-N 120.133 1.083 . . . . 1.0 111.701 -0.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -121.2 -18.31 7.45 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.927 0.87 . . . . 1.0 109.312 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.6 t -138.61 136.94 43.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.029 -0.73 . . . . 1.0 109.029 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.2 m -137.19 174.74 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 CA-C-O 121.771 0.796 . . . . 1.0 111.476 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.0 t -133.07 128.31 35.95 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.137 -0.938 . . . . 1.0 110.465 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 50.2 mt -130.74 120.95 24.58 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 120.954 0.407 . . . . 1.0 110.207 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -86.16 112.12 21.02 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.582 0.706 . . . . 1.0 110.281 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.6 mt -80.68 165.87 21.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.673 -0.694 . . . . 1.0 110.085 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -140.27 130.32 24.86 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.9 0.857 . . . . 1.0 110.971 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.609 ' CD2' HD21 ' A' ' 23' ' ' ASN . 60.5 t-80 -76.19 129.57 36.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.194 -0.912 . . . . 1.0 110.522 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.559 ' CG ' ' H ' ' A' ' 93' ' ' HIS . 12.0 t-80 -73.16 -122.76 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.202 0.525 . . . . 1.0 111.145 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.559 ' H ' ' CG ' ' A' ' 92' ' ' HIS . 79.2 m80 -154.59 155.45 34.76 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.216 0.531 . . . . 1.0 110.494 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.428 ' O ' ' CG ' ' A' ' 95' ' ' HIS . 92.1 m-70 -80.09 121.19 25.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.276 0.56 . . . . 1.0 111.046 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.428 ' CG ' ' O ' ' A' ' 94' ' ' HIS . 38.4 m80 -156.9 4.44 0.15 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.183 -0.462 . . . . 1.0 109.839 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 79.4 m80 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.988 -1.006 . . . . 1.0 110.354 179.788 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 40.6 t . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.548 -0.538 . . . . 1.0 109.548 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.1 t -161.26 162.27 31.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.107 -0.497 . . . . 1.0 109.724 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -67.4 -18.74 65.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.287 0.565 . . . . 1.0 110.124 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.4 p -65.11 130.87 44.93 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.463 -0.569 . . . . 1.0 109.463 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 51.3 tp -64.72 -54.61 28.87 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 122.057 -0.402 . . . . 1.0 111.304 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 7' ' ' ARG . 14.4 p30 177.12 -41.2 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.095 0.474 . . . . 1.0 109.874 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.534 ' NH2' ' CZ ' ' A' ' 40' ' ' TYR . 88.6 mtm180 -72.44 146.65 46.78 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 122.263 1.03 . . . . 1.0 111.381 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -152.28 86.27 4.44 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 115.9 -0.591 . . . . 1.0 111.509 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.95 119.83 6.93 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 122.166 1.911 . . . . 1.0 113.227 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 42.0 m -117.25 87.15 2.65 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 121.312 0.577 . . . . 1.0 110.739 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.771 HD22 ' N ' ' A' ' 11' ' ' LEU . 0.9 OUTLIER -98.6 147.15 25.1 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 122.122 0.963 . . . . 1.0 110.615 -179.462 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.5 m -106.79 124.28 49.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.717 0.77 . . . . 1.0 110.338 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.8 mt -112.99 130.53 56.1 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.107 -0.951 . . . . 1.0 110.131 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.9 m -69.19 161.07 29.94 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.0 tp -113.47 116.89 30.31 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.449 0.643 . . . . 1.0 111.055 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.7 pt -119.04 140.5 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-O 121.877 0.846 . . . . 1.0 110.694 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.27 117.91 17.61 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.22 0.533 . . . . 1.0 110.918 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.2 tptt -112.86 159.3 19.17 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.357 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 53.37 31.15 11.44 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.96 -0.385 . . . . 1.0 109.96 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.0 m -68.93 129.7 92.1 Favored Pre-proline 0 CA--C 1.546 0.823 0 CA-C-O 119.051 -0.499 . . . . 1.0 111.704 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -71.92 117.31 5.08 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 121.245 1.297 . . . . 1.0 111.431 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -42.83 158.15 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.87 0.843 . . . . 1.0 111.617 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.4 m120 73.2 9.71 5.22 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.958 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 90.3 p -112.44 145.13 40.73 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.738 0.78 . . . . 1.0 110.701 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.408 ' SD ' ' O ' ' A' ' 26' ' ' ILE . 12.5 tmm? -139.31 121.07 15.38 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.722 -0.672 . . . . 1.0 110.258 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.408 ' O ' ' SD ' ' A' ' 25' ' ' MET . 54.6 mt -73.8 144.98 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.888 0.851 . . . . 1.0 110.979 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 10.7 tpp -107.34 -26.78 10.85 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.571 -0.741 . . . . 1.0 109.596 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.9 m -81.09 156.49 25.78 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.203 -0.666 . . . . 1.0 109.203 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.438 ' C ' HD22 ' A' ' 30' ' ' LEU . 61.9 pttt -84.18 157.89 21.5 Favored 'General case' 0 CA--C 1.516 -0.362 0 O-C-N 121.273 -0.892 . . . . 1.0 110.19 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.466 HD22 ' N ' ' A' ' 30' ' ' LEU . 4.3 mm? -100.26 97.84 6.89 Favored Pre-proline 0 N--CA 1.484 1.262 0 CA-C-N 115.958 -0.565 . . . . 1.0 112.42 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 29' ' ' LYS . 37.2 Cg_endo -86.1 157.38 9.88 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.486 2.124 . . . . 1.0 112.714 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.4 m -77.35 -178.21 5.04 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.594 -0.691 . . . . 1.0 110.991 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.7 p -140.78 149.82 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 121.31 0.576 . . . . 1.0 111.146 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -102.87 123.83 47.24 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.49 0.662 . . . . 1.0 109.423 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 t -120.29 133.14 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-O 122.265 1.031 . . . . 1.0 111.52 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.437 ' H ' ' HB3' ' A' ' 79' ' ' GLU . 63.6 tttm -103.45 146.29 28.73 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.293 -0.867 . . . . 1.0 110.076 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 43.8 p -131.24 130.63 43.13 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.099 -0.501 . . . . 1.0 111.469 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.431 ' O ' ' O ' ' A' ' 39' ' ' GLY . 83.9 tt0 -57.36 -74.72 0.05 Allowed 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.648 0.737 . . . . 1.0 110.159 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 38' ' ' GLU . . . -50.17 -173.72 0.01 OUTLIER Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.347 -0.701 . . . . 1.0 111.347 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.715 ' O ' HD11 ' A' ' 75' ' ' ILE . 3.0 m-85 -104.92 167.9 9.41 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.494 0.664 . . . . 1.0 110.411 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -120.67 83.88 36.17 Favored Pre-proline 0 N--CA 1.476 0.831 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.412 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.56 -41.26 69.42 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.132 1.888 . . . . 1.0 112.162 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.515 ' O ' ' O ' ' A' ' 44' ' ' ILE . 73.7 m -161.17 -88.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.246 0.546 . . . . 1.0 110.401 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.515 ' O ' ' O ' ' A' ' 43' ' ' SER . 2.8 tt 31.56 100.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.352 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.604 ' C ' ' H ' ' A' ' 47' ' ' ASN . 87.9 m-20 -63.65 96.85 0.13 Allowed 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 120.969 0.414 . . . . 1.0 110.815 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.8 m -66.63 20.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.331 0.586 . . . . 1.0 110.718 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.604 ' H ' ' C ' ' A' ' 45' ' ' ASN . 94.1 m-20 -92.26 12.2 23.22 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.14 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -125.32 -1.23 7.61 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.694 -0.685 . . . . 1.0 110.288 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.8 mt -123.01 133.38 54.35 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -141.09 -166.57 2.2 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.009 0.909 . . . . 1.0 111.592 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -118.7 140.51 49.81 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.798 -1.092 . . . . 1.0 108.389 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -120.36 166.73 13.14 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 122.413 1.101 . . . . 1.0 112.084 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.3 m -133.73 145.49 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 114.475 -1.239 . . . . 1.0 109.305 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -94.92 81.83 3.78 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.709 0.766 . . . . 1.0 110.663 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.2 mp -75.11 -4.09 36.56 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.445 -0.798 . . . . 1.0 110.176 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.8 t -79.06 5.33 12.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.371 -0.377 . . . . 1.0 111.329 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -132.59 52.04 0.84 Allowed Glycine 0 N--CA 1.474 1.213 0 N-CA-C 111.344 -0.702 . . . . 1.0 111.344 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.7 t -153.45 -63.92 0.15 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.536 0.208 . . . . 1.0 111.316 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 66.36 151.92 0.12 Allowed Pre-proline 0 N--CA 1.472 0.625 0 C-N-CA 122.562 0.345 . . . . 1.0 111.443 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -35.06 143.29 0.08 OUTLIER 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 122.866 2.377 . . . . 1.0 113.369 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.513 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . 120.24 16.16 4.86 Favored Glycine 0 N--CA 1.472 1.057 0 N-CA-C 110.935 -0.866 . . . . 1.0 110.935 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.513 ' O ' ' O ' ' A' ' 61' ' ' GLY . 81.6 tt0 57.17 141.07 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 O-C-N 122.12 -0.635 . . . . 1.0 109.9 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.73 ' CG ' ' H ' ' A' ' 64' ' ' ASP . 39.5 t60 -155.55 -163.65 1.57 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 122.883 1.325 . . . . 1.0 112.289 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.73 ' H ' ' CG ' ' A' ' 63' ' ' HIS . 95.6 m-20 -114.58 144.27 43.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.285 -1.325 . . . . 1.0 108.652 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' A' ' 65' ' ' TYR . 48.7 m-85 -134.76 139.15 44.93 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.426 0.631 . . . . 1.0 111.388 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -104.44 149.29 25.56 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.345 -0.843 . . . . 1.0 111.15 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 48.4 t -103.28 116.45 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 121.726 0.774 . . . . 1.0 110.203 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -123.51 139.74 53.71 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.293 1.044 . . . . 1.0 110.344 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.7 t -109.0 136.89 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 115.553 -0.748 . . . . 1.0 110.874 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -72.13 117.26 56.73 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-O 118.557 -0.735 . . . . 1.0 110.091 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -44.96 119.22 2.29 Favored 'Trans proline' 0 N--CA 1.505 2.167 0 C-N-CA 121.754 1.636 . . . . 1.0 113.157 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 33.9 mm -105.93 123.0 40.57 Favored Pre-proline 0 N--CA 1.487 1.39 0 CA-C-O 119.103 -0.475 . . . . 1.0 111.235 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.64 157.86 54.81 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.32 2.014 . . . . 1.0 112.092 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 33.6 t30 80.67 -26.27 0.16 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.481 0.712 . . . . 1.0 110.826 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.715 HD11 ' O ' ' A' ' 40' ' ' TYR . 12.7 mm -132.81 148.46 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 122.206 1.003 . . . . 1.0 110.489 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -113.77 149.6 34.65 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 122.762 1.268 . . . . 1.0 110.961 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.6 tt -91.97 142.99 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.209 -0.905 . . . . 1.0 110.112 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.8 t -120.72 -45.48 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 122.089 -0.382 . . . . 1.0 110.901 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.437 ' HB3' ' H ' ' A' ' 36' ' ' LYS . 81.4 tt0 -96.17 139.4 32.39 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 122.127 0.965 . . . . 1.0 110.667 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.5 mp -135.25 80.82 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 115.435 -0.802 . . . . 1.0 109.723 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.7 m -148.61 148.84 29.47 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 120.281 -0.568 . . . . 1.0 112.018 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.82 141.73 72.64 Favored 'Cis proline' 0 N--CA 1.509 2.423 0 C-N-CA 124.685 -0.964 . . . . 1.0 112.3 -1.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 90.8 mtm180 -61.76 -56.48 19.11 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.567 0.698 . . . . 1.0 109.368 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.1 t -135.21 149.25 28.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.231 -0.655 . . . . 1.0 109.231 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.2 m -144.75 163.73 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 121.647 0.737 . . . . 1.0 111.764 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 74.3 m -111.6 122.82 48.83 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.299 -0.864 . . . . 1.0 110.658 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.4 mt -107.99 -170.13 1.63 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.426 0.632 . . . . 1.0 110.204 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -146.56 112.6 5.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.47 0.652 . . . . 1.0 110.55 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.8 mt -107.33 143.16 36.01 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.555 0.693 . . . . 1.0 110.033 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -132.44 143.71 49.98 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.971 0.891 . . . . 1.0 111.036 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -68.65 131.16 44.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.165 -0.925 . . . . 1.0 110.547 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.425 ' NE2' ' O ' ' A' ' 95' ' ' HIS . 0.7 OUTLIER -133.19 128.22 35.49 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.701 0.762 . . . . 1.0 111.071 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -78.46 89.43 4.43 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.328 0.585 . . . . 1.0 110.317 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.563 ' CG ' ' H ' ' A' ' 95' ' ' HIS . 82.1 t60 52.76 173.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.211 0.529 . . . . 1.0 111.225 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.563 ' H ' ' CG ' ' A' ' 94' ' ' HIS . 83.3 t60 55.68 97.15 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.207 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 . . . . . 0 C--O 1.221 -0.414 0 CA-C-O 117.954 -1.022 . . . . 1.0 110.753 -179.723 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.481 ' H2 ' HG22 ' A' ' 4' ' ' THR . 45.9 t . . . . . 0 N--CA 1.484 1.255 0 N-CA-C 109.418 -0.586 . . . . 1.0 109.418 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.3 t -66.25 -51.72 54.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.874 0.369 . . . . 1.0 111.178 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -173.45 17.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.635 0.731 . . . . 1.0 110.062 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.481 HG22 ' H2 ' ' A' ' 1' ' ' SER . 0.1 OUTLIER -62.21 -43.66 98.34 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.741 0.782 . . . . 1.0 109.658 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 11.1 mp -65.79 167.16 9.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.7 0.762 . . . . 1.0 110.296 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 8' ' ' ASP . 51.6 p-10 -151.17 146.46 26.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.591 -0.732 . . . . 1.0 109.662 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -48.98 -8.82 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.808 -0.633 . . . . 1.0 112.558 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 6' ' ' ASP . 12.2 p-10 -139.21 81.82 20.34 Favored Pre-proline 0 N--CA 1.476 0.867 0 O-C-N 121.942 -0.474 . . . . 1.0 111.329 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.94 134.5 55.53 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.794 2.329 . . . . 1.0 112.739 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.7 m -104.51 85.92 2.42 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.409 0.623 . . . . 1.0 110.143 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.8 mt -86.01 145.52 27.06 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.814 0.816 . . . . 1.0 110.544 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.3 m -109.57 119.56 39.79 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.531 0.682 . . . . 1.0 110.599 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.8 mp -102.54 135.36 44.31 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.39 -0.823 . . . . 1.0 109.879 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 59.3 m -79.33 105.8 10.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.895 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.5 tp -68.52 95.94 0.66 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.591 0.71 . . . . 1.0 110.938 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.3 pt -118.69 165.05 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 121.571 0.701 . . . . 1.0 111.038 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.99 164.34 23.54 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.792 -0.568 . . . . 1.0 111.12 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.1 mmtp -104.11 -56.85 2.13 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.221 0.534 . . . . 1.0 111.402 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -92.89 -54.54 3.7 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.547 0.689 . . . . 1.0 110.144 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.662 ' CG2' HD11 ' A' ' 26' ' ' ILE . 0.3 OUTLIER 45.66 80.91 0.27 Allowed Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 115.831 -0.622 . . . . 1.0 111.592 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.38 134.72 65.52 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.302 2.001 . . . . 1.0 111.238 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.45 -14.4 3.01 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 122.001 -0.437 . . . . 1.0 111.859 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -91.53 -15.34 28.87 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.957 -0.464 . . . . 1.0 111.161 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.4 t -108.3 153.48 23.18 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.524 0.678 . . . . 1.0 110.779 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 45.0 ttp -144.66 115.51 7.8 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.706 0.765 . . . . 1.0 110.086 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.946 ' H ' HD12 ' A' ' 26' ' ' ILE . 2.2 mp -68.11 115.39 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.862 0.839 . . . . 1.0 111.095 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 44.3 ttm -67.67 -28.07 67.38 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.685 -0.689 . . . . 1.0 109.44 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 30' ' ' LEU . 5.9 m -68.88 135.74 51.56 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -68.85 -13.99 62.76 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 121.279 -0.888 . . . . 1.0 111.097 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.474 ' H ' HG22 ' A' ' 28' ' ' THR . 24.1 mt 61.95 91.81 0.07 OUTLIER Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 115.828 -0.624 . . . . 1.0 112.31 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -86.57 158.47 9.27 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.854 2.369 . . . . 1.0 112.755 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 95.4 p -69.13 178.07 2.45 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.666 -0.646 . . . . 1.0 111.268 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.0 p -139.7 151.04 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-O 121.408 0.623 . . . . 1.0 111.053 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 100.0 mtt180 -98.96 129.19 45.26 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.6 t -127.03 154.66 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 122.384 1.087 . . . . 1.0 111.396 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -124.7 142.67 51.23 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.108 -0.951 . . . . 1.0 110.591 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 60.3 p -130.08 136.57 49.49 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.33 0.586 . . . . 1.0 111.264 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -109.84 41.62 1.67 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.526 0.679 . . . . 1.0 109.798 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -125.3 -9.45 5.03 Favored Glycine 0 N--CA 1.472 1.093 0 N-CA-C 111.039 -0.824 . . . . 1.0 111.039 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 59.73 153.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.234 0.54 . . . . 1.0 111.13 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.468 ' ND2' ' N ' ' A' ' 41' ' ' ASN . 0.1 OUTLIER -175.4 148.11 1.02 Allowed Pre-proline 0 CA--C 1.547 0.835 0 O-C-N 122.212 -0.305 . . . . 1.0 110.451 179.854 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.29 -58.97 0.11 Allowed 'Trans proline' 0 N--CA 1.509 2.429 0 C-N-CA 121.507 1.471 . . . . 1.0 112.599 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.484 ' O ' ' HB ' ' A' ' 44' ' ' ILE . 40.2 t -159.42 -56.8 0.06 Allowed 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.71 0.767 . . . . 1.0 110.71 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 43' ' ' SER . 42.3 mt 91.92 -113.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-N 115.39 -0.823 . . . . 1.0 109.73 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.622 ' ND2' HD21 ' A' ' 47' ' ' ASN . 11.2 t-20 -175.87 -19.47 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.653 0.74 . . . . 1.0 110.383 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.444 ' C ' ' O ' ' A' ' 45' ' ' ASN . 17.7 m 28.18 43.58 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-O 121.827 0.822 . . . . 1.0 112.036 -178.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.622 HD21 ' ND2' ' A' ' 45' ' ' ASN . 99.3 m-20 -69.93 -40.92 75.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.577 -0.738 . . . . 1.0 110.754 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -127.95 13.08 6.78 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.617 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 28.5 mt -96.42 110.84 23.12 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.974 0.893 . . . . 1.0 109.597 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -148.24 -160.87 1.23 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 122.191 0.996 . . . . 1.0 111.533 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -117.2 142.49 46.97 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.703 -1.135 . . . . 1.0 108.263 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -134.57 175.12 9.82 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 122.03 0.919 . . . . 1.0 112.345 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.4 m -138.87 146.0 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 114.834 -1.075 . . . . 1.0 109.393 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -86.9 83.02 7.61 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.588 0.709 . . . . 1.0 110.318 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 56' ' ' SER . 0.7 OUTLIER -81.89 -13.79 57.09 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.0 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.454 ' C ' ' O ' ' A' ' 55' ' ' LEU . 77.3 p 20.18 -97.93 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 112.829 0.678 . . . . 1.0 112.829 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.493 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -60.57 -74.53 0.36 Allowed Glycine 0 CA--C 1.531 1.073 0 N-CA-C 110.583 -1.007 . . . . 1.0 110.583 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 3.9 m 101.94 45.24 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 123.94 0.896 . . . . 1.0 111.444 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 60' ' ' PRO . 12.3 mp0 -76.0 130.65 77.68 Favored Pre-proline 0 CA--C 1.548 0.902 0 CA-C-O 119.23 -0.414 . . . . 1.0 111.586 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 59' ' ' GLU . 88.7 Cg_exo -44.11 -179.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.506 2.251 0 C-N-CA 122.076 1.851 . . . . 1.0 113.044 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.54 -141.15 15.16 Favored Glycine 0 N--CA 1.472 1.093 0 N-CA-C 110.713 -0.955 . . . . 1.0 110.713 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.3 mp0 -138.19 75.1 1.5 Allowed 'General case' 0 N--CA 1.471 0.58 0 O-C-N 122.135 -0.626 . . . . 1.0 109.724 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -93.54 137.67 32.59 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.712 0.768 . . . . 1.0 112.013 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -85.37 139.19 31.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.282 -0.872 . . . . 1.0 109.072 178.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -132.11 127.94 37.09 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.718 0.77 . . . . 1.0 111.664 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 32.6 mp0 -67.87 132.81 48.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.091 -0.959 . . . . 1.0 111.318 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.6 t -76.27 124.96 35.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.507 0.67 . . . . 1.0 110.207 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -109.39 121.16 44.57 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.973 0.892 . . . . 1.0 110.196 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.3 m -109.75 129.61 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 115.833 -0.622 . . . . 1.0 111.008 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -50.35 127.76 23.49 Favored Pre-proline 0 CA--C 1.554 1.133 0 CA-C-O 118.87 -0.586 . . . . 1.0 110.554 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.3 112.01 3.42 Favored 'Trans proline' 0 N--CA 1.505 2.178 0 C-N-CA 121.684 1.59 . . . . 1.0 112.218 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.8 mp -82.02 129.71 63.27 Favored Pre-proline 0 CA--C 1.556 1.198 0 CA-C-O 119.411 -0.328 . . . . 1.0 110.795 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -67.15 140.98 55.63 Favored 'Trans proline' 0 N--CA 1.506 2.218 0 C-N-CA 121.755 1.637 . . . . 1.0 112.662 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.9 t30 66.93 10.32 7.55 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.271 0.629 . . . . 1.0 111.476 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mm -124.04 137.13 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-O 122.367 1.079 . . . . 1.0 109.746 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.33 121.14 38.89 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 122.145 0.974 . . . . 1.0 111.013 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.64 HG23 ' O ' ' A' ' 77' ' ' ILE . 7.4 tp -84.12 93.34 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.879 -0.601 . . . . 1.0 110.053 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.8 t -46.9 -53.65 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 O-C-N 121.97 -0.456 . . . . 1.0 110.835 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -170.42 -127.19 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.819 0.819 . . . . 1.0 110.408 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.8 mt -154.23 -77.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.131 -0.692 . . . . 1.0 109.131 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.6 t 58.71 101.94 0.04 OUTLIER Pre-proline 0 CA--C 1.549 0.907 0 CA-C-O 117.544 -1.217 . . . . 1.0 111.778 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -67.74 134.11 24.28 Favored 'Cis proline' 0 N--CA 1.512 2.598 0 CA-C-N 121.028 1.403 . . . . 1.0 111.831 0.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -66.26 -43.53 86.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.761 0.791 . . . . 1.0 109.661 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -130.08 153.21 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 109.377 -0.601 . . . . 1.0 109.377 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.5 p -145.38 136.06 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.604 0.716 . . . . 1.0 111.5 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 37.2 m -81.39 130.36 35.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.282 -0.872 . . . . 1.0 110.441 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 33.5 mt -133.45 124.47 27.12 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.104 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.409 ' CD ' ' N ' ' A' ' 88' ' ' GLN . 18.3 mp0 -93.28 121.43 34.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.687 0.756 . . . . 1.0 110.525 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.0 mt -96.98 162.06 13.56 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.445 -0.798 . . . . 1.0 109.802 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -152.81 151.62 30.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.642 0.734 . . . . 1.0 110.992 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.441 ' O ' ' N ' ' A' ' 93' ' ' HIS . 19.3 p-80 -66.2 139.44 58.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.427 -0.806 . . . . 1.0 110.687 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -65.12 69.52 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.325 0.583 . . . . 1.0 111.165 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.441 ' N ' ' O ' ' A' ' 91' ' ' HIS . 84.7 t60 -67.31 -44.73 78.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.099 0.476 . . . . 1.0 110.402 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -61.97 85.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.123 0.487 . . . . 1.0 110.976 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -76.63 55.84 1.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.055 0.455 . . . . 1.0 109.776 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.936 -1.031 . . . . 1.0 110.838 -179.816 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.7 t . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.675 -0.491 . . . . 1.0 109.675 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.9 p -73.65 157.43 36.61 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.487 -0.56 . . . . 1.0 109.487 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 53.72 88.21 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.397 0.618 . . . . 1.0 110.249 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.4 t -91.35 156.03 18.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.636 0.732 . . . . 1.0 109.572 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.12 136.17 53.4 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.705 0.764 . . . . 1.0 110.54 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.446 ' CG ' ' H ' ' A' ' 7' ' ' ARG . 51.9 t0 178.8 -118.69 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.609 -0.723 . . . . 1.0 109.717 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.446 ' H ' ' CG ' ' A' ' 6' ' ' ASP . 56.5 mmt-85 60.43 -122.56 0.98 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.51 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.478 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 4.9 p-10 44.3 54.35 11.92 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 112.935 0.717 . . . . 1.0 112.935 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.478 ' HD3' ' N ' ' A' ' 8' ' ' ASP . 57.6 Cg_endo -89.8 -178.03 1.54 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.806 2.337 . . . . 1.0 112.801 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 53.9 m -85.51 113.61 21.9 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.647 0.737 . . . . 1.0 110.423 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 74.9 mt -105.85 139.32 40.59 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.673 0.749 . . . . 1.0 110.572 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.472 ' C ' HD12 ' A' ' 13' ' ' LEU . 68.0 m -101.14 124.57 47.04 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.379 0.609 . . . . 1.0 110.428 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.472 HD12 ' C ' ' A' ' 12' ' ' THR . 10.3 mp -108.19 131.15 54.96 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.651 -0.704 . . . . 1.0 109.944 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.6 t -75.83 114.85 14.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.196 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 41.4 tp -69.37 105.99 2.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.246 0.546 . . . . 1.0 110.88 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.7 pt -118.08 142.6 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 121.692 0.758 . . . . 1.0 111.117 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.49 121.5 24.64 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.351 0.596 . . . . 1.0 110.76 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -114.03 50.4 0.93 Allowed 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.404 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 172.81 34.35 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.326 -0.62 . . . . 1.0 109.326 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.0 m -70.17 112.5 12.85 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-O 119.022 -0.513 . . . . 1.0 111.466 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -57.66 145.64 88.62 Favored 'Trans proline' 0 N--CA 1.501 1.948 0 C-N-CA 121.876 1.718 . . . . 1.0 111.832 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.93 150.38 49.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 122.155 0.979 . . . . 1.0 111.388 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 68.06 7.93 6.17 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.129 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.3 p -114.1 152.09 31.61 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.791 0.805 . . . . 1.0 110.521 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 49.0 ttp -141.47 120.27 12.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.704 -0.68 . . . . 1.0 110.082 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 72.2 mt -72.04 117.95 16.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.456 0.645 . . . . 1.0 110.665 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.417 ' SD ' ' OE1' ' A' ' 90' ' ' GLU . 76.4 mtp -83.79 58.64 4.75 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.806 0.812 . . . . 1.0 109.83 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.7 m -165.18 128.29 2.25 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.358 -0.608 . . . . 1.0 109.358 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.515 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 38.2 ttpt -68.2 158.44 33.24 Favored 'General case' 0 CA--C 1.515 -0.393 0 O-C-N 121.229 -0.92 . . . . 1.0 110.682 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.486 HD22 ' N ' ' A' ' 30' ' ' LEU . 4.3 mm? -98.55 96.86 4.12 Favored Pre-proline 0 CA--C 1.557 1.213 0 N-CA-C 112.374 0.509 . . . . 1.0 112.374 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' A' ' 29' ' ' LYS . 39.7 Cg_endo -86.51 152.05 9.02 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.485 2.123 . . . . 1.0 112.635 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.5 p -68.17 177.55 2.22 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.698 -0.626 . . . . 1.0 111.098 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -145.14 154.27 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.557 0.694 . . . . 1.0 111.079 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -104.42 127.0 52.02 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.5 m -131.6 161.75 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 122.169 0.985 . . . . 1.0 111.28 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -125.25 134.03 52.46 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.423 -0.808 . . . . 1.0 110.939 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 30.1 p -141.1 -175.27 4.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.647 0.736 . . . . 1.0 111.211 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -124.37 -138.17 0.29 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.727 -0.67 . . . . 1.0 110.089 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.66 -150.61 38.33 Favored Glycine 0 N--CA 1.458 0.161 0 N-CA-C 110.911 -0.876 . . . . 1.0 110.911 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -144.32 -25.96 0.52 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.252 0.549 . . . . 1.0 111.321 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 61.97 67.43 1.27 Allowed Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.451 -0.341 . . . . 1.0 111.128 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -58.64 -41.12 67.16 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 122.171 1.914 . . . . 1.0 111.92 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 55.4 p -172.07 55.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.614 -0.266 . . . . 1.0 110.533 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.8 mm -90.06 125.52 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.39 0.614 . . . . 1.0 110.062 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.514 ' O ' ' N ' ' A' ' 47' ' ' ASN . 12.0 m120 -75.59 100.89 4.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.459 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.1 m -46.72 -9.54 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.234 0.54 . . . . 1.0 111.817 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 45' ' ' ASN . 33.6 m120 -63.02 -36.14 82.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.228 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -102.98 55.79 0.76 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.001 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.524 ' O ' ' CG ' ' A' ' 50' ' ' PHE . 20.1 mt -152.28 118.97 5.7 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.225 0.536 . . . . 1.0 110.071 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.524 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 59.1 m-85 -161.64 173.91 14.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 122.513 1.149 . . . . 1.0 111.675 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.463 ' C ' ' CG ' ' A' ' 52' ' ' TYR . . . -100.47 170.14 8.6 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 114.219 -1.355 . . . . 1.0 108.728 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.463 ' CG ' ' C ' ' A' ' 51' ' ' ALA . 25.3 m-85 -151.57 163.77 38.33 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 122.221 1.01 . . . . 1.0 111.913 -178.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.1 m -137.19 145.74 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 114.735 -1.12 . . . . 1.0 109.443 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -98.76 81.91 2.72 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.504 0.668 . . . . 1.0 110.643 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.491 ' O ' ' C ' ' A' ' 56' ' ' SER . 70.1 mt -74.71 4.75 5.78 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.577 -0.738 . . . . 1.0 110.197 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.491 ' C ' ' O ' ' A' ' 55' ' ' LEU . 84.2 p 15.02 -113.75 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 115.593 -0.731 . . . . 1.0 112.88 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.41 -143.22 0.01 OUTLIER Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.791 -0.924 . . . . 1.0 110.791 178.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.4 m -151.08 32.25 0.6 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 121.324 -0.15 . . . . 1.0 111.047 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -41.96 101.7 0.25 Allowed Pre-proline 0 CA--C 1.543 0.698 0 CA-C-O 119.625 -0.226 . . . . 1.0 111.394 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -56.02 118.61 5.42 Favored 'Trans proline' 0 N--CA 1.502 2.01 0 C-N-CA 122.607 2.205 . . . . 1.0 112.736 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 149.71 -168.07 29.87 Favored Glycine 0 N--CA 1.465 0.575 0 N-CA-C 110.22 -1.152 . . . . 1.0 110.22 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.514 ' CD ' ' H ' ' A' ' 62' ' ' GLU . 1.2 pm0 -102.62 80.2 1.89 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.375 0.607 . . . . 1.0 109.735 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.438 ' CD2' ' O ' ' A' ' 64' ' ' ASP . 83.7 t60 -90.69 161.37 15.39 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.911 0.862 . . . . 1.0 111.895 -178.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.438 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 69.2 m-20 -88.34 128.1 35.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.126 -0.943 . . . . 1.0 109.432 178.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -122.37 97.7 5.59 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.8 0.81 . . . . 1.0 111.546 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.543 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 39.1 mp0 -59.25 131.72 51.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.969 -1.014 . . . . 1.0 111.463 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.8 t -77.81 128.18 38.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.702 0.763 . . . . 1.0 110.269 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -117.73 137.91 52.38 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.993 0.901 . . . . 1.0 110.346 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.1 t -110.71 129.92 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.038 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -51.14 123.28 19.74 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.45 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.38 88.68 1.13 Allowed 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 122.09 1.86 . . . . 1.0 112.656 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.472 ' H ' HD12 ' A' ' 72' ' ' ILE . 3.3 mp -79.72 128.21 75.26 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 120.935 -0.306 . . . . 1.0 110.735 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.404 ' O ' ' ND2' ' A' ' 74' ' ' ASN . 56.3 Cg_endo -71.33 80.99 1.27 Allowed 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 122.151 1.901 . . . . 1.0 112.782 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.404 ' ND2' ' O ' ' A' ' 73' ' ' PRO . 6.2 m-20 167.78 -52.19 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.844 0.354 . . . . 1.0 110.498 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.3 mm -91.23 136.87 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-O 121.879 0.847 . . . . 1.0 110.201 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -96.41 140.38 31.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 122.288 1.042 . . . . 1.0 111.343 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.8 tt -94.93 135.91 27.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.641 -0.709 . . . . 1.0 110.327 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.7 t -105.47 -52.38 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 O-C-N 122.074 -0.391 . . . . 1.0 110.354 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -148.05 -152.41 0.44 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.998 0.904 . . . . 1.0 110.63 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.417 ' O ' ' O ' ' A' ' 81' ' ' SER . 34.2 mt -144.1 -48.24 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.582 -0.735 . . . . 1.0 109.617 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 80' ' ' ILE . 79.3 p 31.04 96.38 0.04 OUTLIER Pre-proline 0 CA--C 1.557 1.219 0 CA-C-O 118.39 -0.814 . . . . 1.0 112.354 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -68.29 -172.15 6.19 Favored 'Cis proline' 0 N--CA 1.501 1.94 0 CA-C-N 120.2 1.107 . . . . 1.0 111.757 1.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -112.09 -30.93 7.05 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.591 -0.731 . . . . 1.0 109.788 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.3 t -149.04 152.57 11.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.162 -0.681 . . . . 1.0 109.162 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.1 p -143.43 140.56 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.604 0.716 . . . . 1.0 111.664 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 60.4 m -95.76 128.96 43.08 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.281 -0.872 . . . . 1.0 110.789 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.6 mt -116.93 167.17 11.36 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.617 -0.719 . . . . 1.0 110.235 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -118.07 116.7 27.4 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.854 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -105.25 130.26 53.43 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.889 0.852 . . . . 1.0 110.253 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.417 ' OE1' ' SD ' ' A' ' 27' ' ' MET . 39.0 tt0 -134.2 136.64 43.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 122.346 1.07 . . . . 1.0 111.149 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 29.0 p-80 -68.76 116.96 9.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.735 -1.12 . . . . 1.0 110.685 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -91.62 68.43 5.61 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.027 0.441 . . . . 1.0 110.822 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.406 ' CG ' ' O ' ' A' ' 93' ' ' HIS . 14.4 p80 -62.07 99.46 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.426 0.631 . . . . 1.0 110.416 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.516 ' CG ' ' N ' ' A' ' 95' ' ' HIS . 78.3 t60 -164.25 168.07 19.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.607 0.717 . . . . 1.0 110.531 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.516 ' N ' ' CG ' ' A' ' 94' ' ' HIS . 58.6 t-80 -138.38 97.34 3.35 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.835 -0.621 . . . . 1.0 110.066 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 79.1 t60 . . . . . 0 C--O 1.219 -0.549 0 CA-C-O 117.936 -1.031 . . . . 1.0 110.362 -179.888 . . . . . . . . 0 0 . 1 stop_ save_